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Abstract 
Choline oxidase catalyzes the oxidation of choline to glycine betaine. This reaction is of 
considerable medical and biotechnological applications, because the accumulation of glycine 
betaine in the cytoplasm of many plants and human pathogens enables them to counteract 
hyperosmotic environments. In this respect, the study of choline oxidase has potential for the 
development of a therapeutic agent that can specifically inhibit the formation of glycine betaine, 
and therefore render pathogens more susceptible to conventional treatment. The study of choline 
oxidase has also potential for the improvement of the stress resistance of plant by introducing an 
efficient biosynthetic pathway for glycine betaine in genetically engineered economically 
relevant crop plant. In this study, codA gene encoding for choline oxidase was cloned. The 
cloned gene was then used to express and purify the wild-type enzyme as well as to prepare 
selected mutant forms of choline oxidase. In all cases, the resulting enzymes were purified to 
high levels, allowing for detailed characterizations. The biophysical and biochemical analyses of 
choline oxidase variants in which the positively charged residue close to the flavin N(1) locus 
(His466) was removed (H466A) or reversed (H466D) suggest that in choline oxidase, His466 
modulates the electrophilicity of the bound flavin and the polarity of the active site, and 
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contributes to the flavinylation process of the covalently bound FAD as well as to the 
stabilization of the negative charges in the active site.  
Biochemical, structural, and mechanistic relevant properties of selected flavoproteins 
with special attention to flavoprotein oxidases, as well as the biotechnological and medical 
relevance of choline oxidase, are presented in Chapter I. Chapter II summarizes all the 
experimental techniques used in this study. Chapter III-VII illustrate my studies on choline 
oxidase, including cloning, expression, purification and preliminary characterizations (Chapter 
III), spectroscopic and steady state kinetics (Chapter IV), the catalytic roles of His466 and the 
effects of reversing the protein positive charge close to the flavin N(1) locus (Chapter V and VI), 
and the roles of His310 with a special attention to its involvement in a proton-transfer network 
(Chapter VII). Chapter VIII presents a general discussion of the data presented. 
 
INDEX WORDS: Choline Oxidase, Active Site Base, Flavin N(1) Locus, Proton-Transfer 
Network, Chemical Mechanism, Flavoprotein.  
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CHAPTER I 
Introduction 
1.1. Flavoproteins 
Since the discovery and the chemical characterizations of flavins (Figure 1.1) in the 1930s, 
they have been known of being capable of both one- and two-electron transfer processes, and as 
playing a fundamental role in coupling the two-electron oxidation of many organic substrates to 
the one-electron transfers of the respiratory chain (1). The mode of interaction of the 
isoalloxazine nucleus of the flavin with the protein is the key determinant of the type of function 
carried out by a particular enzyme. From a chemical standpoint, the isoalloxazine moiety of the 
flavin is amphipathic, i.e., while the xylene moiety is hydrophobic and can interact with 
hydrophobic parts of the protein, the pyrimidine ring is hydrophilic and electron-deficient, 
enabling the formation of hydrogen bonds and electrostatic interactions with proteins (Figure 
1.2) (2).  
The flavin can exist in three different redox states, the oxidized, semiquinoid, and the fully 
reduced species (Figure 1.3). In addition, the semiquinone can exist in a neutral (blue) or anionic 
(red) form, with a pKa of ~8.5 in solution (3, 4). This pKa can be significantly changed upon the 
binding of the flavin to a specific protein, i.e., while some enzymes can stabilize the neutral 
radical form over the whole pH range at which the enzyme is stable (pKa >> 8.5), others stabilize 
the red anionic semiquinone species (pKa << 8.5). In some enzymes, among which glucose 
oxidase was the first example (5), the pKa is in the detectable pH range, allowing the spectral 
characterizations of these two species (Figure 1.4).  
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At neutral pH, the pyrimidine moiety of the isoalloxazine nucleus is electron rich molecule 
in the reduced state with a negative charge at the N(1)-C(2)=O locus (anionic hydroquinone). A 
pKa value of ~6.5 was determined for the ionization of the N(1) locus of the reduced flavin (2). A 
powerful tool to probe the active center of many flavin enzymes before their crystal structures 
become available is the replacement of the native flavin by suitably modified flavins (6). Many 
flavoprotein enzymes, in which flavin cofactor is not covalently attached, can accept a 
chemically modified flavin ring structure into their active site (7). A large number of chemically 
modified flavins with different substituents at various positions around the isoalloxazine nucleus 
have become available (Figure 1.5). The use of chemically modified flavin substituents has 
proved to be of great value, since they can be used to probe the flavin environment at a specific 
position. In this regard, studies on the interactions of the flavin with the enzyme active site were 
initiated by the use of naturally occurring 6-OH and 8-OH flavin chromophores (8, 9). 
Edmondson et al., were first to probe the importance of the N(5) position in flavin coenzymes 
through the use of 5-deaza-FMN (10). 
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Figure 1.1. Structures of riboflavin, FMN, and FAD. 
Riboflavin, X = H; FMN, X = PO32-; FAD, X = ADP. 
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Figure 1.2. Representation of possible flavin-protein interactions. 
Modified from ref. (2).  
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Figure 1.3. Redox and ionization states of flavins. 
Modified from ref. (2). 
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Figure 1.4. Spectra of glucose oxidase in the oxidized, semiquinone (anionic or neutral), and 
fully reduced states. 
Taken without permission from ref. (5). 
 
Figure 1.5. Artificial flavins that have been used as flavin replacements in flavoproteins. 
Taken without permission from ref. (1). 
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Our understanding of the versatile chemistry of flavins and the mechanisms of action of 
flavoprotein enzymes has progressed significantly in the last 20 years, especially since the X-ray 
crystallographic structures of many flavoprotein enzymes have become available. Flavoenzymes 
can be grouped into relatively small number of classes, where members within the same class 
share several common properties, including the type of reactions that they catalyze, the nature of 
the auxiliary redox centers, and their ability to use molecular oxygen as electron acceptor (11). 
Simple flavoproteins have been classified on the basis of the reactivity of the reduced enzyme 
with molecular oxygen. This classification, as well as the common properties of each class, have 
been reviewed previously by Massey and Hemmerich (6), but for convenience they will be 
summarized here. 
Flavoprotein Monooxygenases. In flavoprotein monooxygenases, such as p-
hydroxybenzoate hydroxylase (PHBH) and bacterial luciferase, the reduced enzyme reacts with 
molecular oxygen with the formation of an observable C(4a)-hydroperoxide intermediate (11). In 
this class of enzymes, the physiological reductant for the reaction is either NADH or NADPH 
(11). The flavin hydroperoxide intermediate then transfers an oxygen atom to the substrate with 
the formation of a C(4a)-hydroxyflavin, which returns to its oxidized state upon dehydration. 
However, in the absence of the organic substrate, the flavin hydroperoxide can convert slowly to 
H2O2 and oxidized flavin (11). 
Electron Transferases. The flavoprotein electron transferases, such as flavodoxin, 
NADPH-cytochrome P-450 reductase, and ferrodoxin-NADP+ reductase, react slowly with 
oxygen with the production of flavin semiquinone and O2-. Enzymes from this class are 
physiologically involved in single-electron transfer reactions. In addition, they all 
thermodynamically stabilize the blue neutral form of the flavin semiquinone species (11). The 
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use of chemically reactive flavins, such as 8-Cl-, 8-SCN-, or 8-SH, showed that the benzene ring 
of the flavin is the only solvent accessible part of the cofactor in that class of enzymes (2). The 
X-ray crystallographic data of flavodoxin and ferrodoxin-NADP+ reductase have strengthened 
that conclusion (12). In contrast to oxidases, enzymes from this group cannot stabilize either a 
flavin-N(5)-sulfite adduct or the benzoquinoid forms of 6- and 8-sustituted flavins (2).      
Flavoprotein Oxidases. In flavoprotein oxidases such as choline oxidase, glucose 
oxidase, cholesterol oxidase, pyranose 2-oxidase, glycolate oxidase, sarcosine oxidase, 
monoamine oxidase, and D-amino acid oxidase, to cite a few examples, the reduced enzyme 
reacts rapidly with molecular oxygen with the production of H2O2 and the oxidized flavin, 
without the formation of any observable flavin intermediate (13). 
  Flavoprotein oxidases have been found to share many common properties (Table 1.1) 
including: 1) they all stabilize a flavin N(5)-sulfite adduct (14-22); 2) they all stabilize the red 
anionic semiquinone flavin radical on the one-electron reduction (16, 17, 22-25); and 3) they all 
stabilize the benzoquinoid anion forms of 6- and 8-substituted hydroxy- and mercaptoflavins (2, 
9, 14, 18, 26, 27). In all the studied to date cases, the negative charge of the anionic flavin is 
localized at the N(1)-C(2)=O region of the isoalloxazine moiety (Figure 1.1) (2). These 
conclusions have led to the further interpretation that a positively charged locus of the protein 
electrostatically interacts with the pyrimidine ring of the flavin to stabilize the negative charge at 
the N(1)-C(2)=O locus of the anionic one- or two-electron reduced flavin (6, 14, 18-20). The 
mechanistic implications for a protein positive charge stabilizing a negative charge on the N(1) 
locus of the flavin are: to render flavin reduction thermodynamically favorable by elevating the 
midpoint reduction-oxidation potential of the bound flavin (18, 20, 26-29); to preferentially 
stabilize the anionic form of the reduced flavin that readily reacts with molecular oxygen (18, 20, 
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28, 29); and to facilitate the flavinylation process for those enzymes in which the flavin is 
covalently linked to the protein moiety (30). In the last few years, the X-ray crystal structures of 
many flavoprotein oxidases have been solved, clearly establishing that a positively charged 
amino acid residue or a dipole of an α-helix is commonly oriented toward the N(1)-C(2)=O locus 
of the enzyme-bound  flavin (31-40). 
1.1.1. The Reactivity of Flavoproteins with Sulfite  
One of the most notable features of flavoproteins is that while the free reduced flavin 
undergoes reaction readily with molecular oxygen, this property is retained only by some 
flavoproteins including, flavoprotein oxidases and flavoproteins monooxygenases. Until the 
discovery of the reactivity of sulfite with flavoproteins, no correlations have been found between 
oxygen reactivity and different properties of flavoenzymes, such as spectral properties, 
fluorescence, or nature of the flavin prosthetic group (FMN or FAD). The ability of sulfite ions 
to react with flavoproteins and to form a reversible flavin-N(5)-sulfite adduct has been examined 
in a large number of flavoenzymes (Figure 1.6) (19). This reaction was found to occur with a 
number of flavoprotein oxidases such as glucose oxidase (Kd = 0.72 mM) (41), lactate oxidase 
(Kd = 28 nM) (14), glycolate oxidase (Kd = 0.27 µM) (42), D- and L-amino acid oxidase (Kd = 
3.4 mM) (19, 43), cholesterol oxidase (Kd ~ 0.14 and 24 mM for Brevibacterium sterolicum and 
Streptomyces hygroscopicus cholesterol oxidase, respectively) (16), monomeric sarcosine 
oxidase (Kd not determined due to the extremely slow complex formation) (22), and choline 
oxidase (Kd = 50 µM) [this study; (44)]. In all cases, it was found that the formation of the flavin-
sulfite adduct is dependent on sulfite concentration, temperature, and pH, but it is not affected by 
oxygen or light (21).  
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Spectrophotometrically, the flavin-N(5)-sulfite adduct is characterized by a bleaching of 
the UV-visible absorbance spectrum of the enzyme-bound flavin, and the subsequent appearance 
of a new absorption band at ~320-330 nm, with a spectrum similar, but not identical, to the 
anionic reduced flavoprotein (Figure 1.7 and Figure 4.6; Chapter IV) (19, 44). It was also found 
that the formation of the reversible flavin-N(5)-sulfite adduct is a characteristic feature of those 
flavoenzymes that react readily with molecular oxygen as an electron acceptor (1, 2, 19, 21). In 
contrast, no sulfite reaction was observed with flavoprotein dehydrogenases (19, 21). Therefore, 
the formation of covalent N(5)-flavin adduct with sulfite has become a common feature that 
distinguishes flavoprotein  oxidases from dehydrogenases (6, 19, 21). The oxidized flavin is 
electron deficient, and sulfite is a powerful nucleophiles; thereby flavin in its oxidized state can 
react with either SO32- or HSO3- (21). In addition, elemental analysis as well as the hydrolysis of 
the crystalline flavin-sulfite complex showed that one SO32- was bound per flavin (21).  
A linear correlation between the dissociation constant of the flavin-N(5)-sulfite adduct 
and the oxidation reduction potentials of the bound flavin has been proposed (21). Recently, a 
linear relationship was shown between the rate constants of flavin-N(5)-sulfite adduct formation 
(kon) and the midpoint redox potentials of enzyme bound flavins of the reconstituted lactate 
oxidase with different FMN analogs bearing various substitutions at the flavin 6- and 8-positions 
(45). In this study, the kon values for sulfite formation showed a pattern similar to those of the kred 
values for lactate, with increasing values as the redox potential was raised, until a breakpoint was 
reached at ~-120 mV, beyond which these values remain unchanged (45). The koff values of 
sulfite, however, showed a consistent decrease with increasing the redox potentials of the 
enzyme-bound flavin with no obvious breakpoint (45). Interestingly, it was also proposed in this 
study that the linear relationship between the rate constants of flavin reductions and flavin-N(5)-
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sulfite adduct formation and the flavin redox potential below the observed breakpoint indicated 
the development of significant negative charge in the transition states of the reactions (45). 
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Figure 1.6. Mode of reaction of sulfite with oxidized flavin. 
P+, protein positively charged amino acid residue or α-helix dipole. 
 
 
 
Figure 1.7. Effect of sulfite on lactate oxidase. 
Curve 1, untreated enzyme (24 µM with respect to FMN content) in 100 mM sodium phosphate, 
pH 7, at 25 °C. Curves 2 to 5, after adding sodium sulfite to concentrations of 6.18 µM, 12.3 µM, 
24.4 µM, and 216 µM, respectively. Taken without permission from ref. (19). 
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1.1.2. Stabilization of Anionic Semiquinone by Flavoprotein Oxidases  
The flavosemiquinone forms of all the simple flavoproteins studied, i.e., flavoprotein 
oxidases, flavoprotein monooxygenases, and electron transferases, were either the anionic (red) 
or neutral (blue) semiquinone forms, each of which has very different and distinctive absorption 
spectra (Figure 1.4) (5). This conclusion has been supported by the use of model flavins to 
provide further evidence for the preferred tautomeric structures of the flavin radicals (Figure 1.3) 
(4, 46). In addition, it can be concluded, with few exceptions, that while the flavoprotein 
oxidases and hydroxylases stabilize the anionic form of the semiquinone upon the one-electron 
reduction of the enzymes, the flavoprotein dehydrogenases stabilize the neutral form of the 
semiquinone (Table 1.1) (1, 2, 19). With the exception of glucose oxidase, which showed an 
ionization with a pKa value of ~7.5 (Figure 1.4) (5), most of the flavoproteins studied did not 
show such ionization; instead, they either stabilize the anionic or the neutral radical species over 
the whole pH range at which the enzyme is stable. Therefore, it has been concluded that the 
particular protein to which the flavin is attached stabilizes either the anionic or the neutral 
semiquinone (19). Furthermore, it has been proposed that either a positively charged amino acid 
residue or a dipole of an α-helix close to the flavin N(1) position is responsible for the 
thermodynamic stabilization of the anionic flavin semiquinone through an electrostatic 
interaction with the negative charge that develops at the N(1)-C(2)=O of flavosemiquinone 
species (16, 23, 24). A positively charged residue could also be responsible for the formation of 
flavin-N(5)-sulfite adduct by facilitating the nucleophilic  attack of sulfite to the N(5) locus of 
the oxidized flavin.    
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Table 1.1. Some Characteristic Properties of Selected Flavoproteins 
Flavoenzyme Cofactor Radical 
N(5)-sulfite 
adduct 
8-Mercapto- 
flavin 
6-Mercapto- 
flavin 
8-Hydroxy- 
flavin 
6-Hydroxy-
flavin 
Choline oxidasea FAD Red Yes nd nd nd nd 
Glucose oxidaseb FAD Red/Blue 
pK 7.3 
Yes Resolved 
benzoquinoid 
nd nd Anion 
pK < 5.6 
Cholesterol oxidasec FAD Red Yes Resolved 
benzoquinoid 
nd nd nd 
Glycolate Oxidased FMN Red Yes Resolved 
benzoquinoid 
nd nd nd 
Lactate oxidasee FMN Red Yes Resolved 
benzoquinoid 
Anion 
pK < 5 
Anion 
pK < 4 
Anion 
pK < 5 
D-Amino acid oxidasef FAD Red Yes Resolved 
benzoquinoid 
Anion 
pK < 5 
 Anion 
pK < 5 
Sarcosine oxidaseg FAD Red Yes nd nd nd nd 
Pyranose 2-oxidaseh FAD       
Polyamine oxidasei FAD       
Vanillyl-alcohol oxidasej FAD       
p-Hydroxy-benzoate hydroxylasek FAD Red/Blue No Thiolate    
pK < 6.9 
Ferrodoxin-NADP+ reductasel FAD Blue No Undefined 
benzoquinoid 
  Neutral 
pK ≥ 10 
Glutathione reductasem FAD Red No Undefined 
benzoquinoid 
Anion 
pK < 4.5 
 Binds 
poorly 
pK ~7.2 
Flavodoxinn FMN Blue No Undefined 
benzoquinoid 
Neutral 
pK 6.4 
Neutral 
pK 6.1 
Neutral 
pK ~9 
Trimethylamine dehydrogenaseo FMN       
Dihydroorotate dehydrogenasep FMN       
Flavocytochrome b2q FMN       
Old yellow enzymer FMN Red No Smooth 
benzoquinoid 
Anion Neutral 
pK 6.2 
Anion 
pK  5.7 
a, (25, 44, 47-49); b, (5, 18, 19, 50-52); c, (16); d, (2, 19, 42); e, (5, 18, 50-52); f, (5, 18, 50-52); g, (22); h, (31); I, (53); j, (54, 55); k, (18, 50-
52); l, (5, 56); m, (57); n, (5, 18, 50-52); o, (30); p, (58, 59); q, (60, 61); r, (5, 18, 50-52); nd, not determined. 
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1.1.3. Stabilization of the Benzoquinoid Anionic Form of 6- and 8-Substituted Hydroxy- 
and Mercaptoflavins by Flavoprotein Oxidases 
The use of modified flavin chromophores at the active sites of many flavoenzymes is a 
powerful tool to probe the protein microenvironment of the bound flavins (2). The presence of a 
positively charged amino acid or a dipole of an α-helix at the active site of many flavoprotein 
oxidases was proposed long before the crystal structures of enzymes became available (6, 14, 18-
20). This proposal was mainly based on the use of modified flavin chromophores that can exist 
in different tautomeric and/or mesomeric forms, such as 6- and 8- hydroxy and mercaptoflavins. 
As an example, 8-Mercaptoflavin has significant spectral differences between the neutral and the 
anionic species, as well as between the corresponding benzenoid and paraquinoid forms (Figure 
1.8) (2). The spectral properties of these chromophores were confirmed by binding to 
flavoproteins with known crystal structure, such as flavodoxin, glutathione reductase, p-
hydroxybenzoate hydroxylase, glucose oxidase, and riboflavin-binding protein (62-65). For both 
glutathione reductase and p-hydroxybenzoate hydroxylase, in which a positive charge from the 
α-helix dipole is oriented toward the N(1)-C(2)=O locus of the bound flavin (63-65), the 
expected spectrum of the anionic paraquinoid species of 8-mercaptoflavin (species D, Figure 1.8) 
was obtained. Similarly, for flavodoxin, in which the flavin C(8) locus is solvent accessible (66), 
the expected spectrum of the anionic paraquinoid species of 8-mercaptoflavin (species C, Figure 
1.8) was also obtained. The most significant effects of binding of 8-mercaptoflavin to the 
proteins were observed with both glucose oxidase  (Figure 1.9) and riboflavin-binding protein. 
While in glucose oxidase the anionic paraquinoid resonance (species D, Figure 1.8) was 
stabilized, a typical spectrum corresponding to the neutral benzenoid form (species A, Figure 
1.8) was obtained upon the binding of 8-mercaptoflavin to riboflavin-binding protein, consistent 
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with the preference of this protein to bind neutral flavin (67). The anionic paraquinoid form of 8-
mercaptoflavin was also observed upon the binding of 8-mercaptoflavin to other flavoprotein 
oxidases, such as D-amino acid oxidase, lactate oxidase, and old yellow enzyme (18).  
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Figure 1.8. Tautomeric and mesomeric forms of 8-mercaptoflavin. 
A, neutral benzenoid species; B, neutral paraquinoid species; C, anionic benzenoid species (8-
thiolate); D, anionic paraquinoid species. Modified from ref. (2). 
 
  
Figure 1.9. Spectral changes upon binding of 8-mercapto-FAD to the apoprotein of glucose 
oxidase. 
Solid curve, 8-mercapto-FAD; broken curve, bound to apo-glucose oxidase. Taken without 
permission from ref. (18). 
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Overall, by the use of 8-mercaptoflavin as a probe of the flavin microenvironment in 
many flavoproteins, three conclusions have been drawn. 1) The 8-thiolate (anionic) form of 8-
mercaptoflavin (species C, Figure 1.8) is stabilized by flavoproteins that catalyze one-electron 
transfer reactions, such as flavodoxin and NADPH-cytochrome P-450 reductase (2, 6, 18). These 
proteins also stabilize the neutral (blue) semiquinone species upon reduction. 2) The anionic 
paraquinoid form of 8-mercaptoflavin (species D, Figure 1.8) is stabilized by flavoproteins of the 
oxidase/dehydrogenase class, such as glucose oxidase, lactate oxidase, D-amino acid oxidase, 
and old yellow enzyme (2, 6, 18). These proteins also stabilize the red anionic form of 
semiquinone and the flavin-N(5)-sulfite adduct as well. 3) Other flavoproteins do not conform to 
the classification above, showing properties of both classes, such as flavoprotein 
transhydrogenases and hydroxylases  (Table 1.1) (18).  
The effect of binding of 8-hydroxyflavins on flavoproteins could be explained by 
following the same principles and structures used with 8-mercaptoflavin. However, the spectral 
changes attributed to the ionized paraquinoid species of 6-hydroxyflavin are consistent with the 
charge being localized in the pyrimidine ring (8). This could be attributed to the difference 
between oxygen and sulfur in electronegativity and in undergoing π-interactions (2).  
The effects of binding of 6-hydroxy- and 6-mercaptoflavin to flavoproteins could be also 
described by the same structures and reasoning used for 8-substituted analogs. In solution, while 
the neutral species is protonated at C(6) locus, the anionic form exhibits a longer (red shifted) 
wavelength absorbance spectrum, consistent with N(1)-blocked 6-hydroxyflavins (Figure 1.10) 
(9, 67, 68). Therefore, it has been suggested that the anionic paraquinoid species of 6-
hydroxyflavin can provide significant information about the charge distribution around the 
bound flavin (2).  
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The microenvironment of the bound flavin could be also probed by monitoring the shifts 
in pKa values of these oxidized flavin analogs upon binding to apoproteins (the pKa values of 8-
SH, 8-OH, 6-SH, and 6-OH flavin analogs are 3.8, 4.8, 5.9, and 7.1, respectively) (2). 
N
N
N
N
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R
XH
N
N
N
N
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O
H
R
X
- H+
X = O or S  
Figure 1.10. Structures of the neutral and the anionic form of 6-hydroxy- and 6-mercaptoflavins. 
Modified from ref. (2). 
 
In conclusion, from the use of 6- and 8-sustituted flavin analogs, along with the 
stabilization of the anionic flavin semiquinone radical or hydroquinone, and the flavin-N(5)-
sulfite adduct as different probes for the flavin microenvironment of many flavoprotein before 
their X-ray crystal structures become available, it has been proposed that a flavoprotein with a 
positive charge (amino acid residue or α-helix dipole) in the vicinity of the flavin N(1) locus 
should: 1) stabilize the anionic semiquinone as well as the hydroquinone species of flavin; 2) 
stabilize a reversible flavin-N(5)-sulfite adduct; 3) stabilize the benzoquinoid anion form of 8-
mercaptoflavin; 4) lower the pKa of the 6- and 8-substituted flavin analogs. Most interestingly, it 
was also proposed that protein-flavin interaction would enhance the uptake of the redox 
equivalents through position N(5) during catalysis, thereby a contribution on the redox potential 
of the enzyme-bound flavin should be also observed as well (18, 20, 26, 27, 69). 
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1.1.4. Positive Charge in Proximity of N(1)-C(2)=O and Flavinylation 
Singer and his coworkers firstly established the covalent attachment of flavins to proteins 
in 1955 in their study of mammalian succinate dehydrogenase enzyme (70-72). Subsequently, 
many flavoproteins have been identified as covalently attached to the flavin cofactors (FAD or 
FMN). In all the flavoproteins studied, the mode of covalent attachment of the flavin cofactor to 
the polypeptide chain of the host protein was found to be one of five modes (Figure 1.11), which 
are summarized for convenience in Table 1.2. These observations raised the question of the 
correlation between the covalent attachment of the flavin cofactor and the mechanism of the 
resulting enzyme. Williamson and Edmondson, by studying the effects of pH on the oxidation-
reduction potentials of 8α-N-imidazolylflavins showed that as the pH increases, the redox 
potential decreases (73). This result strongly suggests that the modulation of the flavin 
microenvironment through the histidyl group pKa of the 8α-N-imidazolylflavins could influence 
the oxidation-reduction potential of the flavin (73). In addition, Edmondson and de Francesco, by 
studying modified aminoacyl flavins, have proposed a correlation between the covalent 
attachment of the flavins and their redox properties (74). The results obtained in their studies 
showed that the oxidation-reduction potentials of aminoacyl flavins were ~50-60 mV more 
positive compared to the unmodified flavins. Furthermore, a number of recent studies of flavin-
dependent enzymes containing covalently bound flavins, namely cholesterol oxidase (75), 
vanillyl-alcohol oxidase (54), and p-cresol methylhydroxylase (76), showed that, irrespective of 
the type of flavin linkage and protein, the removal of the covalent linkage between the flavin and 
the enzyme results in a decrease of the E΄m, 7 value for the bound  flavin of ~100 mV. Therefore, 
a clear correlation between the covalent attachment of the flavin cofactor and the protein and the 
oxidation-reduction potentials of the formed enzymes could be made. 
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Figure 1.11. Mode of covalent attachment of flavin to the protein in flavoproteins. 
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Table 1.2. Examples of Flavoproteins Containing Covalently Linked Flavin Redox Centersa  
Mode of Attachment Enzyme References 
Dimethylamine dehydrogenase (77) 
6-S-Cysteinyl FMN 
Trimethylamine dehydrogenase (30) 
Cholesterol oxidase (75, 78) 
Thiamin dehydrogenase (79, 80) 8-α-N1-Histidyl FAD 
L-Galactonolactone oxidase (81) 
Choline oxidase (82) 
Pyranose 2-oxidase (31) 
Fumarate reductase (83) 
Sarcosine dehydrogenase (84) 
Succinate dehydrogenase (85) 
Vanillyl-alcohol oxidase (54, 55) 
6-Hydroxy-D-nicotine oxidase (86) 
8-α-N3-Histidyl FAD 
D-Gluconolactone oxidase (87) 
8-α-O-Tyrosyl-FAD p-Cresol methylhydroxylase (88) 
Monoamine oxidase A (89, 90) 
Monoamine oxidase B (89, 90) 8-α-S-Cysteinyl FAD 
Monomeric sarcosine oxidase (91) 
a Modified from ref. (92). 
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The mechanism of covalent flavinylation has been proposed and reviewed in several 
flavoproteins, among which p-cresol methylhydroxylase (8-α-O-Tyrosyl-FAD) (88), 6-hydroxy-
D-nicotine oxidase (8-α-N3-Histidyl FAD) (86), monomeric sarcosine oxidase (8-α-S-Cysteinyl 
FAD) (91), trimethylamine dehydrogenase (6-S-Cysteinyl FMN) (30), and N-methyltryptophan 
oxidase (8-α-S-Cysteinyl FAD) (93). In all these cases, it was suggested that a positively 
charged amino acid residue in proximity to the N(1)-C(2)=O region of the bound flavin is 
important to stabilize the negative charge that develops at the N1/C2 region during the 
flavinylation reaction and is therefore suggested to facilitate flavinylation of the enzyme (30, 86, 
88, 91, 92). For p-cresol methylhydroxylase, Arg447 was found to be located at a distance of ~3 
Å from the N1/C2 locus of the bound flavin (88). This residue was proposed to facilitate the 
flavinylation process by stabilizing the negative charge that develops at the N(1)-C(2)=O locus 
of the iminoquinone methide flavin intermediate during the flavinylation process (88). Similarly, 
Arg67, which is located in the vicinity of the N(1)-C(2)=O locus of the bound flavin of 6-
hydroxy-D-nicotine oxidase, was identified as being critical for the flavinylation process (94). 
Mutagenesis studies of that residue have demonstrated the requirement of a positive charge at 
this position (N1/C2) to facilitate the flavinylation process (94). Furthermore, Mewies et al., in 
their studies of the differentially charged mutants at position 222 of trimethylamine 
dehydrogenase, concluded that the positively charged guanidino group of Arg222 stabilizes the 
negative charge as it develops at the N1 position of FMN during flavinylation of the enzyme 
(Figure 1.12) (30). When Arg222 was substituted with Lys (R222K) a significant decrease in the 
amount of the active flavinylated enzyme was observed. However, the removal or reversal of that 
positive charge, as in case of R222V and R222E, resulted in the production of completely 
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inactive enzymes that were totally devoid of FMN, consistent with a critical role of such 
positively charged residue at this position (30). 
 
 
 
 
Figure 1.12. Flavinylation mechanism of trimethylamine dehydrogenase. 
ImH+, the protonated imidazole side-chain of residue His29 that is thought to assist in the 
nucleophilic attack of Cys30 at the C6 atom of flavin by formation of an imidazolium/thiolate 
ion-pair. The role of Arg-222 in stabilizing negative charge as it develops at the N1/O2 positions 
of the flavin is shown. Re-oxidation of the reduced flavin is by internal electron transfer to the 
4Fe-4S center. Taken without permission from ref. (30).  
 
A self-catalytic flavinylation mechanism was also proposed for monomeric sarcosine 
oxidase (8-α-S-Cysteinyl FAD) through the FAD interactions with the positive side chains and 
the helix dipole (95). The X-ray crystal structure of monomeric sarcosine oxidase showed that 
FAD is covalently attached to Cys315 (22, 91). In addition, the crystal structure also showed that 
the bound FAD is located in a highly basic environment that contains seven basic residues. 
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Lys348 was found to be located at a distance of ~2.8 Å from the N(1) locus of the bound FAD 
and hydrogen bonded to C(2)=O of the flavin ring (22, 91). Similarly, the positive charge of the 
α-helix dipole (αF4) was also found to be pointed to the same C(2)=O locus of the bound flavin 
(22, 91). Therefore it was proposed that the negative charge that develops on the N(1)-C(2)=O 
region of the isoalloxazine ring during the process of covalent flavinylation of monomeric 
sarcosine oxidase is stabilized by the positive charge of Lys348 together with the positive charge 
of the α-helix dipole and that this stabilization facilitates the flavinylation process (95). 
Recently, it was observed that the addition of a small excess of sodium borohydride to 
either monomeric sarcosine oxidase or its homologue, N-methyltryptophan oxidase, followed by 
the binding of substrate and reaction with oxygen, resulted in a tautomeric rearrangement 
reaction of 3,4-dihydroflavin to 1,5-dihydroflavin (Figure 1.13) (93). Intermediate I (Figure 1.13) 
in the proposed tautomerization mechanism of 1,3-dihydroflavin was found to be similar to the 
quininoid flavin intermediate produced in the flavinylation process of monomeric sarcosine 
oxidase (95). Therefore, this tautomerization reaction provided insight for a similar flavin 
tautomerization reaction that has been proposed as a key step during the covalent flavinylation 
process of these enzymes. 
A B
 
Figure 1.13. Mechanism of flavinylation of monomeric sarcosine oxidase and N-
methyltryptophan oxidase. 
A, mechanism of tautomerizaton of 3,4-dihydroflavin to an air senstive 1,5-dihydroflavin; B, the 
mechanism proposed for the covalent attachment of flavin to MSOX or MTOX. Taken without 
permission from ref. (93). 
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 1.2. GMC Oxidoreductase Enzyme Superfamily 
The Glucose-Methanol-Choline (GMC) oxidoreductase enzyme superfamily is composed 
of a group of flavoenzymes that are able to catalyze the conversion of alcohols to the 
corresponding aldehydes or ketones (Scheme 1.1) (96). This family includes glucose oxidase 
(34, 39, 62), cholesterol oxidase (16, 38, 97, 98), cellobiose dehydrogenase (32, 99), pyranose 2-
oxidase (31, 33, 100), methanol oxidase (101), choline dehydrogenase (96, 102, 103) (see 
detailed description in Section 1.5), and choline oxidase (25, 47, 48) (see detailed description in 
Section 1.4). The X-ray crystal structures of glucose oxidase (39, 62), cholesterol oxidase (97), 
cellobiose dehydrogenase (32), pyranose 2-oxidase (31, 33), and choline oxidase1, showed a p-
hydroxybenzoate hydroxylase (PHBH) – like fold in the monomeric structures of these enzymes 
(Figure 1.14). In addition, the overall structures of these enzymes showed that with the exception 
of pyranose 2-oxidase, which has a tetrameric structure, they all share dimeric structures, and the 
polypeptide chain of each monomer folds into two domains, a highly conserved FAD binding 
domain and a substrate binding domain. Although GMC enzymes exhibit little sequence 
similarity in their substrate binding domains, the crystal structures of choline oxidase, glucose 
oxidase, cholesterol oxidase, cellobiose dehydrogenase, and pyranose 2-oxidase show that they 
all share highly conserved catalytic sites, suggesting a similar activation mechanism for the 
oxidation of their substrates (Figure 1.15) (31-33, 39, 62, 97). Although the X-ray crystal 
structure of methanol oxidase has not been solved, an unambiguous mechanism has been 
proposed for that enzyme, which will be discussed in this chapter (see 1.2.5). However, the 
mechanism of other GMC oxidoreductase enzymes with known structures is still ambiguous 
                                                 
1 Recently, the X-ray crystal structure of choline oxidase has been resolved at 1.86 Å resolution (Lountos, G. T., 
Fan, F., Gadda, G., and Orville, A. M; unpublished data; see Section 1.4.1. for detailed description). 
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because of the masking of their catalytic steps (reductive or oxidative process) by other rate 
limiting steps in their reaction mechanisms (104-106).  
 
A
C
B
E
D
 
 
Figure 1.14. The three-dimensional structures of members of the GMC oxidoreductase enzyme 
superfamily.  
A, glucose oxidase from Aspergillus niger (PBD code 1CF3); B, cholesterol oxidase from 
Streptococcus (PBD code 1COY); C, pyranose 2-oxidase from Trametes ochracea (PBD code 
1TT0); D, cellobiose dehydrogenase from Phanerochaete chrysosporium (PDB code 1NAA); E, 
choline oxidase from Arthrobacter globiformis (Lountos, G. T., Fan, F., Gadda, G., and Orville, 
A. M; unpublished data). 
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Scheme 1.1. Reactions catalyzed by GMC oxidoreductases. 
A, Glucose oxidase; B, cholesterol oxidase; C, cellobiose dehydrogenase; D, pyranose-2 oxidase; 
E, methanol oxidase (alcohol oxidase). 
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Figure 1.15. The active site residues of GMC oxidoreductase enzyme superfamily.  
A, Glucose oxidase from Aspergillus niger (PBD code 1CF3); B, cholesterol oxidase from 
Brevibacterium sterolicum (PBD code 1COY); C, pyranose 2-oxidase from Trametes ochracea 
(PBD code 1TT0); D, cellobiose dehydrogenase from Phanerochaete chrysosporium (PDB code 
1NAA); E, choline oxidase from Arthrobacter globiformis (Lountos, G. T., Fan, F., Gadda, G., 
and Orville, A. M; unpublished data). 
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1.2.1. Glucose Oxidase  
Glucose oxidase (E.C. 1.1.3.4) is an FAD-dependent enzyme that catalyzes the oxidation 
of β-D-glucose to δ-gluconolactone (Scheme 1.2) (62). Glucose oxidase is used in commercial 
applications, such as the production of gluconic acid (a food preservative), and as an important 
biosensor for the quantitative determination of glucose in bodily fluid, foodstuffs, beverages and 
fermentation liquors (62, 107). The active form of the enzyme has been identified and purified 
from several molds. The most common fungal sources of glucose oxidase are Penicillium 
amagasakiense and Aspergillus niger (108-110). In addition, the enzyme has been recently 
purified from Phanerochaete chrysosporium and Talaromyces flavus fungi as well (62). Glucose 
oxidases from Penicillium amagasakiense and from Aspergillus niger showed high degrees of 
identity (66%) and similarity (79%) (111) and comparable kinetic parameters (112).  
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Scheme 1.2. The enzymatic reaction catalyzed by glucose oxidase. 
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Glucose oxidase is a homodimer with molecular mass ranging from 150 to 180 kDa, 
depending on the degree of glycosylation. Each monomer contains one tightly attached but not 
covalently bound FAD (109). The X-ray structural data of glucose oxidase revealed that the 
monomeric molecule has a compact spheroid structure with PHBH fold (Figure 1.14) (62). The 
prosthetic group of the enzyme, FAD, was found to be located near the dimer interface, but 
without actual interaction with this interface (62). His516, His559, and Glu412 were identified as 
highly conserved residues in the active site of glucose oxidase with respect to other GMC 
enzymes (Figure 1.15) (62). His516, which is fully conserved among the seven GMC enzymes, 
was proposed as the catalytic base that abstracts the proton from the substrate hydroxyl group 
and initiates the reductive half-reaction in which the substrate glucose is oxidized to 
gluconolactone with the subsequent reduction of the bound FAD (39, 62, 104, 111). The results 
obtained from both the pH profiles and the kinetic isotope effects of the mutant enzyme (H516A) 
with respect to wild-type enzyme suggested that the protonated form of this highly conserved 
active site histidine residue functions also as a general acid during the oxidative half-reaction 
(111, 113). NMR studies on the anaerobically reduced species of glucose oxidase at pH 5.6 
indicated the presence of a negative charge at the N(1)-C(2)=O locus of the bound flavin, which 
is stabilized by a positively charged residue (114). The crystal structure of the enzyme showed 
that His516Nε2 is located at a distance of ~3.8 Å from the N(1) locus of the flavin and therefore 
could stabilize in its protonated state the negative charge developing on the N(1)-C(2)=O locus 
of the flavin (62).  
The other active site histidine residue, His559, was found to be hydrogen bonded with 
Glu412 and a water molecule (W110) (62). The studies that preceded the elucidation of the X-
ray crystal structure of glucose oxidase suggested that the carboxylate group of glutamate at 
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position 412 of glucose oxidase plays a major role in substrate binding and specificity (104). The 
modeled enzyme-substrate complex structure of glucose oxidase revealed that substrate binding 
to the enzyme was banned upon protonation of Glu412, which in turn disrupted the hydrogen 
bond with His559 and resulted in reorganization of the active site (39). It was also found that the 
binding of β-D-glucose to the active site was stabilized by hydrophobic contacts to Phe414, 
Trp426, as well as to Tyr68 and FAD. In addition to these important hydrophobic interactions, 
hydrogen bonds were also observed between glucose and several residues in the active site such 
as, Tyr68, Asn514, Arg512, His516, His559, and Thr/Ser110 (39). The disruptions of these 
hydrogen bonds via mutagenesis or by the use of substrate analogs resulted in significant 
decrease in the binding affinity and specificity of the substrate to the active site of the enzyme 
(39). Arg512 and Asn514 were also found to be involved in substrate binding. This study also 
showed that there is a direct interaction between the substrate and His516 (39), which differs 
from the water-mediated interaction between substrate and enzyme in cholesterol oxidase (97, 
115).  
Mechanistically, the chemical reaction catalyzed by glucose oxidase can be summarized 
as follows. 1) During the reductive half-reaction, after the substrate glucose binds to the free 
enzyme, it is oxidized to gluconolactone with the subsequent reduction of the bound FAD. 2) 
During the oxidative half-reaction, the reduced enzyme-bound flavin complexed with the 
oxidized substrate releases product, with the subsequent oxidation of the reduced flavin by 
molecular oxygen (second substrate) and with the production of hydrogen peroxide, consistent 
with a ping-pong oxidation mechanism of glucose catalyzed by glucose oxidase (116). Kinetic 
isotope effects studies with either glucose or 2-deoxyglucose as substrate showed that while with 
glucose the product release is a first order rate-limiting step of the reaction, with 2-deoxyglucose 
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substrate oxidation becomes partially rate limiting for the overall turnover of the enzyme; the 
product release does not limit the enzyme turnover (116). pH dependence studies on kinetic 
parameters (kcat and kcat/Km) of glucose oxidase showed that with increasing pH, the reoxidation 
of the enzyme in the oxidative half-reaction becomes rate limiting rather than the product release 
(117). Kinetic isotope effects showed a small ratio of ~2-3 comparing 1-[2H]-D-glucose 
(deuterated substrate) and D-glucose, which in turn hindered the accurate determination of the 
chemical mechanism of glucose oxidase (104). In contrast, no solvent deuterium isotope effect 
has been detected on any step in the mechanism with either glucose or 2-deoxyglucose as 
substrate (104). These results clearly suggest that the OH and CH bonds are cleaved in different 
steps in catalysis (Scheme 1.3, pathway II) (104, 118).  
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Scheme 1.3. Proposed mechanisms for alcohol oxidation by GMC enzymes. 
I, Hydride transfer mechanism; II, Asynchronous hydride transfer mechanism; III, Oxygen 
radical mechanism. 
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1.2.2. Cholesterol Oxidase 
Cholesterol oxidase (E.C. 1.1.3.6) is an FAD-containing enzyme that catalyzes the 
oxidation and subsequent isomerization of the trans ∆5-∆6-3β-hydroxysteroids to the 
corresponding ∆4-∆5-3-ketosteroids (Scheme 1.1). Cholesterol oxidase has been isolated from 
several microbial sources including Streptomyces sp., Brevibacterium, Pseudomonas, 
Rhodococcus, and Schizophyllum (16). Cholesterol oxidase has also shown a wide range of 
industrial and clinical applications (16). Although the enzyme has shown a wide range of 
substrate steroid specificities, the presence of a 3β-hydroxyl group on the substrate steroid ring is 
essential for enzymatic activity (119-121). The highest enzymatic activity is observed when 
cholesterol is used as a substrate.  
Structurally, cholesterol oxidase is a dimeric protein with a monomeric molecular mass 
of ~55 kDa, and one FAD molecule for each monomer (97). The mode of FAD attachment to the 
enzyme differs in enzymes from different sources, i.e., while FAD is uncovalently bound to 
cholesterol oxidase from Streptomyces sp., the crystal structure of cholestrol oxidase from 
Brevibacterium sterolicum showed that FAD is covalently attached to the protein backbone via 
an 8-hytidinyl-FAD residue (122). The X-ray crystal structure of cholesterol oxidase from either 
Streptomyces sp. or B. sterolicum shows that the monomeric molecule has a compact spheroid 
structure with PHBH fold (Figure 1.14) (40, 97). The prosthetic group of the enzyme, FAD, was 
found to be deeply buried in the protein structure and was involved in extensive contacts, mainly 
with the FAD binding domain (40, 97). In addition, the highly conserved active site residues of 
cholesterol oxidase compared to other GMC enzymes have been identified to be His447, 
Asn485, and Glu361 (Figure 1.15) (40, 97). A hydrogen bonding network between these 
conserved residues along with Wat541 has been previously proposed to help the substrate 
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positioning and to coordinate general base and electrophilic catalysis (105). Furthermore, 
hydrogen bonding between the side chain of Asn485 and the π system of bound FAD that 
modulates the redox potential in the reaction catalyzed by cholesterol oxidase was also proposed 
by Yin et al. (115).  
The role of the fully conserved active site residue His447 (Figure 1.15) was extensively 
studied through the kinetic characterizations of His447 mutant enzymes (105). The results 
suggested that His447 might have the potential to act as the general base that abstract the 
substrate hydroxyl proton to initiate catalysis (105). However, the recent availability of a crystal 
structure of an unliganded form of cholesterol oxidase at sub-Ångstrom resolution (~0.9 Å), in 
which it was shown that the Nε2 position of the active site His447 residue pointing at the substrate 
hydroxyl group is protonated (35), clearly does not support this histidine residue acting as a 
specific base in catalysis. These structural observations prompted the authors to suggest that the 
conserved histidine residue might act as a hydrogen bond donor to the hydroxyl oxygen of the 
substrate, which would assist in positioning the substrate with respect to the flavin for efficient 
catalysis (35). His447 was accordingly suggested to play two roles. The first role is to position 
the substrate with respect to the flavin and Glu361. The second role is to increase the basicity of 
Wat541 instead of being a general base directly (35); i.e., His477 plays a role in a network of 
hydrogen bonds rather than acting directly as a catalytic base that abstracts the hydroxyl proton 
from the steroid during hydride transfer (105, 106). Most interestingly, the X-ray crystal 
structure of cholesterol oxidase also showed that His447Nε2 is located at a distance of ~3.9 Å 
from the N(1) locus of the flavin (35, 97); therefore it could stabilize in its protonated state the 
negative charge in proximity of N(1)-C(2)=O locus of the bound flavin. This point, however, has 
not been addressed in any study.  
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Mechanistically, and based on the structural studies, Li et al. proposed a radical 
mechanism for cholesterol oxidase (97), with a single electron being transferred from the 
hydroxyl oxygen of the substrate to the flavin, followed by the transfer of the proton from C3 of 
the substrate to the N5 position of the flavin ring (Scheme 1.3, pathway III). Alternatively, a 
hydride transfer mechanism was also proposed (97). In this case, the abstraction of the substrate 
hydroxyl proton prompts the transfer of the hydride to the flavin moiety (Scheme 1.3, pathway 
I). Similar to glucose oxidase, an unambiguous characterization of the chemical mechanism for 
CH bond cleavage in cholesterol oxidase was also limited due to the substrate isomerization step 
occurring after the cholesterol oxidation being slow. Indeed, kinetic isotope effects showed a 
small deuterium isotope effect of ~2.2 with 3α-[2H]-cholesterol, and no solvent isotope effects 
for the wild type enzyme (105).  
 
1.2.3. Cellobiose Dehydrogenase 
Cellobiose dehydrogenase (E.C. 1.1.99.18) is an extracellular flavocytochrome that is 
secreted by various cellulolytic fungi (123). Cellobiose dehydrogenase has been purified from 
various filamentous fungi of which the enzyme from the white-rot fungus, Phanerochaete 
chrysosporium, is the best characterized (123, 124). Similar to cellulases, the expression of 
cellobiose dehydrogenase is triggered by the presence of cellulose in the medium and repressed 
in the presence of glucose (125). FAD and porphyrin IX are the two cofactors of the enzyme; 
these have been reported to interact with two distinct domains of the single polypeptide chain of 
cellobiose dehydrogenase (125, 126). These two domains are connected by a glycosylated, 
hydroxyamino-rich linker peptide, which is highly susceptible to cleavage by pepsin, allowing 
the separations of theses two domains (125, 126). Recently, the X-ray crystal structure of each of 
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the two separate domains, the flavin domain (32), and the heme domain (127), has been reported. 
The crystal structure of the flavoprotein domain of the enzyme showed an overall fold that is 
similar to that of other members of GMC family, i.e., a PHBH fold (32). Similar to other GMC 
enzymes, the monomeric polypeptide chain folds into two structurally distinct domains, the FAD 
binding and the substrate binding domains (Figure 1.14). The uncovalently attached FAD was 
found as 6-hydroxy FAD, consistent with the spectral properties of the flavin chromophore (32). 
In addition, the isoalloxazine ring of the bound flavin was found to be sharply bent along N(5)-
N(10) axis (butterfly bending). The partial positive charge provided from the dipole of an α-
helix, which is located in proximity of N(1)-C(2)=O of the bound flavin, together with the 
butterfly bending of the flavin ring, were suggested to modulate the redox potential of the 
semiquinone as well as the hydroquinone of the bound flavin (32). Two highly conserved and 
critical residues have been identified in the active site of cellobiose dehydrogenase, which are 
His689 and Asn732 (Figure 1.15).  Both residues form hydrogen bonds to W1214 (32). Based on 
the structural data and site directed mutagenesis studies, His689, which is fully conserved among 
the GMC family, was suggested to play the role of the general base that abstracts the substrate 
hydroxyl proton to initiate catalysis (32, 128). Moreover, site directed mutagenesis studies of the 
conserved active site residue Asn732 suggested that this residue plays an important role for the 
positioning of the substrate 1-αH and 1-β-OH relative to FAD and His689, respectively, which 
in turn promotes the deprotonation as well as the oxidation of the substrate (128). The X-ray 
crystallographic structure of the flavin domain of cellobiose dehydrogenase showed that 
His689Nε2 is located at a distance of ~4 Å from the N(1) locus of the flavin (32). Therefore, 
His689 in its protonated state could stabilize the negative charge that develops in proximity of 
N(1)-C(2)=O locus of the bound flavin.  
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Mechanistically, the crystal structure of the flavoprotein domain of cellobiose 
dehydrogenase with bound inhibitor (cellobiono-1,5-lactam) suggested a hydride transfer 
mechanism for the dehydrogenation of the substrate (99). In this mechanism, His689 acts as a 
general base that abstracts the substrate hydroxyl proton, followed by a concerted hydride 
transfer from the axially aligned C(1)-H of the substrate to the flavin N(5) via a transition state 
characterized by partial planarization of C(1) (Scheme 1.3, pathway I) (99). 
 
1.2.4. Pyranose 2-Oxidase  
Pyranose 2-oxidase (EC 1.1.3.10) is a 270 kDa homotetramer, which catalyzes the 
oxidation of several aldopyranoses regioselectively at the C2 position to the corresponding 2-
ketoaldoses and with the production hydrogen peroxide (Scheme 1.1) (33, 100). Pyranose 2-
oxidase is located in the hyphal periplasmic space and it is widely distributed among wood-
degrading basidiomycetes (129). Pyranose 2-oxidase has been purified and characterized from 
various fungi, among which Phanerochaete chrysosporium and Trametes ochracea are the best 
studied and have three-dimensional structures available (33, 100). Besides oxidizing a number of 
pyranose sugars at the C2 position, pyranose 2-oxidase acts also on the C3 position of certain 
substrates such as 2-deoxy-D-glucose, 2-keto-D-glucose and methyl β-D-glucosides (130, 131). 
In addition, it has been shown that the enzyme is able to utilize not only oxygen but also various 
quinones as electron acceptors (132). Therefore, it has been proposed that pyranose 2-oxidase 
might be involved in ligninolysis as an H2O2-producing enzyme and as a quinone-reducing 
enzyme (132).  
The monomeric structure of pyranose 2-oxidase folds similarly to other GMC 
oxidoreductase enzymes  (Figure 1.14). The FAD molecule is buried inside the protein, and is 
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covalently bound via its 8α-methyl group to Nε2 of His167, resulting in 8α-(N3)-histidyl 
flavinylation of the enzyme (133). Similar to cellobiose dehydrogenase (32), a butterfly bending 
of the isoalloxazine ring of the flavin cofactor was also observed but to a lesser extent with 
pyranose 2-oxidase (33). A water molecule (W678) was observed to form a hydrogen bond with 
the N5 atom of the FAD isoalloxazine (33). This bending of the isoalloxazine ring has been 
explained due to the presence of acetate in the active site, which originates from the acetate 
buffer used for crystallization (33).  Acetate (Kis = 9.3 mM) and other organic monocarboxylic 
acids such as propionate, formate, and valerate have been determined to be competitive 
inhibitors with respect to β-D-glucose as substrate for pyranose 2-oxidase (33). The highly 
conserved active site residues of pyranose 2-oxidase have been identified to be His548 and 
Asn593 (Figure 1.15) (33). In addition, His548, which is fully conserved throughout the GMC 
family, has been proposed to play the role of the catalytic base that abstracts the substrate 
hydroxyl proton during catalysis (33). Mechanistically, the putative docking model of β-D-
glucose into the active site of pyranose 2-oxidase showed that the β-hydrogen atom of either C2 
or C3 of glucose points directly toward the N5 atom of isoalloxazine nucleus of the bound FAD 
(Figure 1.16). Accordingly, a hydride transfer mechanism was proposed for the oxidation of 
glucose catalyzed by pyranose 2-oxidase (Scheme 1.3, pathway I) (33). 
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Figure 1.16. Docking of β-D-glucose to the pyranose 2-oxidase active site.  
A, Glucose oriented for oxidation at C2. B, Glucose oriented for oxidation at C3. Taken without 
permission from Ref. (33). 
 
1.2.5. Methanol Oxidase (Alcohol Oxidase)  
Although the X-ray crystallographic structure of methanol oxidase has not been solved 
yet, unambiguous mechanistic characterization of the enzyme from Hansenula polymorpha has 
been performed (101). This study was performed through the use of substrate and solvent kinetic 
isotope effects with benzyl alcohol as a substrate or its analogues (101). With benzyl alcohol as 
substrate, a deuterium isotope effect value of 1.0 and a solvent isotope effect of 2.0 were 
observed, suggesting that CH bond cleavage is masked and that OH bond cleavage is a rate-
limiting step. With 2-substituted ethyl alcohol as substrate, however, the primary deuterium 
isotope effects increased to ~5, while solvent isotope effects decreased to ~1. Based on these 
results, an asynchronous hydride transfer mechanism was suggested (Scheme 1.3, pathway II). In 
short, the OH bond is cleaved prior to the CH bond cleavage, forming an alkoxide intermediate 
(101).  
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1.3. Other Structurally and Mechanistically Relevant Flavoproteins 
In this section, some of the structurally and mechanistically relevant flavoenzymes will 
be discussed in details in the following sub-sections. Those flavoenzymes have been kinetically 
well studied and their three dimensional structures are available. Thereby, providing insights on 
the correlation between their structure and the mechanism of reactions that they catalyzed with 
respect to GMC oxidoreductase superfamily to which choline oxidase belong. For convenience, 
all the structurally and mechanistically relevant features of selected flavoenzymes including 
GMC family members are summarized in Table 1.3. 
 
Table 1.3. Some Structural and Mechanistic Features of Selected Flavoenzymes 
Flavoenzyme 
(PDB file) Cofactor 
Folding 
topology 
Protein residue 
contacting  
N(1)-C(2)=O 
Proposed 
mechanism Ref 
Choline Oxidase 
(na) 
FAD PHBH α-Helix/His466 Asynchronous 
hydride transfer 
(134-138) 
Glucose Oxidase 
(1CF3) 
FAD PHBH α-Helix/His516 Concerted 
hydride transfer 
(62) 
Cholesterol Oxidase 
(1COY) 
FAD PHBH α-Helix/His447 Hydride transfer (97, 139) 
Cellobiose Dehydrogenase 
(1NAA) 
FAD PHBH α-Helix/His689 Hydride transfer (32, 99) 
Pyranose 2-Oxidase 
(1TT0) 
FAD PHBH α-Helix/His548 Hydride transfer (33, 100) 
D-Amino Acid Oxidase 
(1DDO) 
FAD PHBH α-Helix/Arg285 Concerted 
hydride transfer 
(37, 140) 
Polyamine Oxidase 
(1B37) 
FAD PHBH α-Helix  (53) 
Monomeric Sarcosine Oxidase 
(1L9F) 
FAD PHBH α-Helix/K348 Polar /Hydride 
transfer 
(95) 
p-Hydroxybenzoate Hydroxylase 
(1PHH) 
FAD PHBH   (141, 142) 
Vanillyl-Alcohol Oxidase 
(2VAO) 
FAD 2 domains 
α + β 
R504  (143, 144) 
Flavocytochrome b2 
(1FCB) 
FMN (α/β)8 Barrel K349 Asynchronous 
hydride transfer 
(60, 61) 
Glycolate Oxidase 
(1GOX) 
FMN (α/β)8 Barrel K230 Hydride transfer (145, 146) 
Trimethylamine Dehydrogenase 
(2TMD) 
FMN (α/β)8 Barrel R222  (30, 147) 
Dihydroorotate Dehydrogenase 
(2DOR) 
FMN (α/β)8 Barrel K164  (58, 59) 
Old yellow Enzyme 
(1OYB) 
FMN (α/β)8 Barrel R243  (148) 
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1.3.1. Glycolate Oxidase 
Glycolate oxidase (E. C. 1.1.3.15) is an FMN dependent enzyme that catalyzes the 
oxidation of the α-hydroxy acid glycolates to the corresponding α-keto acids (glyoxalates) 
(Scheme 1.4) (36, 42). Glycolate oxidase is a member of the family of the α-hydroxy acid 
oxidases. In plants, the oxidation of glycolates to glyoxalates catalyzed by the peroxisomal 
glycolate oxidase is considered as a key step in photorespiration (36). In animals, the enzyme is 
located in liver peroxisomes; it is involved in oxalate production and is therefore related to 
oxalate-mediated disorders, including renal lithiasis and hyperoxaluria (36, 146).  
HO
O
O-
FMN
H2O2 O2
FMNH-
O
O
O-
Glycolate Glyoxalate  
Scheme 1.4. Reaction catalyzed by glycolate oxidase. 
 
Glycolate oxidase in solution is a homotetramer/octamer with molecular mass of ~43 kDa 
for each monomer (36). Similar to other members of the α-hydroxy acid oxidase family, the X-
ray crystal structure of spinach glycolate oxidase showed that the polypeptide chain of the 
enzyme folds into the (αβ)8 barrel structural motif (Figure 1.17) (149, 150). However, additional 
helices were observed besides the (αβ)8 barrel, forming a “lid” structure that covers the top of 
the active site (149). The FMN cofactor molecule is deeply buried in the barrel, with only the N5 
atom being exposed to the solvent (149). Most interestingly, Lys230, which is located near the 
N(1)-C(2)=O of the bound FMN, has been proposed to stabilize the negative charge that 
develops in proximity of N(1)-C(2)=O locus of the bound flavin (Figure 1.17) (17, 36, 42, 149, 
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150). This positively charged side chain in this region has also been proposed to be responsible 
for some of the typical flavoprotein oxidase characteristics such as the formation of flavin-N(5)-
sulfite adducts and the stabilization of the red anionic flavin semiquinone and of the 
benzoquinoid  form of 8-mercaptoflavin (2). It has been shown that glycolate oxidase maintains 
all these features and thereby can be considered as a typical member of this class of flavoproteins 
(42).  
A B
C D  
Figure 1.17. The three-dimensional structures of FMN-dependent enzymes that oxidize α-
hydroxy acids.  
A and C, flavocytochrome b2 from Saccharomyces cerevisiae (PBD code 1FCB); B and D, 
glycolate oxidase from spinach (PBD code 1AL8); PYR, pyruvic acid; DHP, 3-decyl-2,5-dioxo-
4-hydroxy-3-pyrroline (TKP). 
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The detailed structural investigation of the active site of glycolate oxidase showed that a 
number of residues are conserved in comparison with other FMN-dependent α-hydroxy acid 
oxidizing enzymes (Figure 1.17) (17, 36, 149, 150). The positively charged residues Arg257 and 
Arg164, along with Tyr24, were proposed to interact with the carboxylate-group of the substrate 
(Figure 1.17) (36). Glycolate oxidase was also crystallized in complex with two inhibitors, 3-
decyl-2,5-dioxo-4-hydroxy-3-pyrroline (TKP) or 4-carboxy-5-(1-pentyl)hexylsulfanyl-1,2,3-
triazole (TACA) (Figure 1.18) (146). The carboxyl group of the ligands was observed to form 
hydrogen bonds with the side chains of Arg257 and Tyr24, as well as that of Arg164. The only 
notable exception was Trp108, which, while it forms hydrogen bond with TKP, it is not 
interacting with TACA (146). Therefore, it has been suggested that Trp108 is playing an 
important role in determining the substrate specificity via size exclusion (146).  
Mechanistically, it has been proposed based on the available structural data that the 
carboxyl part of glycolate is bound to Arg257 and Tyr24, while the hydroxyl group bound to 
Tyr129 (Figure 1.19). Site directed mutagenesis studies of Tyr24 and Tyr129 confirmed these 
assumptions, and also indicated a role for Tyr129 in stabilizing the transition state intermediate 
during catalysis (17, 145). In addition, His254 was proposed to be responsible for proton 
abstraction from the substrate during catalysis (36, 146). Previously, a carbanion mechanism was 
generally accepted for the catalytic mechanism of glycolate oxidase. Although little kinetic 
characterization of glycolate oxidase is available, the carbanion mechanism was proposed for 
glycolate oxidase in analogy to previous studies on flavocytochrome b2, which suggested that the 
substrate α-proton is abstracted by the conserved His254 prior to the electron transfer to FMN 
(36). However, there is no firm evidence that rules out a hydride transfer mechanism for 
glycolate oxidase (151). Therefore, the mechanism of glycolate oxidase is still ambiguous, 
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although a hydride transfer mechanism seems to be more likely for glycolate oxidase as the case 
of the most recently proposed mechanism for flavocytochrome b2 (152), yet more detailed 
studies with glycolate oxidase have to be carried out to validate this mechanism. 
 
Figure 1.18. The hydrogen bonding pattern of the inhibitors at the active site of glycolate 
oxidase.  
The holoenzyme is colored red, the TACA complex green, and the TKP complex blue. Distances 
less than 3.2 Å from the inhibitors are marked with dashed lines. Taken without permission from 
ref. (146). 
 
 
Figure 1.19. Schematic presentation of the proposed transition state of glycolate oxidase. 
Taken without permission from ref. (146). 
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1.3.2. Flavocytochrome b2 
Flavocytochrome b2 (E. C. 1.1.2.3) is the best studied member of the α-hydroxy acid 
oxidases family. Flavocytochrome b2 is an FMN-dependent enzyme that catalyzes the oxidation 
of L-lactate to pyruvate (Scheme 1.5), which is the product of lactate oxidation for the Krebs 
cycle (153). The expression of flavocytochrome b2 is induced by oxygen and L-lactate (154). 
Besides its role in producing pyruvate, flavocytochrome b2 also participates in a short electron 
transport chain involving cytochrome c and cytochrome oxidase. This leads to the transfer of the 
reducing equivalents gained from L-lactate oxidation to oxygen, yielding one molecule of ATP 
for every L-lactate molecule consumed (155). Flavocytochrome b2 is a homotetramer with a 
molecular mass of ~58 kDa for each monomer. Each monomer contains two noncovalently 
bound cofactors, FMN and heme (155).  
OH
O
O-
O
O
O-
2 Cytc
L-Lactate Pyruvate  
Scheme 1.5. Reaction catalyzed by flavocytochrome b2. 
 
The X-ray crystallographic structure of flavocytochrome b2 showed that each subunit of 
the tetrameric structure of the enzyme folds into two domains, the heme-binding domain (11 kDa 
at N-terminal) and the flavin-binding domain (45 kDa at C-terminal). The two domains are 
connected by a short, yet flexible, hinge peptide (61). In addition, the polypeptide chain of the 
flavin domain folds into an (α/β)8 barrel structure, consistent with other members of the α-
hydroxy acid oxidases family (Figure 1.17) (61). The FMN cofactor molecule was found to be 
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buried in the central β-barrel, suggesting that the flavin cofactor is sequestered from the solvent 
(61).   
The X-ray crystallographic structure of the enzyme complexed with its product pyruvate 
implied that the product is stabilized in the active site of the enzyme through the interactions of 
its carboxylate group with the side chains of Arg376 and Tyr143 (Figure 1.17), suggesting an 
important role for Arg376 and Tyr143 in substrate binding and specificity (61). On the other 
hand, His373 and Tyr254 were observed to interact with the ketooxygen atom of pyruvate and 
were therefore suggested to play important roles in catalysis (Figure 1.17) (61, 154). It was 
proposed that Lys349, which was found to be located close to the N(1)-C(2)=O locus of the 
bound FMN, is responsible for the stabilization of the anionic semiquinone and hydroquinone as 
well as the formation of a tight flavin-N(5)-sulfite adduct through its electrostatic interactions 
with the negative charge that develops at that region (Figure 1.17) (61).  
Mechanistically, kinetic characterizations were carried out on the wild type enzyme and 
enzymes containing mutations on catalytic relevant residues, such as His373 and Tyr254, to gain 
insights into flavocytochrome b2 (156). Kinetic studies on the mutant form of the proposed active 
site histidine, H373Q, showed ≥ 105 decrease in the rate of lactate oxidation compared to the 
wild type enzyme (156), suggesting an important role of His373 in catalysis. However, this does 
not distinguish between the postulated carbanion mechanism and the hydride transfer 
mechanism. Sobrado et al. performed a thorough mechanistic characterization of 
flavocytochrome b2 using kinetic isotope effects as probes, via both steady state and pre-steady 
state kinetics (60). The results obtained from these studies suggested that the CH and OH bonds 
are cleaved in a stepwise manner during catalysis. However the kinetic characterization of the 
mutant form of enzyme in which Tyr254 was replaced with phenylalanine (Y254F) was 
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consistent with the cleavages of OH and CH bonds becoming concerted compared to the wild 
type enzyme (152). This change was explained with a reduced stabilization of the alkoxide 
intermediate in the phenylalanine variant, which is formed after the proton abstraction by His373 
in a hydride transfer mechanism (Scheme 1.6). Tyr254 was therefore suggested to play a role in 
stabilizing the alkoxide intermediate by forming a hydrogen bond with the charged lactate 
hydroxyl oxygen. The alternative carbanion mechanism appears unlikely because it is hard to 
reconcile with the more concerted mechanism observed in the Y254 mutant enzyme. If a 
carbanion mechanism were adopted by the enzyme, losing the interaction between Tyr254 and 
substrate hydroxyl oxygen should substantially slow down the latter step and result in more 
stepwised CH and OH bond cleavages (152). Based on these observations, the authors suggested 
a stepwise hydride transfer as the mechanism for the chemical step in wild type flavocytochrome 
b2 and, by extension, the family of enzymes that oxidizes α-hydroxy acids (Scheme 1.6).  
 
 
 
 
Scheme 1.6. Proposed mechanism of L-lactate oxidation by flavocytochrome b2. 
Taken without permission from ref. (152). 
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1.3.3. D-Amino Acid Oxidase 
D-Amino acid oxidase (EC 1.4.3.3, DAAO) catalyzes the dehydrogenation of D-isomers 
of amino acids to the corresponding α-imino acids, which after subsequent hydrolysis yield α-
keto acids and ammonia (Scheme 1.7). The kinetic mechanism of DAAO, as is common in 
flavoprotein oxidases, is divided into a reductive half-reaction, in which the amino acid is 
oxidized with the concomitant reduction of the bound flavin, and an oxidative half-reaction, in 
which the reduced flavin is oxidized by molecular oxygen with the subsequent release of the 
product (Scheme 1.8). This FAD-dependent enzyme was shown to play a vital role in the 
modulation of serine levels in mammalian brain (157, 158).  
C
R
O
O-
H
H3N
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H2O2 O2
FADH-
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O
O-
2HN
H2O NH4
+
C
R
O
O-
O
D-Amino acid α-Imino acid α-Keto acid  
Scheme 1.7. Reaction catalyzed by D-amino acid oxidase. 
 
 
Scheme 1.8. Kinetic mechanism of D-amino acid oxidase. 
Taken without permission from ref. (140). 
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Although the enzyme is well studied, no unequivocal mechanism for the dehydrogenation 
of the substrate has yet been established (28, 140, 159). Over the years, two different 
mechanisms have been proposed for the reaction catalyzed by this flavoprotein oxidase: the 
hydride transfer mechanism and the carbanion mechanism. Evidence that favors a direct hydride 
transfer mechanism comes from the transfer of the α-hydrogen of the substrate to the C(5) 
position of the enzyme reconstituted with 5-deaza-FAD (160). Similarly, the elimination of 
halide from β-chloro-D-alanine validates the hypothesis that the reductive half-reaction of 
DAAO involves the initial formation of a carbanion intermediate after the abstraction of the α-
hydrogen of the substrate as a proton (161). Finally, a direct hydride transfer mechanism was 
considered in which α-H+ abstraction is coupled with the hydride transfer (162).  
Two different research groups have described the X-ray crystallographic structure of 
DAAO from pig kidney with the inhibitor benzoate bound (37, 163). The X-ray structure of the 
enzyme showed that there is no active site residue properly placed to act as a base for carbanion 
formation. The only notable interaction of the inhibitor with the active site residue includes the 
carboxylic group of benzoate with Arg283 and Tyr228 (37, 163). A similar interaction was 
observed between the carboxylic group of D-3,3,3-F3-alanine and the homologous arginine and 
tyrosine residues (Arg285 and Tyr223) in a recent structure of DAAO from Rhodotorula gracilis 
(Figure 1.20) (164). In addition, the amino group of D-3,3,3-F3-alanine was also observed to 
form a hydrogen bond with a water molecule and the carbonyl oxygen of Ser335 (164). In all 
structures the carbon atom of the inhibitor, which corresponds to the α-carbon of the amino acid 
substrate, was found to be located at a distance of ~3.4 Å from the N(5) of the isoalloxazine ring 
of the bound flavin (37, 163, 164). These structural data clearly suggest a direct hydride transfer 
mechanism as well as argue against the carbanion mechanism that was proposed earlier. 
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Figure 1.20. Active site of R. gracilis DAAO with D-3,3,3-F3-alanine bound (PDB code 1C0L).  
FLA, D-3,3,3-F3-alanine.  
 
The currently available structures of DAAO from different sources in complex with 
ligands have showed that Arg285 interacts with the carboxylate group of the ligand and that the 
negative charge that develops at the vicinity of N(1)-C(2)=O locus of the bound flavin is 
stabilized by the dipole of α-helix F5 (37, 163). This result argued against the previously 
proposed role of Arg285 in stabilizing the negative charge that develops in proximity of N(1) 
locus of the bound flavin. Consequently, this result disagreed with the involvement of Arg285 in 
the stabilization of the anionic flavin semiquinone and hydroquinone, and for the formation of 
tight flavin-N(5)-sulfite adduct as well as in the modulation of the electrophilicity of the bound 
flavin by increasing the oxidation-reduction potentials of the bound FAD (165). Recently, 
Pollegioni et al., through their biochemical and spectroscopic analyses of different mutant forms 
of DAAO in which Arg285 was replaced by selected residues (R285A, R285K, and R285D), 
concluded that in the free enzyme, Arg285 is still involved in the stabilization of the negative 
charge on the N(1)-C(2)=O locus of the flavin (159). This conclusion was based on the 
assumption that although the guanidinium group of Arg285 was found to be located at a distance 
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of ~7 Å from the N(1)-C(2)=O locus of the flavin in the structures of the enzyme in complex 
with substrate or ligands, in the absence of substrate or ligands the side chain of Arg285 would 
be able rotate to a distance of ~3 Å from the N(1)-C(2)=O locus of flavin (159). The role of 
Arg285 in stabilizing the negative charge at the vicinity of the N(1)-C(2)=O locus of the bound 
flavin in DAAO is still ambiguous due to the unavailability of the X-ray crystal structure of the 
unliganded enzyme 
Fitzpatrick and his co-workers in the last few years have performed a thorough kinetics 
characterization of DAAO by using substrate and solvent kinetic isotope effects approaches to 
probe the order of CH bond cleavage and the C=N bond formation (140, 166-168). The results 
obtained from the analysis of isotope effects studies agree well with the structural studies 
allowed Fittzpatrick to conclude that the mechanism of DAAO is a direct hydride mechanism, in 
which both the CH bond cleavage and the C=N bond formation occur in the same transition state 
(Scheme 1.9). In agreement with this conclusion, a recent computational studies also suggested a 
direct hydride transfer mechanism involving the anionic form of the amino acid substrate (169).  
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Scheme 1.9. Proposed direct hydride transfer mechanism of D-amino acid oxidase. 
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1.4. Choline Oxidase 
Mann et al. first reported the isolation of choline oxidase in 1938. In that study, choline 
oxidase of rat liver was shown to be a typical dehydrogenase (170). It was assumed that choline 
oxidase system was composed of choline dehydrogenase, cytochrome c, and cytochrome 
oxidase. The oxidation of choline was inhibited by betaine, as well as the HNMe3+ 
(trimethylammonium) and NH4+ ions. In addition, it was also concluded that the 
trimethylammonium headgroup of choline is important for the specific binding of the substrate to 
the enzyme (170). A second active form of choline oxidase, which oxidized choline to betaine 
aldehyde with the uptake of one or two mol of oxygen at pH 6.7 or 7.8, respectively, was also 
isolated from rat liver in 1938 (171). This form of active choline oxidase was also found in rat 
kidney but not in blood, muscle, or brain (171).    
The Arthrobacter globiformis choline oxidase was first purified by fractionations with 
ammonium sulfate and acetone, followed by column chromatography using the anionic 
exchanger DEAE-cellulose and gel filtration Sephadex G-200 columns (172). The purified 
enzyme showed absorbance maxima at 363 and 450 nm, consistent with the purified protein 
being a flavoenzyme (172). The enzyme showed a molecular mass of ~71 kDa by SDS-PAGE 
and ~83 kDa by gel filtration, and an isoelectric point (pI) around pH 4.5 (172). The catalytic 
activity of the purified enzyme was tested using either choline or betaine aldehyde as substrate. 
The enzymatic activity assays showed the ability of choline oxidase to utilize both choline and 
betaine aldehyde as substrate, with the subsequent production of glycine betaine (172). On the 
other hand, the enzymatic activity of choline oxidase was significantly decreased by using a 
number of substrate analogs, suggesting high substrate specificity of the enzyme for either 
choline (100%) or betaine aldehyde (46%) (172). A Km value of 1.2 mM and 8.7 mM was 
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determined for choline and betaine aldehyde, respectively. Therefore, it was proposed that 
choline oxidase from Arthrobacter globiformis catalyzes the oxidation of choline or betaine 
aldehyde with the production of glycine betaine in a reaction where oxygen is acting as electron 
acceptor and with the production of hydrogen peroxide (Scheme 1.10) (172, 173).  
 
(CH3)3N
+ OH
H2O2
O2
(CH3)3N
+ H
H2O2
(CH3)3N
+ O
OH2O, O2O  
Scheme 1.10.  Reaction catalyzed by choline oxidase. 
 
 
The prosthetic group of A. globiformis choline oxidase was also investigated by 
subjecting the enzyme to trypsin-chymotrypsin digestion (82). One of the purified peptide 
fragments yielded a UV-visible absorbance spectrum similar to that of flavin (FMN or FAD). To 
identify whether the prosthetic group of choline oxidase was FMN or FAD, the fluorescence 
intensity of the purified flavin peptide was tested after enzymatic hydrolysis with nucleotide 
pyrophosphatase at pH 3. The flavin fluorescence intensity increased by 2-fold upon releasing 
AMP by hydrolysis with nucleotide pyrophosphatase, consistent with FAD rather than FMN 
being the cofactor (82). The position of flavin attachment was investigated using aminoacyl 
riboflavin, for which covalent linkage occurs at the 8α-methylene group of the isoalloxazine ring 
(82). The fluorescence excitation spectrum of aminoacyl riboflavin along with the purified flavin 
peptide of choline oxidase at pH 3 showed a ~25 nm hypsochromic shift of the visible peak 
centered at 346 nm as compared to free riboflavin (from 373 nm to 346 nm), suggesting that in 
choline oxidase flavinylation occurs at the 8α-methylene group of the isoalloxazine moiety (82). 
To establish whether N(1) or N(3) of the histidine residue of the protein bound to the 8α-
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methylene group of FAD, reduction with sodium borohydride and the fluorescence properties of 
the bound flavin were examined. The purified flavin peptide was not reduced with sodium 
borohydride, consistent with the covalently bound flavin isolated from the A. globiformis choline 
oxidase being 8α-[N(3)-histidyl]-FAD. Indeed, it had been reported previously that the N(1) 
isomer of histidyl flavin can be reduced with borohydride and its fluorescence is quenched, while 
the N(3) isomer cannot (174). The electrophoretic mobility of the hydrolysate of the methylated 
histidylflavin of choline oxidase from Alcaligens sp. at pH 6.25 also confirmed 8α-[N(3)-
histidyl]-FAD as the prosthetic group (25). The covalently bound FAD showed maxima at 358 
and 453 nm and a shoulder at 480 nm, with a stoichiometric amount of 1 mol of FAD per mol of 
enzyme. Furthermore, the covalently bound FAD was reduced anaerobically upon addition of 
choline or betaine aldehyde, and re-oxidized upon aeration (25).  
A comprehensive study on the spectroscopic properties of choline oxidase from 
Alcaligens sp. was conducted for better understanding of the properties of the covalently bound 
FAD of choline oxidase (48). The authors drew several conclusions based on the spectroscopic 
properties of the covalently bound FAD. 1) Choline oxidase from Alcaligens sp. was able to 
stabilize the anionic flavin semiquinone as an intermediate during the course of the enzyme 
reduction using either dithionite or by photo-irradiating the enzyme in the presence of EDTA. 2) 
The presence of a catalytic amount (3.7 µM) of free riboflavin significantly enhanced the 
photoreduction rate not only to the semiquinone state but also to the fully reduced form of flavin. 
3) The produced semiquinone did not showed any reactivity toward the substrates choline or 
betaine aldehyde and most importantly, did not show any reactivity toward oxygen, which is an 
unusual feature among flavoprotein oxidases. 4) The oxidized enzyme was able to form a 
complex with glycine betaine (the product of the reaction); the dissociation constant of such 
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complex was determined through spectroscopic titration to be 17 mM at pH 7.5. 5) No 
significant anionic semiquinone was observed upon the reduction of the enzyme-bound glycine 
betaine by either dithionite or by photoreduction in the presence of EDTA. 6) The biphasic 
reactivity of the fully reduced form of the enzyme-bound glycine betaine toward oxygen (rapid 
and slow phases) led the authors to propose a mechanism for the photoreaction of the enzyme-
product complex, wherein a C(4a)-adduct (slowly reacting with oxygen) and the fully reduced 
flavin via an N(5)-adduct (rapidly reacting with oxygen) were formed (48).          
In the past 10 years, studies on choline oxidase were mainly focused on the 
biotechnological applications of the enzyme (175-179), which will be discussed in detail in 
Section 1.5. 
In a recent study by Rand et al. aimed at identifying the type of flavin linkage as well as 
the amino acid residue to which FAD is attached in choline oxidase from A. globiformis, it was 
concluded that choline oxidase contains 8α-[N(1)-histidyl]-FAD at position 87 in the 
polypeptide chain (49). The results obtained in this study were mainly dependent on the 
nucleotide sequence of codA gene coding for A. globiformis choline oxidase, which had been 
previously reported in Genbank (accession number X84895) (180). The sequencing analysis of 
the recently cloned codA gene from A. globiformis genome in our laboratory indicated that the 
nucleotide sequence of codA originally reported in GenBank (accession number X84895) 
contains seven flaws, resulting in a translated protein with a significantly altered amino acid 
sequence between position 298 and 410. Therefore, the results obtained here in this study might 
lack of accuracy. Indeed, the recently solved X-ray crystal structure of A. globiformis choline 
oxidase showed that FAD is covalently linked to His99Nε2 (for details see 1.4.1), confirming the 
inaccuracy of the results obtained in that study.  
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Recently, the kinetic mechanism of the commercially available choline oxidase from A. 
globiformis (Sigma-Aldrich, St. Louis, MO) was characterized in our laboratory using different 
kinetic approaches (181, 182). The steady state kinetic data showed that choline oxidase 
catalyzed the four-electron oxidation of choline to the carboxylic acid glycine betaine. This 
reaction occurs through two sequential flavin-linked hydride transfers from choline and the 
resulting betaine aldehyde intermediate to molecular oxygen (181). In addition, pH and 
deuterium kinetic isotope effects studies on the oxidation of choline to betaine aldehyde in air 
saturated buffer showed that a catalytic base with an apparent pKa value of ~8 is required for the 
oxidation of choline to glycine betaine. When the pH is at least one pH unit below the pKa of 
such catalytic base, the C-H bond cleavage becomes fully rate limiting for catalysis (182). In that 
study, from an analysis of the amino acid sequence of choline oxidase from A. globiformis2 (180) 
with respect to other members of GMC oxidoreductase superfamily (39, 97, 105, 183), histidine 
466 was proposed to act as the catalytic base in choline oxidase (182).   
Choline oxidase from A. globiformis was recently cloned in our laboratory (47). The 
recombinant enzyme was expressed and purified to high purity and quantity, allowing detailed 
biophysical, biochemical, and spectroscopic characterizations of the enzyme, as well as 
mechanistic and structural studies with site-directed mutants (44, 47, 137, 138). These studies 
will be discussed in detail in Chapters 3-7.  
In a recent study that has been carried out in our laboratory on the recombinant enzyme, 
choline and glycine betaine analogs have been used as substrates and inhibitors for the enzyme at 
pH 6.5 to probe the structural determinants that are relevant for substrate specificity and binding 
                                                 
2 The sequencing analysis of the recently cloned codA gene from A. globiformis genome in our laboratory indicated 
that the nucleotide sequence of codA originally reported in GenBank (accession number X84895) contains seven 
flaws, resulting in a translated protein with a significantly altered amino acid sequence between position 298 and 
410 (46). 
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(184). As shown in Table 1.4, the Kis values that were determined for the competitive inhibition 
patterns of glycine betaine, N,N-dimethylglycine, or N-methylglycine with respect to choline 
were found to increase monotonically with decreasing number of methyl groups, consistent with 
the importance of the trimethylammonium moiety of the ligand for substrate binding (Table 1.4) 
(184). On the other hand, the Kis values did not show any changes upon substituting glycine 
betaine with inhibitors containing methyl, ethyl, allyl, and 2-amino-ethyl esters, which strongly 
suggests that the acetate moiety of the ligand does not participate in substrate binding (Table 1.4) 
(184). In agreement with the inhibition data, the second-order rate constants kcat/Km (which 
reflect the specificity of the enzyme for the organic substrate) decreased upon using N,N-
dimethylethanolamine and N-methylethanolamine as substrate with respect to choline (Table 1.5) 
(184). In addition to the methyl groups of the trimethylammonium moiety, the positive charge on 
the same moiety has also been shown to be important for substrate binding and specificity. When 
choline was substituted with its isosteric analogue 3,3-dimethyl-1-butanol as substrate for 
choline oxidase, a significant decrease in both the turnover number (kcat) and the kcat/Km values 
were observed (Table 1.5) (184). These results suggest that the positive charge on the 
trimethylammonium headgroup of the substrate is important for substrate binding and catalysis 
(184). An energetic contribution of ~29 kJ mol-1 was determined from the kinetic data for the 
interaction of the quaternary ammonium portion of the substrate with the active site of choline 
oxidase, i.e., ~7 kJ mol-1 from each methyl group and ~8 kJ mol-1 from the positive charge (184). 
This value compares well with the value of ~33 kJ mol-1 that was determined before for the 
contribution of the quaternary ammonium moiety of acetylcholine in acetylcholinestrase (185, 
186). Similar observations have also been reported before for enzymes that use molecules 
containing choline moiety as substrates, including acetylcholine, phosphatidylcholine, and 
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phosphocholine (185-188). Among these enzymes, phospholipase C, acetyl-cholinestrase, and 
CTP:phosphocholine cytidyltranseferase have been well characterized for the substrate binding 
properties (185-188). The X-ray crystal structures of those enzymes complexed with their 
specific inhibitors suggested that the trimethylammonium headgroup of the ligands is stabilized 
by π-cation interaction to specific active site aromatic residues (185-188). 
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Table 1.4. Inhibition Studies of Choline Oxidase at pH 6.5 a 
Inhibitor Structure Type of inhibition Kis, mM R
2 
Glycine betaine COO-N
CH3
CH3
H3C
 
competitive 15 ± 2 0.984 
N,N-Dimethylglycine COO-N
CH3
H
H3C
 
competitive 57 ± 1 0.995 
N-Methylglycine COO-N
H
H
H3C
 
competitive 405 ± 2 0.998 
Tetramethylamine N
CH3
CH3
H3C CH3
 
competitive 11 ± 1 0.997 
Trimethylamine N
CH3
CH3
H3C H
 
competitive 2.4 ± 0.2 0.998 
Dimethylamine N
CH3
H
H3C H
 
competitive 6 ± 1 0.998 
Methylamine N
H
H
H3C H
 
competitive 26 ± 1 0.996 
Trimethylethylamine N
CH3
CH3
H3C C2H5
 
competitive 13 ± 2 0.988 
Dimethylethylamine N
CH3
H
H3C C2H5
 
competitive 9 ± 1 0.995 
Methylethylamine N
H
H
H3C C2H5
 
competitive 8 ± 1 0.995 
Allyltrimethylamine N
CH3
CH3
H3C
 
competitive 15 ± 1 0.999 
2-Amino-trimethylethylamine N
CH3
CH3
H3C NH3
 
competitive 9 ± 1b 0.993 
a Choline oxidase activity was measured at varying concentrations of both choline and 
inhibitor in air-saturated 50 mM sodium pyrophosphate, pH 6.5 and 25 oC. b Value 
determined for the protonated form of 2-amino-trimethylethylamine. Modified from ref. 
(184).  
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Table 1.5. Steady State Kinetic Parameters for Choline and N-Substituted Choline Analogs as 
Substrates for Choline Oxidase at pH 8a 
Substrate Structure kcat, s-1 kcat/Km, M-1s-1b R2 
Choline N
CH3
CH3
H3C OH
 
86 ± 1 200,000 ± 10,000 0.995 
N,N-Dimethylethanolamine N
CH3
H
H3C OH
 
5.9 ± 0.1 18,400 ± 300 0.996 
N-Methylethanolamine N
CH3
H
H
OH
 
0.37 ± 0.01 710 ± 10 0.994 
3,3-Dimethyl-1-butanol C
CH3
CH3
H3C OH
 
8.0 ± 0.1 7,900 ± 980 0.980 
a Choline oxidase activity was measured at varying concentrations of organic substrate and 
oxygen in 50 mM sodium pyrophosphate, pH 8, and 25 oC. b kcat/Km is the kcat/Km value for the 
organic substrate. Modified from ref. (184). 
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In a subsequent study by our group, primary deuterium and solvent kinetic isotope effects 
were used to investigate the mechanism of substrate oxidation (CH and OH bond cleavages) by 
recombinant choline oxidase using both rapid kinetics and steady-state kinetics techniques (134). 
That study showed that in the reductive half-reaction, the CH bond cleavage is not masked by 
other kinetic steps as indicated by the pH independent value (in the pH range 6.5-10) of ~10.6 
for D(kcat/Km) with deuterated choline (Figure 1.21) (134). In good agreement with that value, at 
pH 10 a Dkred value of ~8.9 was also determined for the anaerobic reduction of the bound-flavin 
by choline, irrespective of whether protio or deuterated solvent was used (134). In addition, the 
study also showed that while the Dkcat and D2Okcat values were 7.3 and 1.1, respectively, the 
D2O(kcat/Km) and the D2Okred values were equal to unity with either choline or deuterated choline 
(134). Overall, the results obtained have indicated that chemical steps of choline oxidation 
catalyzed by choline oxidase are fully rate limiting for both the overall turnover and the 
reductive half-reaction in which choline is oxidized to betaine aldehyde. In addition, the removal 
of the substrate hydroxyl proton and the hydride transfer from the substrate α-carbon to the N(5) 
locus of the flavin cofactor occur in a stepwise fashion with the formation of a transient alkoxide 
intermediate species (Scheme 1.11) (134). 
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Figure 1.21. pH-Dependence of the deuterium isotope effects. 
pH-dependence of the deuterium isotope effects on kcat/Km (•) and kcat (ο) values. Activity assays 
of choline oxidase were performed in 50 mM buffer with choline and 1,2-[2H4]-choline as 
substrate, at 25 °C. Data were fit by y = 10.6 and y = 7.5 for kcat/Km and kcat values, respectively. 
Taken without permission from ref. (134). 
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Scheme 1.11.  Chemical mechanism of choline oxidase for oxidation of choline at pH 10. 
Modified from ref. (134). 
 
 
In another recent study on recombinant choline oxidase, the effects of temperature and 
oxygen concentration on the kinetic isotope with deuterated choline have been investigated 
(135). At saturating oxygen concentrations, the Dkcat and the D(kcat/Km) values with 1,2-[2H4]-
choline were pH-independent, whereas at oxygen concentration ≤ 0.97 mM, they decreased at 
high pH to limiting values that depended on oxygen concentration (Figure 1.22 and Table 1.6) 
(135). In addition, the kcat and kcat/Km pH profiles also showed similar patterns reaching plateaus 
at high pH. By using choline as a substrate at oxygen concentration of ≤ 0.25 mM, both the 
limiting kcat/Km at high pH and the pKa values moved to lower values (Table 1.7) (135). These 
data suggested that oxygen availability is the major determinant that dictates whether the reduced 
enzyme-betaine aldehyde complex proceeds forward to catalysis or reverts to the oxidized 
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enzyme-choline alkoxide complex during turnover of the enzyme with choline (135).  To test the 
involvement of quantum mechanical tunneling in the hydride transfer mechanism catalyzed by 
choline oxidase, the effect of temperature on the Dkcat and the D(kcat/Km) values at saturating 
oxygen concentration were determined (135). The effect of temperature on the kinetic isotope 
effects can provide evidence on whether hydride transfer occurs quantum mechanically or by 
following the classical over-the barrier behavior (135). The D(kcat/Km) was temperature dependent 
and with value similar to the isotope effects on the preexponential factors (AH'/AD'). The large 
isotope effect on the preexponential factors (AH'/AD') determined from the temperature 
dependence of the kcat/Km values with choline and 1,2-[-2H4]-choline, with a value of ~14, rules 
out a classical over-the-barrier behavior for hydride transfer, for which AH'/AD' values between 
0.7 and 1.7 are expected (135). Similar enthalpies of activation (∆H‡) with values of 18 ± 2 and 
18 ± 5 kJ mol-1 were determined for choline and 1,2-[2H4]-choline, respectively. Overall, these 
data suggested that the reversible hydride transfer mechanism of choline catalyzed by choline 
oxidase occurred quantum mechanically. In such mechanism, the tunneling behavior of the 
hydride transfer is mainly affected by the distance between the hydride donor and acceptor (135).  
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Figure 1.22. pH dependence of D(kcat/Km) and Dkcat values with 1,2-[2H4]-choline as substrate for 
choline oxidase at 0.07 (□), 0.25 (■), 0.97 mM (○) and saturating (●) oxygen concentrations. 
Activity assays of choline oxidase were performed in 50 mM buffer with choline or 1,2-[2H4]-
choline as substrate, at 25 oC. Taken without permission from ref. (135). 
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Table 1.6. pH Dependence of Kinetic Isotope Effects at Different Oxygen Concentrations a
D(kcat/Km) Dkcat [O2], 
mM YLb YHb pKa YL YH pKa 
∞c 10.6 ± 0.6 10.6 ± 0.6 n.a.d 7.5 ± 0.3 7.5 ± 0.3 n.a.d 
0.97 10.3 ± 0.4 5.6 ± 0.4 7.2 ± 0.3 7.2 ± 1.0 5.5 ± 0.3 5.9 ± 0.9 
0.25 10.5 ± 0.4 3.7 ± 0.4 7.5 ± 0.2 7.3 ± 0.3 3.2 ± 0.2 6.3 ± 0.1 
0.07 10.1 ± 0.2 2.6 ± 0.2 7.2 ± 0.2 7.5 ± 0.6 1.8 ± 0.1 6.0 ± 0.1 
a Conditions: 50 mM buffer, pH from 5 to 10 and 25 oC. b YL and YH are the limiting values at 
low and high pH, respectively. c Data are from ref.  (134). d n.a., not applicable. Taken without 
permission from ref. (135). 
Table 1.7. pKa Values for Steady State Kinetic Parameters with Choline or 1,2-[2H4]-Choline as 
Substrate a 
  kcat/Km, M-1s-1 kcat, s-1 
substrate [O2], mM pKa Yb pKa Yb 
choline ∞c 7.6 ± 0.2 130,000 ± 30,000 7.1 ± 0.1 58 ± 8 
 0.97 7.5 ± 0.1 150,000 ± 13,000 6.9 ± 0.1 41 ± 3 
 0.25 7.3 ± 0.1 66,000 ± 9,000 6.5 ± 0.1 21 ± 1 
 0.07 7.0 ± 0.1 47,000 ± 5,000 6.0 ± 0.1 6.6 ± 0.3 
1,2-[2H4]-choline ∞c 7.8 ± 0.2 14,000 ± 5,000 7.1 ± 0.2 7.5 ± 1.2 
 0.97 7.5 ± 0.2 29,000 ± 6,000 7.0 ± 0.1 7.6 ± 0.9 
 0.25 7.6 ± 0.1 18,000 ± 3,000 6.9 ± 0.1 6.7 ± 0.4 
 0.07 7.6 ± 0.1 18,000 ± 3,000 6.7 ± 0.1 3.6 ± 0.2 
a Conditions: 50 mM buffer, pH from 5 to 10 and 25 oC. b Y, limiting value at high pH. c Data are 
from ref. (134). Taken without permission from ref. (135). 
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Recently, another study on recombinant choline oxidase was carried out in our laboratory 
aimed at understanding the mechanism of betaine aldehyde oxidation through the kinetic and 
spectroscopic analyses of the oxidation of betaine aldehyde and its isosteric analog 3,3-
dimethylbutyraldehyde (136). While the anaerobic stopped-flow mixing of the enzyme with 
either choline or betaine aldehyde at pH 8 resulted in complete reduction of the bound flavin 
with similar kred values ≥48 s-1, only 10 to 26% of the enzyme-bound flavin was reduced by 3,3-
dimethylbutyraldehyde between pH 6 and 10 (136). In addition, 3,3-dimethylbutyraldehyde was 
found to act as a competitive inhibitor versus choline in the reaction catalyzed by choline oxidase 
(136). At air-saturation oxygen concentrations, the pH dependence of the kinetic parameters kcat 
and kcat/Km with betaine aldehyde indicated that a catalytic base with pKa value of ~6.7 is 
required for the oxidation of betaine aldehyde catalyzed by choline oxidase (136). Previous 
studies showed that, at saturating oxygen concentrations, flavin reduction is the rate-limiting for 
the overall turnover number of betaine aldehyde, with a limiting value of 135 s-1, at high pH 
(134). Because kcat/KO2 value for the oxidation of the reduced enzyme bound betaine aldehyde 
complex (k5) is ~9 × 104 M-1 s-1 (44), therefore, the rate constant for oxidation of the reduced 
enzyme bound betaine aldehyde at a concentration of oxygen of 0.25 mM at 25 °C (atmospheric 
conditions) is expected to be ~22 s-1. Accordingly, the apparent pKa value observed in the kcat/Km 
pH profile of betaine aldehyde would be perturbed to lower values by 0.85 pH unit with respect 
to the intrinsic pKa value of 7.5, which has been recently determined from the kcat/Km pH profile 
with choline and its analogues as substrate for choline oxidase (44, 184). Therefore, it was 
proposed that an active site base triggers the hydride transfer mechanism of betaine aldehyde, 
which is most likely the same base that triggers the hydride transfer mechanism of choline (136). 
The NMR spectroscopic analyses of both betaine aldehyde and its isosteric analog 3,3-
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dimethylbutyraldehyde revealed that while betaine aldehyde exists predominantly (99%) as a 
diol form in aqueous solution, 3,3-dimethylbutyraldehyde favors the aldehyde (≥65%) over the 
hydrated form in the pH range between 6 and 10 (Table 1.8) (136). Overall, the results obtained 
in this study suggested that choline oxidase oxidizes the hydrated form of betaine aldehyde 
through a base-catalyzed hydride transfer mechanism from the organic substrate to the enzyme-
bound flavin (Scheme 1.12) (136). 
Overall, based on the results obtained from the different biochemical and kinetic studies 
carried on the wild-type as well as some selected mutant proteins of choline oxidase (this thesis), 
our proposed model of the mechanism of reactions for the four-electron oxidation of choline to 
glycine betaine catalyzed by choline oxidase can be summarized as follows. 1) During the 
reductive half-reaction, an unidentified active site base with a pKa of 7.5 activates the alcohol 
substrate with formation of an alkoxide species (species 1 and 2 in Scheme 1.13) (44, 134). 2) 
This alkoxide intermediate is transiently stabilized in the active site through electrostatic 
interaction with the Nε2 atom of the imidazolium side chain of His466 (species 3 in Scheme 1.13, 
Chapter 5) (137). 3) Similarly, the protonated His466 also stabilizes electrostatically the negative 
charge that develops on the N(1)-C(2)=O locus of the reduced flavin (anionic species) through its 
Nε2 atom (species 3 in Scheme 1.13, Chapter 6) (138). 4) The hydride transfer from the α-
carbon of the substrate to the N(5) locus of the bound flavin occurs quantum mechanically from 
the activated choline alkoxide species (species 3 in Scheme 1.13) (135). 5) During the oxidative 
half-reaction, the electron delocalization form the N(1) locus of the anionic hydroquinone along 
with the proton transfer from the unidentified catalytic base result in the formation of the C(4a)-
hydroperoxo-flavin (species 5 in Scheme 1.13). 6) The highly unstable C(4a)-hydroperoxo-flavin 
abstracts the second proton from the hydride at the N(5) locus of the FAD with the subsequent 
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release of H2O2 and the formation of oxidized enzyme-bound FAD (species 6 and 7 in Scheme 
1.13). 7) Finally, the oxidation of the hydrated betaine aldehyde occurs through a base catalyzed 
transfer of a hydride ion from the organic substrate to the enzyme-bound FAD, with a 
mechanism that is similar to that proposed for the oxidation of choline as proposed recently in a  
study by our group on the mechanism of aldehyde oxidation (136).  
  
66
 
 
Table 1.8. NMR Determination of Hydration Ratio of Betaine 
Aldehyde and 3,3-Dimethylbutylraldehyde in Aqueous Solution a 
pD 
betaine aldehyde 
[diol]/[aldehyde] 
3,3-dimethylbutylraldehyde 
[diol]/[aldehyde] 
5.9 nd b 0.42 
6.9 99 nd 
7.3 99 0.35 
8.5 99 0.27 
9.5 99 0.22 
10.7 99 0.20 
12.1 99 0.14 
a Conditions: 50 mM aldehyde, dissolved in 99.9% D2O, at 25 oC. 
b nd, not determined. Taken without permission from ref. (136). 
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Scheme 1.12. Proposed mechanism for the oxidation of betaine aldehyde catalyzed by choline 
oxidase. 
Taken without permission from ref. (136). 
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Scheme 1.13. Proposed mechanism for the four-electron oxidation of choline to glycine betaine 
catalyzed by choline oxidase. 
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1.4.1. X-ray Structure of Choline Oxidase 
The X-ray crystallographic structure of choline oxidase from A. globiformis was recently 
determined at 1.86 Å resolution (George Lountos, Fan Fan, Giovanni Gadda, and Allen M. 
Orville, unpublished results).  
Overall structure. The crystal structure of choline oxidase at resolution of 1.86 Å was 
solved by molecular replacement using the coordinates of glucose oxidase [1CF3, (39)] as a 
template. The crystallographic data confirmed our previously obtained results for the 
oligomerization state of the enzyme in solution (47), and showed that choline oxidase has a 
dimeric structure, with approximate dimensions of 88 Å x 70 Å x 46 Å (Figure 1.23). The two 
monomers interact with each other in an antiparallel manner. The overall structure of choline 
oxidase was found to be similar to the PHBH-fold (p-hydroxy-benzoate hydroxylase) previously 
reported for other GMC enzymes (31, 33, 34, 39, 62, 97). In addition, the polypeptide chain of 
each monomer folded into two domains, the substrate-binding domain and the FAD binding 
domain, with the active site being located between these two domains (Figure 1.23). 
Flavin-binding domain. The flavin-binding domain comprises residues 1-159, 201-311, 
and 464-527. The secondary structure of the flavin-binding domain consists of six-stranded β-
sheets flanked by three-stranded antiparallel β-sheets and α-helices, consistent with other GMC 
enzymes (Figure 1.23) (31, 33, 34, 39, 62, 97). In addition, a typical Rossmann fold (βαβ) 
(residues 16-44) was observed for the binding of the ADP sp. of the FAD (Figure 1.24). This 
ADP-binding motif includes the highly conserved sequence, GXGXXG (residues 20-25: 
GGGSAG). Among these residues, Ser23 forms several interactions with the flavin, with its 
main chain being 3.3 Å from the first phosphate group of the ADP moeity, and its side chain 
being 2.7 and 3.4 Å from the oxygen atoms of ribityl (O4*) and second phosphate group of ADP, 
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respectively (Figure 1.24). Glu44Oε2 is located 2.7 and 3.2 Å from the ribose O2´ and O3´, 
respectively, of the adenosine sp. (Figure 1.24). With the exception of these two residues, no 
direct interactions between the enzyme and flavin adenine and ribitol were observed, which 
clearly shows the importance of covalent flavinylation in positioning the FAD in choline 
oxidase. For other GMC enzymes, in which FAD is not covalently attached to the protein such 
as, glucose oxidase and cellobiose dehydrogenase, intensive interactions were observed between 
the enzyme and the flavin. The increased interactions may compensate the noncovalently linked 
FAD in glucose oxidase and cellobiose dehydrogenase (189-192). A conserved loop structure 
composed of residues 65 – 95, which covers the entrance of the active site, was also observed 
(Figure 1.23). A similar active site loop structure was reported before for cholesterol oxidase 
(193). In that enzyme it was proposed through mutagenesis studies that such loop plays an 
important role in facilitating the movement of the substrate into and of the product out of the 
enzyme active site (193).  
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Figure 1.23. Three-dimensional structure of choline oxidase from Arthrobacter globiformis.  
Choline oxidase is shown in dimeric (A) and monomeric (B and C) structures. In B, the structure 
is colored by secondary structure elements (cyan: α-helix, magenta: β-sheet, wheat: loop); in C, 
the structure is rotated by ~45o with respect to the structure in B, and colored to show different 
domains (blue: substrate binding domain, cyan: flavin binding domain, red: active site loop 
structure). In all structures, the FAD molecule is colored in yellow. 
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Figure 1.24. Rossmann fold (ADP-binding motif) structure of choline oxidase.  
Rossmann fold (βαβ) (cyan: α-helix, magenta: β-sheet, wheat: loop); the FAD molecule is 
colored in yellow. 
 
 Electron density clearly showed that the FAD is covalently linked to His99Nε2 (Figure 
1.25). This result disagrees with a previous mass spectrometric study on choline oxidase, which 
concluded that choline oxidase contains 8α-[N(1)-histidyl]-FAD at position 87 in the 
polypeptide chain (49). The electron density maps shown in Figure 1.25 demonstrate that the 
isoalloxazine ring of the bound flavin is not planar. The plane of the pyrimidine ring was at an 
angle of ~130° with respect to the relatively flat piperizine and dimethylbenzene rings (Figure 
1.25). The pyrimidine ring was also significantly distorted from planarity with a “half-boat” 
configuration. All atoms in the distorted pyrimidine ring were in the same plane with the 
exception of C4a, which was observed as sp3 hybridized. In addition, the C10a was also observed 
as partially sp3 hybridized. This structure is significantly different from both the oxidized flavin, 
and the reduced flavins, which typically exhibit an angle of ~150° along the N5-N10 axis defined 
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by the dimethylbenzene and pyrimidine rings (194-196). A possible rationale that explains such 
an unusual distortion of the flavin in choline oxidase is that it could be due the formation of 
flavin-C4a- and C10a-adducts. The formation of the FAD-C4a-O2 in situ could occur in two 
steps: 1) the bound FAD is reduced by the high brilliance synchrotron X-ray (photoreduction); 2) 
molecular oxygen within the aerobic crystal diffuses to the C4a position of the reduced FAD 
resulting in the formation of a FAD-C4a-O-O- adduct (197, 198). Further studies are currently 
underway to investigate the possible reasons of such unusual flavin distortion in choline oxidase.  
Substrate-binding domain. The substrate-binding domain of choline oxidase consists of 
residues 160-200 and 312-463. It comprises three α-helices and a slightly distorted five-stranded 
β-sheet; two strands in the β-sheet form the bottom of the active site. A large hydrophobic 
residue, Trp331, was observed within β-sheet strand, which lies about ~8.5 Å from FAD. This 
distance fits well with substrate choline sandwiched between Trp331 and FAD, consistent with 
the role of Trp331 in substrate binding. In addition to Trp331, a number of hydrophobic residues 
were observed also in the active site in the substrate binding domain, including, Trp330, Ile333, 
Tyr352, as well as Phe357 (Figure 1.26). Furthermore, Glu312 was also observed in the substrate 
binding domain facing towards the active site, suggesting a role of this residue in facilitating 
substrate binding (vide infra). 
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Figure 1.25. Approximately orthogonal views of the 50 - 1.86 Å resolution electron density 
maps for the FAD isoalloxazine ring in choline oxidase.  
The refined atomic model is shown superimposed with C, N, and O atoms are colored grey, blue 
and red, respectively. From Lountos, G. T., Fan, F., Gadda, G., and Orville, A. M.; unpublished 
data. 
 
 
 
Figure 1.26. Active site structures of choline oxidase, fitting with DMSO.  
The important residues from substrate- and FAD-binding domains are shown. 
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Active site. The enzyme active site is located between the substrate binding domain and 
the flavin binding domain, with a conserved loop structure (residues 65-95) covering its entrance 
(Figure 1.23). One water molecule was observed in the enzyme active site, consistent with other 
GMC enzymes such as glucose oxidase, cholesterol oxidase, pyranose 2-oxidase, and cellobiose 
dehydrogenase (31, 33, 34, 39, 62, 97). Electron density showed a small molecule, not from the 
enzyme in the active site. By carefully reviewing all the reagents used in crystallization, DMSO 
was observed to fit well within the observed density map (Figure 1.26). The substrate choline 
was docked into the structure based on the density map with DMSO (Figure 1.27). Two histidine 
residues, His351 and His466, were also observed in the active site of choline oxidase (Figure 
1.27). Earlier mechanistic studies on cholesterol oxidase, cellobiose dehydrogenase, and glucose 
oxidase, suggested that a histidine residue, which is fully conserved within the GMC family and 
corresponds to His466 of choline oxidase, might act as the specific base that participates in the 
oxidation of the alcohol substrate (39, 105, 113, 128, 199, 200). However, our recent 
biochemical and mechanistic studies of His466 mutant proteins (CHO-H466A and CHO-H466D) 
suggested that His466 is most likely not the active site base that abstracts the substrate hydroxyl 
proton during catalysis (these studies will be discussed in detail in Chapters 5 and 6). The X-ray 
crystallographic structure of the enzyme docked with choline showed that while His466 is 
located at a distance of ~4.8 Å from the hydroxyl group of the docked substrate choline, His351 
is located at a distance of ~3.3 Å from the same region. Therefore, His351 might function as the 
specific base that abstracts the hydroxyl proton of the substrate during catalysis. Val464 is also 
likely to interact with choline, as suggested by the close distances to choline, i.e., 2.5 Å from its 
main chain and 3.5 Å from its side chain (Figure 1.27).  
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As pointed out earlier, the trimethylammonium headgroup of choline is the major 
determinant for substrate binding and specificity (184). The X-ray structural data of choline 
oxidase showed that three residues (Glu312, Trp331, and Phe357) are located close to the 
trimethylammonium moiety of the docked choline in the active site (Figure 1.27). In this respect, 
these three residues are likely to be the components of the previously proposed π-cation 
interactions of the substrate to selected active site residues of the enzyme (184), i.e. Glu312 can 
form an ion pair with the positive charge of the trimethylammonium moiety, and the two 
hydrophobic residues can interact with the methyl groups to form π-cation interactions, which in 
turn facilitates the substrate binding and positioning for catalysis. Similar observations have been 
reported before in many choline-binding enzyme such as phospholipase C, CTP: phosphocholine 
cytidyltranseferase, and acetyl-cholinestrase, where π-cation interactions between their substrates 
and specific active site residues were the major determinant for substrate binding and specificity 
(185-188). 
The X-ray crystallographic data of choline oxidase also showed that the Nε2 atom of the 
conserved active site residue His466 is located at a distance of ~3.3 Å from the N(1) locus of the 
enzyme-bound FAD (Figure 1.28), consistent with other GMC enzymes (31, 33, 34, 39, 62, 97), 
and suggesting an important role of such residue in catalysis and modulation of the bound flavin 
as well (this hypothesis will be discussed in details in Chapter 5 and 6). Most interestingly, the 
X-ray structure of choline oxidase showed that another histidine residue, His310, is located at a 
distance of ~2.9 Å from His466 (His466Nδ1-His310Nδ1) (Figure 1.28). Polarographic preliminary 
results on the enzyme obtained by substituting His310 by an alanine residue showed that the 
purified mutant enzyme completely lost its catalytic activity with choline as a substrate. 
Spectrophotometrically, CHO-H310A was still able to bind choline with the subsequent 
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reduction of the enzyme-bound flavin, which occurred relatively slower than that of wild-type 
choline oxidase (16 h vs 1 s) and in a biphasic way. These results, together with the structural 
information, suggest an essential role of His310 in catalysis and the modulation of the enzyme-
bound flavin, which will be discussed in detail in Chapter 7.  
In conclusion, the X-ray crystallographic structure of choline oxidase was resolved at 
1.86 Å resolution. The overall structure of choline oxidase resembles that of PHBH as previously 
observed for other GMC enzymes. A covalent linkage between the His99Nε2 and FADC8M atoms 
was observed. The electron density maps for the FAD reveal an unusually distorted isoalloxazine 
ring system that can be rationalized as a C4a- or C10a-covelant adduct. The substrate choline 
was docked into the active site of choline oxidase structure based on the density map of DMSO, 
which was found in the active site structure. The resulting orientation of substrate is consistent 
with His351 being the active site catalytic base that abstracts the substrate hydroxyl proton 
during catalysis. The distance and the orientation of the Glu312, Trp331, and Phe357 to the 
trimethylammonium headgroup of choline are consistent with π-cation interactions between the 
quaternary ammonium moiety of the substrate and these residues. The distance between the 
modeled choline α-carbon and flavin N5 locus was found to be ~3 Å, consistent with hydride 
transfer mechanism for the oxidation of choline catalyzed by choline oxidase. This in turn, also 
provides structural basis for the tunneling behavior of hydride transfer. 
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Figure 1.27. Active site structures of choline oxidase, showing its cavity (A) and docking with 
choline (B).  
The important residues from the substrate- and FAD-binding domains are shown. 
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Figure 1.28. Active site structures of choline oxidase showing the proton-transfer network.  
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1.5. Choline Dehydrogenase  
Choline dehydrogenase (E.C. 1.1.99.1) is an inner mitochondrial membrane protein that 
catalyzes the four-electron oxidation of choline to glycine betaine via a betaine aldehyde 
intermediate and requires an electron acceptor other than oxygen (103, 201, 202) (Scheme 1.14). 
This reaction is of considerable interest for both biomedical and biotechnological applications, 
because the reaction product, glycine betaine, enables tolerances towards various environmental 
stresses, such as hypersalinity and low and high temperatures in both transgenic plants (176-179) 
and pathogens (203-205) (see Section 1.6).  
(CH3)3N
+ OH H2X (CH3)3N
+ H H2X (CH3)3N
+ O
OH2O, XO
X
 
Scheme 1.14.  Oxidation of choline to glycine-betaine catalyzed by choline dehydrogenase. 
X, Primary electron acceptor. Modified from ref. (102). 
 
To date, no in depth biochemical or kinetic characterization has been performed on 
choline dehydrogenase, mainly due to the difficulty in its purification because of the instability 
of the enzyme in vitro. Although choline dehydrogenase has been grouped in the GMC flavin-
dependent oxidoreductase superfamily (96), the presence of FAD as a cofactor is still ambiguous 
for this enzyme. Pyrroloquinoline quinone (PQQ) has been proposed to be the prosthetic group 
of the purified Pseudomonas choline dehydrogenase (103). Choline dehydrogenase has been also 
purified from rat liver mitochondria (201). The purified enzyme from either rat liver 
mitochondria or from Pseudomonas sp. showed to use phenazine methosulfate as a primary 
electron acceptor instead of oxygen (103, 201). In another study, the mitochondrial choline 
dehydrogenase showed a similar kcat and Km (0.8 mM) values with either phenazine methosulfate 
or ubiquinone as electron acceptors at infinite concentration (206).  
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Recently, we have reported the first recombinant choline dehydrogenase expressed and 
purified in E. coli by cloning the betA gene that codes for choline dehydrogenase from the 
moderate halophile Halomonas elongata (102). The purified enzyme showed its ability to react 
with either choline or betaine aldehyde as substrate with similar specificities, using phenazine 
methosulfate as the primary electron acceptor. Similar to the Pseudomonas enzyme, no evidence 
for the presence of FAD was observed in H. elongata choline dehydrogenase. The enzyme also 
showed ability to react with molecular oxygen as electron acceptor, but with four- to seven-fold 
decrease in kcat values with respect to phenazine methosulfate (10.9 vs 1.5 µmol of O2/min/mg 
for choline as substrate, and 5.7 vs 1.4 µmol of O2/min/mg for betaine aldehyde as substrate, in 
50 mM potassium phosphate, pH 7, at 25 °C), suggesting that the enzyme can act as an oxidase 
when electron acceptors other than molecular oxygen are not available (102). 
Choline dehydrogenase from E. coli K12 was also cloned, and expressed in E. coli strain 
BL21(DE3) in our laboratory (Powell, N., Dissertation, Chemistry Department, Georgia State 
University). The recombinant enzyme was partially purified, and showed a molecular mass of 
~62 kDa on SDS-PAGE. The partially purified enzyme also showed ability to react with both 
choline and betaine aldehyde as substrate, and to utilize either phenazine methosulfate or 
molecular oxygen as primary electron acceptor. The UV-visible absorbance spectrum of the 
purified enzyme showed absorbance maxima at ~275, ~375, and ~455 nm, as expected for a 
flavin-containing enzyme, but with relative intensities of the peaks in the near UV and visible 
regions of the spectrum suggesting that the bound flavin was present as a mixture of oxidized 
and anionic semiquinone states (Figure 1.29) (Powell, N., Dissertation, Chemistry Department, 
Georgia State University). This recombinant form choline dehydrogenase was highly unstable in 
vitro, which hindered any further biochemical and mechanistic investigations of that enzyme. 
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Figure 1.29. UV-visible absorbance spectrum of choline dehydrogenase containing a His-tag 
from Escherichia coli K 12, in air saturated 100 mM potassium phosphate, pH 7.0, at 25 oC. 
Taken from (Powell, N.; Dissertation, Chemistry Department, Georgia State University). 
 
 
The amino acid sequence alignment comparison of choline oxidase from A. globiformis 
with choline dehydrogenase from H. elongata and choline dehydrogenase from E. coli revealed 
that the identities and the similarities between choline oxidase and choline dehydrogenase are 
35% and 65%, respectively (Figure 1.30). The amino acid sequence alignment comparison of the 
two enzymes showed highly conserved residues in both the flavin binding domain and the active 
site of the enzymes (Figure 1.30). Due to the important roles of glycine betaine in bacterial 
survival under stressful environmental conditions (see Section 1.6 for details), the study of 
choline dehydrogenase has potential for the development of therapeutic agents that can inhibit 
the biosynthesis of glycine betaine in many humans’ pathogenic diseases. However, due to the 
high insolubility and instability of choline dehydrogenase, studies of cytosolic choline oxidase, 
which shares ~65% similarity with choline dehydrogenase and catalyzes the same enzymatic 
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reaction, can shed light on the catalytic properties of choline dehydrogenase. The analysis of the 
sequence alignment comparison of choline oxidase with choline dehydrogenase showed that the 
major difference between the two proteins is limited to a short hydrophobic peptide (23 
residues), which is absent in choline oxidase (Figure 1.30). This peptide might play an important 
role in anchoring choline dehydrogenase to the mitochondrial membrane. In addition, the crystal 
structure of choline oxidase showed that this region is located on the surface of the protein 
(Figure 1.31). Therefore, it is conceivable that a soluble and stable choline dehydrogenase might 
be obtained by mutagenizing choline dehydrogenase through the deletion of the nucleotides 
encoding for such short hydrophobic peptide.      
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CHO-Ag    MHIDNIENLSDREFDYIVVGGGSAGAAVAARLSEDPAVSVALVEAGPDDRGVPEVLQLDR 60 
CHD-He    -------MSQATEFDYIIIGAGSAGNVLATRLTEDSDVSVLLLEAGGPDYRFDFRTQMPA 53 
CHD-Ec    -----------MQFDYIIIGAGSAGNVLATRLTEDPNTSVLLLEAGGPDYRFDFRTQMPA 49 
             .. .  .  :****::*.**** .:*:**:**. .** *:***  *  .    *:   
 
CHO-Ag    WMELLESG--YDWDYPIEPQ-ENGNSFMRHARAKVMGGCSSHNSCIAFWAPREDLDEWEA 117 
CHD-He    ALAYPLQGKRYNWAFETDPEPHMDNRRMECGRGKGLGGSSLINGMCYIRGNALDYDHWAK 113 
CHD-Ec    ALAFPLQGKRYNWAYETEPEPFMNNRRMECGRGKGLGGSSLINGMCYIRGNALDLDNWAQ 109 
           :    .*  *:* :  :*:   .*  *. .*.* :**.*  *.   : .   * *.*   
 
CHO-Ag    KYGATGWNAEAAWPLYKRLETNEDAGPDAPHHGDSGPVHLMNVPPKDPTGVALLDACEQA 177 
CHD-He    QPGLEEWDYLSCLPYFKKSET-RDIGPNDYHGGDGPVSVTTPKAGNNPLYRTFIEAGKQA 172 
CHD-Ec    EPGLENWSYLDCLPYYRKAET-RDMGENDYHGGDGPVSVTTSKPGVNPLFEAMIEAGVQA 168 
          : *   *.   . * ::: **..* * :  * **.        .  :*   ::::*  ** 
 
CHO-Ag    GIPRAKFNTGTTVVNGANFFQINRRADGTRSSSSVSYIHPIVEQENFTLLTGLRARQLVF 237 
CHD-He    GYPETEDVNGYQQE-GFGPMDRFVTPKGRRASTARGYLDTAKQRSNLTIETRAVTDVIEF 231 
CHD-Ec    GYPRTDDLNGYQQE-GFGPMDRTVTPQGRRASTARGYLDQAKSRPNLTIRTHAMTDHIIF 227 
          * *.:.  .*    .* . ::    ..* *:*:: .*:.   .: *:*: *   :  : * 
 
CHO-Ag    DADRRCTGVDIVDSAFGHTHRLTARNEVVLSTGAIDTPKLLMLSGIGPAAHLAEHGIEVL 297 
CHD-He    EGKR-AVGVRYEQKGQ--PKQARARREVLLCGGAIASPQILQRSGVGNPEWLKELGIPVV 288 
CHD-Ec    DGKR-AVGVEWLEGDSTIPTRATANKEVLLCAGAIASPQILQRSGVGNAELLAEFDIPLV 286 
          :..* ..**   :     . :  *..**:*. *** :*::*  **:* .  * * .* :: 
 
CHO-Ag    VDSPGVGEHLQDHPEGVVQFEAKQPM-----------------------VAESTQWWEIG 334 
CHD-He    HELPGVGENLQDHLEMYIQYECKEPISLYPALKWYNQPKIGAEWLFKGTGVGASNQFESC 348 
CHD-Ec    HELPGVGENLQDHLEMYLQYECKEPVSLYPALQWWNQPKIGAEWLFGGTGVGASNHFEAG 346 
           : *****:**** *  :*:*.*:*:                        . ::: :*   
 
CHO-Ag    IFTPTEDGLDRPDLMMHYGSVPFDMNTLRHGYPTTENGFSLTPNVTHARSRGTVRLRSRD 394 
CHD-He    GFIRSRDDEEWPNLQYHFLPIAISYNGK---SAVQAHGFQAHVGSMRSESRGRIRLTSKD 405 
CHD-Ec    GFIRSREEFAWPNIQYHFLPVAINYNGS---NAVKEHGFQCHVGSMRSPSRGHVRIKSRD 403 
           *  :.:    *::  *: .:.:. *    . ..  :**.   .  :: *** :*: *:* 
 
CHO-Ag    FRDKPMVDPRYFTDPEGHDMRVMVAGIRKAREIAAQPAMAEWTGRELSPGVEAQTDEELQ 454 
CHD-He    PHAAPSILFNYMAKEK--DWEEFRDAIRLTREIIAQPAFDRYRGREISPGPDVQSDEELD 463 
CHD-Ec    PHQHPAILFNYMSHEQ--DWQEFRDAIRITREIMHQPALDQYRGREISPGVECQTDEQLD 461 
           :  * :  .*::. :. * . :  .** :***  ***: .: ***:*** : *:**:*: 
 
CHO-Ag    DYIRKTHNTVYHPVGTVRMGAVEDEMSPLDPELRVKGVTGLRVADASVMPEHVTVNPNIT 514 
CHD-He    NFVKQHAETAYHPCGSCRMG--EGDMAVTDAQGRVHGLEGLRVVDASLFPVIPTGNLNAP 521 
CHD-Ec    EFVRNHAETAFHPCGTCKMG--YDEMSVVDGEGRVHGLEGLRVVDASIMPQIITGNLNAT 519 
          :::::  :*.:** *: :**:  .:*:  * : **:*: ****.***::*   * * * . 
 
CHO-Ag    VMMIGERCADLIRSARAGETTTADAELSAALA----- 546 
CHD-He    TIMLAEKIADRIRGREPLPRASVDYYVANGAPAKQAS 558 
CHD-Ec    TIMIGEKIADMIRGQEALPRSTAGYFVANGMPVRAKK 556 
          .:*:.*: ** **. ..   ::..  :: . .      
 
Figure 1.30. Alignment of choline oxidase with choline dehydrogenase.  
CHO-Ag, choline oxidase from A. globiformis (GenBank accession no. AAP68832); CHD-He, choline 
dehydrogenase from Halomonas elongata (GenBank accession no. CAB77176); CHD-Ec, choline 
dehydrogenase from Escherichia coli (GenBank accession no. P17444). Yellow highlighted sequence, 
conserved flavin binding domain; gray highlighted sequence, conserved active site; cyan highlighted 
sequence, site of the major differences between CHO and CHD; *, identical residues; :, conserved 
substitution; ., semi-conserved substitution. 
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Figure 1.31. The surface of the monomeric structure of choline oxidase.  
Red highlighted residues, are Pro322, Met323, Val324, and Ala325. The FAD molecule is 
colored in yellow. 
 
  
85
 
1.6. Biological Applications 
The chemical reaction catalyzed by choline oxidase is of considerable interest for 
biotechnological and biomedical applications, because accumulation of glycine betaine in many 
economically relevant crop plants and human pathogens enables their stress resistance toward 
hyperosmotic environments (207). Therefore, the study of choline oxidase has potential for the 
development of therapeutic agents that inhibit the biosynthesis of glycine betaine and render 
pathogenic bacteria susceptible to either conventional treatments or the innate immune system, 
and for the improvement of water stress resistance in genetically engineered crops lacking 
efficient glycine betaine biosynthetic systems.  
The exposure of microorganisms to high osmolality environments enhances rapid fluxes 
of water outside the cell, thereby resulting in dehydration and reduction in turgor of the 
cytoplasm. Microorganisms counteract the outflow of water from their cytoplasm by increasing 
the uptake of potassium ions and organic osmolytes (also called compatible solutes or 
osmoprotectants) to increase their intracellular solute pool and prevent the cytoplasmic outflow 
of water (208). Osmoprotectants are defined as exogenously provided organic solutes that 
promote bacterial growth under hyperosmotic environments. These compounds may act as 
precursors that can be enzymatically converted into compatible solutes or they may themselves 
be compatible solutes (207). The intracellular uptake of compatible solutes is not restricted to 
bacteria but is also used as a common strategy among fungi, plants, animals, and even human 
cells to compensate the adverse effects of high osmolality and high ionic strength (209, 210). In 
microorganisms, only a limited number of organic compounds serve as compatible solutes, 
including sugars (trehalose), free amino acids (glutamate and proline) and derivatives thereof  
(proline betaine and ecotine), polyols (glycerol and glucosylglycerol), and quaternary amines and 
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their sulfonium analogs (glycine betaine, carnitine, and dimethylsulfoniopropionate) (Figure 
1.32) (207). In general, compatible solutes are highly soluble and at physiological pH their net 
charges are equal to zero. Compatible solutes can reach high intracellular concentration without 
interfering with the vital physiological functions of the cells (211). Glycine betaine (N,N,N–
trimethylglycine) is one of the most commonly used compatible solutes that is accumulated in 
the cytoplasm of microorganisms to counteract hyperosmotic environments (212).  
In microorganisms, the intracellular accumulation of glycine betaine is achieved either 
through transporters (osmotically stimulated uptake systems) that enhance the intracellular 
uptake of exogenous glycine betaine across the cell membrane or by endogenous intracellular 
biosynthetic pathways (207). In E. coli and Salmonella typhymurium, two transporters are mainly 
responsible for the intracellular uptake of exogenous glycine betaine across the cell membrane, 
ProP and ProU (Figure 1.33). The penetration of exogenous glycine betaine through the outer 
membrane of those two bacterial species is achieved by passive diffusion through the nonspecific 
porin transporters, i.e., OmpC and OmpF (Figure 1.33). The expression of porin structural genes 
is regulated by medium osmolality. OmpC synthesis prevails in hypertonic media, while the 
production of OmpF predominates under hypotonic environments (213). E. coli can synthesize 
glycine betaine by the two-step oxidation of its precursor choline catalyzed by the membrane 
bound choline dehydrogenase (Figure 1.33) (214). A limited number of other bacterial strains 
such as A. globiformis, H. elongata, S. aureus, and P. aeruginosa can also accumulate glycine 
betaine intracellulary by stepwise methylation of glycine (204, 215).  In Bacillus subtilis, while 
the intracellular uptake of proline is controlled by the highly substrate-specific transport system 
OpuE (osmoprotectants uptake), the intracellular uptake of glycine betaine is controlled by 3 
highly effective transporters, OpuA, OpuC, and OpuD, which enhance the exogenous uptake of 
  
87
 
glycine betaine from the environment up to a cellular concentration level that exceed 1 M under 
osmotic stress conditions (Figure 1.34) (207).  
 
 
Figure 1.32. Structures of selected osmoprotectants. 
Taken without permission from ref. (207). 
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Figure 1.33. Osmostress response systems of E. coli. 
GB glycine betaine, Glc glucose, Glc-6-P glucose-6-phosphate, Tre trehalose, Tre-6-P trehalose-
6-phosphate, UDP-Glc uridine disphosphate-glucose. Taken without permission from ref. (207).  
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Figure 1.34. Osmostress response systems of Bacillus subtilis. 
Taken without permission from ref. (207). 
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1.6.1. Glycine Betaine as an Osmoprotectant 
Glycine betaine (N,N,N–trimethylglycine) is a zwitterionic molecule that is widely 
distributed in a large variety of microorganisms, animals, and plants. The high intracellular 
concentration of glycine betaine does not interfere with the normal physiological functions 
within the cytoplasm of the cells but instead it maintains cell turgor and stabilizes the structure 
and function of several macromolecules (216). Consequently, the intracellular accumulation of 
glycine betaine enhances cells growth and proliferation under stress conditions. Glycine betaine 
acts as an osmoprotectant by stabilizing the highly ordered structures of proteins and membranes, 
particularly the quaternary structures of complex proteins (212).  
The osmoprotective effects of glycine betaine on bacteria (E. coli) were first reported in 
an experiment that showed that in the presence of glycine betaine in the medium, E. coli can 
grow under inhibitory high concentration of NaCl (0.8 M) (217). Cayley et al. reported that the 
amount of glycine betaine increased monotonically in the cytoplasm of E. coli K12 with 
increasing osmolality (218). Similarly, it was observed that glycine betaine was responsible for 
the survival of the halophilic bacterium Halomonas elongata in a salinity range of 0.1-4 M NaCl 
(219). It has also been reported that the addition of glycine betaine can restore the depreciated 
growth rate of E. coli under high osmolality (211, 220). Such reversion of the inhibitory effect of 
high osmolality was also observed in other non-halophilic bacteria, such as Bacillus subtilis, and 
Salmonella oranienburg (221, 222).  
In plants, glycine betaine has been shown to be a critical determinant of stress tolerance. 
The presence of glycine betaine as osmoprotectant is usually associated with enhanced growth 
and germination of plants in dry or saline environments (210). Moreover, the exogenous 
inclusion of glycine betaine has shown a significant effect on the growth and survival of a wide 
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range of plants under different stress conditions (178). The protective functions of glycine 
betaine for plants were confirmed by transforming betaine-synthesizing genes into plants that 
were deficient in glycine betaine. The gene that encodes for choline oxidase (codA), which 
converts choline to glycine betaine, has been the most commonly used in these transformations. 
The transformation of Arabidopsis thaliana with the codA gene from Arthrobacter globiformis 
resulted in a significant accumulation of glycine betaine in different organs of the transformed 
plants (178). The transgenic Arabidopsis have shown a significant tolerance to high-salt 
conditions (100 - 600 mM NaCl) during seed germination and during the growth of seedlings 
and mature plants (Figure 1.35) (178). Similarly, the imbibition and the germination of the seeds 
as well as the growth of the seedlings of transgenic plants showed enhanced tolerance to non-
freezing low temperatures (5 °C) compared to those of wild-type plants (175, 178). In addition, 
the accumulation of glycine betaine in transgenic Arabidopsis plants resulted in a considerable 
tolerance to high-temperature (35-42 °C) during imbibition and germination (176). Finally, 
transformed Arabidopsis thaliana has shown a significant tolerance to high-intensity light 
stresses compared to wild type plants, which results from the fast recovery of the photosystem II 
complex from the light-induced inactivated state (177). Therefore, the accumulation of glycine 
betaine in many pathogens and plants enables their stress-resistance towards hyperosmotic 
environments.  
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Figure 1.35. Enhanced tolerance of transgenic Arabidopsis to salt stress.  
Enhanced tolerance to salt at various developmental stages of transgenic Arabidopsis that 
accumulates GB as a consequence of the introduction of the codA gene from A. globiformis. A, 
Seeds were germinated on gel-solidified medium supplemented with 100 mM NaCl and 
incubated for 20 d. The left two plants are transformed plants and the right two plants are wild 
type. B, Two-week-old seedlings were exposed to 600 mM NaCl for 4 h, and after transferring to 
normal conditions they were allowed to grow for 3 weeks. Left, Transformed plants; right, wild-
type plants. C, Thirty-day-old plants were watered with 200 mM NaCl for 10 d. Left, 
Transformed plant; right, wild-type plant. Taken without permission from ref. (216).  
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1.6.2. Biotechnological Application of Glycine Betaine 
Several economically relevant crop plants such as soybean, rice, and potato are deficient 
in osmoprotectants (223). As previously discussed (Section 1.6.1), several studies have strongly 
confirmed that glycine betaine is one of the most potent osmoprotectant in transgenic plants. 
Genetically engineered plants are expected to accumulate glycine betaine in their cytoplasm due 
to their inability to catabolize glycine betaine. Consequently, numerous studies have been carried 
out with the goal of genetically engineering increased stress tolerance in economically relevant 
crop plants (176, 177, 180, 224-226).  
The introduction of betaine-producing enzymes (choline dehydrogenase) enhanced the 
survival of transgenic tobacco under varying salinity and temperature conditions (224). 
Transgenic lines of Indica rice have been transformed with the codA gene from Arthrobacter 
globiformis (227). The exposure of the genetically modified plants to salt stress (0.15 M NaCl) 
for one week, followed by a recovery period, showed that more than 50% of the transgenic plants 
could survive salt stress and set seed whereas wild-type plants failed to recover (227).  
Recently, tomato plants, which normally do not accumulate glycine betaine and are 
susceptible to chilling stress, have been transformed with the codA gene from Arthrobacter 
globiformis (228). The genetically engineered plants have shown a notable improvement of 
chilling stress tolerance compared to wild-type plants in various developmental phases. The 
overall yield of the transgenic tomato plants during reproduction was enhanced by an average of 
10–30% more fruit following chilling stress. It has been assumed that the increased levels of 
H2O2 in codA transgenic plants, as a byproduct of choline oxidase-catalyzed glycine betaine 
synthesis, might activate an H2O2-inducible protective mechanism, resulting in improved chilling 
and oxidative tolerances in glycine betaine accumulating codA transgenic plants. Overall, the 
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introduction of a biosynthetic pathway of glycine betaine into tomato through genetic 
engineering is a valuable approach for improving chilling tolerance (228). 
1.6.3. Biomedical Applications of Glycine Betaine 
The accumulation of the major osmoprotectant glycine betaine has been observed in a 
number of human pathogens, including Listeria monocytogenes, Staphylococcus aureus, and 
Pseudomonas aeruginosa (203, 205, 208). Hyperosmolarity is frequently encountered at human 
infection sites (229), where glycine betaine precursors, i.e., choline, acetylcholine, 
phosphatidylcholine, and phosphorylcholine, are abundant (230-232). Therefore, pathogens can 
employ these precursors not only to produce glycine betaine as a potent osmoprotectant, but also 
as carbon and nitrogen sources to survive at infectious sites.  
P. aeruginosa is a human opportunistic microbe, which causes a variety of human 
systemic infections. For P. aeruginosa, glycine betaine does not only act as the major 
osmoprotectant of the pathogen, but it also serves as a metabolic intermediate as well (215). To 
examine the role of glycine betaine accumulation for bacterial growth under stressful infectious 
conditions, disulfiram was tested as an inhibitor for P. aeruginosa betaine aldehyde 
dehydrogenase (an enzyme that catalyzes the last irreversible step of glycine betaine synthesis 
from choline), with the goal of development of potent therapeutic agents for P. aeruginosa 
infection (215). Although in vivo studies are necessary before drawing any further conclusions, 
disulfiram totally and irreversibly inhibited the activity of betaine aldehyde dehydrogenase, 
suggesting a significant role for this inhibitor as an antimicrobial agent.  
Several studies have shown that L. monocytogenes, which is causative agent of human 
food poisoning, can survive and tolerate a variety of environmental stress conditions due to the 
accumulation of glycine betaine (233, 234). The intracellular accumulation of glycine betaine in 
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the cytoplasm of L. monocytogenes enables the pathogens to tolerate not only external adverse 
environmental conditions such as high or low temperature prior to ingestion to host, but also the 
internal environment within the host with high salt concentration ranges from 0.3 to 0.7 M (205). 
The effects of glycine betaine accumulation on the virulence of L. monocytogenes were studied 
by mutating the glycine betaine transporter OpuC. In murine studies, the mutated pathogen 
showed a significant reduction in glycine betaine accumulation as well as a significant decrease 
of the bacterial colonies in small intestine of the host cell (205). These results strongly suggest an 
important role of glycine betaine synthesis in the virulence of pathogen. 
E. coli is considered as the most frequent causative agent of human urinary tract 
infections. The osmolality of human urine can widely vary in a range between 0.04 to 1.4 mol/kg 
(235, 236). The human urinary tract experiences a wide range of pH fluctuations upon washing 
with urine that contains high levels of organic acid. The pH of human urine can vary between 5 
to 8, depending on the nature of ingested diet (235). As a direct prove of the role of glycine 
betaine in enhancing the ability of E. coli to survive and grow in human urinary tract, glycine 
betaine was detected to be accumulated during the growth of E. coli in medium containing 1.2 M 
NaCl (235). 
Staphylococcus aureus is now considered as the second most common cause (after E. 
coli) of urinary tract infection. This organism is also considered the most osmotolerant among 
the non-halophilic eubacteria (204).  S. aureus  has also shown its ability to withstand a wide 
range of osmolarity, it can grow well either at high (3.5 M NaCl) or low osmolalities, consistent 
with a highly developed system in regulating cytoplasmic osmolality (204). The urinary isolates 
of S. aureus accumulate glycine betaine in both the presence and absence of osmotic stress. 
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Unlike E. coli, S. aureus did not accumulate other betaines in presence of glycine betaine, 
suggesting the crucial role of glycine betaine for the survival and pathogenity of S. aureus (204).  
Overall, the accumulation of glycine betaine in many human pathogenic bacteria, which 
enables their growth and survival at human infection sites under hyperosmotic conditions, points 
potential of studying choline oxidase or its analog choline dehydrogenase for the development of 
therapeutic agents that inhibit the formation of glycine betaine and render pathogenic bacteria 
susceptible to either conventional treatments or the innate immune system. 
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1.7. Goals 
Choline oxidase (E.C. 1.1.3.17) from A. globiformis is a flavin-dependent enzyme that 
catalyzes the four-electron oxidation of choline to glycine betaine, one of a limited number of 
compounds that accumulates to high levels in the cytoplasm of cells to counteract the adverse 
effects of hyperosmotic environments (207). The accumulation of glycine betaine has been 
observed in a number of human pathogenic bacteria, such as Staphylococcus aureus, 
Mycobacterium tuberculosis, Pseudomonas aeruginosa, Listeria monocytogenes, Enterococcus 
faecalis, Klebsiella pneumoniae, Vibrio sp. and E. coli O157: H7 (203-205, 208, 235, 237, 238). 
Osmotic stress conditions are frequently observed at human infection sites where glycine betaine 
precursors, i.e., choline and its analogues, are very abundant (229, 230, 232). Consequently, the 
study of choline oxidase or its analog choline dehydrogenase has potential for the development 
of therapeutic agents that inhibit the formation of glycine betaine and render pathogenic bacteria 
susceptible to either conventional treatments or the innate immune system. Furthermore, the 
recent findings that many crop plants accumulate glycine betaine in their cytoplasm in response 
to adverse environmental conditions, such as high or low temperature, high salts, and water 
deficiency, have motivated considerable interest in studying glycine betaine biosynthesis, with 
the objective of genetically engineering enhanced resistance towards environmental stress in 
economically relevant crop plants (176, 177, 180, 224-226).  
Up to 2003, despite a wealth of studies on the biomedical and biotechnological 
applications of the enzyme, minimal biochemical and mechanistic studies on choline were 
reported. The biotechnological and biomedical potentials for choline oxidase require a 
meticulous biochemical, biophysical, kinetic, and structural characterization of the enzyme, 
which is the goal of this study. This study will provide a solid background for the different 
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biomedical and biotechnological applications of choline oxidase. It will also provide new 
insights for other flavoproteins that are structurally and functionally related to choline oxidase.   
The biophysical, biochemical, structural, and mechanistic characterization of an enzyme 
usually require large quantities of the pure, active and stable form of such enzyme. 
Consequently, the first step in this project was aimed to clone codA gene that encodes for choline 
oxidase from A. globiformis. The cloned gene can then be used not only for production of 
enzyme, but also for the preparation of a number of mutant forms of choline oxidase to 
investigate the role of specific active site residues. In addition, efficient approaches for protein 
expression and purification, which can provide large quantities of pure and stable the enzymes, 
are required as well.  
For a newly purified enzyme, it is important to understand firstly the different 
biophysical, biochemical, spectrophotometrical, kinetic, and mechanistic properties of the wild-
type form prior of the further investigation of the role of specific active site residues by preparing 
different mutant forms of the enzyme. Thus, biophysical, biochemical, spectrophotometrical, 
kinetic, and mechanistic properties of the wild-type choline oxidase were studied in parallel with 
similar studies on selected mutant forms of the enzyme. From a structural standpoint, the X-ray 
crystallographic structures of most flavoprotein oxidases including choline oxidase (George 
Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; unpublished results) have shown that 
a positively charge amino acid residue or a dipole of an α-helix is oriented to the N(1)-C(2)=O 
locus of the enzyme-bound flavin (31-33, 35-40, 95, 183), with mechanistic implications for the 
modulation of flavin reactivity. While the effects of replacing the positive charge with a neutral 
amino acid on the flavin properties have been investigated for lactate monooxygenase (239), no 
studies have addressed the characterization of the flavin properties of an oxidase in which the 
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positive charge close to the flavin N(1) was reversed. The main goals of this study were aimed to 
obtain insights on the roles played by the positively charged conserved active site residue, His466, 
proximal to the N(1) locus of the bound flavin in choline oxidase; and for the first time to 
characterize a flavoprotein oxidase with a negative charge near the flavin N(1) locus. Mutant 
forms of choline oxidase were prepared in which the conserved active site residue, His466, was 
substituted with either a neutral (alanine) or a negatively charged (aspartate) amino acid, 
followed by the biophysical, biochemical and mechanistic characterizations of those mutant 
forms with respect to the wild-type choline oxidase. 
Since unambiguous biochemical, structural, and mechanistic characterizations of other 
related flavoprotein oxidases that oxidize alcohols were hindered, the biochemical and the 
mechanistic studies of wild-type choline oxidase along with its active site mutants can shed light 
on other flavoproteins that are structurally and functionally related to choline oxidase. 
Interestingly, for the first time obtaining insights for flavoprotein oxidase with a negative charge 
near the flavin N(1) locus. From biotechnological and biomedical standpoints, these biochemical 
and mechanistic studies of choline oxidase will be the foundation for future rational design of 
efficient transition state analogs and inhibitors that could be used for the development of 
therapeutic agents that inhibit the formation of glycine betaine, and in turn render pathogenic 
bacteria susceptible to conventional treatments. 
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 CHAPTER II 
Material and Methods 
Materials 
Escherichia coli strain JM109 harboring plasmid pGAH/codA was a kind gift from Dr. 
Murata, National Institute for Basic Biology, Okazaki, Japan (1, 2). A freeze-dried culture of 
Arthrobacter globiformis (ATCC 8010) was obtained from American Type Culture Collection. 
Restriction endonucleases Nde I and EcoR I, calf intestinal alkaline phosphatase, T4 DNA ligase, 
Taq DNA polymerase, deoxynucleotide triphosphates, and bovine serum albumin were 
purchased from Promega. Cloned Pfu DNA polymerase, DpnI, and E. coli strain XL1-Blue were 
obtained from Stratagene (La Jolla, CA). Bgl II, BamH I, and Hind III were from New England 
Biolab. Luria-Bertani agar, Luria-Bertani broth, chloramphenicol, tetracycline, kanamycin, 
isopropyl-β-D-thiogalactopyranoside (IPTG), lysozyme, sodium hydrosulfite (dithionite), 
sodium sulfite, phenylmethylsulfonyl fluoride (PMSF), and betaine aldehyde bromide were 
obtained from Sigma-Aldrich (St. Louis, MO). Carbenicillin, ampicillin, choline chloride, and 
electrophoresis-grade agar were purchased from ICN Biomedicals (Aurora, OH). Nutrient Broth 
and Nutrient Agar #3 were from Difco. 1,2-[2H4]-Choline bromide was from Isotec Inc. 
(Miamisburg, OH). Deuterium oxide (D2O) was from Cambridge Isotope Laboratories Inc. 
(Andover, MA). All other reagents were of the highest purity commercially available. 
Oligonucleotides were custom synthesized on a Beckman Oligo model 1000 M by the DNA 
Core Facility of the Biology Department of Georgia State University, or by Sigma Genosys (The 
Woodlands, TX).  
A. globiformis genomic DNA was purified using the DNeasy midi-kit from Qiagen 
(Valencia, CA). Plasmids and products deriving from primer extension reaction and PCR were 
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purified by using QIAprep Spin Miniprep kit from Qiagen. E. coli strains Novablue and 
Rosetta(DE3)pLysS were from Novagen (Madison, WI). E. coli strain Novablue cells harboring 
plasmid pET/codA1 or pET/codA2, strain XL1-Blue cells harboring plasmid pET/codA3, and 
strain Rosetta(DE3)pLysS cells harboring plasmid pET/codA1 or pET/codA3 were stored at –80 
oC as 7% DMSO suspensions. E.coli MKH13 harboring pJB004 was a kind gift from Dr. Erhard 
Bremer (Philipps Universität, Marburg, Germany). DNA sequencing was carried out with an 
Applied Biosystems Big Dye kit on an Applied Biosystems model ABI 377 DNA sequencer by 
the DNA Core Facility of the Biology Department of Georgia State University. 
Instruments  
UV-visible absorbance spectra were recorded using an Agilent Technologies diode-array 
spectrophotometer model HP 8453 equipped with a thermostated water bath. Fluorescence 
emission spectra were recorded with a Shimadzu Spectrofluorometer model RF-5301 PC 
thermostated at 15 °C. Circular dichroism spectra were acquired using a Jasco J-810 
spectropolarimeter at 5 °C. Enzyme activity was measured polarographically by monitoring the 
rate of oxygen consumption with a Hansatech oxygen electrode (HansaTech Oxy-32) 
thermostated at 25 oC. Rapid kinetics was carried out on a Hi-Tech 61 SF-DX2 Double mixing 
stopped-flow spectrophotometer thermostated at 25 oC.   
Subcloning and cloning of codA  
E. coli  strain JM109 harboring plasmid pGAH/codA was grown on Luria-Bertani agar 
medium containing kanamycin at a final concentration of 15 µg/ml for 16 h at 37 oC. Single 
colonies were used to inoculate 2 ml of Luria-Bertani broth medium containing kanamycin (15 
µg/ml) and the resulting liquid cultures were grown at 37 oC for 7 h. After harvesting the cells by 
centrifugation at 14,000 x g for 10 min, the plasmid vector was isolated by using a QIAquick 
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Spin Miniprep kit (Qiagen) following the manufacturer’s protocol. The isolated plasmid DNA 
was then used for primer extension reaction of the codA gene encoding for choline oxidase by 
using the oligonucleotide primers Chox-for A and Chox-rev containing NdeI and EcoR I 
restriction endonuclease sites designed to anneal to the 5’ and 3’ ends of the gene, respectively 
(Table 2.1).  The NdeI and EcoR I restriction sites introduced at the 5’ ends of the sense and 
antisense primers allowed cloning of codA into the corresponding sites of pET20b(+). Primer 
extension reaction was performed in the presence of DMSO at a final concentration of 2% for 1 
min at 95 oC, followed by 31 three-step cycles of 0.5 min at 95 oC, 1 min at 55 oC, 4.5 min at 68 
oC, with a final 5-min step at 68 oC, in a total volume of 50 µl by using ~15 ng of template DNA, 
2.5 U of Pfu DNA polymerase, and the manufacturer’s suggested protocol. The resulting 
amplicons were purified by agarose gel electrophoresis using the QIAquick Gel Extraction kit 
(Qiagen) following the manufacturer’s protocol. 
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Table 2.1. Oligonucleotide primers used for primer extension amplification and PCR of 
codA, as well as the mutagensis for pET/codA 
Primer Nucleotide sequence Purpose 
ChoxforA CGGCAAGGAGAACCATATGCACATCGACAACATCTG Cloning 
Choxrev CCCCGGAATTCGCCGCTCCCGCTTAGG Cloning 
PET-for a CACTATAGGGAGACCACAACG Sequencing 
PET-revA GCTTATGCTAGTTATTGCTCAGC Sequencing 
Choxag 3 CAATGAAGTCGTGCTCTCC Sequencing 
Choxag 5 CGAAGTTCAACACC Sequencing 
Choxag 7 CGATGCAGGAGTTGTGG Sequencing 
Cho-H466Af CAACACCGTCTACGCCCCCGTGGGCACCGTGC Mutagensis 
Cho-H466Ar CACGGTGCCCACGGGGGCGTAGACGGTGTTGTGC Mutagensis 
Cho-H466Df CAACACCGTCTACGACCCCGTGGGCACCGTGC Mutagensis 
Cho-H466Dr CACGGTGCCCACGGGGTCGTAGACGGTGTTGTGC Mutagensis 
Cho-H310Af CGAGCACCTGCAGGACGCCCCGGAAGGCGTGG Mutagensis 
Cho-H310Ar GCACCACGCCTTCCGGGGCGTCCTGCAGGTGCTCGCC Mutagensis 
Cho-H310Df GGGCGAGCACCTGCAGGACGACCCGGAAGGCGTGGTGC Mutagensis 
Cho-H310Dr GCACCACGCCTTCCGGGTCGTCCTGCAGGTGCTCGCC Mutagensis 
Cho-H310Nf GGGCGAGCACCTGCAGGACAACCCGGAAGGCGTGGTGC Mutagensis 
Cho-H310Nr GCACCACGCCTTCCGGGTTGTCCTGCAGGTGCTCGCC Mutagensis 
Cho-E370Af CGGCTACCCCACCACGGCGAACGGCTTCAGCC Mutagensis 
Cho-E370Ar GAGGCTGAAGCCGTTCGCCGTGGTGGGGTAGCC Mutagensis 
Cho-H87Af GCAACTCCTTCATGCGCGCTGCCCGTGCCAAGGTC Mutagensis 
Cho-H87Ar CCTTGGCACGGGCAGCGCGCATGAAGGAGTTGC Mutagensis 
Cho-H87Cf GCAACTCCTTCATGCGCTGTGCCCGTGCCAAGGTC Mutagensis 
Cho-H87Cr CCTTGGCACGGGCACAGCGCATGAAGGAGTTGC Mutagensis 
Cho-Y465Af CACAACACCGTCGCCCACCCCGTGGGCACCGTGC Mutagensis 
Cho-Y465Ar CACGGTGCCCACGGGGTGGGCGACGGTGTTGTGC Mutagensis 
Cho-Y465Hf CACAACACCGTCCACCACCCCGTGGGCACCGTGC Mutagensis 
Cho-Y465Hr CACGGTGCCCACGGGGTGGTGGACGGTGTTGTGC Mutagensis 
Underlined nucleotides indicate endonuclease restriction sites for NdeI and EcoR I enzymes in 
cloning primers and mismatches sites in mutagensis primers. 
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Cloning was performed from A. globiformis strain ATCC 8010, which was grown on 
Difco #3 Nutrient Agar medium for 48 h at 26 oC. Single colonies were used to inoculate eight 5 
ml of Difco #3 Nutrient Broth and the resulting liquid cultures were grown overnight at 26 oC. 
The cells were harvested by centrifugation at 14,000 x g for 10 min, and the genomic DNA was 
isolated using the DNeasy Midi-kit (Qiagen) according to the manufacturer’s instructions. The 
isolated genomic DNA was then used for PCR of the codA gene with the oligonucleotide primers 
described above. PCR was carried out with an Eppendorf Mastercycler in the presence of 4% 
DMSO for 1 min at 95 oC, followed by 31 cycles of 1 min at 95 oC, 1 min at 50 oC, 2 min at 72 
oC, and a final 5-min step at 72 oC in a total volume of 50 µl by using ~200 ng of template DNA, 
5 U of Taq DNA polymerase, 3 mM magnesium chloride, and the polymerase manufacturer’s 
suggested protocol. The resulting amplicons were purified by agarose gel electrophoresis using 
the QIAquick Gel Extraction kit (Qiagen) following the manufacturer’s protocol. 
Endonuclease digestion of both the amplified codA from A. globiformis and pET20b(+) 
with NdeI and EcoR I, dephosphorylation of the plasmid with calf intestine alkaline phosphatase, 
and ligation were carried out as described above, and 1 µl of the ligation reaction mixture was 
used directly to transform by electroporation 100 µl of E. coli strain Novablue competent cells. 
The resulting transformant colonies obtained by plating on Luria-Bertani agar plates containing 
50 µg/ml ampicillin and 12.5 µg/ml tetracycline were screened for the presence of codA by 
colony PCR. PCR was performed with 5 U of Taq DNA polymerase in the presence of 2% 
DMSO for 1 min at 95 oC followed by 31 three-step cycles of 1 min at 95 oC, 2 min at 55 oC, 2 
min at 72 oC, and a 5-min final step at 72 oC, using sense and antisense oligonucleotide primers 
designed to bind to DNA regions of pET20b(+) flanking the inserted gene. The correct 
constructs, pET/codA1 and pET/codA2, were sequenced in both directions as described above. E. 
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coli strain Rosetta(DE3)pLysS competent cells were transformed with plasmid pET/codA1 for 
protein expression. 
Enzyme preparation  
Permanent frozen stocks of E. coli cells Rosetta(DE3)pLysS harboring plasmid 
pET/codA1 were used to inoculate 50 ml of Luria-Bertani broth medium containing ampicillin 
(or carbenicillin) and chloramphenicol at final concentrations of 50 and 34 µg/ml, respectively, 
at 37 oC. After 9 h, 1 ml of the starter culture was used to inoculate 3 x 1.5 liters of the same 
liquid culture medium at 30 oC. When the culture reached an optical density at 600 nm between 
0.8 and 1.4, typically after 16 h, IPTG was added to a final concentration of 50 µM and the 
temperature of the culture was lowered between 21 and 25 oC. Cells were harvested by 
centrifugation at 20,000 x g for 20 min at 4 oC and stored at –20 oC. Typically, ~8 g of wet cell 
paste were obtained from 1.5 liters of cells culture. 
Unless otherwise stated, all the purification steps were carried out at 4 oC. The cell paste, 
typically 25 g, was suspended in 6 volumes of a solution of 0.1 mM PMSF, 0.2 mg/ml lysozyme, 
1 mM EDTA, and 50 mM potassium phosphate at pH 7 and allowed to incubate with stirring for 
30 min on ice. The resulting slurry was passed three times through an SLM Aminco French 
pressure cell at 20,000 lb/in2 and then centrifuged at 20,000 x g for 20 min. The supernatant was 
collected, incubated with stirring for 30 min on ice with 20 µg/ml RNase and 50 µg/ml DNase in 
the presence of 10 mM magnesium chloride, and centrifuged as described above. The soluble 
fraction was brought to 30% ammonium sulfate saturation, incubated for 30 min on ice, and 
separated from the insoluble fraction by centrifugation as described above. Choline oxidase was 
then collected in the pellet fraction by treatment with ammonium sulfate at a final saturation of 
65%, followed by centrifugation as described above. The resulting pellet was suspended in 25 ml 
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of 200 mM Tris-Cl, pH 8, and dialyzed against three 1-liter changes of the same buffer over 20 
h. After dialysis, precipitated proteins were removed by centrifugation at 18,700 x g for 20 min 
and the resulting supernatant was loaded onto a DEAE-Sepharose Fast Flow column (3 x 28 cm) 
connected to an Åktaprime Amersham Pharmacia Biotech system equilibrated with 200 mM 
Tris-Cl at pH 8. The column was eluted with 2 volumes of the same buffer, followed by a linear 
gradient from 0 to 0.5 M NaCl developed over 5 volumes at a flow rate of 2 ml/min. The 
fractions with the highest purity as judged by enzymatic activity and UV-visible absorbance 
spectroscopy were pooled together and concentrated with the addition of 65% ammonium sulfate 
saturation followed by centrifugation. Oxidized FAD-containing choline oxidase was prepared at 
4 oC by dialysis against three 1-liter changes of 20 mM sodium phosphate, 20 mM sodium 
pyrophosphate, pH 6, over 24 hours, followed by two 1-liter changes of 20-200 mM Tris-Cl, pH 
8 over five hours. This enzyme could be stored at -20 oC for at least 7 months without losses in 
enzymatic activity. 
Site-directed mutagenesis 
A QuikChange kit was used to prepare the mutant enzymes choline oxidase-H466A 
(CHO-H466A), choline oxidase-H466D (CHO-H466D), choline oxidase-H310A (CHO-H310A), 
choline oxidase-H310D1 (CHO-H310D), choline oxidase-H310N2 (CHO-H310N), choline 
oxidase-E370A3 (CHO-E370A), choline oxidase-H87A (CHO-H87A), choline oxidase-H87C 
(CHO-H87C), choline oxidase-Y465A (CHO-Y465A), and choline oxidase-Y465H (CHO-
Y465H). The method used was essentially according to the manufacturer’s instructions, using 
                                                 
1 Ongoing project. 
2 Ongoing project. 
3 E370A mutant form of choline oxidase has been expressed and purified. The biochemical and the kinetic 
characterization of that mutant form showed that there is no significant different between that mutant and the wild-
type enzyme. Furthermore, the recently solved  X-ray crystallographic structure of choline oxidase showed that this 
residue is located at the surface of protein, consistent with its similarity to the wild-type enzyme. 
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pET/codA1 plasmid (3) as a template and the corresponding forward and reverse primers (Table 
3.1). DNA was sequenced at the DNA Core Facility at Georgia State University using an 
Applied Biosystems Big Dye Kit on an Applied Biosystems model ABI 377 DNA sequencer. 
Sequencing confirmed the presence of the mutant genes in the correct orientation. E. coli strain 
Rosetta(DE3)pLysS competent cells were transformed with the mutated plasmid by 
electroporation. 
Expression and purification of the mutated enzymes  
Permanent frozen stocks of E. coli cells Rosetta(DE3)pLysS harboring the mutated 
plasmid were used to inoculate 4.5 liters of Luria-Bertani broth medium containing 50 µg/ml 
ampicillin and 34 µg/ml chloramphenicol, and liquid cultures were grown overnight at 37 °C. 
The cultures were induced for protein expression by adding 0.05 mM IPTG and then incubated 
for an additional 5 h at 22 °C. 100 µl aliquots was taken 5 h after induction with IPTG to be used 
for visualization of the expressed proteins using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis following the Laemmli method (4). The gel was stained with Commassie 
Brilliant Blue G-250. The mutant enzymes (CHO-H466A, CHO-H466D, CHO-H310A, and 
CHO-E370A) were purified to homogeneity using the same procedure used previously for the 
purification of the wild-type enzyme (3). 
Enzyme assays  
The concentration of choline oxidase was determined with the method of Bradford (5), by 
using the Bio-Rad protein assay kit with bovine serum albumin as the standard. The oxidized 
flavin content of choline oxidase as purified was determined from the ∆A452 after treatment of 
the enzyme with 5 mM dithionite in air-saturated 200 mM Tris-Cl, pH 8, using an ε452 value of 
8.4 mM-1cm-1, which corresponds to the difference between the extinction coefficients for the 
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enzyme-bound oxidized flavin (ε452 = 8.4 mM-1cm-1) and semiquinone flavin (ε452 = 3 mM-1cm-1) 
(6). Enzyme activity was measured with the method of the initial rates (7) in air-saturated 50 mM 
potassium phosphate at pH 7 by monitoring the rate of oxygen consumption with a computer-
interfaced Oxy-32 oxygen-monitoring system  (Hansatech Instrument Ltd.) thermostated at 25 
oC. The reactions were started by the addition of choline oxidase to a 1 ml reaction mixture, with 
the final concentration of enzyme in the 0.1 to 0.5 µM range; the concentration of choline or 
betaine aldehyde was between 0.02 and 35 mM. The effect of pH on the kinetic parameters of 
CHO-H466A were determined over a pH range from 5.5 to 11 by a series of enzyme activity 
assays at varying choline concentrations ranging from 0.025 to 45 mM in air-saturated 50 mM 
sodium pyrophosphate at 25 °C. The kinetic isotope effects of CHO-H466A were obtained by 
determining the kinetic parameters of the enzyme using either choline or 1,2-[2H4]-choline as 
substrate in either aqueous or deuterated solvent, in air-saturated 50 mM sodium pyrophosphate 
at 25 °C and pL 10. For the determinations of solvent isotope effects, buffers were prepared 
using 99.9% deuterium oxide by adjusting the pD value with NaOD. The pD values were 
determined by adding 0.4 to the pH electrode readings (8). For all steady state kinetic isotope 
effects, activity assays were carried out by alternating substrate or solvent isoptomers. Product 
inhibition studies were carried out by varying the concentrations of both glycine betaine, in the 
range between zero and 60 mM, and choline, in the range between 0.02 and 20 mM, in air-
saturated 50 mM sodium pyrophosphate at 25 °C, over a pH range from 7 to 11. The effect of 
imidazole on the turnover number of CHO-H466A was determined by measuring the enzymatic 
activity with 10 mM choline as substrate for the enzyme in the presence of varying 
concentrations of imidazole in the range from 0 to 250 mM in air-saturated 50 mM potassium 
phosphate, pH 7, or 50 mM sodium pyrophosphate for other pH values.    
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Spectral studies  
The UV-visible absorbance and fluorescence emission or excitation spectra of CHO-
H466D, CHO-WT and CHO-H466A, were acquired in 20 mM sodium phosphate, 20 mM 
sodium pyrophosphate and 10% glycerol, pH 64 at 15 °C. The UV-visible absorbance spectra of 
the reduced form of enzymes were acquired using an anaerobic cuvette in 50 mM sodium 
phosphate, 50 mM sodium pyrophosphate and 10% glycerol, pH 6 at 15 °C. The cuvette 
contained one ml final volume of enzyme at a final concentration between 20 and 30 µM, 300 
µM xanthine, and 10 µM methyl viologen. A sidearm attached to the cuvette contained xanthine 
oxidase at a final concentration of ~0.5 µM. The cuvette and contents were made anaerobic by at 
least 15 cycles of alternate degassing under vacuum and flushing with O2-free argon. The 
enzyme solution was then mixed with xanthine oxidase in the side arm, and the reduction of the 
enzyme-bound flavin was monitored spectrophotometrically. The extinction coefficient of the 
wild-type or mutant forms of choline oxidase were determined in Tris-Cl, pH 8, after 
denaturation of the enzymes either by incubation at 40 °C for one hour in the presence of urea at 
a final concentration of 4 M or 0.1% SDS at 100 °C for 5 min, based upon the ε450 value of 11.3 
mM-1 cm-1 for free FAD (9). The spectral properties of CHO-WT and CHO-H466A before and 
after the addition of 200 mM of glycine betaine were determined at 15 °C in 100 mM sodium 
pyrophosphate buffer, pH 6.5. All spectra were normalized to the molar extinction of the 
uncomplexed enzyme and corrected for dilution. For reactions with sodium sulfite, the reagent 
was prepared freshly as 1 M stock solution in 100 mM sodium pyrophosphate, pH 6.5. Different 
amounts of sodium sulfite at final concentrations ranging from 25 to 100 mM were added to the 
                                                 
4 The spectral properties of the oxidized forms of CHO-WT, CHO-H466A, and CHO-H466D, were compared at pH 
6 to avoid artifactual contributions on the UV-visible absorbance spectra due to pH, since the three enzyme variants 
showed pH effects on the UV-visible absorbance spectra of the oxidized enzymes with pKa ≥ 8.2. 
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enzyme solution in 100 mM sodium pyrophosphate, pH 6.5, at 15 °C, and the UV-visible 
absorbance spectra were recorded at different times. The pH dependences of the UV-visible 
absorbance spectra of oxidized enzymes were determined in 20 mM sodium phosphate, 20 mM 
sodium pyrophosphate, 10% glycerol, at 15 °C, by titrating sodium hydroxide into the enzyme 
solution at pH 6. The pH dependences of the UV-visible absorbance spectra of the reduced 
enzymes were determined in an all-glass spectrophotometer custom made anaerobic cuvette 
(Lillie Glassblowers, Smyrna, GA) that was fitted with a pH micro-electrode through a glass 
joint and an anaerobic syringe containing sodium hydroxide. The cuvette contained 3 ml of 
enzyme at a final concentration between 20 and 30 µM in 50 mM sodium phosphate, 50 mM 
sodium pyrophosphate, and 10 % glycerol, pH 6. A sidearm attached to the cuvette was loaded 
with choline at a final concentration of 150 mM. The cuvette and contents were made anaerobic 
by at least 15 cycles of alternate degassing under vacuum and flushing with O2-free argon. The 
enzyme solution was then mixed with choline in the side arm in order to reduce the enzyme-
bound flavin. With CHO-H466D, which could not be reduced anaerobically with choline, a 
syringe filled with anaerobic ~2 mM dithionite was inserted firstly into the cuvette under positive 
argon pressure, and the reduction of the enzyme-bound flavin was monitored 
spectrophotometrically until completion. In all the cases, once the UV-visible absorbance 
spectrum of the hydroquinone species was observed, a pH micro-electrode and a syringe 
containing anaerobic 3 M sodium hydroxide were mounted onto the anaerobic cuvette under 
positive argon pressure. The pH of the anaerobic enzyme solution was then changed stepwise by 
addition of the base, and both the pH and the UV-visible absorbance spectra were recorded after 
each step. 
  
130
 
The CD spectra of CHO-WT and mutant enzymes were recorded at 5 °C in 20 mM Tris-
Cl, pH 8, at concentrations of enzyme of 5 and 15 µM for the far and the near UV, respectively. 
The fluorescence emission spectra of CHO-WT and mutant enzymes were acquired in 20 mM 
sodium phosphate, 20 mM sodium pyrophosphate and 10% glycerol, pH 6 at 15 °C.  
For the quantitation of the ratio of the covalently to the uncovalently bound flavin to the 
enzymes, ~ 20 µM of enzymes were incubated on ice for 30 min after the addition of 10 % 
trichloroacetate, followed by removal of precipitated protein by centrifugation, and the 
determination of the concentration of FAD in both the supernatant and the dissolved pellet in 4 
M urea solution using an ε450 nm value of 12 mM-1 cm-1. The nature of the flavin cofactor of 
CHO-H466D was also verified through MALDI-TOF mass spectrometry in both the positive and 
negative ion mode using a 50:50 methanol/acetonitrile matrix. 
Potentiometric titrations  
Potentiometric redox titrations were carried out to either the unliganded (CHO-WT, 
CHO-H466A and CHO-H466D) or the glycine betaine-liganded enzymes (CHO-WT and CHO-
H466A) at 15 °C in a cell similar to the one described by Edmondson (1985). Potentials were 
measured by using a Pt electrode relative to an Ag/AgCl double junction reference electrode with 
an Orion Model 701A pH/mV meter (10). The reference electrode was calibrated prior to each 
titration as described by Edmondson (10), using a deoxygenated, saturated quinhydrone solution 
in 0.09 M KCl and 0.01 M HCl at 25 °C. In a typical titration, 2.5 ml of ~20-30 µM of either free 
or glycine betaine-liganded choline oxidase (at a final concentration of 1.5 M) in 20 mM Tris-Cl, 
pH 7, was scrubbed free of oxygen by at least 15 cycles of alternate degassing under vacuum and 
flushing with O2-free argon. The following redox mediators were added to ensure complete 
redox equilibration: 2 µM methyl viologen (-440 mV), 0.5 µM dichlorophenolindophenol (+217 
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mV), 0.5 µM phenazine methosulfate (+80mV), 0.5 µM thionin (+60 mV), 0.5 µM duroquinone 
(-5 to +5 mV), 0.5 µM resorufin (-50 mV), and 0.5 µM indigo carmine (-125 mV) (11, 12). The 
ligand-bound enzyme solutions were titrated electrochemically as described by Dutton (13), 
using freshly prepared sodium dithionite as reductant and potassium ferricyanide as oxidant in 20 
mM Tris-Cl, pH 7 (13). Adequate time was permitted for electronic equilibration after each 
addition of sodium dithionite or potassium ferricyanide prior to the spectrum being recorded; 
equilibrium of the system was considered to be obtained when the measured potential drift was 
less than 1 mV in 5 min, which was typically achieved after 30 to 60 min. UV-visible absorbance 
spectra were recorded using an Agilent Technologies diode-array spectrophotometer model HP 
8453 equipped with a thermostated cell holder and a magnetic stirrer beneath the cell holder. All 
spectra were corrected for any drift in the baseline by subtracting the absorbance at 800 nm. 
Steady state kinetics  
Enzyme activity was measured polarographically by monitoring the rate of oxygen 
consumption with a Hansatech oxygen electrode thermostated at 25 oC. The determination of the 
steady state kinetic parameters was carried at varying concentrations of both choline (or betaine 
aldehyde), in the range from 0.02 to 35 mM, and oxygen, in the range from 0.04 to 1.1 mM. The 
reaction mixture was first equilibrated at the desired concentration of oxygen by bubbling the 
appropriate O2/N2 gas mixture for at least 10 min. The reactions were then started by adding 5-25 
µl choline oxidase at a final concentration of ~0.1-0.5 µM into a reaction mixture with a final 
volume of 0.5-1 ml. Enzyme assays were conducted in 50 mM sodium pyrophosphate, except for 
pH 7 and 7.5 where potassium phosphate was used. One unit of enzymatic activity corresponds 
to the consumption of one µmol of oxygen per min. 
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Rapid kinetics  
Rapid kinetics was carried out on a Hi-Tech SF-61 stopped-flow spectrophotometer 
thermostated at 25 oC. The rate of flavin reduction was measured by monitoring the decrease in 
absorbance at 452 nm that results from the decreasing of oxidized flavin species upon mixing the 
enzyme with the substrate. The enzyme solution was loaded into a tonometer and subjected to a 
23-cycle degassing procedure by alternately applying vacuum and flushing with oxygen-free 
argon (pre-treated with an oxygen scrubbing cartridge, Agilent, Palo Alto, CA).  Subsequently, 
the degassed enzyme solution was mounted onto the stopped-flow instrument, which had been 
subjected to an overnight treatment with an oxygen scrubbing system composed of 100 mM 
glucose and 30 units ml-1 glucose oxidase. The organic substrate (~2 ml), was dissolved in 
desired buffer in H2O and then degassed by flushing oxygen-free argon for at least 15 min before 
mounting onto the stopped-flow. The enzyme was mixed anaerobically with an equal volume of 
substrate, yielding a reaction mixture containing ~15 - 40 µM choline oxidase and 0.05 to 10 
mM choline.  
Data analysis  
Data were fit with KaleidaGraph software (Synergy Software, Reading, PA) and Enzfitter 
software (Biosoft, Cambridge, UK). The steady state kinetic parameters for choline oxidase at 
atmospheric oxygen were determined by fitting the data to the Michaelis-Menten equation for 
one substrate (eq 1), where ka represents the Michaelis-Menten constant for choline (or betaine 
aldehyde) (A) and kcat is the turnover number of the enzyme (e). The steady state kinetic 
parameters at varying concentrations of both choline and oxygen were determined by fitting the 
initial rate data to eqs 2 and 3, which describe ternary complex mechanisms with reversible and 
irreversible catalytic steps, respectively. Data with betaine aldehyde were fit into eq 4, which 
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describes a ternary complex mechanism with negligible Ka value. In these equations, e represents 
the concentration of enzyme, kcat is the turnover number of the enzyme at infinite substrates 
concentrations, Ka and Kb represent the Michaelis constants for the organic substrate (A) and 
oxygen (B), respectively. For the kinetic isotope effects of wild-type choline oxidase with 
choline as substrate, data obtained were divided into two sets, one with unlabeled substrate or 
solvent, and one with isotopically labeled substrate or solvent. The steady state kinetic 
parameters of the two sets were determined independently with eq 2 or 3, and the kinetic isotope 
effects were determined by taking the ratios of the steady state kinetic parameters of interest. For 
CHO-H466A, under atmospheric oxygen conditions at 25 oC (i.e., with a concentration of 
dissolved oxygen of 0.25 mM), due to the low Km value for oxygen with a value of 5 ± 2 µM at 
pH 10  (Ghanem, M., and Gadda, G.; unpublished data), CHO-H466A is > 97% saturated with 
oxygen. Therefore, with CHO-H466A the true kinetic isotope effect could be determined from 
the Dkcat/Km value under atmospheric conditions.  
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The pH dependencies of steady-state kinetic parameters were determined by fitting initial 
rate data to eq 5, which describes a curve with a slope of +1 and a plateau region at high pH. The 
pH dependence of inhibition by glycine betaine was determined by fitting the initial rate data to 
eq 6, which describes a curve with a slope of -1 and a plateau region at low pH. C is the pH-
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independent value of the kinetic parameter of interest. Data of the pH dependencies of the 
absorbance spectra for both the oxidized wild-type and mutant enzymes were fit to eq 7, which 
describes a curve with a slope of -1 and plateau regions at low and high pH, where A and B 
represent the absorbance values at 500 nm at low and high pH, respectively. 
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 Product inhibition studies were performed by varying the concentrations of both glycine 
betaine and choline at a fixed concentration of oxygen. The data were fit to eqs 8 to 10, which 
describe competitive, uncompetitive, and noncompetitive inhibition patterns of the product and 
the organic substrate, respectively. P is the concentration of glycine betaine, Kis and Kii are the 
inhibition constants for the slope and intercept term, respectively. 
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Data of the spectrophotometric titrations for complex formation between choline oxidase 
and various ligands were fit to eq 11, where Y and A are the observed and maximal absorbance 
changes at the selected wavelength, respectively, X is the concentration of the varied ligand, and 
K is the complex dissociation constant. Data of the pH dependencies of the absorbance spectra of 
the oxidized CHO-H466D were fit to eq 2, which describes a curve with a slope of +1 and 
plateau regions at low and high pH, where A and B represent the absorbance values at 500 nm at 
low and high pH, respectively. The midpoint reduction-oxidation potentials of the enzymes were 
determined by fitting the data to eq 13, where Eh is the observed electrode potential at 
equilibrium at each point in the titration, E′m is the midpoint reduction-oxidation potential, R is 
the gas constant, with a value of 8.31 J mol-1 K-1 at 15 °C, T is the temperature in Kelvin, n is the 
number of electrons transferred, and F is Faraday’s constant, with a value of 96.48 kJ V-1 mol-1. 
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CHAPTER III 
 
Cloning, Sequence Analysis, and Purification of Choline Oxidase From Arthrobacter 
globiformis: a Bacterial Enzyme Involved in Osmotic Stress Tolerance 
(This chapter has been published verbatim in Ghanem, M., Fan, F., and Gadda, G., (2004), Arch. 
Biochem. Biophys. 142, 149-58. © 2003 Elsevier Inc. All rights reserved. The first two authors 
share equal contribution to the publication. The sequence reported in this paper has been 
deposited in the GenBank database with accession no. AY304485. In particular, my contribution 
to this study pertains the cloning and sequencing the codA gene from the bacterial genome, 
expression and purification of the recombinant enzyme, and the preliminary biophysical and 
spectroscopic characterization of the recombinant enzyme).  
 
Abstract 
Choline oxidase catalyzes the four-electron oxidation of choline to glycine betaine, one of a 
limited number of compounds that accumulate to high levels in the cytoplasm of cells to prevent 
dehydration and plasmolysis in adverse hyperosmotic environments. In the present study, the 
highly GC rich codA gene encoding for choline oxidase was cloned from genomic DNA of 
Arthrobacter globiformis strain ATCC 8010 and expressed to high yields in Escherichia coli 
strain Rosetta(DE3)pLysS. The resulting enzyme was purified to high levels in a single 
chromatoghraphic step using DEAE-Sepharose, as shown by SDS-PAGE analysis. Denaturation 
and mass spectroscopic analyses showed that the covalent linkage between the FAD cofactor and 
the protein is preserved in recombinant choline oxidase, consistent with protein flavinylation 
being a self-catalytic process. The enzyme was shown to be a homodimer of 120,000 Da by size-
exclusion chromatography and to be active with both choline and betaine aldehyde as substrate. 
Sequencing analysis indicated that the nucleotide sequence of codA originally reported in 
GenBank contains seven flaws, resulting in a translated protein with a significantly altered amino 
acid sequence between position 298 and 410. 
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 Introduction 
Choline oxidase (E.C. 1.1.3.17) catalyzes the four-electron oxidation of choline to 
glycine betaine (N,N,N-trymethylglycine; betaine) via betaine aldehyde as intermediate. 
Molecular oxygen acts as primary electron acceptor in the reaction (Scheme 3.1) (1). The 
enzyme is of importance because glycine betaine is one of a limited number of compatible 
solutes that accumulate to high levels in the cytoplasm of cells to prevent dehydration and 
plasmolysis in adverse hyperosmotic environments (2-6). Regulation of intracellular osmolality 
to hyperosmotic environments is also intimately connected to a number of physiological 
responses, such as increased heat and cold tolerance, as well as regulation of the internal pH and 
ionic strength (7-12). Hyperosmolarity is often encountered at human infection sites (13), where 
choline and its precursors are very abundant (14-16), and is a major environmental signal 
controlling the expression of genes associated with cellular invasion and virulence in a number 
of human pathogens (17-24). For these reasons, the study of choline oxidase is of considerable 
interest both for genetically engineering water and osmotic stress resistance in economically 
relevant crop plants lacking efficient glycine betaine biosynthetic systems (10, 11, 25-29), and 
for the potential development of therapeutic agents that inhibit the biosynthesis of glycine 
betaine thereby making bacteria more susceptible to conventional treatments. 
Choline oxidase has been purified from Cylindrocarpon didymum M-1 (30), Alcaligenes 
sp. (31), and Arthrobacter globiformis (1). Based on amino acid sequence comparisons, the 
enzyme can be grouped in the GMC oxidoreductase enzyme superfamily (32), which comprises 
enzymes like glucose oxidase, cholesterol oxidase, or cellobiose dehydrogenase, that utilize FAD 
as cofactor for catalysis and nonactivated primary alcohols as substrate. Despite a wealth of 
studies on the biotechnological applications of the enzyme, minimal biochemical and 
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mechanistic investigations of choline oxidase have been reported to date. In this respect, our 
group has recently reported the analyses of the steady state kinetic mechanism and of the pH and 
deuterium kinetic isotope effects on the oxidation of choline to betaine aldehyde catalyzed by 
choline oxidase from A. globiformis (33, 34). One of the most critical impediments to future 
studies is the obtainment of large quantities of choline oxidase for detailed biophysical, 
mechanistic, and structural investigations. In the present study, we have cloned from A. 
globiformis genomic DNA the codA gene encoding for choline oxidase and heterogously 
expressed it in Escherichia coli. The resulting recombinant enzyme has been purified to 
homogeneity in a single chromatographic step and characterized for its flavin content, catalytic 
activity, and oligomerization state. 
 
 
Scheme 3.1. Reaction catalyzed by choline oxidase. 
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Materials and Methods 
Materials. E. coli strain JM109 harboring plasmid pGAH/codA was a kind gift from Dr. 
Murata, National Institute for Basic Biology, Okazaki, Japan (27, 28). A freeze-dried culture of 
A. globiformis (ATCC 8010) was obtained from American Type Culture Collection. Restriction 
endonucleases NdeI and EcoR I, calf intestinal alkaline phosphatase, T4 DNA ligase, Taq DNA 
polymerase, deoxynucleotide triphosphates, and bovine serum albumin were purchased from 
Promega. Pfu DNA polymerase was obtained from Stratagene or Roche Molecular Biomedicals. 
Luria-Bertani agar, Luria-Bertani broth, chloramphenicol, tetracycline, kanamycin, isopropyl-β-
D-thiogalactopyranoside (IPTG), lysozyme, phenylmethylsulfonyl fluoride (PMSF), and betaine 
aldehyde bromide were obtained from Sigma-Aldrich. Carbenicillin, ampicillin, choline chloride, 
and electrophoresis-grade agar were purchased from ICN Biomedicals. Nutrient Broth and 
Nutrient Agar #3 were from Difco. All other reagents were of the highest purity commercially 
available. Oligonucleotides were custom synthesized on a Beckman Oligo model 1000 M by the 
DNA Core Facility of the Biology Department of Georgia State University. A. globiformis 
genomic DNA was purified using the DNeasy midi-kit from Qiagen. Plasmids and products 
deriving from primer extension reaction and PCR were purified by using mini-kits from Qiagen. 
E. coli strains Novablue (Novagen) and XL1-Blue (Stratagene) were used during cloning 
procedures, whereas strain Rosetta(DE3)pLysS (Novagen) was used for protein expression. E. 
coli strain Novablue cells harboring plasmid pET/codA1 or pET/codA2, strain XL1-Blue cells 
harboring plasmid pET/codA3, and strain Rosetta(DE3)pLysS cells harboring plasmid 
pET/codA1 or pET/codA3 were stored at –80 oC as 7% DMSO suspensions. DNA sequencing 
was carried out with an Applied Biosystems Big Dye kit on an Applied Biosystems model ABI 
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377 DNA sequencer by the DNA Core Facility of the Biology Department of Georgia State 
University. 
Sub-Cloning of codA into the Expression Vector pET20b(+). E. coli  strain JM109 
harboring plasmid pGAH/codA was grown on Luria-Bertani agar medium containing kanamycin 
at a final concentration of 15 µg/ml for 16 h at 37 oC. Single colonies were used to inoculate 2 ml 
of Luria-Bertani broth medium containing kanamycin (15 µg/ml) and the resulting liquid 
cultures were grown at 37 oC for 7 h. After harvesting the cells by centrifugation at 14,000 x g 
for 10 min, the plasmid vector was isolated by using a QIAquick Spin Miniprep kit (Qiagen) 
following the manufacturer’s protocol. The isolated plasmid DNA was then used for primer 
extension reaction of the codA gene encoding for choline oxidase by using the oligonucleotide 
primers Chox-for A and Chox-rev containing NdeI and EcoR I restriction endonuclease sites 
designed to anneal to the 5’ and 3’ ends of the gene, respectively (Table 3.1).  The NdeI and 
EcoR I restriction sites introduced at the 5’ ends of the sense and antisense primers allowed 
cloning of codA into the corresponding sites of pET20b(+). Primer extension reaction was 
performed in the presence of DMSO at a final concentration of 2% for 1 min at 95 oC, followed 
by 31 three-step cycles of 0.5 min at 95 oC, 1 min at 55 oC, 4.5 min at 68 oC, with a final 5-min 
step at 68 oC, in a total volume of 50 µl by using ~15 ng of template DNA, 2.5 U of Pfu DNA 
polymerase, and the manufacturer’s suggested protocol. The resulting amplicons were purified 
by agarose gel electrophoresis using the QIAquick Gel Extraction kit (Qiagen) following the 
manufacturer’s protocol. 
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Table 3.1. Oligonucleotide Primers Used for Primer Extension Amplification and PCR of codA.
Primer Nucleotide sequence Purpose 
Chox-for A CGGCAAGGAGAACCATATGCACATCGACAACATCTG Cloning 
Chox-rev CCCCGGAATTCGCCGCTCCCGCTTAGG Cloning 
PET-for A CACTATAGGGAGACCACAACG Sequencing 
PET-rev A GCTTATGCTAGTTATTGCTCAGC Sequencing 
Choxag 3 CAATGAAGTCGTGCTCTCC Sequencing 
Choxag 5 CGAAGTTCAACACC Sequencing 
Choxag 7 CGATGCAGGAGTTGTGG Sequencing 
Endonuclease restriction sites for NdeI and EcoR I enzymes are underline. 
 The pET20b(+) plasmid vector was isolated from an E. coli strain XL1-Blue grown for 
16 h at 37 oC in 4 ml of Luria-Bertani broth containing ampicillin at a final concentration of 50  
µg/ml by using the QIAprep Spin Miniprep kit from Qiagen, following the manufacturer’s 
instructions. 
Both the amplified codA and pET20b(+) vector were digested for 3 h at 37 oC with 30 U 
of NdeI and 36 U of EcoR I in a total volume of 60 µl of 10 mg/ml bovine serum albumin, 0.15 
mM sodium chloride, 6 mM magnesium chloride, 1 mM dithiothreitol, and 6 mM Tris-Cl at pH 
7.9, followed by purification of the DNA by agarose gel electrophoresis using the QIAquick Gel 
Extraction kit. To ensure minimal self-ligation of the plasmid, pET20b(+) was further treated 
with 3 U of calf intestine alkaline phosphatase for 3 h at 37 oC, followed by purification of the 
DNA by gel electrophoresis extraction. The codA gene (160 ng) was then ligated into the 
pET20b(+) (120 ng) plasmid in the presence of 2% DMSO by incubation for 16 h at 4 oC with 3 
U of T4 DNA ligase in a total volume of 60 µl, and 5 µl of the ligation reaction mixture were 
used to transform directly 100 µl of E. coli strain XL1-Blue competent cells by using the 
electroporation method. The resulting transformant colonies obtained by plating on Luria-Bertani 
agar plates containing ampicillin (or carbenicillin) at a final concentration of 50 µg/ml were 
screened for the presence of codA by colony primer extension amplification with 2.5 U of Pfu 
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DNA polymerase in the presence of 2% DMSO using the protocol described above. Sense and 
antisense oligonucleotide primers designed to bind to the DNA regions of pET flanking the 
inserted gene were used in the screening (Table 3.1). The correct construct, pET/codA3, was 
sequenced in both directions by using the oligonucleotide primers shown in Table 3.1, and E. 
coli strain Rosetta(DE3)pLysS competent cells were then transformed with plasmid pET/codA3 
following the procedures described above. 
Cloning of codA from A. globiformis Genome into the Expression Vector pET20b(+). 
A. globiformis strain ATCC 8010 was grown on Difco #3 Nutrient Agar medium for 48 h at 26 
oC. Single colonies were used to inoculate eight 5 ml of Difco #3 Nutrient Broth and the 
resulting liquid cultures were grown overnight at 26 oC. The cells were harvested by 
centrifugation at 14,000 x g for 10 min, and the genomic DNA was isolated using the DNeasy 
Midi-kit (Qiagen) according to the manufacturer’s instructions. The isolated genomic DNA was 
then used for PCR of the codA gene with the oligonucleotide primers described above. PCR was 
carried out with an Eppendorf Mastercycler in the presence of 4% DMSO for 1 min at 95 oC, 
followed by 31 cycles of 1 min at 95 oC, 1 min at 50 oC, 2 min at 72 oC, and a final 5-min step at 
72 oC in a total volume of 50 µl by using ~200 ng of template DNA, 5 U of Taq DNA 
polymerase, 3 mM magnesium chloride, and the polymerase manufacturer’s suggested protocol. 
The resulting amplicons were purified by agarose gel electrophoresis using the QIAquick Gel 
Extraction kit (Qiagen) following the manufacturer’s protocol. 
Endonuclease digestion of both the amplified codA and pET20b(+) with NdeI and EcoR 
I, dephosphorylation of the plasmid with calf intestine alkaline phosphatase, and ligation were 
carried out as described above, and 1 µl of the ligation reaction mixture was used directly to 
transform by electroporation 100 µl of E. coli strain Novablue competent cells. The resulting 
  
145
 
transformant colonies obtained by plating on Luria-Bertani agar plates containing 50 µg/ml 
ampicillin and 12.5 µg/ml tetracycline were screened for the presence of codA by colony PCR. 
PCR was performed with 5 U of Taq DNA polymerase in the presence of 2% DMSO for 1 min 
at 95 oC followed by 31 three-step cycles of 1 min at 95 oC, 2 min at 55 oC, 2 min at 72 oC, and a 
5-min final step at 72 oC, using sense and antisense oligonucleotide primers designed to bind to 
DNA regions of pET20b(+) flanking the inserted gene. The correct constructs, pET/codA1 and 
pET/codA2, were sequenced in both directions as described above. E. coli strain 
Rosetta(DE3)pLysS competent cells were transformed with plasmid pET/codA1 for protein 
expression. 
Expression of Choline Oxidase in E. coli. Permanent frozen stocks of E. coli cells 
Rosetta(DE3)pLysS harboring plasmid pET/codA1 were used to inoculate 50 ml of Luria-Bertani 
broth medium containing ampicillin (or carbenicillin) and chloramphenicol at final 
concentrations of 50 and 34 µg/ml, respectively, at 37 oC. After 9 h, 1 ml of the starter culture 
was used to inoculate 3 x 1.5 liters of the same liquid culture medium at 30 oC. When the culture 
reached an optical density at 600 nm between 0.8 and 1.4, typically after 16 h, IPTG was added 
to a final concentration of 50 µM and the temperature of the culture was lowered between 21 and 
25 oC. Cells were harvested by centrifugation at 20,000 x g for 20 min at 4 oC and stored at –20 
oC. Typically, ~8 g of wet cell paste were obtained from 1.5 liters of cells culture. 
Purification of Recombinant Choline Oxidase. Unless otherwise stated, all the 
purification steps were carried out at 4 oC. The cell paste, typically 25 g, was suspended in 6 
volumes of a solution of 0.1 mM PMSF, 0.2 mg/ml lysozyme, 1 mM EDTA, and 50 mM 
potassium phosphate at pH 7 and allowed to incubate with stirring for 30 min on ice. The 
resulting slurry was passed three times through an SLM Aminco French pressure cell at 20,000 
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lb/in2 and then centrifuged at 20,000 x g for 20 min. The supernatant was collected, incubated 
with stirring for 30 min on ice with 20 µg/ml RNase and 50 µg/ml DNase in the presence of 10 
mM magnesium chloride, and centrifuged as described above. The soluble fraction was brought 
to 30% ammonium sulfate saturation, incubated for 30 min on ice, and separated from the 
insoluble fraction by centrifugation as described above. Choline oxidase was then collected in 
the pellet fraction by treatment with ammonium sulfate at a final saturation of 65%, followed by 
centrifugation as described above. The resulting pellet was suspended in 25 ml of 200 mM Tris-
Cl, pH 8, and dialyzed against three 1-liter changes of the same buffer over 20 h. After dialysis, 
precipitated proteins were removed by centrifugation at 18,700 x g for 20 min and the resulting 
supernatant was loaded onto a DEAE-Sepharose Fast Flow column (3 x 28 cm) connected to an 
Åktaprime Amersham Pharmacia Biotech system equilibrated with 200 mM Tris-Cl at pH 8. The 
column was eluted with 2 volumes of the same buffer, followed by a linear gradient from 0 to 0.5 
M NaCl developed over 5 volumes at a flow rate of 2 ml/min. The fractions with the highest 
purity as judged by enzymatic activity and UV-visible absorbance spectroscopy were pooled 
together and concentrated with the addition of 65% ammonium sulfate saturation followed by 
centrifugation. The resulting pellet was resuspended in 10 ml of 200 mM Tris-Cl, pH 8, and 
dialyzed against three 250-ml changes of the same buffer over 20 h. After removal of the 
precipitated protein by centrifugation, the enzyme stored at –20 oC was stable for at least six 
months. 
Enzyme Assays. The concentration of choline oxidase was determined with the method 
of Bradford (35), by using the Bio-Rad protein assay kit with bovine serum albumin as the 
standard. The oxidized flavin content per enzyme active site was determined as described in (36). 
Enzyme activity was measured with the method of the initial rates (37) in air-saturated 50 mM 
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potassium phosphate at pH 7 by monitoring the rate of oxygen consumption with a computer-
interfaced Oxy-32 oxygen-monitoring system  (Hansatech Instrument Ltd.) thermostated at 25 
oC. The reactions were started by the addition of choline oxidase to a 1 ml reaction mixture, with 
the final concentration of enzyme in the 0.1 to 0.5 µM range; the concentration of choline or 
betaine aldehyde was between 0.02 and 10 mM. UV-Visible absorbance spectra were recorded 
using an Agilent Technologies diode-array spectrophotometer Model HP 8453 equipped with a 
thermostated water bath. Fluorescence emission spectra were recorded with a Shimadzu 
Spectrofluorometer Model RF-5301 PC thermostated at 15 oC. 
Methods. The molecular mass of the enzyme was determined by MALDI-TOF mass 
spectrometry on a Micromass TofSpec 2E at the Mass Spectrometry Laboratory of the Georgia 
Institute of Technology, Atlanta. Samples were prepared for MALDI-TOF analysis by gel 
filtration using a Sephadex G-25 column (PD-10, Amersham Pharmacia Biotech) equilibrated 
with 5 mM Tris-Cl, pH 8. MALDI-TOF spectra were acquired in the positive ion mode using 
sinapinic acid as the matrix, with an acceleration voltage of -20 kV and a pulse voltage of -16 
kV. Cytochrome c [12,400], myoglobin [17,000], trypsinogen [24,000], and bovine serum 
albumin [66,000] were used as standards for mass calibration. The molecular weight of the 
enzyme under non-denaturing conditions was determined by size exclusion chromatography 
through a Sephacryl S-400 column (1 x 50 cm) connected to an Åktaprime Amersham Pharmacia 
Biotech system equilibrated with 300 mM KCl in 20 mM potassium phosphate, pH 7, at a flow 
rate of 0.5 ml/min. The following proteins were used as standards: horse heart cytochrome c 
[12,400], bovine serum albumin [66,000], yeast alcohol dehydrogenase [150,000], sweet potato 
-amylase [200,000], and horse spleen apoferritin [443,000]. SDS-PAGE according to the 
method of Laemmli (38) and PAGE under non-denaturing conditions were performed in 12% 
  
148
 
polyacrylamide slab gels, with visualization of the proteins by staining with Coomassie brilliant 
blue G-250. 
For denaturation experiments, choline oxidase was incubated at 40 oC for 1 h in the 
presence of urea at a final concentration of 4 M in 100 mM Tris-Cl, pH 8, before recording the 
UV-visible absorbance spectrum. The flavin content per monomer of enzyme was calculated 
from the ratio of the concentration of flavin in the denatured enzyme using an ε450 nm value of 
11.3 mM-1cm-1 (39) to the concentration of protein determined using the Bradford assay (35). To 
establish whether the flavin is covalently bound to recombinant choline oxidase, the enzyme was 
incubated with trichloroacetic acid at a final concentration of 10% for 5 min at 100 oC, followed 
by removal of denatured protein by centrifugation at 14,000 x g for 10 min before measuring the 
UV-visible absorbance spectrum of the resulting supernatant.  
Data Analysis. Kinetic data were fit with the KaleidaGraph software (Adalbeck 
Software, Reading, PA). Apparent kinetic parameters in atmospheric oxygen were determined by 
fitting initial reaction rates at different substrate concentrations to the Michaelis-Menten equation 
(eq. 1), where Ka represents the Michaelis constant for choline (or betaine aldehyde) (A) and kcat 
is the turnover number of the enzyme (e).  
AK
Ak
e
v
a
cat
+=           (1) 
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Results 
Cloning of codA. The codA gene from A. globiformis encoding for choline oxidase was 
previously cloned in the binary vector plasmid pGAH for in vivo experiments aimed at 
conferring tolerance to salt stress in cyanobacteria and plants (10, 11, 25-28, 40, 41). In this 
study, codA was amplified from pGAH/codA by primer extension reaction by using Pfu DNA 
polymerase in the presence of 2% DMSO. Addition of DMSO was required to ensure complete 
denaturation of the highly GC rich DNA template in the primer extension reaction. Directional 
cloning of codA into pET20b(+) to construct plasmid pET/codA3 was achieved by inserting NdeI 
and EcoR I endonuclease restriction sites at the 5' and 3' terminal ends of the gene, respectively. 
Plasmid pET/codA3 was then used to transform E. coli competent cells strain XL1-Blue. 
Successful construction of plasmid pET/codA3 was confirmed by nucleotide sequence analysis. 
However, seven differences were found in the nucleotide sequence of codA with respect to the 
sequence of the gene deposited in GenBank (accession no. X84895). Of the observed 
discrepancies, three accounted for missing nucleotides at position 891, 1117, and 1232, resulting 
in a translated sequence of 113 amino acid residues in the central portion of the protein being 
different from the published sequence (GenBank accession no. S52489). Surprisingly, no internal 
stop codons were created by the three single-point deletions, resulting in a translated protein of 
546 amino acid residues. Two other differences were observed at position 764 and 1496, which 
resulted in the substitution of an arginine with a histidine residue and of a glycine with an alanine 
residue, respectively. Finally, two silent nucleotide substitutions that resulted in no change at the 
amino acid level were observed at position 832 and 846. The nucleotide sequence of codA was 
found to contain the same seven discrepancies when the gene was sequenced directly from 
pGAH/codA, suggesting that the differences did not originate in the sub-cloning procedure. 
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To further verify that the nucleotide differences were not introduced in the sub-cloning 
process from pGAH/codA, genomic DNA from A. globiformis strain ATCC 8010 was used as 
template to amplify the codA gene by using PCR with Taq DNA polymerase. The rationale for 
this strategy was that possible misincorporations of nucleotides occurring in the gene 
amplification procedure most likely would occur at different positions in the nucleotide sequence 
of the gene by using different DNA template, DNA polymerase, and PCR protocol. As a further 
control, codA was cloned from genomic DNA in two independent experiments to produce the 
constructs pET/codA1 and pET/codA2. The nucleotide sequence of the codA gene cloned from 
genomic DNA was the same as that determined using pGAH/codA. 
Heterologous Expression of codA in E. coli. Heterologous expression of soluble choline 
oxidase from pET/codA1 was achieved within 5 h of induction with 50 µM IPTG at 25 oC in E. 
coli strain Rosetta(DE3)pLysS, which supplies tRNAs for codons that are rarely used in E. coli. 
The choice of such a bacterial host strain for protein expression was dictated by the observation 
that, due to its high GC content, codA contains 27 of such rare codons. Recombinant choline 
oxidase was purified to homogeneity, as judged by SDS-PAGE analysis (Figure 3.1), using 30 to 
65% ammonium sulfate saturation followed by anion exchange chromatography onto a DEAE-
Sepharose Fast Flow column equilibrated in 200 mM Tris-Cl at pH 8. Typically, between 150 
and 200 mg of pure choline oxidase could be obtained from 4.5 liters of liquid Luria-Bertani 
culture medium (Table 3.2). 
  
151
 
 
Figure 3.1. Purification of recombinant A. globiformis choline oxidase heterogously expressed in 
E. coli.  
Lane 1, marker proteins; lane 2, cell-free extract of E.coli strain Rosetta(DE3)pLysS harboring 
plasmid pET/codA1 induced with 0.05 mM IPTG for 5 hours at 22 oC; lane 3, sample treated 
with 20 µg/ml RNase and 50 µg/ml DNase in the presence of 10 mM MgCl2; lane 4, sample 
treated with 30 and 65% ammonium sulfate saturation; and lane 5, purified choline oxidase in 
200 mM Tris-Cl, pH 8, after DEAE-Sepharose column chromatography. The molecular mass of 
purified choline oxidase is indicated. 
 
 
 
Table 3.2. Purification of Recombinant A. globiformis Choline Oxidase Heterogously Expressed 
in E. coli. 
Step Total 
protein, 
mg 
Total activitya, 
µmol O2 min-1 
Specific activity, 
µmol O2 min-1 mg-
1 
Yield,
% 
Cell-free extract 1,830 1,080 0.59 100 
Nuclease treated 1,500 1,060 0.71 98 
30-65% Saturation of (NH4)2SO4 1,240 1,040 0.84 96 
DEAE-Sepharose FF  185 940 5.3 87 
aEnzymatic activity was measured with 10 mM choline as substrate in air-saturated 50 mM 
potassium phosphate, pH 7.0 and 25 oC, by monitoring the rate of oxygen consumption with a 
Clark-type oxygen electrode. 
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Physical Properties of Recombinant Choline Oxidase. The molecular weight of 
recombinant choline oxidase was determined by MALDI-TOF mass spectrometry. Two peaks 
with m/z+ values of 30,307.5 and 60,618.3 were observed using the positive ion mode, 
corresponding to the doubly and singly protonated species of the protein, respectively (Figure 
3.2). A molecular weight of 60,614 ± 5 was calculated from the mass spectroscopic data, in 
agreement with the expected value of 60,612 calculated from the amino acid composition of the 
protein with one linked FAD moiety [31,43,44]. 
The oligomerization state of choline oxidase was determined by size exclusion 
chromatography onto a Sephacryl S-400 column under non-denaturing conditions. The results 
indicated that at concentrations of 10 or 100 µM the enzyme has apparent molecular weights of 
117,000 and 122,000, respectively (data not shown), indicating that the enzyme exists in solution 
as a dimer. Non-denaturing PAGE conditions of the enzyme at concentrations in the range 
between 2 and 48 µM yielded single bands with similar relative migration, suggesting that the 
oligomerization state of choline oxidase is not dependent on the concentration of the enzyme 
(data not shown).  
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Figure 3.2. MALDI-TOF mass spectrometric analysis of recombinant choline oxidase.  
Choline oxidase at a concentration of 46 µM was prepared as described in Experimental 
Procedures. Peaks with m/z+ values of 60,618.3 and 30,307.5 represent the singly and doubly 
protonated species of the protein. 
   
Flavin Content of Recombinant Choline Oxidase. The UV-visible absorbance spectrum 
of the enzyme as purified is shown in Figure 3.3. Absorbance maxima were observed at 272, 
373, and 454 nm, as expected for a flavin-containing enzyme but with relative intensities of the 
peaks in the near UV and visible regions of the spectrum suggesting that the bound flavin was 
present as a mixture of oxidized and anionic semiquinone states 1 (42). Significant variability in 
the relative intensities of the absorbance maxima in the near UV and visible regions of the 
spectrum was observed among different preparations of enzyme, with A454/A373 ratios ranging 
from 0.4 to 0.7 (data not shown). Upon denaturation of the enzyme by treatment with urea, a 
                                                 
1 A spectroscopic investigation of recombinant choline oxidase by using UV-visible and fluorescence spectroscopy, 
electron spin resonance, and circular dichroism, is consistent with the presence of an anionic semiquinone flavin in 
the enzyme as purified (36). Steady state kinetic data on the enzyme as purified suggest that the semiquinone flavin 
of choline oxidase is not catalytically relevant (36). 
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decrease in the 373 nm peak with concomitant increase in the absorbance in the 450 nm region 
were observed (Figure 3.3), consistent with oxidation of the semiquinone to form fully oxidized 
FAD in the denatured enzyme. This enzyme was devoid of enzymatic activity using 10 mM 
choline as substrate at pH 7, suggesting that the treatment with urea completely denatured the 
enzyme. No significant changes in the UV-visible absorbance spectrum of the denatured enzyme 
were seen after dialysis with decreasing amounts of urea, consistent with FAD being covalently 
bound to the enzyme (data not shown). Also, the UV-visible spectrum of a soluble fraction 
prepared upon treatment of choline oxidase with 10% trichloroacetic acid followed by 
centrifugation to remove the denatured protein was devoid of absorbance (Figure 3.3), further 
consistent with FAD being covalently bound to the protein. A stoichiometry of 0.88 ± 0.12 
FAD/monomer of enzyme could be calculated from the results of six independent experiments. 
The visible fluorescence emission spectrum of purified choline oxidase showed a maximum in 
the 525 to 530 nm region (with λex at 454 nm), with about 6% the intensity of an equimolar 
solution of free FAD (Figure 3.3). 
Kinetic Properties of Recombinant Choline Oxidase. The steady state kinetic parameters 
for choline and betaine aldehyde as substrate for the enzyme as purified were determined in air-
saturated 50 mM potassium phosphate at pH 7 and 25 oC. Apparent kcat values of 13.4 ± 0.5 and 
11.6 ± 0.3 s-1 per active site oxidized flavin and Km values of 0.6 ± 0.1 and 2.3 ± 0.2 mM were 
determined with choline and betaine aldehyde, respectively. While the Km values for 
recombinant choline oxidase compared well with the values of 0.6 and 2.4 mM previously 
reported for choline and betaine aldehyde as substrates for the native enzyme from A. 
globiformis, the kcat values were between 3- and 6-fold larger, suggesting a higher purity of our 
enzyme preparation as compared to that of the commercially available enzyme (33).  
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Figure 3.3. UV-Visible absorbance spectrum of recombinant choline oxidase.  
Solid line, choline oxidase as purified at a concentration of 112 µM in 200 mM Tris-Cl, pH 8; 
dashed line, after treatment with 4 M urea at 40 oC for 40 min; dotted line, soluble fraction after 
treatment of choline oxidase with 10% trichloroacetic acid for 5 min at 100 oC and centrifugation 
to remove denatured protein. Inset, fluorescence emission spectrum of choline oxidase as 
purified at a concentration of 28 µM in 200 mM Tris-Cl, pH 8 and 15 oC. The excitation 
wavelength was at 454 nm. 
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   Discussion 
Our group recently reported studies on the steady state kinetic mechanism, pH and 
substrate kinetic isotope effects on choline oxidase from A. globiformis (33, 34). Those studies 
define a framework for advanced biophysical and mechanistic studies on choline oxidase, for 
which large amounts of enzyme are required. To date, the enzyme from A. globiformis is the 
only choline oxidase for which the nucleotide sequence of the full gene has been reported (27). 
In the present study, we have cloned and heterogously expressed in E. coli the gene encoding for 
choline oxidase from A. globiformis genomic DNA, and purified to homogeneity the resulting 
protein. 
Purified choline oxidase expressed in E. coli contains covalently bound FAD, as 
indicated by the mass spectroscopic analysis of the purified enzyme. Thus, the covalent linkage 
between His-87 and the 8α position of the flavin ring is preserved in the recombinant enzyme 
(43), consistent with flavinylation of the protein being a self-catalytic process. In this respect, 
self-flavinylation of histidyl, tyrosyl, and cysteinyl residues to the 8α position of the flavin ring 
was previously proposed to occur through initial flavin tautomerization to yield an electrophilic 
iminoquinone methide, which is stabilized by the presence of a positive charge located near the 
N(1)-C(2)=O(2) position of the flavin (43-46). Consistent with such a proposed mechanism for 
protein flavinylation, the presence of a weak positive charge in proximity of the flavin N(1)-
C(2)=O(2) locus of choline oxidase is suggested by both stabilization of the anionic flavin 
semiquinone and formation of a complex with sulfite (36,47). 
Under non-denaturing conditions, choline oxidase is a dimer of identical subunits with 
each subunit containing FAD in a 1:1 stoichiometry per monomer of protein. The 
oligomerization state of the recombinant enzyme determined in this study does not agree with 
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earlier results on native choline oxidase from A. globiformis and Alcaligenes sp., showing masses 
of 83,000 and 72,000 Da, respectively (1, 31). In this respect, lower native masses were reported 
for cholesterol oxidase from Schizophyllum commune (48) and Streptomyces hygroscopicus (49), 
for which interactions of the enzyme with the matrix of the resins used for the size exclusion 
chromatography experiments were proposed. In contrast, a dimeric oligomerization state was 
determined in previous studies for the enzyme from Cylindrocarpon didymum M-1 (30). 
Choline oxidase does not contain dissociable flavins, as suggested by acid treatment of 
the enzyme followed by centrifugation to remove the precipitated protein. In this respect, the 
enzyme is different from sarcosine oxidase, a well-characterized enzyme containing both 8α-
N(3)-histidyl-FMN and non-covalently bound FAD (50, 51). The mechanistic implication of 
choline oxidase containing only one type of flavin, 8α-N(1)-histidyl-FAD (43), is that a possible 
catalytic mechanism in which one flavin in the dimeric protein is responsible for choline 
oxidation while the second flavin carries out the oxidation of betaine aldehyde seems unlikely2. 
These observations are consistent with oxidation of choline to betaine aldehyde and of the 
aldehyde intermediate to glycine betaine occurring at the same enzyme active site in two 
subsequent catalytic steps (Scheme 3.1). 
Our studies show that the A. globiformis genomic sequence originally reported in 
GenBank for the gene encoding for choline oxidase contains seven flaws, resulting in an amino 
acid sequence of the translated protein that is significantly different from the previously reported 
one. Mass spectrometric analysis of the resulting enzyme expressed in E. coli confirmed the 
                                                 
2 The presence of a single type of flavin in choline oxidase also suggests that a catalytic mechanism in which one 
flavin in the dimeric enzyme dehydrogenates the substrate whereas a second flavin is responsible for oxygen 
reduction is also unlikely. 
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validity of the sequencing results3. Furthermore, the protein homology between choline oxidase 
and other members of the GMC oxidoreductase superfamily increased significantly when the 
newly determined amino acid sequence was used instead of the previously determined one 
(Figure 3.4). For example, the identities and similarities between choline oxidase and choline 
dehydrogenase increased from 28 to 34% and from 57 to 63%, respectively. The errors in the 
nucleotide sequence of the codA gene previously reported using the pGAH/codA construct likely 
arose from the high GC content of the codA gene, which could affect the fidelity of DNA 
polymerase in the sequencing reaction. 
In summary, choline oxidase was cloned from genomic DNA of A. globiformis and 
heterogously expressed to high yields in E. coli. The resulting recombinant enzyme was highly 
purified and showed to be a dimer of identical subunits containing covalently bound FAD. To 
our knowledge, this study represents the first instance in which recombinant choline oxidase has 
been overexpressed and obtained in pure form. The availability of large quantities of 
recombinant choline oxidase will prove an invaluable tool for detailed mechanistic and structural 
studies aimed at a better understanding of four-electron oxidations of unactivated alcohols and of 
the mechanism of CH bond cleavage of alcohols and aldehydes catalyzed by the same flavin-
linked active site. Finally, the determination of the correct nucleotide sequence of the gene 
encoding for choline oxidase will provide the basis for performing site-directed mutagenesis 
studies in this enzyme of biotechnological and medical interest. 
                                                 
3 The mass of the enzyme with one linked FAD moiety is 60,612 Da when calculated by using the newly determined 
amino acid sequence, and 59,648 Da by using the previously reported amino acid sequence. Therefore, the 
experimentally determined mass of 60,614 Da for the enzyme as purified is in good agreement with the sequencing 
results. 
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Figure 3. 4. Alignment of choline oxidase with selected members of the GMC oxidoreductase 
enzyme superfamily.  
CHO, choline oxidase from A. globiformis (GenBank accession no. AAP68832); CHD, choline 
dehydrogenase from Halomonas elongata (GenBank accession no. CAB77176); AO, alcohol 
oxidase from Candida bodinii (GenBank accession no. JC1117); and GO, glucose oxidase from 
Aspergillus niger (GenBank accession no. AF234246.2).   
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CHAPTER IV 
Spectroscopic and Kinetic Properties of Recombinant Choline Oxidase from Arthrobacter 
globiformis 
(This chapter was published verbatim in Ghanem, M., Fan, F., Francis, K., and Gadda, G., 
(2003), Biochemistry 42, 15179-88. © 2003 American Chemical Society. All rights reserved. 
The first two authors share equal contribution to the publication. In particularly, my contribution 
to this study pertains the spectrophotometric characterization of the enzyme bound flavin (E-
FADOx/ E-FADSq), the reaction of choline oxidase with sulfite, and the enzymatic turnover with 
choline.) 
 
Abstract 
Choline oxidase catalyzes the four-electron oxidation of choline to glycine betaine, with 
molecular oxygen acting as primary electron acceptor. Recently, the recombinant enzyme 
expressed in Escherichia coli was purified to homogeneity and shown to contain FAD in a 
mixture of oxidized and anionic semiquinone redox states [Fan et al. (2004) Arch. Biochem. 
Biophys., 421, 149-58]. In this study, methods have been devised to convert the enzyme-bound 
flavin semiquinone to oxidized FAD and vice versa, allowing characterization of the resulting 
forms of choline oxidase. The enzyme-bound oxidized flavin showed typical UV-visible 
absorbance peaks at 359 and 452 nm (with ε452 = 11.4 M-1cm-1), and emitted light at 530 nm 
(with λex at 452 nm). The affinity of the enzyme for sulfite was high (with a Kd value of ~50 µM 
at pH 7 and 15 oC), suggesting the presence of a positive charge near the N(1)C(2)=O locus of 
the flavin. The enzyme-bound anionic flavin semiquinone was unusually insensitive to oxygen or 
ferricyanide at pH 8, and showed absorbance peaks at 372 and 495 nm (ε372 = 19.95 M-1cm-1), 
maximal fluorescence emission at 454 nm (with λex at 372 nm), circular dichroic signals at 370 
and 406 nm, and an ESR peak-to-peak linewidth of 13.9 G. Both UV-visible absorbance studies 
on the enzyme under turnover with choline and steady state kinetic data with either choline or 
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betaine aldehyde were consistent with the flavin semiquinone being not involved in catalysis. 
The pH dependence of the kinetic parameters at varying concentrations of both choline and 
oxygen indicated that a catalytic base is required for choline oxidation but not for oxygen 
reduction and that the order of the kinetic steps involving substrate binding and product release is 
not affected by pH. 
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  Introduction  
Choline oxidase (E.C. 1.1.3.17) catalyzes the four-electron oxidation of choline to 
glycine betaine (N,N,N-trimethylglycine; betaine) via betaine aldehyde as intermediate (Scheme 
4.1) (1). The enzyme contains covalently bound FAD and utilizes molecular oxygen as primary 
electron acceptor (2-4). Among the members of the GMC oxidoreductase superfamily within 
which the enzyme can be grouped (5, 6), choline oxidase is unique in that it catalyzes the 
oxidation of a substrate primary alcohol to a carboxylic acid via an aldehyde intermediate. A 
similar oxidation reaction of an alcohol to a carboxylic acid is catalyzed by histidinol 
dehydrogenase (E.C. 1.1.1.23), a pyridine nucleotide-dependent enzyme well-characterized in its 
mechanistic and biochemical properties (7-17). In contrast, limited kinetic information is 
available on choline oxidase (18, 19). Consequently, the study of the mechanistic properties of 
choline oxidase provides the opportunity to compare the biochemical and mechanistic properties 
of the flavin-dependent oxidoreductases with those of the pyridine nucleotide-dependent 
reductases able to carry out a four-electron oxidation of a substrate alcohol. The study of an 
enzyme involved in glycine betaine biosynthesis is also of considerable interest for both 
biotechnological and biomedical applications, because recent studies have shown that 
accumulation of glycine betaine in the cytoplasm of cells allows growth in hyperosmotic 
environments of transgenic plants lacking efficient glycine betaine biosynthetic systems (20-26) 
and of clinical isolates of a number of human pathogens (27-34). 
The analyses of the steady state kinetic mechanism and of the pH and deuterium kinetic 
isotope effects on the oxidation of choline to betaine aldehyde catalyzed by Arthrobacter 
globiformis choline oxidase were recently reported (18, 19). Briefly, with choline as substrate 
(lower loop in Scheme 4.2), after formation of the E-FADox-C complex and oxidation of choline 
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to yield betaine aldehyde bound to the reduced enzyme, oxygen reacts with the E-FADred-BA 
complex. The catalytically competent E-FADox-BA species undergoes a second oxidation 
reaction in which glycine betaine is formed. Finally, the E-FADred-GB complex reacts with 
oxygen before release of glycine betaine from the oxidized enzyme. With betaine aldehyde as 
substrate (upper loop in Scheme 4.2), after formation of the E-FADox-BA complex, betaine 
aldehyde is oxidized to yield glycine betaine bound to the reduced enzyme. Turnover is 
completed with reaction of the E-FADred-GB complex with molecular oxygen and the final 
release of the product glycine betaine. A catalytic base with pKa 7.5 was proposed to participate 
in catalysis based on pH and substrate kinetic isotope effect studies on the enzyme (19).  
Our group recently cloned the gene encoding for choline oxidase from genomic DNA of A. 
globiformis strain ATCC 8010 and expressed it to high yields in Escherichia coli (6). The 
resulting protein was purified to homogeneity and shown to be a homodimer of 120,000 Da with 
each subunit containing covalently-linked FAD in a mixture of semiquinone and oxidized redox 
states (6). In the present study, we have devised methods to obtain homogeneous preparations of 
recombinant choline oxidase with the flavin cofactor either in the oxidized or semiquinone state, 
and have characterized the biochemical and kinetic properties of the resulting forms of enzyme. 
  
169
 
 
(CH3)3N
+ OH
H2O2
O2
(CH3)3N
+ H
H2O2
(CH3)3N
+ O
OH2O, O2O  
 
Scheme 4.1. Reaction catalyzed by choline oxidase. 
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Scheme 4.2. Steady state kinetics for choline oxidase. 
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 Experimental Procedures 
Materials. Choline chloride was from ICN Pharnaceutical, Inc. Betaine aldehyde and 
glycine betaine were from Sigma-Aldrich. Recombinant choline oxidase from A. globiformis 
strain ATCC 8010 was expressed from plasmid pET/codA1 and purified to homogeneity as 
described in (6). Choline oxidase as purified was stored at -20 oC in 200 mM Tris-Cl, pH 8, and 
found to be stable for at least six months. All other reagents were of the highest purity 
commercially available.  
Enzyme Assays. The concentration of choline oxidase was determined with the method 
of Bradford (35), by using the Bio-Rad protein assay kit with bovine serum albumin as the 
standard. Enzyme activity was measured with the method of the initial rates (36) in air-saturated 
50 mM potassium phosphate at pH 7 by monitoring the rate of oxygen consumption with a 
computer-interfaced Oxy-32 oxygen-monitoring system  (Hansatech Instrument Ltd.) 
thermostated at 25 oC. The reactions were started by the addition of choline oxidase to a 1 ml 
reaction mixture, with the final concentration of enzyme in the 0.2 to 0.6 µM range; the 
concentration of choline or betaine aldehyde was between 0.02 and 15 mM. When both choline 
(or betaine aldehyde) and oxygen concentrations were varied, the assay reaction mixture was 
equilibrated at the concentration of oxygen by bubbling the appropriate O2/N2 gas mixture for 10 
min before the reaction was started by the addition of the enzyme. When the pH was varied, 50 
mM potassium phosphate was used between pH 6 and 8, and 50 mM sodium pyrophosphate was 
used in the pH ranges 5 to 6 and 8 to 10. Product inhibition studies were carried out by varying 
the concentrations of both glycine betaine and choline (or betaine aldehyde) in air-saturated 50 
mM potassium phosphate, pH 6.75. One unit of enzymatic activity corresponds to the 
consumption of one µmol of oxygen per min. 
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UV-Visible absorbance spectra were recorded using an Agilent Technologies diode-array 
spectrophotometer Model HP 8453 equipped with a thermostated water bath. Fluorescence 
emission spectra were recorded with a Shimadzu Spectrofluorometer Model RF-5301 PC 
thermostated at 15 oC. Circular dichroism spectra were acquired using a Jasco J-810 
spectropolarimeter at 22 oC. 
Methods. Oxidized FAD-containing choline oxidase was prepared at 4 oC by dialysis 
against three 1-liter changes of 20 mM potassium phosphate, 20 mM sodium pyrophosphate, pH 
6, over 24 hours, followed by two 1-liter changes of 200 mM Tris-Cl, pH 8 over five hours. This 
enzyme could be stored at -20 oC for at least 7 months without losses in enzymatic activity. The 
oxidized flavin content of choline oxidase as purified was determined from the ∆A452 after 
treatment of the enzyme with 5 mM dithionite in air-saturated 200 mM Tris-Cl, pH 8, using an 
ε452 value of 8.4 mM-1cm-1, which corresponds to the difference between the extinction 
coefficients for the enzyme-bound oxidized flavin (ε452 = 8.4 mM-1cm-1) and semiquinone flavin 
(ε452 = 3 mM-1cm-1). Reduction of choline oxidase with sodium dithionite was conducted 
aerobically in 200 mM Tris-Cl, pH 8, at 15 oC. Dithionite was either prepared just before use in 
the same buffer or added to the enzyme solution as a powder. For reactions with sodium sulfite, 
the reagent was prepared just prior to use as 1 M stock solution in 200 mM Tris-Cl, pH 8. 
Different amounts of sodium sulfite ranging from 0.5 to 25 mM were added to the enzyme 
solution in 200 mM Tris-Cl, pH 8, at 15 oC, and UV-visible absorbance spectra were recorded at 
different interval periods. Reversibility of the flavin-sulfite complex was determined by 
following the increase in absorbance at 452 nm following removal of the unbound sulfite by gel 
filtration using a Sephadex G-25 column (PD-10 column, Amersham-Pharmacia Biotech) 
equilibrated with 200 mM Tris-Cl, pH 8. For treatment of choline oxidase with an oxidizing 
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agent under non-denaturing conditions, the enzyme was incubated with 10 mM potassium 
ferricyanide for 30 min on ice in 10% glycerol, 1 mM EDTA, 20 mM Tris-Cl, pH 8, before 
removing ferricyanide by gel filtration using a Sephadex G-25 column equilibrated with 20 mM 
Tris-Cl, pH 8.  
ESR spectral data were recorded in 3-mm quartz tubes at 141 K using a Bruker ER200D 
spectrophotometer equipped with an Oxford cryostat. Samples were prepared for ESR analysis 
by gel filtration through a Sephadex G-25 column equilibrated in 50 mM HEPES, pH 8, 
followed by freezing in liquid nitrogen. The following conditions and instruments settings were 
used: microwave power, 2 mW; modulation amplitude, 2 G; and microwave frequency, 9.4 GHz. 
Data Analysis. Kinetic data were fit with the KaleidaGraph software (Adalbeck 
Software, Reading, PA) and the Enzfitter software (Biosoft, Cambridge, UK). Apparent kinetic 
parameters in atmospheric oxygen were determined by fitting initial reaction rates at different 
substrate concentrations to the Michaelis-Menten equation for one substrate. Initial rates 
determined by varying the concentration of both choline or betaine aldehyde and oxygen were fit 
to equations 1 and 2, respectively. Equation 1 describes a sequential steady state kinetic 
mechanism, whereas equation 2 describes a sequential mechanism in which Ka «Kia (37). Ka and 
Kb are the Michaelis constants for choline (or betaine aldehyde) (A) and oxygen (B), respectively, 
and kcat is the turnover number of the enzyme (e). 
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The pH dependences of steady state kinetic parameters were determined by fitting initial 
rate data to equation 3, which describes a curve with slope of +1 and a plateau region at high pH. 
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The pH dependence of inhibition by glycine betaine was determined by fitting the initial rate 
data to equation 4, which describes a curve with slope of -1 and a plateau region at low pH. C is 
the pH-independent value of the kinetic parameter of interest. 
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Product inhibition studies were performed by varying the concentrations of both glycine 
betaine and choline (or betaine aldehyde) at a fixed concentration of oxygen. The data were fit to 
equations 5 to 7, which describe competitive, uncompetitive, and noncompetitive inhibition 
patterns of the product and the organic substrate, respectively. P is the concentration of glycine 
betaine, Kis and Kii are the inhibition constants for the slope and intercept term, respectively. 
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Results 
Choline Oxidase as Purified (E-FADox/sq). As shown in Figure 4.1, the UV-visible 
absorbance spectrum of recombinant choline oxidase as purified at pH 8 suggests that the 
enzyme-bound FAD is present as a mixture of oxidized and anionic semiquinone states (E-
FADox/sq) (6). Upon treatment of the enzyme with 10 mM potassium ferricyanide at pH 8 
followed by gel filtration to remove the oxidizing agent, no significant spectral changes in the 
near-UV and visible regions of the absorbance spectrum were observed (data not shown). These 
results indicate that the addition of an oxidant under non-denaturing conditions had no effect on 
the enzyme-bound flavin semiquinone.  
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Figure 4.1. Reaction of recombinant choline oxidase with sodium dithionite.  
Dashed line, the UV-visible absorbance spectrum of choline oxidase as purified was recorded at 
a concentration of 60 µM in 200 mM Tris-Cl, pH 8; solid line, air-stable flavin semiquinone-
containing enzyme prepared by treatment with 5 mM sodium dithionite in aerobiosis and gel 
filtration onto a Sephadex G-25 column equilibrated with the same buffer; dotted line, after 
treatment of the flavin semiquinone-containing enzyme with 4 M urea at 40 oC for 40 min. Inset, 
fluorescence emission spectrum of flavin semiquinone-containing choline oxidase at a 
concentration of 8 µM in 200 mM Tris-Cl, pH 8 and 15 oC. The excitation wavelength was at 
372 nm. 
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  Spectral Properties of Flavin Semiquinone-Containing Choline Oxidase (E-FADsq). 
When the enzyme was incubated aerobically with 5 mM dithionite, a bleaching of the peak at 
454 nm was observed in the visible absorbance spectrum of the enzyme and a spectrum with 
maxima at 372 and 495 nm was obtained (data not shown). The ∆A452 was used to determine the 
FADox content per enzyme active site, by using the ε452 values determined for the enzyme-bound 
flavin in the oxidized and semiquinone states (see below). Typically, the enzyme as purified 
contained variable amounts of flavin in the oxidized state, ranging from 15 to 55% of the total 
flavin content (data not shown). Removal of excess dithionite by gel filtration yielded a similar 
absorbance spectrum (Figure 4.1), indicating that the enzyme is capable of stabilizing the anionic 
semiquinone species of the flavin (FADsq.) in the presence of molecular oxygen. Upon 
incubation of the FADsq-containing choline oxidase in the presence of 4 M urea, the visible 
absorbance spectrum of oxidized FAD with the typical peaks centered at 350 and 452 nm was 
observed (Figure 4.1), consistent with the FADsq being stabilized by the protein 
microenvironment and the cofactor becoming fully oxidized by molecular oxygen upon 
unfolding the protein. An extinction coefficient of 19.95 mM-1cm-1 was calculated at 372 nm for 
the enzyme-bound semiquinone of choline oxidase based upon the ε450 nm value of 11.3 mM-1cm-
1 for FAD 1 after denaturation of the enzyme by treatment with urea (38). At pH 8 and 15 oC, the 
enzyme-bound anionic semiquinone emitted light at 454 nm upon excitation at 372 nm (Figure 
4.1). As for the case of the visible absorbance spectrum, the typical fluorescence properties of 
oxidized FAD with maximal emission at 530 nm (with λmax at 450 nm) were observed upon 
denaturation of the FADsq-containing enzyme by treatment with urea (data not shown). The 
                                                 
1 It is assumed here that the ε450 nm for 8α-N(1)-histidyl FAD is the same as that for free FAD in solution, with a 
value of 11.3 mM-1cm-1. 
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circular dichroism spectrum of the E-FADsq form of choline oxidase showed a negative band at 
370 nm, a sharp positive band at 406 nm, and a broad negative dichroic signal spanning from 
450 to 650 nm (Figure 4.2). Such a spectrum is in agreement with previously reported circular 
dichroic spectra of enzyme-bound anionic flavin semiquinones (39, 40). 
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Figure 4.2. Circular dichroism spectrum of flavin semiquinone-containing choline oxidase.  
Solid line, choline oxidase after treatment with 5 mM sodium dithionite in aerobiosis followed 
by gel filtration onto a Sephadex G-25 column equilibrated with 200 mM Tris-Cl, pH 8; dotted 
line, after treatment of the flavin semiquinone-containing enzyme with 4 M urea at 40 oC for 30 
min. Spectra were recorded at 22 oC. 
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As an independent approach to characterizing the enzyme-bound semiquinone flavin of 
choline oxidase, ESR spectra of the enzyme as purified and of the semiquinone-containing 
enzyme were determined. As shown in Figure 4.3, E-FADox/sq yielded an ESR signal at 2 G with 
a peak-to-peak linewidth of 15.4 G, providing further evidence for the presence of an anionic 
flavin semiquinone in the enzyme (41). A similar ESR spectrum with peak linewidth of 13.9 G 
was observed when the enzyme was analyzed after treatment with dithionite and gel filtration to 
remove the excess dithionite, further consistent with the formation of an air-stable anionic 
semiquinone upon reduction of the enzyme by dithionite. 
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Figure 4.3. Electron spin resonance spectrum of recombinant choline oxidase.  
Spectra of choline oxidase were acquired at a concentration of 60 µM in 50 mM HEPES, pH 8. 
The following spectral conditions were used: microwave power, 2 mW; modulation amplitude, 2 
G; gain, 6.3 x 105; temperature, 141 K. Panel A, choline oxidase as purified; panel B, flavin 
semiquinone-containing choline oxidase prepared freshly by addition of sodium dithionite and 
gel filtration onto a Sephadex G-25 column. 
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  Spectral Properties of Oxidized FAD-Containing Choline Oxidase (E-FADox). 
Treatment of choline oxidase at pH 6 and 15 oC resulted in the slow bleaching of the near-UV 
band centered at 373 nm and concomitant increase of absorbance at 452 nm (Figure 4.4). The 
resulting enzyme species showed absorbance maxima in the near-UV and visible regions 
centered at 359 and 452 nm, as expected for an enzyme with the bound flavin in the oxidized 
state (E-FADox). At 15 oC, a kobs value of 219 ± 1 x 10-6 s-1 was determined from the absorbance 
changes at 452 nm for the complete conversion of E-FADox/sq to E-FADox (Figure 4.4, inset). To 
minimize possible protein losses due to the prolonged incubation of the enzyme at pH 6, E-
FADox was also prepared by dialysis at 4 oC. When 1,300 units of choline oxidase as purified 
were dialyzed at pH 6 for 24 hours 4,100 units of E-FADox were recovered, consistent with 
formation of E-FADox being due to oxidation rather than denaturation of E-FADsq. As shown in 
Figure 4.5, an extinction coefficient at 452 nm of 11.4 ± 0.6 mM-1cm-1 was calculated for E- 
FADox from six independent experiments after denaturation of the enzyme by treatment with 
urea. A fluorescence emission spectrum with a maximum at 530 nm (with λex at 452 nm) was 
observed for E-FADox, providing further evidence for the presence of oxidized FAD. As for the 
case of the E-FADox/sq species, a UV-visible absorbance spectrum identical to that of E-FADsq 
was obtained upon aerobic addition of dithionite to E-FADox (data not shown). 
Formation of a covalent N(5)-flavin adduct with sulfite is a feature that distinguishes 
flavoprotein oxidases from dehydrogenases (42, 43). As shown in Figure 4.6, treatment of 
FADox-containing choline oxidase with sodium sulfite resulted in the bleaching of the peak at 
452 nm with the concomitant appearance of a peak centered at 320 nm, consistent with formation 
of a sulfite N(5)-flavin adduct. At pH 7 and 15 oC, complex formation was slow and required 
several hours for completion at concentrations of sulfite as high as 25 mM. Values for the rate of 
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complex formation (kon) and dissociation (koff) of 0.035 ± 0.001 M-1s-1 and 4.9 ± 8.4 x 10-6 s-1 
were calculated from a plot of kobs versus sulfite concentration, respectively (Figure 4.6, inset). 
Although a koff value not significantly different from zero was observed, by using the upper 
limiting koff value of 1.33 x 10-5 s-1 calculated from the sum of the y-intercept value in Figure 4.5 
and the standard deviation associated with the measurement, an upper Kd value of ~40 µM could 
be estimated from the ratio of the koff to kon values. From a plot of ∆A452 versus [sulfite], a Kd 
value of 51 ± 10 µM was determined from the reaction at various concentrations of sulfite (data 
not shown), in fairly good agreement with the value determined kinetically. Reversibility of the 
flavin-sulfite adduct was established by following the increase in absorbance at 452 nm after 
removing the excess sulfite by gel filtration (data not shown). However, an accurate 
determination of the koff value could not be carried out due to instability of the enzyme over the 
prolonged incubation times required for complete sulfite dissociation. Although the slow rates of 
sulfite complex formation and dissociation observed with choline oxidase are atypical for 
flavoprotein oxidases, similar results were recently observed for another flavin-linked enzyme, 
N-methyltryptophan oxidase (44). 
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Figure 4. 4. Conversion of E-FADox/sq to E-FADox.  
Choline oxidase as purified at a concentration of 33 µM was incubated in air-saturated buffer at 
pH 6 and 15 oC. Absorbance spectra were recorded at different times of incubation until no 
further spectral changes were observed. Only selected spectra are shown: curve 1, absorbance 
spectrum of choline oxidase recorded 1 min after gel filtration of the enzyme through a Sephadex 
G-25 column equilibrated with 20 µM potassium phosphate, 20 mM sodium pyrophosphate, pH 
6; curve 6, same sample after 15 h of incubation. Inset, time course of absorbance changes at 452 
nm. The curve is a fit of the data to y = 0.420-0.071*e(0.79x) (R2=0.9997). 
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Figure 4. 5. Reaction of FADox-containing choline oxidase with sodium dithionite.  
Solid line, the UV-visible absorbance spectrum of FADox-containing choline oxidase was 
recorded at a concentration of 75 µM in 200 mM Tris-Cl, pH 8; Dashed line, air-stable 
semiquinone-containing enzyme prepared by treatment with 5 mM sodium dithionite in 
aerobiosis and gel filtration onto a sephadex G-25 column equilibrated with the same buffer. 
Inset, fluorescence emission spectrum of FADox-containing choline oxidase at a concentration of 
15 µM in 200 mM Tris-Cl, pH 8 and 15 oC. The excitation wavelength was at 453 nm. 
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Figure 4.6. Reaction of choline oxidase with sulfite.  
FADox-containing choline oxidase at a concentration of 15 µM was incubated with 25 mM 
sodium sulfite in air-saturated 100 mM potassium phosphate, pH 7 and 15 oC. Absorbance 
spectra were recorded at different times of incubation until no further spectral changes were 
observed. Only selected spectra are shown: curve 1, absorbance spectrum of choline oxidase 
recorded 10 s after addition of sulfite; curve 20, same sample after 2 h of incubation. Inset, plot 
of the observed rate of decrease in absorbance at 452 nm versus the concentration of sulfite. The 
line is a fit of the data to y = 0.035x+0.0000049 (R2=0.999). 
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  Enzymatic Turnover of E-FADox/sq, E-FADsq and E-FADox with Choline. To determine 
whether the flavin semiquinone of choline oxidase participates in catalysis, choline oxidase 
containing either FADox/sq, FADsq, or FADox, was incubated with 4 mM choline in air-saturated 
200 mM Tris-Cl, at pH 8 and 15 oC. As shown in Figure 4.7, a UV-visible absorbance spectrum 
with maxima at 372 and 495 nm was observed with the FADox/sq-containing enzyme, suggesting 
that the enzyme-bound oxidized flavin was fully reduced in the presence of the substrate, and 
that the flavin semiquinone did not react with choline or oxygen under enzyme turnover. After 
removal of the excess choline by gel filtration, a UV-visible absorbance spectrum substantially 
identical to that of the resting state of E-FADox/sq was observed (Figure 4.7), further consistent 
with the flavin semiquinone not participating in catalysis. When a freshly prepared sample of the 
E-FADsq form of choline oxidase was subjected to the same treatment, no changes were observed 
in the UV-visible absorbance spectra of both the enzyme under turnover and in the resting state 
after removal of excess choline by gel filtration (Figure 4.7), in good agreement with the results 
observed with the enzyme containing a mixture of oxidized and semiquinone flavins. Finally, a 
peak centered at 356 nm was observed in the UV-visible absorbance spectrum of the FADox-
containing enzyme in the presence of choline and oxygen, suggesting that this species of enzyme 
was fully reduced under these conditions (Figure 4.7). After removing the excess choline by gel 
filtration, an absorbance spectrum substantially identical to that of the initial E-FADox species in 
the resting state was observed (Figure 4.7). Altogether, the results of these experiments are 
consistent with the flavin semiquinone of choline oxidase being not catalytically competent and 
with the enzyme-bound flavin cycling between fully oxidized and reduced states during catalytic 
turnover of the enzyme with the substrates.  
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Figure 4.7. UV-Visible absorbance spectra of choline oxidase during turnover with choline.  
Choline oxidase containing different relative amounts of flavin semiquinone and oxidizied flavin 
was incubated for 30 min with 4 mM choline in air-saturated 100 mM potassium phosphate, pH 
7 and 15 oC, before stopping the reaction by gel filtration onto a Sephadex G-25 column 
equilibrated with the same buffer. UV-Visible absorbance spectra were recorded for the enzyme 
in the resting state before turnover (solid curve), under turnover (dashed curve), and in the 
resting state after turnover (dotted curve). Panel A, 95 µM choline oxidase containing FADox/sq; 
panel B, 50 µM choline oxidase containing FADsq; and panel C, 79 µM choline oxidase 
containing FADox. Spectra for the resting enzyme after turnover were normalized to those of the 
resting enzyme before turnover. 
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  Steady State Kinetics. The steady state kinetic parameters for recombinant choline 
oxidase were determined for both the E-FADox and E-FADox/sq forms of choline oxidase, by 
measuring the rate of oxygen consumption at varying concentrations of both the organic 
substrate and oxygen at pH 7 and 25 oC. As expected based on previous studies on A. globiformis 
choline oxidase (18), the kinetic data with choline and betaine aldehyde were fit best by 
equations 1 and 2, which describe sequential kinetic mechanisms with finite and negligible Ka 
values, respectively (37). As shown in Table 4.1, when the kinetic parameters were expressed per 
active site oxidized flavin content, no significant differences were observed in the kcat and kcat/Km 
values when enzyme forms with different FADox/FADtotal ratios were compared, providing 
independent evidence that the flavin semiquinone of choline oxidase does not participate in 
catalysis 2. 
Product Inhibition Studies. As an independent approach to examining the steady state 
kinetic mechanism of recombinant choline oxidase, the inhibition patterns of the product glycine 
betaine with respect to either choline or betaine aldehyde were determined in air-saturated buffer 
at pH 6.75. As shown in Table 4.2, the results were best fit by equation 5, consistent with glycine 
betaine being competitive versus either choline or betaine aldehyde. Moreover, similar kinetic 
parameters were obtained irrespective of the use of E-FADox/sq or E-FADox when the initial rates 
were expressed per active site oxidized flavin (Table 4.2). 
                                                 
2 If the flavin semiquinone were as catalytically competent as the oxidized flavin in the reaction catalyzed by 
choline oxidase, similar kcat and kcat/Km values should have been obtained by expressing the enzymatic activity per 
active site total flavin content. Alternatively, if the flavin semiquinone were either less or more catalytically 
competent than the oxidized flavin, due to the kinetic complexity of the reaction catalyzed by choline oxidase, 
significantly different kcat, Km, Kia, and kcat/Km values should have been observed irrespective of whether the 
enzymatic activity is expressed per active site oxidized flavin content or total flavin content. Within experimental 
error, the kinetic results observed with enzyme forms containing different relative amounts of flavin semiquinone 
and oxidized flavin are therefore consistent with the conclusion that the oxidized flavin is solely responsible for 
catalytic activity.  
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Table 4.1. Steady-State Kinetic Parameters for Recombinant Choline Oxidase with Choline or Betaine Aldehyde as Substrate at pH 
7a 
Substrate 
FADOX/
FADtotalb 
kcat, 
s-1 c 
Ka, 
mMd 
kcat/Ka, 
M-1s-1 e 
KO2, 
µM 
kcat/KO2, 
M-1s-1 
Kia, 
mM eq. R2 
Choline 1.00 61 ± 6 1.7 ± 0.3 36,000 ± 6,400   703 ± 102      87,100 ± 15,300  0.2 ± 0.05 1 0.998
Choline 0.37 60 ± 5 2.9 ± 0.3 21,000 ± 3,000    830 ± 90    72,400 ± 9,900  0.2 ± 0.03 1 0.999
betaine aldehyde 1.00 69 ± 1   1090 ± 30    64,000 ± 2,100  2.2 ± 0.09 2 0.998
betaine aldehyde 0.37 67 ± 1   970 ± 1 69,000 ± 100  2.3 ± 0.01 2 1.000
a Enzyme activity was measured at varying concentrations of both organic substrate and oxygen in 50 mM potassium phosphate, pH 
7 and 25oC. b Oxidized flavin content per total enzyme-bound flavin. c Rates are expressed per active site oxidized flavin content. d Ka 
is the Km value for either choline or betaine aldehyde as substrate. e kcat/Ka is the kcat/Km value for either choline or betaine aldehyde 
as substrate. 
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Table 4.2. Product Inhibition Studies of Recombinant Choline Oxidase with Glycine Betainea 
Substrate 
FADOX/ 
FADtotalb 
type of 
inhibitionc 
kcat, 
s-1 d 
Km, 
mM 
Kis, 
mM 
Kii, 
mM eq R2 
Choline 1.00 C 10.6 ± 0.2 0.8 ± 0.1 15 ± 1  5 0.999 
  UC 11.3 ± 0.2  1.1 ± 0.1   27 ± 1 6 0.929 
  NC   9.3 ± 0.4 0.6 ± 0.1 12 ± 2     108  ± 1014 7 0.995 
 0.37 C  9.7 ± 0.1 0.8 ± 0.1    12 ± 0.3  5 0.993 
  UC  9.4 ± 0.1 0.7 ± 0.1      21 ± 0.1 6 0.941 
  NC  9.7 ± 0.1 0.8 ± 0.1    12 ± 0.1     108  ± 1011 7 0.993 
betaine aldehyde 1.00 C  6.1 ± 0.1 2.0 ± 0.1 56 ± 2  5 0.991 
  UC 10.0 ± 0.1 5.0 ± 0.1  41 ± 2 6 0.971 
  NC   7.6 ± 0.7 2.8 ± 0.7   51 ± 26    103 ± 104 7 0.960 
 0.37 C   5.9 ± 0.1 2.6 ± 0.1  48 ± 4  5 0.996 
  UC     7.8 ± 0.1 4.0 ± 0.1   29 ± 1 6 0.982 
  NC   7.2 ± 0.3 3.3 ± 0.4    49 ± 11    755 ± 926 7 0.993 
a Enzyme activity was measured at varying concentrations of organic substrate and glycine betaine in air-saturated 50 mM potassium 
phosphate, pH 6.75 and 25 ºC. b Oxidized flavin content per total enzyme-bound flavin. c C, competitive; UC, uncompetitive, NC, 
noncompetitive. d Rates are expressed per active site oxidized flavin content. 
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pH Dependence of the kcat and kcat/Km Values. The pH-dependence of the kinetic 
parameters with choline as substrate was determined at varying concentrations of both choline 
and oxygen in the pH range 6 to 10. As shown in Figure 4.8, both the kcat/Km and kcat values for 
choline increased with increasing pH, reaching limiting values above pH 8. Apparent pKa values 
of 7.6 ± 0.2 and 7.1 ± 0.2 were determined for a group that must be unprotonated for catalysis 
from the kcat/Km and kcat pH-profiles, respectively. In contrast, the kcat/Km values for oxygen were 
independent of pH, with values in the 104 M-1s-1 range (Figure 4.9). 
To establish whether a measurable Km value could be determined with betaine aldehyde 
as substrate for the enzyme, initial rates of reaction were measured at pH 6.5 and 10 by varying 
the concentrations of both betaine aldehyde and oxygen. At both pH values the data were fit best 
to equation 2 (data not shown), consistent with kcat being independent of the concentration of 
betaine aldehyde (37). The kcat values with betaine aldehyde were 42 ± 2 at pH 6.5 and 70 ± 1 s-1 
at pH 10. As for the case of choline, the kcat/Km values for oxygen determined with betaine 
aldehyde as the organic substrate were independent of the pH (Figure 4.9). 
As an approach to establishing whether some changes in the kinetic properties of the 
enzyme take place in the conversion of E-FADox/sq to E-FADox, the pH dependences of the 
kinetic parameters with choline as substrate for both enzyme species were determined in air-
saturated buffer in the pH range from 5 to 10. As shown in Figure 4.10, both the kcat/Km and kcat 
values yielded similar pH profiles irrespective of whether the E-FADox or the E-FADox/sq species 
was used, indicating that no changes other than oxidation of E-FADsq occur in the preparation of 
E-FADox by treatment at pH 6. The pKa values were 7.4 ± 0.1 and 7.3 ± 0.1 in the kcat/Km pH 
profiles, and 6.4 ± 0.1 and 6.6 ± 0.1 in the kcat pH profiles with E-FADox and E-FADox/sq, 
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respectively, in agreement with the values of 7.2 ± 0.2 and 6.4 ± 0.1 recently determined for 
choline oxidase from A. globiformis (19). 
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Figure 4.8. pH Dependence of the kcat/Km and kcat values for choline as substrate for recombinant 
choline oxidase. 
Choline oxidase activity was measured at varying concentration of both choline and oxygen at 25 
oC as described in the Experimental Procedures section. The lines are fits of the data to equation 
3. Panel A, pH dependence of the kcat/Km values; panel B, pH dependence of the kcat values. 
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Figure 4.9. pH Dependence of the kcat/Km values for oxygen with choline or betaine aldehyde as 
substrate for recombinant choline oxidase.  
Choline oxidase activity was measured at varying concentration of both choline (or betaine 
aldehyde) and oxygen at 25 oC as described in the Experimental Procedures section. (T) Values 
determined with choline; (U) values determined with betaine aldehyde. The line represents the 
average pH-independent kcat/Km value with choline as substrate. 
 
 
  
189
 
3
4
5
6
5 6 7 8 9 10
 lo
g 
k c
at
/K
m
, M
-1
s-
1
pH
A
0
1
2
5 6 7 8 9 10
lo
g 
k c
at
, s
-1
pH
B
 
Figure 4.10. pH Dependence of the apparent kinetic parameters of E-FADox/sq and E-FADox with 
choline as substrate.  
Choline oxidase activity was measured in air-saturated buffer at 25 oC. (z) Values determined 
with E-FADox; ({) values determined with E-FADox/sq. The lines are fits of the data to equation 
3. Panel A, pH dependence of the kcat/Km values; panel B, pH dependence of the kcat values.  
 
pH Dependence of Inhibition by Glycine Betaine. The pH dependence of the inhibition 
by glycine betaine was determined in atmospheric oxygen using choline as substrate for E-
FADox. As shown in Figure 4.11, the data were fit best by equation 4, consistent with a single 
ionizable group with a pKa value of 7.5 ± 0.1 that must be protonated for inhibition. 
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Figure 4.11. pH Dependence of inhibition by glycine betaine.  
At each pH value, choline oxidase activity was measured at varying concentrations of both 
choline and glycine betaine in air-saturated buffer at 25 oC. The Kis values for glycine betaine 
were determined by fitting the initial rate data to equation 5. The line is a fit of the data to 
equation 4. 
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Discussion 
Recombinant choline oxidase expressed in E. coli cells contains between 35 and 85% of 
bound flavin in an anionic semiquinone form that requires the protein microenvironment to be 
stabilized. At pH 8, this enzyme-bound flavosemiquinone is unusually insensitive to both 
molecular oxygen 3 and the oxidizing agent ferricyanide, suggesting that the unpaired electron is 
localized in a region of the flavin that is not accessible for reaction. Earlier studies on native 
choline oxidase from Alcaligenes sp. showed that an anionic semiquinone that was poorly 
reactive towards oxygen is stabilized by the enzyme (45), suggesting that this property does not 
arise from the expression of the recombinant enzyme in the heterologous system used in our 
study. A rationale for the unusual air-stability of the flavin semiquinone can be proposed based 
on recent ab initio theoretical calculations, showing that most of the spin density in anionic 
flavin semiquinones is distributed on either the benzene ring or the N(5) position of the flavin 
(46, 47). The flavin N(5) locus is expected to be freely accessible to oxygen, because of the role 
it plays in catalysis by accepting the hydride equivalent generated in the oxidation of the 
substrate. In contrast, the benzene ring of FAD is involved in a 8α-N(1)-histidyl linkage with the 
protein (4) and is likely to be hindered by the protein moiety. Stabilization of the spin density on 
the benzene ring of the anionic semiquinone might further be contributed by the inductive effect 
of the flavin 8α-N(1)-histidyl linkage with the protein moiety.  
The choline oxidase-bound semiquinone undergoes a slow conversion to the fully 
oxidized state at pH 6, indicating that a hundred fold increase in proton concentration 
significantly destabilizes the flavin radical. Although not investigated further in this study, a 
                                                 
3 The rate of reaction with oxygen of anionic flavin semiquinones in solution is almost diffusion-controlled, with 
second order rate constant values of 108 M-1s-1 (69, 70). That for enzyme-bound anionic semiquinones has been 
reported for glucose oxidase to be in the 104 M-1s-1 range (49). 
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possible rationale for the oxidation of the flavin semiquinone in choline oxidase is that at low pH 
a limited fraction of the enzyme-bound semiquinone becomes protonated to yield the neutral 
species of the semiquinone, which would be readily oxidized by molecular oxygen because of 
localization of the unpaired electron on the highly oxygen-reactive C(4a) locus of the flavin (43). 
pH-Dependent stabilization of both anionic and neutral flavin semiquinones by the same enzyme 
was previously shown in another member of the GMC oxidoreductase superfamily, glucose 
oxidase (42, 48), for which it was shown that the neutral semiquinone reacts with oxygen with a 
second order rate constant of 1.4 x 104 M-1s-1 at 25 oC (49). Unusual stabilization of neutral 
semiquinones by flavoprotein oxidases was also reported for nitroalkane oxidase (50) and D-
amino acid oxidase in the presence of benzoic acid (51). 
The spectral studies of the enzyme under turnover establish that the flavin semiquinone 
of choline oxidase is not catalytically relevant and that the enzyme under turnover cycles 
between its fully oxidized and fully reduced states. This conclusion is further supported by 
kinetic data, showing a good correlation between the turnover numbers of the enzyme with 
choline and betaine aldehyde as substrate and the content of oxidized flavin per active site. 
Consistent with the lack of catalytic role for the flavin semiquinone, variable FADox/FADsq ratios 
for the enzyme-bound flavin are observed among different preparations of enzyme (6). Thus, 
choline oxidase appears to be similar to methanol oxidase, which was shown in earlier studies to 
contain a mixture of oxidized FAD and an air-stable anionic semiquinone that is not required for 
catalysis (52). In contrast, air-stable flavin semiquinones for which a catalytic role of the flavin 
radical was proposed (53, 54) were reported in the resting state of monoamine oxidase B (55-57) 
and E. coli DNA photolyase (58, 59). 
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A weak positive charge is located in the active site of choline oxidase in proximity of the 
N(1)-C(2)=O locus of FAD, as suggested by both the stabilization of the anionic semiquinone 
and the high affinity of the enzyme for sulfite (43). By analogy with other members of the GMC 
oxidoreductase superfamily whose three-dimensional structure is available, such as glucose 
oxidase (60, 61), cholesterol oxidase (62, 63), and cellobiose dehydrogenase (64), it is likely that 
the positive charge in choline oxidase is provided by the dipole of an α-helix. 
A steady state kinetic analysis of choline oxidase from A. globiformis was recently 
reported at pH 7 (18). The results of the kinetic studies reported here indicate that recombinant 
and native choline oxidase share identical steady state sequential mechanisms in which the 
products are released from the oxidized enzyme (Scheme 4.2) and, most importantly, that the 
order of the kinetic steps involving substrate binding and product release is not affected by pH. 
Independent evidence for product release occurring after reaction of the reduced enzyme with 
oxygen is provided by the competitive inhibition patterns observed with glycine betaine versus 
both choline and betaine aldehyde. The product inhibition patterns observed in this study also 
rule out possible kinetically relevant conformational changes occurring after release of the 
product from the enzyme active site, such as those observed with nitroalkane oxidase (65). 
His-466 with a pKa value of 7.5 was recently proposed to participate in catalysis by 
accepting the hydroxyl proton of choline, based on pH dependence studies in atmospheric 
oxygen with choline oxidase from A. globiformis and sequence alignment comparison with other 
members of the GMC enzyme superfamily (19). Consistent with those results, an amino acid 
residue with pKa value of 7.6 is seen in the kcat/Km pH-profile of recombinant choline oxidase 
determined at varying concentrations of choline and oxygen. In the kinetic mechanism of 
Scheme 4.2, the kcat/Km value for choline is a combination of rate constants reflecting substrate 
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binding, k1 and k2, the catalytic step in which choline is oxidized to betaine aldehyde, k3 and k4, 
and the kinetic step in which the reduced enzyme-product complex is oxidized by oxygen, k5, as 
illustrated by equation 8. This raises the possibility that the catalytic base may be involved in 
oxygen reduction rather than in substrate oxidation. However, the observation that the kcat/Km 
values for oxygen are independent of pH unequivocally establishes the involvement of the 
catalytic base in the oxidation of choline to betaine aldehyde.  
[ ]
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++=           (8) 
The pKa value of 7.5 seen in the pH profile of glycine betaine inhibition is due to an 
amino acid residue that must be protonated for product binding, as expected if this residue is 
involved in binding the caboxylate moiety of glycine betaine. This amino acid group is likely to 
be the same histidine residue that must be unprotonated for catalysis and is responsible for the 
pKa value of 7.6 observed in the kcat/Km pH profile. Since pKa values determined with 
competitive inhibitors are expected to reflect true equilibrium dissociation constants, these 
results establish choline as a slow substrate with little if any external forward commitment to 
catalysis (66). This conclusion does not agree with that recently reported for choline oxidase 
from A. globiformis based on pH and kinetic isotope effects studies using [1,2-2H4]-choline in 
atmospheric oxygen, showing a decrease in the Dkcat/Km values with increasing pH (19). A 
reasonable explanation that accounts for all the available data is that the decrease in the apparent 
Dkcat/Km values with increasing pH when the concentration of oxygen is well below saturation is 
not due to choline being a fast substrate for the enzyme as originally proposed (19), but to the 
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reverse catalytic step (k4 in Scheme 4.2) becoming significantly fast as compared to the kinetic 
step in which the enzyme-bound reduced flavin is oxidized (k5 in Scheme 4.2) 4. 
No ionizable groups with pKa value in the pH range from 6 to 10 are required for oxygen 
reduction in the betaine aldehyde- or glycine betaine-choline oxidase complexes, as suggested by 
the pH independence of the kcat/Km values for oxygen with either choline or betaine aldehyde as 
substrate. These data are consistent with a hydrophobic environment being required for flavin 
activation in the reduced enzyme-product complexes. In this respect, a hydrophobic channel that 
may serve as an entrance for oxygen to the active site was recently proposed for another member 
of the GMC oxidoreductase superfamily, cholesterol oxidase (67). Oxygen reactivity in choline 
oxidase therefore appears to be different from that of glucose oxidase, for which protonation of 
the active site His-516 residue was recently shown to increase the reactivity of the reduced 
enzyme towards oxygen by about 4 orders of magnitude (68). 
In summary, the results of the studies on choline oxidase presented herein have 
established that the enzyme is a typical flavoprotein oxidase, showing formation of an anionic 
flavin semiquinone and reactivity with sulfite.  However, stabilization of the flavin semiquinone 
by the enzyme is unusual in that it occurs in the presence of molecular oxygen. Such a lack of 
                                                 
4 In the kinetic mechanism of Scheme 4.2, the observed isotope effect on the kcat/Km value is given by 
][
1
][
24.1
25
4
2
3
25
4
2
3
3
Ok
k
k
k
Ok
k
k
kk
K
k
D
m
cat
D
+++
++
=  (66), where 1.24 is the value for the equilibrium kinetic isotope effect for the 
conversion of an alcohol to an aldehyde (71). If the forward commitment to catalysis k3/k2 is negligible, any 
decrease in the observed kinetic isotope effect must be due to the reverse commitment to catalysis k4/k5[O2], which 
depends on the concentration of oxygen. Since choline oxidase from A. globiformis has a Km value for oxygen of 0.6 
mM at pH 7 and 19 oC (18), and the concentration of oxygen in air-saturated buffers at 19 oC is ~0.3 mM,  it follows 
that under these conditions the rate of oxidation of the enzyme-bound reduced flavin becomes signhificantly slow. 
Consequently, a significant increase in the reverse commitment to catalysis is expected at concentrations of oxygen 
well below saturation in the enzyme-catalyzed oxidation of choline. 
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reactivity towards oxygen has allowed a spectroscopic characterization of the enzyme-bound 
anionic flavin semiquinone and to establish that the flavin semiquinone does not participate in 
catalysis. From a mechanistic standpoint, the kinetic data presented here have indicated that the 
recently proposed catalytic base of choline oxidase, His-466, participates in the oxidation of the 
organic substrate but not in the reduction of molecular oxygen. 
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CHAPTER V 
On the Catalytic Role of the Conserved Active Site Residue His466 of Choline Oxidase 
(This chapter was published in verbatim in Ghanem, M., and Gadda, G., (2005), Biochemistry 
44, 893-904. © 2005 American Chemical Society. All rights reserved.) 
 
Abstract 
The oxidation of alcohols to aldehydes is catalyzed by a number of flavin-dependent 
enzymes, which have been grouped in the Glucose-Methanol-Choline oxidoreductase enzyme 
superfamily. These enzymes exhibit little sequence similarity in their substrates binding 
domains, but share a highly conserved catalytic site, suggesting a similar activation mechanism 
for the oxidation of their substrates. In this study, the fully conserved histidine residue at position 
466 of choline oxidase was replaced with an alanine residue by site-directed mutagenesis and the 
biochemical, spectroscopic, and mechanistic properties of the resulting CHO-H466A mutant 
enzyme were characterized. CHO-H466A showed kcat and kcat/Km values with choline as 
substrate that were 60- and 1000-fold lower than the wild-type enzyme, while the kcat/Km value 
for oxygen was unaffected, suggesting the involvement of His466 in the oxidation of the alcohol 
substrate but not in the reduction of oxygen. Replacement of His466 with alanine significantly 
affected the microenvironment of the flavin, as indicated by the altered behavior of CHO-H466A 
with sulfite and dithionite. In agreement with this conclusion, a midpoint reduction potential of 
+106 mV for the two-electron transfer in the catalytically competent enzyme-product complex 
was determined at pH 7 for CHO-H466A, which was ~25 mV more negative than that of the 
wild-type enzyme. Enzymatic activity in CHO-H466A could be partially rescued with exogenous 
imidazolium, but not imidazole, consistent with the protonated form of histidine exerting a 
catalytic role. pH profiles for glycine betaine inhibition, the deprotonation of the N(3)-flavin 
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locus, and the kcat/Km value for choline all showed a significant shift upward in their pKa values, 
consistent with a change in the polarity of the active site. Finally, kinetic isotope effects with 
isotopically labeled substrate and solvent indicated that the histidine to alanine substitution 
affected the timing of substrate OH and CH bond cleavages, consistent with removal of the 
hydroxyl proton being concerted with hydride transfer in the mutant enzyme. All taken together, 
the results presented in this study suggest that in choline oxidase, His466 modulates the 
electrophilicity of the enzyme-bound flavin and the polarity of the active site, and contributes to 
the stabilization of the transition state for the oxidation of choline to betaine aldehyde. 
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Introduction  
The oxidation of alcohols to aldehydes is catalyzed by a number of flavin-dependent enzymes, 
among which are choline oxidase (1, 2), choline dehydrogenase (3), glucose oxidase (4, 5), 
cholesterol oxidase (6), and cellobiose dehydrogenase (7). These enzymes all utilize FAD as a 
cofactor for catalysis and have been grouped in the Glucose-Methanol-Choline (GMC1) 
oxidoreductase enzyme superfamily (8). Although GMC enzymes exhibit little sequence 
similarity in their substrate binding domains, the crystal structure of glucose oxidase (9, 10), 
cholesterol oxidase (11-13), and the flavin domain of cellobiose dehydrogenase (14), show that 
they all share a highly conserved catalytic site (Figure 5.1), suggesting a similar activation 
mechanism for the oxidation of their substrates. Recent mechanistic studies on choline oxidase 
with the use of isotopically labeled substrate and solvent indicated that alcohol oxidation occurs 
through a base-catalyzed formation of an alkoxide species that precedes the transfer of a hydride 
from the substrate α-carbon to the isoalloxazine system of the FAD cofactor (Scheme 5.1) (15). 
To date, the nature of both the catalytic base that abstracts the hydroxyl proton from the substrate 
and the amino acid residue(s) that provide the necessary stabilization of the ensuing alkoxide 
species in catalysis remains elusive. Earlier mechanistic studies on cholesterol oxidase (16, 17), 
cellobiose dehydrogenase (18), and glucose oxidase (10, 19, 20), suggested that an histidine 
residue, which is fully conserved within the GMC family and corresponds to His466 of choline 
oxidase, might act as the specific base that participates in the oxidation of the alcohol substrate 
                                                 
1 Abbreviations: CHO-H466A, mutant form of choline oxidase with His466 replaced with Ala; CHO-WT, wild-type 
choline oxidase; GMC, Glucose-Methanol-Choline oxidoreductase enzyme superfamily; Dkcat/Km and Dkcat/Km(D2O) 
indicate substrate kinetic isotope effects determined with 1,2-[2H4]-choline in aqueous and deuterated solvent, 
respectively; D2Okcat/Km and D2Okcat/Km(D) represent solvent kinetic isotope effects determined with choline and 
deuterated choline, respectively; D,D2Okcat/Km is multiple kinetic isotope effect determined with choline in H2O and 
deuterated choline in D2O. 
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(Figure 5.1). However, the recent availability of a crystal structure of an unliganded form of 
cholesterol oxidase at sub-atomic resolution, in which it was shown that the Nε2 position of the 
active site His447 residue pointing at the substrate hydroxyl group is protonated (13), clearly does 
not support this histidine residue acting as a specific base in catalysis. These structural 
observations prompted the authors to suggest that the conserved histidine residue might act as a 
hydrogen bond donor to the hydroxyl oxygen of the substrate, which would assist in positioning 
the substrate with respect to the flavin for efficient catalysis (13). 
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Figure 5.1. The conserved active site residues in the GMC oxidoreductase superfamily.  
Panel A, hypothetical structure of choline oxidase generated by using SWISS-MODEL software 
and energy minimization by using SYBIL 6.9 software and the structure of glucose oxidase as 
template; panel B, glucose oxidase (PDB code 1CF3); panel C, cholesterol oxidase (PDB code 
1COY); panel D, cellobiose dehydrogenase (PDB code 1NAA). 
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Scheme 5.1. Chemical mechanism for choline oxidation catalyzed by choline oxidase.  
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Scheme 5.2. Chemical reaction catalyzed by choline oxidase. 
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Our group recently cloned and overexpressed the gene coding for choline oxidase (E.C. 
1.1.3.17) from Arthrobacter globiformis strain ATCC 8010 (21), and showed that the resulting 
enzyme maintains biochemical and kinetic properties similar to those of the native choline 
oxidase (21-23). The enzyme is a homodimer of 120 kDa, with each subunit containing 
covalently bound FAD in a 8α-N(1)-histidyl linkage (21, 23, 24), and it catalyzes the oxidation 
of choline to glycine betaine through two sequential flavin-linked hydride transfers from choline 
and the ensuing betaine aldehyde intermediate to molecular oxygen (Scheme 5.2) (21-23). This 
reaction is of considerable interest for medical and biotechnological applications, since 
accumulation of glycine betaine in many pathogens and plants enables their stress-resistance 
towards hyperosmotic environments (25, 26). Consequently, the study of choline oxidase has 
potential for the development of therapeutic agents that inhibit the biosynthesis of glycine 
betaine and render pathogenic bacteria susceptible to either conventional treatments or the innate 
immune system, and for the improvement of water stress resistance in genetically engineered 
crops lacking efficient glycine betaine biosynthetic systems. 
 In the present study, a mutant choline oxidase in which the active site residue His466 was 
replaced with alanine was prepared by site-directed mutagenesis and the biochemical, 
spectroscopic, and mechanistic properties of the resulting CHO-H466A mutant enzyme were 
characterized in order to obtain insights on the catalytic role played by this conserved histidine 
residue. The results of the studies presented herein provide new insights into the chemical 
mechanism of choline oxidase and, by extension, of the GMC oxidoreductase enzyme 
superfamily.  
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Experimental Procedures 
Materials. Escherichia coli strain Rosetta(DE3)pLysS were from Novagen (Madison, 
WI). The QuikChange Site-Directed Mutagenesis kit was from Stratagene (La Jolla, CA). The 
QIAprep Spin Miniprep kit was from Qiagen (Valencia, CA). Oligonucleotides used for site-
directed mutagenesis and for sequencing of the mutant gene were custom synthesized by the 
DNA Core Facility of the Department of Biology of Georgia State University or by Sigma 
Genosys (The Woodlands, TX). Oligonucleotides, bovine serum albumin, chloramphenicol, 
tetracycline, isopropyl-β-D-thiogalactopyranoside (IPTG), lysozyme, sodium hydrosulfite 
(dithionite), sodium sulfite, betaine aldehyde, glycine betaine, Luria-Bertani agar and broth, and 
PMSF were from Sigma (St. Louis, MO). Choline chloride and ampicillin were from ICN 
(Aurora, OH). 1,2-[2H4]-Choline bromide was from Isotec Inc. (Miamisburg, OH). Deuterium 
oxide (D2O) was from Cambridge Isotope Laboratories Inc. (Andover, MA). Wild-type choline 
oxidase (CHO-WT) from Arthrobacter globiformis strain ATCC 8010 was expressed from 
pET/codA1 and purified to homogeneity as previously described (21). The fully oxidized FAD-
containing CHO-WT was prepared as described in ref. (27). All other reagents were of the 
highest purity commercially available. 
Instruments. UV-visible absorbance spectra were recorded using an Agilent 
Technologies diode-array spectrophotometer model HP 8453 equipped with a thermostated water 
bath. Fluorescence emission spectra were recorded with a Shimadzu Spectrofluorometer model 
RF-5301 PC thermostated at 15 °C. Circular dichroism spectra were acquired using a Jasco J-810 
spectropolarimeter at 5 °C. 
Site-Directed Mutagenesis. A QuikChange kit was used to prepare the mutant enzyme 
choline oxidase-H466A (CHO-H466A). The method used was essentially according to the 
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manufacturer’s instructions, using pET/codA1 plasmid (21) as a template and Cho-H466Af 
(5′CAACACCGTCTACGCCCCCGTGGGCACCGTGC 3′) and Cho-H466Ar 
(5′CACGGTGCCCACGGGGGCGTAGACGGTGTTGTGC 3′) oligonucleotides as forward and 
reverse primers (underlined letters indicate mismatches), respectively. DNA was sequenced at 
the DNA Core Facility at Georgia State University using an Applied Biosystems Big Dye Kit on 
an Applied Biosystems model ABI 377 DNA sequencer. Sequencing confirmed the presence of 
the mutant gene in the correct orientation. E. coli strain Rosetta(DE3)pLysS competent cells 
were transformed with plasmid  pET/codA1-H466A  by electroporation. 
Expression and Purification of CHO-H466A. Permanent frozen stocks of E. coli cells 
Rosetta(DE3)pLysS harboring plasmid pET/codA1-H466A were used to inoculate 4.5 liters of 
Luria-Bertani broth medium containing 50 µg/ml ampicillin and 34 µg/ml chloramphenicol, and 
liquid cultures were grown overnight at 37 °C. The cultures were induced for protein expression 
by adding 0.1 mM IPTG and then incubated for an additional 5 h at 22 °C. A 100 µl aliquot was 
taken 5 h after induction with IPTG to be used for visualization of the expressed protein using 
sodium dodecyl sulfate polyacrylamide gel electrophoresis following the Laemmli method (28). 
The gel was stained with Commassie Brilliant Blue G-250. The mutant enzyme CHO-H466A 
was purified to homogeneity using the same procedure used previously for the purification of the 
wild-type enzyme (21). 
Spectral Studies. The extinction coefficient of CHO-H466A was determined in Tris-Cl, 
pH 8, after denaturation of the enzyme by treatment with 0.1% SDS at 100 °C for 5 min, based 
upon the ε450 value of 11.3 mM-1 cm-1 for free FAD (29). The spectral properties of CHO-WT 
and CHO-H466A before and after the addition of 200 mM of glycine betaine were determined at 
15 °C in 100 mM sodium pyrophosphate buffer, pH 6.5. All spectra were normalized to the 
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molar extinction of the uncomplexed enzyme and corrected for dilution. For reactions with 
sodium sulfite, the reagent was prepared freshly as 1 M stock solution in 100 mM sodium 
pyrophosphate, pH 6.5. Different amounts of sodium sulfite at final concentrations ranging from 
25 to 100 mM were added to the enzyme solution in 100 mM sodium pyrophosphate, pH 6.5, at 
15 °C, and the UV-visible absorbance spectra were recorded at different times. Since previous 
studies on wild type choline oxidase showed that the enzyme is reduced by treatment with 
dithionite in the presence of oxygen (23), reduction of CHO-H466A with dithionite was carried 
out aerobically in 20 mM Tris-Cl, pH 8, at 15 °C, by adding dithionite to the enzyme solution as 
a powder. The excess amount of dithionite was removed by gel filtration using a Sephadex G-25 
column equilibrated with 20 mM Tris-Cl, pH 8. The pH dependence of the absorbance spectra 
for both wild-type and mutant enzymes at concentrations of ~20 µM in 20 mM sodium 
phosphate, 20 mM sodium pyrophosphate, pH 6, and 15 °C, were determined by titrating with 
sodium hydroxide.  
The CD spectra of CHO-WT and CHO-H466A were recorded at 5 °C in 20 mM Tris-Cl, 
pH 8, at concentrations of enzyme of 5 and 15 µM for the far and the near UV, respectively. The 
fluorescence emission spectra of CHO-WT and CHO-H466A were acquired in 20 mM Tris-Cl 
buffer, pH 8 at 15 °C. The excitation wavelengths for CHO-WT and CHO-H466A were 453 nm 
and 458 nm, respectively. 
Enzyme Assays. The enzymatic activity of CHO-H466A was measured by the method of 
initial rates as described for the wild-type enzyme (21, 23) using a computer-interfaced Oxy-32 
oxygen-monitoring system (Hansatech Instrument Ltd.). The kinetic parameters of CHO-H466A 
were determined by varying the concentrations of both choline, in the range between 2.5 and 35 
mM, and oxygen, in the range between 24 and 460 µM, as substrates, in 50 mM potassium 
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phosphate, pH 7, at 25 °C. The effect of pH on the kinetic parameters of CHO-H466A were 
determined over a pH range from 5.5 to 11 by a series of enzyme activity assays at varying 
choline concentrations ranging from 0.025 to 45 mM in air-saturated 50 mM sodium 
pyrophosphate at 25 °C. The kinetic isotope effects of CHO-H466A were obtained by 
determining the kinetic parameters of the enzyme using either choline or 1,2-[2H4]-choline as 
substrate in either aqueous or deuterated solvent, in air-saturated 50 mM sodium pyrophosphate 
at 25 °C and pL 10. For the determinations of solvent isotope effects, buffers were prepared 
using 99.9% deuterium oxide by adjusting the pD value with NaOD. The pD values were 
determined by adding 0.4 to the pH electrode readings (30). For all steady state kinetic isotope 
effects, activity assays were carried out by alternating substrate or solvent isoptomers. Product 
inhibition studies were carried out by varying the concentrations of both glycine betaine, in the 
range between zero and 60 mM, and choline, in the range between 0.02 and 20 mM, in air-
saturated 50 mM sodium pyrophosphate at 25 °C, over a pH range from 7 to 11. The effect of 
imidazole on the turnover number of CHO-H466A was determined by measuring the enzymatic 
activity with 10 mM choline as substrate for the enzyme in the presence of varying 
concentrations of imidazole in the range from 0 to 250 mM in air-saturated 50 mM potassium 
phosphate, pH 7, or 50 mM sodium pyrophosphate for other pH values.    
 Potentiometric Titrations. All redox titrations of wild-type and H466A CHO were 
carried out on the glycine betaine-liganded enzyme at 15 °C in a cell similar to the one described 
by Edmondson (1985). Potentials were measured by using a Pt electrode relative to an Ag/AgCl 
double junction reference electrode with an Orion Model 701A pH/mV meter (31). The reference 
electrode was calibrated prior to each titration as described by Edmondson (31), using a 
deoxygenated, saturated quinhydrone solution in 0.09 M KCl and 0.01 M HCl at 25 °C. In a 
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typical titration, 2.5 ml of ~20-30 µM choline oxidase containing glycine betaine at a 
concentration of 1.5 M in 20 mM Tris-Cl, pH 7, was scrubbed free of oxygen by at least 15 
cycles of alternate degassing under vacuum and flushing with O2-free argon. The following 
redox mediators were added to ensure complete redox equilibration: 2 µM methyl viologen (-440 
mV), 0.5 µM dichlorophenolindophenol (+217 mV), 0.5 µM phenazine methosulfate (+80mV), 
0.5 µM thionin (+60 mV), 0.5 µM duroquinone (-5 to +5 mV), 0.5 µM resorufin (-50 mV), and 
0.5 µM indigo carmine (-125 mV) (32, 33). The ligand-bound enzyme solutions were titrated 
electrochemically as described by Dutton (34), using freshly prepared sodium dithionite as 
reductant and potassium ferricyanide as oxidant in 20 mM Tris-Cl, pH 7 (34). Adequate time 
was permitted for electronic equilibration after each addition of sodium dithionite or potassium 
ferricyanide prior to the spectrum being recorded; equilibrium of the system was considered to 
be obtained when the measured potential drift was less than 1 mV in 5 min, which was typically 
achieved after 30 to 60 min. UV-visible absorbance spectra were recorded using an Agilent 
Technologies diode-array spectrophotometer model HP 8453 equipped with a thermostated cell 
holder and a magnetic stirrer beneath the cell holder. All spectra were corrected for any drift in 
the baseline by subtracting the absorbance at 800 nm. 
Data Analysis. Kinetic data were fit with the KaleidaGraph software (Synergy Software, 
Reading, PA) and the Enzfitter software (Biosoft, Cambridge, UK). Apparent kinetic parameters 
in atmospheric oxygen were determined by fitting initial reaction rates at different substrate 
concentrations to the Michaelis-Menten equation for one substrate. Initial rates determined by 
varying the concentration of both choline and oxygen were fit to eq 1, which describes a 
sequential steady-state kinetic mechanism. Ka and Kb are the Michaelis constants for choline (A) 
and oxygen (B), respectively, and kcat is the turnover number of the enzyme (e). Product 
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inhibition studies data were fit to eq 2, which describes competitive inhibition pattern of the 
product and the organic substrate. P is the concentration of glycine betaine, and Kis is the 
inhibition constant for the slope effect. The pH dependencies of steady-state kinetic parameters 
were determined by fitting initial rate data to eq 3, which describes a curve with a slope of +1 
and a plateau region at high pH. The pH dependence of inhibition by glycine betaine was 
determined by fitting the initial rate data to eq 4, which describes a curve with a slope of -1 and a 
plateau region at low pH. C is the pH-independent value of the kinetic parameter of interest. Data 
of the pH dependencies of the absorbance spectra for both wild-type and mutant enzymes were 
fit to eq 5, which describes a curve with a slope of -1 and plateau regions at low and high pH, 
where A and B represent the absorbance values at 500 nm at low and high pH, respectively. The 
mid-point reduction potentials of the enzymes were determined by fitting the data to the Nernst 
equation (eq 6), where Eh is the measured electrode potential at equilibrium at each point in the 
titration; Em is the mid-point redox potential; R is the gas constant, with a value of 8.31 J mol-1 at 
15 °C; T is the temperature in Kelvin; n is the number of electron transferred; F is Faraday’s 
constant, with a value of 96.48 kJ V-1 mol-1.  
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Results 
Expression and Purification of CHO-H466A. CHO-H466A was expressed and purified 
to homogeneity as judged by SDS-PAGE using the same protocol developed for the wild-type 
enzyme (data not shown). As for the case of the wild-type enzyme, about 150 mg of pure mutant 
enzyme could be typically obtained from 4.5 liters of Luria-Bertani culture medium. The specific 
activity of the H466A form of choline oxidase was ~45-times lower than that of the wild-type 
enzyme [0.12 vs. 5.3 µmol O2 min-1 mg-1 (21)], suggesting that His466 plays a role in catalysis in 
choline oxidase. 
Spectral Properties. In order to verify that the mutant enzyme maintains an overall fold 
similar to that of the wild-type enzyme, the structural properties of CHO-H466A were examined 
using CD and fluorescence spectroscopy. The near- and the far-UV CD spectra of CHO-H466A 
were found to be similar to those of the wild-type enzyme (Figure 5.2), suggesting an overall 
fold of the mutant enzyme similar to that of the wild-type enzyme. As shown in Figure 5.2, the 
protein fluorescence emission spectrum of CHO-H466A obtained upon excitation at 285 nm 
yielded a peak at 340 nm, as for the case of the wild-type enzyme, but with increased intensity. 
Such an increase in fluorescence intensity is consistent with either a decrease in the polarity of 
the microenvironment surrounding nearby aromatic residues (35) or the removal of a quenching 
effect upon substituting the active site histidine with an alanine residue, both effects attributable 
to the presence of a tyrosine residue, Tyr465, adjacent to the site of mutation in the amino acid 
sequence of the enzyme (21).   
The UV-visible absorbance spectrum of CHO-H466A at pH 8 showed the typical flavin 
peaks in the near-UV and visible region of the absorbance spectrum (Figure 5.2), indicating that 
the enzyme-bound flavin cofactor in the mutant enzyme as purified is in the oxidized state. As 
  
216
 
expected for an enzyme containing covalently bound FAD, the soluble fraction prepared upon 
treatment of CHO-H466A with 10% trichloroacetic acid followed by centrifugation to remove 
the denatured protein was devoid of absorbance (data not shown). A stoichiometry of 0.32 ± 0.05 
FAD per monomer of protein was calculated for CHO-H466A, indicating that the flavin content 
of the mutant enzyme was significantly less than that of the wild-type choline oxidase, for which 
a stoichiometry close to unity was previously reported2 (21). The enzyme-bound flavin of CHO-
H466A showed an extinction coefficient at 458 nm of 12 mM-1 cm-1, in agreement with the value 
of 11.4 mM-1 cm-1 at 452 nm previously determined with the wild-type form of the enzyme (23). 
The flavin fluorescence emission spectrum of CHO-H466A had a maximum at ~530 (λex at 458 
nm), with a relative intensity of ~50% of that seen for the wild-type enzyme (Figure 5.2), 
consistent with an altered flavin microenvironment in the mutant protein. 
The absence of a flavin semiquinone in the UV-visible absorbance spectrum of CHO-
H466A as purified (Figure 5.2) is in stark contrast to the observation recently reported for the 
wild-type form of choline oxidase, for which the enzyme-bound cofactor was found as a mixture 
of oxidized and air-stable anionic semiquinone flavin species (21, 23). Treatment of the mutant 
enzyme under aerobic conditions with dithionite at pH 8 resulted in the rapid bleaching of the 
peak at 458 nm and the appearance of a spectrum with maxima at 372 and 495 nm (data not 
shown), consistent with reduction of the enzyme-bound flavin to the semiquinone state, as for the 
case of wild-type enzyme (23). 
                                                 
2 A lower flavin to protein stoichiometry was reported in earlier studies on mutant forms of trimethylamine 
dehydrogenase and p-cresol methylhydroxylase, in which a positively charged arginine residue in the proximity of 
the N(1)-C(2)=O locus of the flavin cofactor was selectively replaced (36, 37). Although the low degree of enzyme 
flavinylation in CHO-H466A was not investigated further in this study, it is reasonable that the low flavin content in 
the mutated enzyme might be due to the removal of the positively charged His466 (vide infra) from the active site of 
the enzyme, which results in an altered flavin microenvironment in CHO-H466A. In this context, an effect of the 
alanine replacement of His466 on the flavin microenvironment of choline oxidase is supported by several 
observations presented herein. 
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Figure 5.2. Comparison of the spectral properties of CHO-H466A (solid curves) and CHO-WT 
(dotted curves).  
Panels A and B, circular dichroism spectra of CHO-H466A and CHO-WT in 20 mM Tris-Cl, pH 
8, at 5 °C. Enzyme concentrations were 15 and 5 µM for the near-UV and far-UV 
determinations, respectively; panel C, protein fluorescence emission spectra of CHO-H466A and 
CHO-WT in 20 mM Tris-Cl, pH 8, at 15 °C, the excitation wavelength was 285 nm for both 
enzymes; panel D, UV-visible absorbance and fluorescence emission spectra of CHO-H466A 
and CHO-WT in 20 mM Tris-Cl, pH 8, at 15 °C, the excitation wavelengths for CHO-WT and 
CHO-H466A were 453 nm and 458 nm, respectively. 
 
However, while no spectral changes were observed with the wild-type enzyme upon 
aerobic incubation at pH 8 of the semiquinone-containing enzyme after removal of the excess 
dithionite by gel filtration (23), complete reoxidation of the enzyme-bound anionic flavin 
semiquinone was observed with CHO-H466A as indicated by the increase in absorbance at 458 
nm (data not shown). These data clearly indicate that the lack of flavin semiquinone in the CHO-
H466A protein as purified is due to an impaired ability of this mutant enzyme to stabilize the 
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anionic flavin semiquinone rather than to promote its formation. In contrast to wild type choline 
oxidase, which was recently shown to form a tight reversible N(5)-flavin sulfite adduct with a Kd 
value of ~50 µM at 15 °C (23), no significant absorbance changes were observed upon treatment 
of CHO-H466A with either 25 or 100 mM sodium sulfite at pH 6.5 over 3.5 h of incubation 
(Figure 5.3). All taken together, these data further suggest a change in the flavin 
microenvironment upon replacing His466 with alanine. 
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Figure 5.3. Reaction of CHO-H466A with sulfite.  
UV-visible absorbance spectra of CHO-H466A after 3.5 hours of incubation with 100 mM 
sodium sulfite in the absence (solid curve) or the presence (dotted curve) of 100 mM imidazole. 
Enzyme concentrations were 50 µM in 100 mM sodium pyrophosphate, pH 6.5, at 15 °C.  
 
Effect of pH on the Spectral Properties of CHO-H466A and Wild-type Choline 
Oxidase.   The effect of pH on the spectral properties of the histidine mutant was determined and 
compared to that of wild-type enzyme. At pH 6, CHO-H466A exhibited absorbance maxima at 
458 and 369 nm, whereas the wild-type enzyme showed maxima at 455 and 357 nm (data not 
shown). As the pH is increased, a decrease in absorbance in the near-UV and visible regions of 
the spectra associated with increased resolution in the 430-500 nm region were observed with 
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both CHO-H466A and the wild-type enzymes (Figure 5.4). Such spectral perturbations are 
consistent with deprotonation of the FAD at the N(3)-H position occurring as the pH is increased 
(38). From the spectral changes at 500 nm, a pKa value of 9.3 ± 0.2 was determined for the 
ionization of the N(3)-H locus of the enzyme-bound 8α-N(1)-histidyl-FAD in CHO-H466A 
(Figure 5.4). Such a value compares well with the value of 9.7 that is observed for 8α-N-
imidazoyl-riboflavin in solution (31). In contrast, a pKa value of 8.2 ± 0.1 was determined for the 
wild-type enzyme (Figure 5.4). These data are consistent with His466 significantly affecting the 
ionization of the oxidized flavin at the N(3)-H locus in choline oxidase, and with a change in the 
flavin microenvironment upon replacing His466 with alanine. 
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Figure 5.4. Effect of pH on the spectral properties of CHO-H466A and CHO-WT.  
Absorbance spectra were recorded at an enzyme concentration of 21 µM in 20 mM sodium 
phosphate, 20 mM sodium pyrophosphate, at 15 °C. Only selected difference absorbance spectra 
in the pH range between 6 (curve 1) to 12 (curve 7) are shown for CHO-H466A. Insets, UV-
visible absorbance values at 500 nm of CHO-H466A (•) and CHO-WT  (○) as a function of pH; 
the curves are fits of the data to eq (5).  
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  Redox Potentiometry. The mid-point reduction-oxidation potential of CHO-H466A in 
complex with glycine betaine was determined through the reductive titration of the enzyme with 
sodium dithionite as a reductant, and was compared to that for the wild-type form of the enzyme. 
This determination was carried out on the glycine betaine-enzyme complex rather than the 
unliganded enzyme because the catalytic transfers of hydride equivalents from choline and the 
aldehyde intermediate to molecular oxygen via the flavin cofactor occur when the active site of 
the enzyme is occupied by either the substrate or the product of the reaction (22, 23). As shown 
in Figure 5.5, the oxidized flavin bound to CHO-H466A was reduced to the hydroquinone with 
no significant formation of semiquinone species, as expected based on previous data indicating 
that the enzyme under turnover cycles between the oxidized and reduced states3 (23). At pH 7, a 
mid-point reduction-oxidation potential (Em,7) of +106 ± 0.5 mV was determined in two 
independent experiments for CHO-H466A by fitting the data to Nernst equation (eq 6). A value 
of 24 mV was calculated from the slope in a plot of the reduction-oxidation potential as a 
function of the logarithm of [oxidized]/[reduced] flavin (Figure 5.5), in good agreement with the 
theoretical value of 28.5 mV for a two-electron transfer reaction at 15 °C. A similar analysis of 
the wild-type enzyme yielded an Em,7 value of  +132 ± 1 mV for the two-electron transfer in the 
glycine betaine-enzyme complex (data not shown), a value that is in keeping with previously 
reported values for other flavoenzymes whose cofactor is covalently linked to the protein, such 
                                                 
3 Attempts to determine the Em,7 through the oxidative titration of the enzyme using potassium ferricyanide as an 
oxidant failed with both the mutant and wild-type enzymes, mainly due to instability of the enzyme in the reduced 
state over the prolonged times required for equilibration of the system after each addition of oxidant. Nonetheless, 
we are confident of the quality of the data reported herein since with both the mutant and wild-type enzymes the Em,7 
values determined in two independent experiments were in excellent agreement with each other. Furthermore, the 
Em,7 values for both enzymes differed by less than 2% when the data where analyzed by using 
28.5E)/-(E
28.5E)/(E
m,7
m,7
458
10  1
 10    
+
×+= −baA , where a and b are component absorbance values contributed by the flavin in 
the oxidized and reduced states, respectively, and E and Em,7 are the electrode potential and the midpoint reduction-
oxidation potential for a two-electron transfer process, respectively (34, 39). 
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as p-cresol methylhydroxylase (Em,7 = 84 mV) (40) or vanillyl alcohol oxidase (Em,7 = 55 mV) 
(41). Consequently, a ~25 mV decrease in the reduction-oxidation potential of the enzyme-bound 
flavin is effected by the replacement of the active site histidine with an alanine residue. 
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Figure 5.5. Potentiometric redox titration of CHO-H466A in complex with glycine betaine. 
Curve 1, UV-absorbance spectrum of the fully oxidized CHO-H466A at a concentration of ~23 
µM in the presence of 1.5 M glycine betaine, in 20 mM Tris-Cl, pH 7 at 15 °C; curves 2-19, are 
selected intermediate spectra recorded during the reduction of the ligand bound CHO-H466A 
after each addition of sodium dithionite; curve 20, UV-absorbance spectrum of the fully reduced 
ligand bound CHO-H466A. Inset, Nernst plot of the potentiometric data for the reduction of the 
enzyme-bound flavin in CHO-H466A. The line is a fit of the data to eq 6.   
 
Steady-State Kinetics. The steady-state kinetic parameters for wild-type choline oxidase 
with choline as substrate were recently reported (23). Here, the steady-state kinetic parameters of 
CHO-H466A were determined by monitoring the rate of oxygen consumption at varying 
concentrations of both choline and oxygen at pH 7 and 25 °C. As expected from previous data 
with the wild-type enzyme, the best fit of the data was observed to a sequential steady-state 
kinetic mechanism (eq 1), consistent with the order of the kinetic steps involving substrate 
binding and product release being not changed by the substitution of His466 with alanine. When 
the kinetic parameters for CHO-H466A were compared to those of the wild-type enzyme (Table 
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5.1), a 60- and 1000-fold decrease in both the kcat and kcat/Km values for choline were observed, 
respectively, indicating a direct participation of His466 in the oxidation of choline. In contrast, the 
kcat/Km value for oxygen was only 1.5-times lower in CHO-H466A as compared to the wild-type 
enzyme (Table 5.1), suggesting a minimal involvement of the histidine residue in the oxidation 
of the enzyme-bound reduced flavin by molecular oxygen. 
Rescuing Effects of Imidazole. From a structural standpoint, the histidine to alanine 
mutation in the active site of choline oxidase is equivalent to the removal of an imidazole moiety 
from the side chain of the amino acid residue at position 466. In principle, both the kinetic and 
biochemical properties that have been affected by such a mutation should be at least partially 
restored in the enzyme in the presence of exogenous imidazole. At pH 7, the kcat value with 
choline as substrate increased in a concentration-dependent pattern with increasing amounts of 
exogenous imidazole in the assay reaction mixture (Table 5.2), indicating that CHO-H466A 
activity can be rescued by imidazole. In contrast, no significant effect was observed with the 
wild-type enzyme under the same conditions. Although the effect of imidazole accounted for 
only a limited rescue of the enzymatic activity of CHO-H466A when compared to that of the 
wild-type enzyme, i.e., less than 10% at pH 7, it was nonetheless significant and allowed the 
determination of the effect of pH on the imidazole effect in order to establish whether the 
protonated or the unprotonated form of imidazole is responsible for the effect. 
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Table 5.1. Steady State Kinetic Parameters of CHO-H466A and CHO-WT 
with Choline as Substrate at pH 7a 
kinetic parameters CHO-H466A CHO-WTb 
kcat, s-1  1.1 ± 0.1 61 ± 6 
Ka, mMc 29 ± 1 1.7 ± 0.3 
kcat/Ka, M-1s-1 c 38 ± 2 36000 ± 6400 
KO2, µM 21 ± 2 703 ± 102 
kcat/KO2, M-1s-1 55000 ± 5000 87100 ± 15300 
Kia, mM 8.5 ± 2.9 0.20 ± 0.05 
R2 0.997 0.998 
a Enzymatic activity was measured by varying the concentrations of both 
choline and oxygen in 50 mM potassium phosphate, pH 7, at 25 °C. 
b From ref. (23). 
cKa and kcat/Ka are the Km and kcat/Km values for choline, respectively. 
 
 
Table 5.2. The Effect of Imidazole on the Turnover Number of CHO-H466A at Different 
pH Values a  
PH kcat, s-1b kcat (Imidazole), s-1b KImidazole, mMc R2 
5.5 0.03 0.21 ± 0.05  52 ± 6 0.998 
6 0.07 0.32 ± 0.02  71 ±15 0.985 
7 0.37 0.52 ± 0.06 18 ± 3 0.992 
8 0.72 0.67d ndf Nd 
10 0.73 0.70e nd Nd 
a Enzymatic activity was measured in the presence of imidazole (0-250 mM) with 10 mM 
choline as a substrate in 50 mM air-saturated buffer at 25 °C.  
b kcat and kcat (Imidazole) are the turnover numbers of the enzyme in the absence and the 
presence of  saturated imidazole, respectively. 
c KImidazole is the concentration of imidazole at which half the maximal turnover number is 
observed.  
d,eTurnover number in the presence of 80 mM and 100 mM imidazole, respectively. 
fnd, not determined. 
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As summarized in Table 5.2, no changes on kcat with choline were observed in the 
presence of imidazole at both pH 8 and 10, whereas 5- and 10-fold increases in the kcat values 
were seen at pH 6 and 5.5, respectively. When the relative increase in the kcat values due to 
exogenous imidazole was analyzed as a function of pH (Figure 5.6), the data could be fit to a 
curve with a slope of -1 (eq 5), indicating a pH effect on the rescuing of the enzymatic activity of 
CHO-H466A. These results clearly indicate that the protonated form of imidazole is the 
catalytically relevant species responsible for the partial rescue of enzymatic activity in CHO-
H466A, thereby providing strong evidence against His466 acting as a the specific base in choline 
oxidase. 
Addition of exogenous imidazole was also effective in restoring the ability of CHO-
H466A to stabilize an N(5)-flavin adduct with sulfite, as indicated by the bleaching of the flavin 
peak at 458 nm upon incubating the enzyme with 100 mM sodium sulfite at pH 6.5 in the 
presence of 100 mM imidazole (Figure 5.3).  
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Figure 5.6. pH dependence of the imidazole-rescued activity of CHO-H466A.  
The percentage of increase in kcat values of CHO-H466A as a function of pH, calculated from the 
ratio of the kcat value with choline measured in the presence of saturating imidazole to the kcat 
value measured in the absence of imidazole. The curve is a fit of the data to eq 5. 
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pH Dependence of the kcat and kcat/Km Values. Previous pH dependence studies with 
choline oxidase established the requirement of a catalytic base with pKa value of ~7.5 in the 
oxidation of choline but not in the subsequent oxidation of the reduced enzyme-bound flavin 
(23). Here, the kinetic parameters of CHO-H466A were measured as a function of pH by varying 
the concentration of choline in air-saturated buffer since, as previously shown, with wild-type 
choline oxidase the pKa value determined in the kcat/Km pH profile for the organic substrate is 
independent of the concentration of oxygen (21, 23, 27). With CHO-H466A, both the kcat/Km and 
kcat values for choline increased with increasing pH and reached limiting values at high pH 
(Figure 5.7), consistent with the requirement for an unprotonated group in catalysis with the 
mutant enzyme. A pKa value of 9.0 ± 0.1 was determined in the pH profile for the kcat/Km value, 
consistent with replacement of the histidine with an alanine at position 466 affecting the 
electrostatic properties of the active site and with His466 not being the active site catalytic base in 
choline oxidase4. A pKa value of 6.0 ± 0.1 was also determined in the pH profile of the kcat value 
for CHO-H466A. 
Substrate and Solvent Kinetic Isotope Effects. Substrate and solvent kinetic isotope 
effects on the kcat/Km value with 1,2-[2H4]-choline as substrate for wild-type choline oxidase 
were recently reported and are summarized in Table 5.3 (21). With that enzyme, the observed 
Dkcat/Km value corresponds to the true kinetic isotope effect and can be used to probe the status of 
the CH bond in catalysis, since at saturating oxygen concentrations both the forward and reverse 
                                                 
 
4 In principle, the results of the pH dependence studies of CHO-H466A are also consistent with the histidine residue 
being the catalytic base in the wild-type enzyme, and with some amino acid residues other than His466 becoming the 
catalytic base in the mutant enzyme devoid of histidine, as originally suggested for H447 of cholesterol oxidase (17). 
If this were the case, the increase in the enzymatic activity of the CHO-H466A mutant protein in the presence of 
imidazole should show pH dependence with maximal effects above pH 7, i.e., above the pKa value of imidazole, at 
which the fraction of unprotonated imidazole that might act as a base is higher. The data presented in Figure 6 
clearly do not support this alternative interpretation of the pH profile data. 
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commitments to catalysis are negligible (21). Here, the effect of isotopically substituted choline 
on the kcat/Km value with CHO-H466A was determined in air-saturated 50 mM sodium 
pyrophosphate at pH 10 and 25 oC, at which the true kinetic isotope effects could be measured5. 
With CHO-H466A there was a significant decrease in the Dkcat/Km value with respect to the wild-
type enzyme (Table 5.3), consistent with either a nonlinear transition state in which the 
stretching vibration of the hydride in motion is not completely lost in the transition state (42-44), 
or with the kinetic step in which the substrate CH bond is cleaved becoming partially masked by 
some other slow kinetic steps in the mutant enzyme. The effect of deuterated solvent, which was 
previously used to establish that OH bond cleavage of the choline substrate is kinetically fast in 
the reaction catalyzed by the wild-type enzyme (21), was also determined at a pL value of 10. As 
shown in Table 5.3, a significant D2Okcat/Km value was observed with CHO-H466A, suggesting 
that OH bond cleavage has become partially rate-limiting in the mutant enzyme. No significant 
changes in the Dkcat/Km value were observed upon substituting H2O with D2O. Similarly, the 
D2Okcat/Km value was the same irrespective of the isotopic composition of the substrate. Finally, a 
multiple kinetic isotope effect on the kcat/Km value that was equal to the product of the substrate 
and the solvent isotope effects was determined. These kinetic data are consistent with removal of 
the hydroxyl proton being concerted with hydride transfer to the flavin in CHO-H466A (45). 
From a mechanistic standpoint, these data indicate that in choline oxidase the replacement of the 
histidine at position 466 with an alanine residue results in a significant perturbation of the timing 
of substrate bond cleavage in the oxidation of the choline substrate. 
                                                 
5 Under atmospheric oxygen conditions at 25 oC (i.e., with a concentration of dissolved oxygen of 0.25 mM), due to 
the low Km value for oxygen with a value of 5 ± 2 µM at pH 10  (Ghanem, M., and Gadda, G.; unpublished data), 
CHO-H466A is > 97% saturated with oxygen. Therefore, with CHO-H466A the true kinetic isotope effect could be 
determined from the Dkcat/Km value under atmospheric conditions. 
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Figure 5.7. pH dependence of kcat/Km (•) and kcat (○) values of CHO-H466A for choline as 
substrate.  
Enzymatic activity was measured at varying concentrations of choline in air-saturated buffer 
between pH 5.5 and 11, at 25 °C. The curves are fits of the data to eq 3. 
 
 
Table 5.3. Substrate and Solvent Isotope Effects on the Oxidation of Choline 
Catalyzed by CHO-H466A 
kinetic parameters CHO-H466Aa CHO-WTb 
Dkcat/Km 6.3 ± 0.8 10.7 ± 2.6 
Dkcat/Km(D2O) 6.0 ± 0.7 ndc 
D2Okcat/Km 2.2 ± 0.3 1.1 ± 0.2 
D2Okcat/Km(D) 2.0 ± 0.2 nd 
D, D2Okcat/Km 13.2 ± 1.3 10.4 ± 1.8 
a Enzymatic activity was measured by varying the concentrations of either 
choline or 1,2-[2H4]-choline in air-saturated 50 mM sodium pyrophosphate, pL 
10, at 25 °C. Values shown are the average of two independent experiments. 
bFrom ref. (21). 
cnd, not determined. 
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Binding of Glycine Betaine. Recent kinetic data showed that glycine betaine inhibits 
choline oxidase by binding at the active site of the enzyme, resulting in spectral perturbations of 
the UV-visible absorbance spectrum (23, 27). Here, the effect of glycine betaine binding on the 
spectral properties of CHO-H466A was determined and compared to that of the wild-type 
enzyme by recording the absorbance spectrum for the enzyme before and after the addition of 
200 mM glycine betaine, at pH 6.5 and 15 °C. As shown in Figure 5.8, binding of the inhibitor to 
the enzyme resulted in significant spectral perturbations in the 300 to 500 nm region of the 
absorbance spectrum, with a maximal increase in absorbance at ~496 nm. In contrast, the wild-
type enzyme produced a maximal increase in absorbance at ~450 nm upon binding glycine 
betaine (Figure 5.8). The pH dependence of the inhibition by glycine betaine was determined in 
atmospheric oxygen using choline as substrate for CHO-H466A. As shown in Figure 8, the data 
were consistent with a single ionizable group that must be protonated for inhibition, as expected 
from previous studies on the wild-type enzyme (23). Although the pKa value for such a 
protonated group was poorly defined due to instability of the CHO-H466A enzyme at high pH 
values, a pKa value ≥ 9 could be estimated from the visual inspection of the data in Figure 8. 
Such a value is at least 1.5 pH units higher than the value of 7.5 previously determined for wild-
type choline oxidase (23, 27, 46). Interestingly, glycine betaine binding was slightly tighter with 
CHO-H466A than with the wild-type enzyme, as suggested by the limiting Kis values of 5.2 ± 
0.5 and 12.5 ± 1.1 determined at low pH for the two enzymes (Figure 5.8), suggesting that His466 
does not directly participate in product binding. 
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Figure 5.8. Binding of glycine betaine to CHO-H466A.  
Panel A, the UV-visible absorbance spectra of CHO-H466A at a concentration of 51 µM were 
recorded in 100 mM sodium pyrophosphate, pH 6.5 and 15 °C, before (solid curve) and after 
(dotted curve) the addition of 200 mM glycine betaine. Inset, comparison of the difference 
spectrum of CHO-H466A (solid curve) with that of CHO-WT (dotted curve) under the same 
conditions. Panel B, comparison between the pH dependence of the product inhibition of CHO-
H466A (•) and wild-type enzyme (○) from ref. (23), using glycine betaine. Enzymatic activity 
was measured at varying concentrations of choline and glycine betaine in air-saturated buffer 
between pH 7 and 11 for CHO-H466A, and between pH 5.5 to 9 for wild-type enzyme, at 25 °C. 
The lines are fits of the data to eq 4. The Kis values for glycine betaine were determined by fitting 
the initial rate data to eq 2. 
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Discussion 
The mutant form of choline oxidase in which the active site histidine at position 466 was 
replaced by an alanine residue maintains structural and kinetic properties that are similar to those 
of the wild-type enzyme, as indicated by both the spectroscopic and the steady-state kinetics data 
presented in this study. Consequently, the mechanistic properties that allow the elucidation of the 
role this amino acid residue plays in the reaction catalyzed by choline oxidase could be 
investigated by using a combination of biochemical, spectroscopic, and mechanistic probes. 
The active site residue His466 is involved in the oxidation of the choline substrate, but not 
in the following reduction of molecular oxygen catalyzed by choline oxidase. Evidence 
supporting this conclusion comes from the steady-state kinetic data with CHO-H466A as 
compared to those with the wild-type enzyme, showing that the kcat/Km value for choline 
decreases by three orders of magnitude whereas that for oxygen is not significantly changed in 
the mutant enzyme. The lack of involvement of His466 in the oxidative half-reaction agrees well 
with previous kinetic data on choline oxidase as a function of pH, showing that no ionizable 
groups with pKa values between 6 and 10 are required for oxidation of the enzyme-bound 
reduced flavin in catalysis (23). 
His466 is likely not the specific base with pKa of ~7.5 that abstracts the hydroxyl proton of 
the substrate in the reductive half-reaction in which choline is oxidized to betaine aldehyde. 
Strong evidence supporting this conclusion comes from the pH dependence of the imidazole 
effect with CHO-H466A, showing that imidazolium, but not imidazole, is the catalytically 
relevant species responsible for the partial rescue of the enzymatic activity of the mutant 
enzyme. These data are clearly difficult to reconcile with the assumption that His466 is the 
catalytic base participating in the oxidation of choline since, if that were the case, maximal 
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rescue of the enzymatic activity of the mutant enzyme would have been observed at increasing 
pH. Consistent with His466 not being the catalytic base in choline oxidase, the limiting kcat/Km 
value with choline at high pH is only ~20-fold lower in CHO-H466A as compared to the wild-
type enzyme (23). In this respect, recent structural data at sub-atomic resolution showed that the 
Nε2 atom of the equivalent histidine residue in the active site of cholesterol oxidase, His447, is 
protonated, suggesting that this conserved residue in the GMC oxidoreductase superfamily may 
play a role other than acting as a specific base in catalysis (13). In this context, a number of 
observations presented in this study suggest that in choline oxidase His466 contributes to catalysis 
by modulating the electrophilicity of the flavin cofactor and the polarity of the active site, and by 
stabilizing the negative charge that is formed in the transition state for the oxidation of choline to 
betaine aldehyde.  
A significant contribution to the electrophilicity of the FAD cofactor, which accounts for 
a fraction of the decreased rate of choline oxidation, is provided by the side chain of His466, as 
indicated by the decrease of ~25 mV in the midpoint reduction potential of the enzyme-bound 
flavin in CHO-H466A with respect to the wild-type choline oxidase. A direct electrostatic 
interaction of the imidazole side chain, through its Nε2 locus, and the N(1)-locus of the flavin 
cofactor was previously proposed in glucose oxidase based on X-ray crystallographic data (9), 
suggesting that an analogous interaction might occur in choline oxidase (Figure 5.9). Evidence 
supporting the presence of such an interaction in choline oxidase is provided by the lack of 
stabilization of the anionic flavin semiquinone and of the sulfite N(5)-flavin adduct that were 
observed with CHO-H466A, which is consistent with a change in the protein microenvironment 
surrounding the N(1)-C(2)=O region of the flavin (36, 47-52). From the ∆Em,7 value of -25 mV 
determined upon replacing H466 with alanine in choline oxidase one can calculate an energetic 
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contribution of ~4.2 kJ mol-1, which accounts for a five-fold decrease in the rate of hydride 
transfer to the flavin in the mutant enzyme as compared to the wild-type form of choline oxidase. 
Since mechanistic investigations on wild-type choline oxidase are consistent with the kcat/Km 
value for choline reflecting the kinetic step of choline oxidation (21), a ~20-fold decrease in the 
rate of choline oxidation can be estimated from the ratio of the limiting kcat/Km values for choline 
at high pH determined in this study with CHO-H466A and the wild-type enzyme (23). 
Consequently, while His466 contributes to the electrophilicity of the enzyme-bound flavin for 
efficient substrate oxidation, such an effect cannot fully explain the decreased catalytic activity 
observed with the mutant enzyme, consistent with His466 contributing to catalysis by using also 
other strategies (vide infra). The modulation of the redox potential of the flavin does not appear 
to correlate with the rate of electron transfer from the reduced flavin to molecular oxygen, as 
indicated by the similar kcat/Km values for oxygen of CHO-H466A and the wild-type enzyme. 
Thus, it is likely that other factors, such as steric or solvation effects, are important in the 
activation of the reduced flavin for reaction with molecular oxygen. 
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Figure 5.9. Proposed interaction of His466 with the flavin N(5)-sulfite adduct.  
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His466 provides stabilization to the transition state that is formed in the oxidation of 
choline to betaine aldehyde, thereby facilitating the activation of the alcohol substrate for facile 
hydride transfer to the flavin cofactor (Scheme 5.3). Such a transition state in the mechanism of 
choline oxidase is supported by mechanistic studies on the wild-type form of choline oxidase 
using substrate and solvent deuterium kinetic isotope effects. (21) Evidence for stabilization of 
the alkoxide species by His466 comes from the effects of histidine replacement on the relative 
timing for bond cleavage in the mutant enzyme, showing that the hydroxyl proton is in flight in 
the transition state for CH bond cleavage. Indeed, the loss of stabilization of the alkoxide species 
would make its formation energetically unfavorable, resulting in the loss of the "chelating effect" 
provided by the electrostatic interaction in the wild-type enzyme. In the absence of such a 
"chelating effect" catalysis would still occur, but it would be significantly slower because it 
requires that the vibrational motions of the pairs of atoms involved in bond breaking and making, 
i.e., the hydroxyl proton and the catalytic base along with the flavin N(5) and the α-carbon 
hydrogen, be in phase to allow both proton and hydride transfer to occur. Alternatively, initiation 
of the hydride transfer would decrease the pKa of the oxygen sufficiently for proton transfer to 
the catalytic base. In either case, removal of the hydroxyl proton would be concerted with 
hydride transfer, as was observed with CHO-H466A. Independent evidence for stabilization of 
the alkoxide species comes from the complete loss of the ability of CHO-H466A to form an 
N(5)-flavin adduct with sulfite, which is restored in the presence of exogenous imidazole. 
Although following the seminal work of Massey (49-51), the ability of flavoenzymes to stabilize 
a tight flavin adduct with sulfite has been mainly used as a probe of the electrophilicity of the 
flavin, N(5)-flavin adducts with sulfite depend also on steric factors as well as stabilizing 
interactions in the active site. With choline oxidase, it is likely that the negatively charged 
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oxygen atom of the sulfite N(5)-flavin adduct is stabilized by a direct interaction with the side 
chain of His466 (Figure 5.9). In the absence of this interaction, such as in the case of CHO-
H466A, the N(5)-flavin adduct with sulfite would not be stabilized; exogenous imidazole would 
restore such an interaction in the mutant enzyme by bridging the methyl side chain of the alanine 
residue at position 466 to the oxygen atom of the sulfite-flavin adduct. Such a direct interaction 
between the sulfite oxygen and an active site amino acid residue was previously observed in the 
three-dimensional structures of flavocytochrome b2 (53) and glycolate oxidase (52), providing 
direct structural support for an analogous interaction in choline oxidase. The stabilization of the 
transition state is likely provided by the protonated form of His466, as suggested by the pH 
studies on the rescuing effect of the activity of CHO-H466A by exogenous imidazole, showing 
that the enzymatic activity of the mutant enzyme can be partially restored by imidazolium, but 
not imidazole. A stabilization of an alkoxide species by an active site tyrosine residue similar to 
that proposed here for His466 of choline oxidase was recently proposed in flavocytochrome b2 
(54), suggesting that this might be a common strategy utilized by flavin-dependent enzymes for 
the oxidation of inactivated as well activated alcohols, such as α-hydroxy acids. 
The polarity of the active site, which is essential for efficient proton transfer of the 
hydroxyl proton from the alcohol substrate to the active site proton acceptor, is modulated by 
His466. Evidence supporting this conclusion comes from the pH profiles of the absorbance 
spectra of CHO-H466A and the wild-type enzyme, showing that the pKa value for the ionization 
of the N(3) locus of FAD increases by one pH unit upon substituting His466 with alanine. Such an 
increase in the pKa value is consistent with a decreased polarity in the protein microenvironment 
surrounding the flavin N(3) locus (38). Consistent with a less polar active site, an increase in 
both the protein fluorescence of the unliganded enzyme and the absorbance at 496 nm of the 
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enzyme in complex with glycine betaine is seen with CHO-H466A with respect to the wild-type 
enzyme (35, 38). The decrease in polarity of the active site of CHO-H466A results in the 
perturbation of equilibria for ionization of groups that participate in catalysis, among which the 
amino acid group that accepts the hydroxyl proton from the substrate. Indeed, in CHO-H466A 
the pKa value for the catalytic base in the active site is raised from 7.5 to ~9, as indicated by the 
pH profile of the kcat/Km values for choline. In agreement with previous studies on wild-type 
choline oxidase (23), the same pKa value of ~9 is seen in the pH-profile of glycine betaine 
inhibition with CHO-H466A.  Thus, His466 appears to be important for regulating the reactivity 
of the catalytic base that accepts the hydroxyl proton of the substrate for efficient catalysis. 
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Scheme 5.3. Proposed role of His466 in stabilizing the transition state during the oxidation of 
choline catalyzed by choline oxidase. 
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On the basis of the results of the rescuing experiments with imidazole, showing that the 
activity of CHO-H466A can be partially rescued by imidazolium, one would expect His466 to 
interact with the carboxylate moiety of the glycine betaine product of the reaction. This 
expectation would be reinforced by the proposed role for His466 in the stabilization of the 
alkoxide intermediate, since both the alkoxide and the carboxylate bear negatively charged 
oxygen. If this were the case, a significant increase to the extent of 2 to 3 orders of magnitude 
should be observed in the inhibition constant for glycine betaine with the CHO-H466A enzyme, 
as in the case of mutant forms of D-amino acid oxidase (48) or sarcosine oxidase (55), where 
positively charged groups on the enzyme that ion pair the carboxylate moieties of the product 
were replaced. However, the results of the product inhibition studies show that binding of 
glycine betaine to CHO-H466A is unaffected, if not slightly tighter, with respect to the wild-type 
enzyme. In this respect, recent studies with a number of substituted product analogs indicated 
that in choline oxidase the acetate moiety of glycine betaine does not contribute to binding, but 
that the trimethylammonium headgroup is a major determinant instead (27). This apparent 
discrepancy of His466 interacting with the negatively charged oxygen of the transient alkoxide 
species but not with that of the carboxylate product is readily dissipated when one considers the 
spatial location of their respective oxygen atoms with respect to the histidine residue. Indeed, 
while the positioning of both the alkoxide and the product is dictated by the interactions 
established in the active site by the trimethylammonium headgroup (27), the alkoxide oxygen is 
linked to an sp3-hybridized carbon whereas the carboxylate oxygen is attached to an sp2-
hybridized carbon. The change from the tetrahedral configuration of the alkoxide to the planar 
configuration of the carboxylate-containing product results in the carboxylate oxygen moving ~1 
Å away from the side chain of His466, thereby abating the electrostatic interaction between the 
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two charges. Although the results presented here do not allow us to draw any conclusion 
concerning the binding of the substrate in choline oxidase, it is expected that due to the lack of a 
negatively charged oxygen, binding of choline is somewhat weaker than that of the alkoxide. A 
similar result where substitution of an active site histidine residue resulted in differential binding 
of the substrate and the transition state was recently reported for (S)-mandelate dehydrogenase 
(56).  
In summary, the results presented herein using a combination of biochemical, 
spectroscopic, and mechanistic approaches support evidence for the conserved His466 playing 
multiple, but equally important, roles in the oxidation of the alcohol substrate catalyzed by 
choline oxidase. This residue modulates the electrophilicity of the enzyme-bound FAD for 
efficient hydride transfer from the substrate; it contributes to the polarity of the active site for 
efficient proton transfer from the substrate hydroxyl oxygen; and, it stabilizes the choline 
alkoxide transient species to facilitate hydride transfer from the substrate to the flavin. In light of 
the structural similarities among the members of the GMC oxidoreductase superfamily, the 
present results strongly suggest that those enzymes that catalyze the oxidation of unpolarized 
alcohols are likely to use similar catalytic strategies. Finally, the conclusions presented herein 
provide an example of the difficulty in developing a comprehensive description of the role 
carried out by amino acid residues located at the active site of enzymes, which arises from the 
complex nature of enzyme function to which individual residues are likely to contribute through 
multiple strategies. Current studies in our laboratory are aimed at the elucidation of the nature of 
the catalytic base that abstracts the hydroxyl proton from the alcohol substrate in the active site 
of choline oxidase. 
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CHAPTER VI 
Effects of Reversing the Protein Positive Charge in Proximity of the N(1)-Flavin Locus of 
Choline Oxidase 
(This chapter was published in verbatim in Ghanem, M., and Gadda, G., (2006), Biochemistry 
45, 3437-47. © 2006 American Chemical Society. All rights reserved.) 
 
Abstract 
A protein positive charge near the flavin N(1) locus is a distinguishing feature in common 
to most flavoprotein oxidases, with mechanistic implications for the modulation of flavin 
reactivity. A recent study showed that in the active site of choline oxidase the protein positive 
charge is provided by His466. Here, we have reversed the charge by substitution with aspartate 
(CHO-H466D), and for the first instance characterized a flavoprotein oxidase with a negative 
charge near the flavin N(1) locus. CHO-H466D formed a stable complex with choline, but lost 
the ability to oxidize the substrate. In contrast to the wild type enzyme, which binds FAD 
covalently in a 1:1 ratio, CHO-H466D contained ~0.3 FAD per protein, of which 75% was not 
covalently bound to the enzyme. Anaerobic reduction of CHO-H466D resulted in the formation 
of neutral hydroquinone, with no stabilization of flavin semiquinone; in contrast, the anionic 
semiquinone and hydroquinone species were observed with the wild type and a H466A variant of 
the enzyme. The midpoint reduction potential for the oxidized/reduced couple in CHO-H466D 
was ~160 mV lower than that of the wild type enzyme. Finally, CHO-H466D lost the ability to 
form complexes with glycine betaine or sulfite. Thus, upon reversing the protein charge near the 
FAD N(1) locus, choline oxidase lost the ability to stabilize negative charges in the active site, 
irrespective of whether they develop on the flavin or are borne on ligands, resulting in defective 
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flavinylation of the protein, decreased electrophilicity of the flavin, and consequent loss of 
catalytic activity. 
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Introduction 
The presence of a protein positive charge proximal to the N(1) locus of the flavin has 
been proposed in flavoprotein oxidases long before the three dimensional structures of a number 
of flavin-dependent oxidases have become available (1-5). Indeed, most flavoprotein oxidases 
stabilize thermodynamically the anionic flavin semiquinone (6-11), form a stable reversible 
N(5)-flavin adduct with sulfite (1-4, 6, 7, 11-13), and stabilize the benzoquinoid anion forms of 
6-hydroxy-, 8-hydroxy-, 6-mercapto-, and 8-mercapto-flavin analogs (4, 14-17), all features that 
require the stabilization of a negative charge localized in the N(1)-C(2)=O region of the flavin. 
The mechanistic implications for a protein positive charge stabilizing a negative charge on the 
N(1) locus of the flavin are: i) to render flavin reduction thermodynamically favorable by 
elevating the midpoint reduction-oxidation potential of the bound flavin (1, 4, 15, 17-19); ii) to 
preferentially stabilize the anionic form of the reduced flavin that readily reacts with oxygen (1-
4, 18, 19); iii) to facilitate the flavinylation process for those enzymes in which the flavin is 
covalently linked to the protein moiety (20). To date, the X-ray crystallographic structures of 
glucose oxidase from Aspergillus niger (21) and Penicillium amagasakiense (22), cholesterol 
oxidase from Brevibacterium sterolicum (23) and Streptomyces sp. (24, 25), pyranose 2-oxidase 
from Peniophora sp. (26) and Trametes multicolor (27), cellobiose dehydrogenase from 
Phanerochaete chrysosporium (28), baker's yeast flavocytochrome b2 (29), spinach glycolate 
oxidase (30), pig kidney D-amino acid oxidase (31), and bacterial sarcosine oxidase (32), 
trimethylamine dehydrogenase (33), and dihydroorotate dehydrogenase (34), have shown that 
either a positively charged amino acid residue or a dipole of an α-helix is oriented toward the 
N(1)-C(2)=O region of the enzyme-bound flavin. While the effects of replacing the positive 
charge with a neutral amino acid on the flavin properties have been investigated for lactate 
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monooxygenase (35), no studies have addressed the characterization of the flavin properties of 
an oxidase in which the positive charge close to the flavin N(1) was reversed. 
Choline oxidase (E.C. 1.1.3.17) is a flavin-dependent enzyme that oxidizes choline to 
glycine betaine via an enzyme-bound aldehyde intermediate (Scheme 1). This reaction is of 
considerable interest for medical and biotechnological applications, since accumulation of 
glycine betaine in many pathogens and plants enables their stress-resistance towards 
hyperosmotic environments (36, 37). Choline oxidase has been characterized in its biophysical, 
structural, and mechanistic properties. The enzyme is a homodimer with a mass of 120 kDa (38), 
contains covalently linked FAD in a 1:1 stoichiometry (38), and under turnover cycles between 
its fully oxidized and reduced states (39, 40). A detailed picture of the catalytic mechanism of 
choline oxidase has emerged from pH, kinetic isotope, and temperature effects studies (39-43), 
as well as mechanistic studies with substrate and product analogs (44) and site-directed mutants 
(45). Briefly, in catalysis an unidentified active site base with pKa of 7.5 activates the alcohol 
substrate with formation of an alkoxide species (species 1 in Scheme 2) (39), which is transiently 
stabilized in the active site through electrostatic interaction with the imidazolium side chain of 
His466 (45) (species 2 and 3 Scheme 2). Hydride transfer from the α-carbon of the substrate to 
the enzyme-bound flavin occurs quantum mechanically from the activated choline alkoxide 
species (species 3 in Scheme 2) (41). Substrate binding is mainly dictated by interactions 
involving the trimethylammoniun headgroup of the alcohol, with little participation of the ethyl 
moiety (44). In a recent study in which His466 was replaced with alanine, our group showed that 
in catalysis His466 is protonated and that, besides stabilizing the transient alkoxide species that is 
formed in catalysis, this protein group modulates the electrophilicity of the enzyme-bound FAD 
and the polarity of the active site (species 3 in Scheme 2) (45). Consistent with the proposed 
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roles, the recent determination of the X-ray structure of choline oxidase showed that His466 is 
located at distance of ~3.3 Å from the N(1) locus of the enzyme-bound flavin (Figure 1) (George 
Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; unpublished results). 
In the present study, we have prepared by site-directed mutagenesis a choline oxidase variant in 
which His466 was replaced with aspartate, and characterized the biochemical and biophysical 
properties of the enzyme-bound flavin in the mutant enzyme bearing a negative charge at 
position 466. The results presented show that the protein positive charge proximal to the flavin 
N(1) locus is important for correct flavinylation of the enzyme, modulation of flavin reactivity 
and, consequently, the catalytic activity of the enzyme. 
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Scheme 6.1. Reaction catalyzed by choline oxidase.  
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Figure 6.1. Line draw showing the interaction of His466 with the N(1)−C(2)═O locus of FAD 
and the choline alkoxide species in the transition state for the oxidation of choline catalyzed by 
choline oxidase. 
The positioning of His466 relative to the flavin is from the X-ray crystallographic structure of the 
enzyme recently determined at 1.86 Å resolution (George Lountos, Fan Fan, Giovanni Gadda, 
and Allen M. Orville; unpublished results), the positioning of choline is arbitrary. 
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Experimental Procedures 
Materials. Escherichia coli strain Rosetta(DE3)pLysS was from Novagen (Madison, 
WI). The QuikChange Site-Directed Mutagenesis kit was from Stratagene (La Jolla, CA). The 
QIAprep Spin Miniprep kit was from Qiagen (Valencia, CA). Oligonucleotides used for site-
directed mutagenesis and for sequencing of the mutant gene were custom synthesized by the 
DNA Core Facility of the Department of Biology of Georgia State University or by Sigma 
Genosys (The Woodlands, TX). Nucleotides, bovine serum albumin, chloramphenicol, 
tetracycline, isopropyl-β-D-thiogalactopyranoside (IPTG), lysozyme, sodium hydrosulfite 
(dithionite), sodium sulfite, betaine aldehyde, glycine betaine, xanthine, xanthine oxidase, Luria-
Bertani agar and broth, and PMSF were from Sigma (St. Louis, MO). Choline chloride and 
ampicillin were from ICN (Aurora, OH). Recombinant choline oxidase (CHO-WT)1 from 
Arthrobacter globiformis strain ATCC 8010 was expressed in E. coli strain Rosetta(DE3)pLysS 
from plasmid pET/codA1 and purified to homogeneity as previously described (38). Fully 
oxidized FAD-containing CHO-WT was prepared as described in ref. (44). The mutant form of 
choline oxidase with histidine 466 replaced with alanine (CHO-H466A) was prepared, expressed 
and purified to homogeneity according to ref. (45). All other reagents were of the highest purity 
commercially available. 
Instruments. UV-visible absorbance spectra were recorded using an Agilent 
Technologies diode-array spectrophotometer model HP 8453 equipped with a thermostated water 
bath. Fluorescence spectra were recorded with a Shimadzu Spectrofluorometer model RF-5301 
                                                 
1 CHO-WT, wild type choline oxidase; CHO-H466D, mutant form of choline oxidase with histidine 466 replaced 
with aspartate; CHO-H466A, mutant form of choline oxidase with histidine 466 replaced with alanine; E'1 and E'2, 
midpoint reduction-oxidation potential of the oxidized/semiquinone and semiquinone/reduced FAD redox couples; 
E'm, 7, midpoint reduction-oxidation potential of the oxidized/reduced FAD redox couple determined at pH 7. 
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PC thermostated at 15 °C. Enzymatic activity of choline oxidase was measured polarographically 
using a computer-interfaced Oxy-32 oxygen-monitoring system (Hansatech Instrument Ltd.).  
Site-Directed Mutagenesis. A QuikChange kit was used to prepare CHO-H466D, in 
which histidine 466 was replaced with aspartate. The method used was essentially according to 
the manufacturer’s instructions, using the pET/codA1 plasmid (38) as a template and Cho-
H466Df (5′-CAACACCGTCTACGACCCCGTGGGCACCGTGC-3′) and Cho-H466Dr (5′-
CACGGTGCCCACGGGGTCGTAGACGGTGTTGTGC-3′) oligonucleotides as forward and 
reverse primers, respectively (underlined letters indicate mismatches). DNA was sequenced at 
the DNA Core Facility at Georgia State University using an Applied Biosystems Big Dye Kit on 
an Applied Biosystems model ABI 377 DNA sequencer. Sequencing confirmed the presence of 
the correct mutation. E. coli strain Rosetta(DE3)pLysS competent cells were transformed with 
plasmid  pET/codA1-H466D by electroporation. 
Expression and Purification of CHO-H466D. CHO-H466D was expressed and purified 
to homogeneity as judged by SDS-PAGE using the same procedure used previously for the 
purification of CHO-WT and CHO-H466A (38, 45). Glycerol at a final concentration of 10% 
was incorporated in the buffers throughout the purification procedure to increase the stability of 
the enzyme. 
Spectrophotometric Studies. The UV-visible absorbance and fluorescence emission or 
excitation spectra of CHO-H466D, CHO-WT and CHO-H466A, were acquired in 20 mM 
sodium phosphate, 20 mM sodium pyrophosphate and 10% glycerol, pH 6 at 15 °C. The UV-
visible absorbance spectra of the reduced form of enzymes were acquired using an anaerobic 
cuvette in 50 mM sodium phosphate, 50 mM sodium pyrophosphate and 10% glycerol, pH 6 at 
15 °C. The cuvette contained one ml final volume of enzyme at a final concentration between 20 
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and 30 µM, 300 µM xanthine, and 10 µM methyl viologen. A sidearm attached to the cuvette 
contained xanthine oxidase at a final concentration of ~0.5 µM. The cuvette and contents were 
made anaerobic by at least 15 cycles of alternate degassing under vacuum and flushing with O2-
free argon. The enzyme solution was then mixed with xanthine oxidase in the side arm, and the 
reduction of the enzyme-bound flavin was monitored spectrophotometrically. Spectra of the 
reduced enzymes reported in this study were recorded prior to the accumulation of significant 
amounts of viologen radical. 
The extinction coefficient of CHO-H466D was determined in 20 mM Tris-Cl, pH 8, after 
denaturation of the enzyme by incubation at 40 °C for one hour in the presence of urea at a final 
concentration of 4 M, based upon the ε450 value of 11.3 mM-1 cm-1 for free FAD (46). A value of 
12 mM-1 cm-1 was determined at 450 nm, which was similar to the values of 11.4 mM-1 cm-1 at 
452 nm for CHO-WT and 12 mM-1 cm-1 at 458 nm for CHO-H466A (40, 45). For the 
quantitation of covalently bound flavin, ~20 µM CHO-H466D was incubated on ice for 30 min 
after the addition of 10 % trichloroacetic acid, followed by removal of precipitated protein by 
centrifugation. The concentration of FAD was then determined in both the supernatant and the 
pellet dissolved in 4 M urea solution as described above. Identification of the flavin cofactor 
released by acid treatment was carried out through MALDI-TOF mass spectrometry in both 
positive and negative ion modes using a 50:50 methanol/acetonitrile matrix. Anaerobic 
incubation of CHO-H466D with choline was carried out in 20 mM Tris-Cl, pH 8, after 
anaerobiosis was established by repeated cycles of alternate degassing under vacuum and 
flushing with ultra-pure O2-free argon in an anaerobic cell equipped with two side arms. Choline, 
at a final concentration of 10 mM, was initially loaded into a side arm and subsequently mixed 
with CHO-H466D under anaerobiosis. Few grains of sodium dithionite were loaded into the 
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second side arm and mixed with CHO-H466D in complex with choline after an hour of 
anaerobic incubation to ensure the functionality of the enzyme-bound flavin. Binding of glycine 
betaine and sulfite to the enzymes was carried out as previously described (40, 45). The pH 
dependence of the UV-visible absorbance spectra of oxidized CHO-H466D was determined in 
20 mM sodium phosphate, 20 mM sodium pyrophosphate, 10% glycerol, at 15 °C, by titrating 
sodium hydroxide into the enzyme solution at pH 6. The pH dependences of the UV-visible 
absorbance spectra of the reduced enzymes were determined in a custom made anaerobic cuvette 
(Lillie Glassblowers, Smyrna, GA) that was fitted with a pH micro-electrode through a glass 
joint and an anaerobic syringe containing sodium hydroxide. The cuvette contained 3 ml of 
enzyme at a final concentration between 20 and 30 µM in 50 mM sodium phosphate, 50 mM 
sodium pyrophosphate, and 10 % glycerol, pH 6. A sidearm attached to the cuvette was loaded 
with choline at a final concentration of 150 mM. The cuvette and contents were made anaerobic 
by at least 15 cycles of alternate degassing under vacuum and flushing with O2-free argon. The 
enzyme solution was then mixed with choline in the side arm in order to reduce the enzyme-
bound flavin. With CHO-H466D, which could not be reduced anaerobically with choline, a 
syringe filled with anaerobic ~2 mM dithionite was inserted firstly into the cuvette under positive 
argon pressure, and the reduction of the enzyme-bound flavin was monitored 
spectrophotometrically until completion. In all the cases, once the UV-visible absorbance 
spectrum of the hydroquinone species was observed, a pH micro-electrode and a syringe 
containing anaerobic 3 M sodium hydroxide were mounted onto the anaerobic cuvette under 
positive argon pressure. The pH of the anaerobic enzyme solution was then changed stepwise by 
addition of the base, and both the pH and the UV-visible absorbance spectra were recorded after 
each step.   
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Potentiometric Titrations. The midpoint reduction-oxidation potentials of unliganded 
CHO-H466D, CHO-H466A, and CHO-WT, were determined through the reductive titration of 
the enzyme with sodium dithionite as a reductant as previously described for CHO-WT and 
CHO-H466A in complex with glycine betaine (45).  
Enzyme Assays. The enzymatic activity of CHO-H466D was measured polarographically 
with choline by measuring the rate of oxygen consumption as described for the wild type enzyme 
(38, 40).  
Data Analysis. Data of the spectrophotometric titrations for complex formation between 
choline oxidase and various ligands were fit to eq 1, where Y and A are the observed and 
maximal absorbance changes at the selected wavelength, respectively, X is the concentration of 
the varied ligand, and K is the complex dissociation constant. Data of the pH dependencies of the 
absorbance spectra were fit to eq 2, which describes a curve with a slope of +1 and plateau 
regions at low and high pH, where A and B represent the absorbance values at 500 nm at low and 
high pH, respectively. The midpoint reduction-oxidation potentials of the enzymes were 
determined by fitting the data to eq 3, where Eh is the observed electrode potential at equilibrium 
at each point in the titration, E′m is the midpoint reduction-oxidation potential, R is the gas 
constant, with a value of 8.31 J mol-1 K-1, T is the temperature in Kelvin, n is the number of 
electrons transferred, and F is Faraday’s constant, with a value of 96.48 kJ V-1 mol-1. 
 
KX
AXY +=                                           (1) 
 
apKpH
pHapK
10 10
10B 10AY −−
−−
+
×+×=                   (2) 
 
  
255
][FAD
][FAD
log3032
Redor  Sq
Sqor Ox 
mh    nF
  RT.E'E +=                 (3) 
 
 
 
  
256
Results 
Expression and Purification of CHO-H466D. CHO-H466D was expressed and purified 
at pH 8 to high level as judged by SDS-PAGE using the same protocol used for the wild type 
enzyme (Figure 6.2). About 100-150 mg of pure CHO-H466D could be typically obtained from 
4.5 liters of Luria-Bertani culture medium. In contrast to the wild type enzyme, for which 35 to 
85% of the bound flavin exists at pH 8 in an air-stable anionic semiquinone state (38, 40) that 
can be oxidized by extended incubation at pH 6 (40), the flavin in CHO-H466D was in the 
oxidized state throughout the purification procedure. In this respect, CHO-H466D is similar to 
CHO-H466A, for which no flavin semiquinone was observed in the UV-visible absorbance 
spectrum of the purified enzyme (45). Purified CHO-H466D at final concentrations as high as 20 
µM showed no oxygen consumption when assayed with 30 mM choline as a substrate at pH 7 
and 25 oC. In comparison, the CHO-WT at a final concentration of 0.1 µM typically shows a 
catalytic activity of ~15 s-1 with 10 mM choline (38), suggesting that replacement of the histidine 
at position 466 with aspartate results in the complete loss of catalytic activity in choline oxidase. 
 1 2 3 4 
60  kDa 
 
Figure 6.2. Purification of CHO-H466D. 
 Lane 1, molecular weight marker proteins; lane 2, cell-free extract of Escherichia coli strain 
Rosetta(DE3)pLysS harboring plasmid pET/codA-H466D induced with 0.05 mM IPTG for 5 h at 
23 °C; lane 3, sample treated with 30 and 65% ammonium sulfate saturation; lane 4, purified 
CHO-H466D in 20 mM Tris-Cl and 10% glycerol, pH 8, after DEAE-Sepharose column 
chromatography. The molecular mass of the purified CHO-H466D is indicated. 
  
257
Spectral Properties of Oxidized CHO-H466D. The UV-visible absorbance spectrum of 
oxidized CHO-H466D at pH 62 showed a 10 nm hypsochromic shift of the visible peak centered 
at ~450 nm and a 10% decrease in the intensity of the 372 nm peak with respect to both CHO-
WT and CHO-H466A (Figure 6.3A), suggesting an altered protein microenvironment in the 
protein containing aspartate at position 466. Accordingly, the relative intensity of the flavin 
fluorescence emission at ~525 nm (with λex at 447 nm) was 5 and 10 times larger than that 
observed with CHO-WT and CHO-H466A, respectively (Figure 6.3B). Similarly, the flavin 
fluorescence excitation spectrum of CHO-H466D had maxima at 376 and 460 nm (with λem at 
530 nm), with 5- and 10-fold the intensities seen with the CHO-WT and CHO-H466A (Figure 
6.3C). In contrast, no significant differences were seen in the intensities of the protein 
fluorescence emission peaks at 340 nm among the three different forms of enzyme (Figure 
6.3D), suggesting that the overall folds of the mutant enzymes were similar to that of the wild 
type enzyme. The spectral properties of oxidized CHO-H466D, CHO-WT and CHO-H466A, are 
summarized in Table 6.1. 
                                                 
2 The spectral properties of the oxidized forms of CHO-WT, CHO-H466A, and CHO-H466D, were compared at pH 
6 to avoid artifactual contributions on the UV-visible absorbance spectra due to pH, since the three enzyme variants 
showed pH effects on the UV-visible absorbance spectra of the oxidized enzymes with pKa ≥ 8.2 (this study and ref. 
(45). 
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Figure 6.3. Comparison of the spectral properties of CHO-H466D, CHO-WT and CHO-H466A. 
Comparison of the spectral properties of CHO-H466D (thick solid curves), CHO-WT (thin solid 
curves) and CHO-H466A (dotted curves) in 20 mM sodium phosphate, 20 mM sodium 
pyrophosphate and 10% glycerol, pH 6 at 15 °C. Panel A, UV-visible absorbance spectra of the 
oxidized and reduced species of enzymes after treatment with xanthine (300 µM) and xanthine 
oxidase (~0.5 µM). Inset, difference absorbance spectrum of oxidized CHO-H466D (thick solid 
curve) minus that of CHO-WT as a reference; panel B, flavin fluorescence emission spectra, the 
excitation wavelengths were 447, 457 and 457 nm for CHO-H466D, CHO-WT and CHO-
H466A, respectively; panel C, flavin fluorescence excitation spectra, the emission wavelength 
was 530 nm for all forms of enzyme; panel D, protein fluorescence emission spectra, the 
excitation wavelengths were 285 nm. 
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Table 6.1. Comparison of the Spectral Properties Parameters of CHO-H466D, CHO-H466A, and 
CHO-WT, at pH 6 
 CHO-H466D CHO-H466A CHO-WT 
E-FADOx    
UV-visible absorbance (λmax, nm) 276, 372, 447 267, 361, 457 279, 366, 457 
ε (mM-1 cm-1) 210, 10, 12 272, 11.8, 13 154, 11.3, 12.4 
Stoichiometry (FAD/protein) 0.29 ± 0.03 0.32 ± 0.05 a 0.88 ± 0.12 b 
% of FAD covalently bound  ~25% 100% a 100% b 
Fluorescence emission (λmax, nm) 
λex  = 447 or 457 nm 
λex  = 372, 361 or 366 nm 
λex  = 285 nm 
 
525 
524 
339 
 
524 
519 
342 
 
524 
522 
335 
Fluorescence excitation (λmax, nm) 
λem  = 530 nm 
 
376, 460 
 
371, 475 
 
361, 470 
pKa (N(3)−H) 10.3 ± 0.1 9.3 ± 0.2 a 8.2 ± 0.1 a 
E-FADRed    
UV-visible absorbance (λmax, nm) ~340, ~400  ~350, ~400 347 
ε (mM-1 cm-1) ~6.7, ~2.9 ~5.8, ~3.3 4.2 
E-FADOx-glycine betaine     
UV-visible absorbance (λmax, nm) nd c  361, 459 358, 455 
Kd, mM nd 4.2 ± 0.4 15 ± 2 
Kis, mM d nd 5.2 ± 0.5 13 ± 1 
a From ref (45). b From ref (38). c Not determined. d Limiting inhibition constant determined 
kinetically with choline as substrate at low pH; from ref (45). 
 
 
 
Flavin Stoichiometry and Content of CHO-H466D. Previous studies showed that 
choline oxidase contains covalently linked FAD in a 1:1 stoichiometry (38). In contrast, upon 
denaturation of the CHO-H466D variant by treatment with urea, a stoichiometry of 0.29 ± 0.03 
FAD per monomer of enzyme could be determined from two independent experiments. Similar 
flavin content was previously reported for the CHO-H466A variant (Table 6.1) (45), suggesting 
that the flavin content in choline oxidase is significantly affected by replacement of the active 
site histidine with either a neutral or anionic amino acid residue. Interestingly, treatment of 
CHO-H466D with 10% cold trichloroacetic acid followed by centrifugation to remove the 
denatured protein yielded a UV-visible absorbance spectrum of the soluble fraction with peaks at 
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370 and 450 nm, suggesting that at least part of the flavin in CHO-H466D is not covalently 
bound (Figure 6.4). A MALDI-TOF mass spectrometric analysis of the flavin released from 
CHO-H466D yielded a m/z− ratio of 784.1 (Figure 6.4), consistent with the non-covalently bound 
flavin in CHO-H466D being FAD. From the intensities of the peaks at 450 nm in the supernatant 
and pellet dissolved in 4 M urea obtained upon acid treatment of CHO-H466D, it was estimated 
that ~75% of the flavin in CHO-H466D is tightly but not covalently bound to the enzyme. These 
data clearly suggest that reversing the positive charge in proximity of the FAD N(1) locus affects 
not only the flavin content in the protein but also the extent of protein flavinylation. 
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Figure 6.4. Stoichiometry and flavin content of CHO-H466D.  
Thick solid curve, UV-visible absorbance spectrum of CHO-H466D in 20 mM Tris-Cl and 10% 
glycerol, pH 8; dotted curve, UV-visible absorbance spectrum of the soluble fraction after 
treatment of CHO-H466D with 10% of trichloroacetic acid for 30 min on ice and centrifugation 
to remove denatured protein; thin solid curve, UV-visible absorbance spectrum of the denatured 
precipitated fraction after solubilization in 4 M urea. Inset, MALDI-TOF mass spectrometric 
analysis of the soluble fraction after treatment of CHO-H466D with 10% of trichloroacetic acid. 
The spectrum was recorded in negative ion mode with a 50:50 methanol/acetonitrile matrix. 
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Spectrophotometric Properties of Reduced CHO-H466D. The UV-visible absorbance 
spectrum of the fully reduced form of CHO-H466D was obtained by anaerobic incubation of the 
enzyme with xanthine and xanthine oxidase, at pH 6. As shown in Figure 6.3A, an indistinct 
shoulder with no well-defined peaks was observed in the 400 to 450 nm region of the absorbance 
spectrum of CHO-H466D hydroquinone, suggesting that at pH 6 the flavin hydroquinone bound 
to this enzyme variant was present in the neutral form (47-49). During the reduction process, no 
flavin semiquinone intermediate was observed (data not shown). A similar reduction of CHO-
WT yielded a UV-visible absorbance spectrum with a well-defined peak at 347 nm (Figure 
6.3A), consistent with previous data on anaerobic substrate reduction of the wild type enzyme 
that suggested the presence of the reduced flavin in the anionic state (40). In the case of CHO-
H466A, anaerobic reduction of the enzyme at pH 6 resulted in a UV-visible absorbance spectrum 
with features that were intermediate between those of CHO-H466D and CHO-WT, i.e., both a 
poorly defined peak at ~350 nm and a shoulder in the 400 nm region (Figure 6.3A). Thus, at pH 
6 the reduced flavin in CHO-H466A is likely present as a mixture of anionic and neutral 
hydroquinones. The spectral properties of the three enzyme variants in the reduced state are 
summarized in Table 6.1. 
Effect of pH on the Spectrophotometric Properties of CHO-H466D.  The effects of pH 
on the UV-visible absorbance spectra of CHO-H466D were determined on the oxidized and 
reduced enzymes. As shown in Figure 6.5, the absorbance at 500 nm increased between limiting 
values upon increasing pH, yielding a pKa value of 10.3 ± 0.1, which could be assigned to the 
ionization of the N(3) locus of the oxidized enzyme-bound FAD (50). Previous data on CHO-
H466A and CHO-WT yielded pKa values of ~9.3 and ~8.2, respectively (45), consistent with 
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significant changes in the microenvironment surrounding the FAD N(3) locus upon replacing 
His466 with a neutral or anionic amino acid. 
No significant spectral changes were observed in the UV-visible absorbance spectrum of 
CHO-H466D hydroquinone upon raising the pH from 6 to 10, consistent with the neutral species 
of the reduced flavin being stabilized in this pH range (data not shown). Similarly, no spectral 
changes were observed in the same pH range with CHO-WT hydroquinone, suggesting that 
ionization of the N(1) position of FAD has a pKa significantly lower than 6 or that the N(1) 
position of FAD is not solvent accessible in the wild type reduced enzyme (data not shown). In 
contrast, the UV-visible absorbance spectrum of CHO-H466A hydroquinone at pH 8 showed 
features that are typically associated with the anionic reduced flavin, i.e., a distinct peak at 356 
nm (Figure 6.6). Thus, in CHO-H466A the relative amount of anionic versus neutral 
hydroquinone increased significantly upon increasing the pH from 6 to 8, suggesting that the 
flavin N(1) locus in this enzyme variant is both solvent accessible and ionizable in this pH range.  
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Figure 6.5. Effect of pH on the spectral properties of CHO-H466D.  
UV-visible absorbance spectra were recorded at an enzyme concentration of ~20 µM in 20 mM 
sodium phosphate, 20 mM sodium pyrophosphate and 10% glycerol, at 15 °C. Only selected 
spectra are shown for the enzyme at pH 6 (thick solid curve), pH 10 (dotted curve), and pH 12 
(thin solid curve). Inset, Absorbance values at 500 nm as a function of pH; data were fit to eq (2). 
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Figure 6.6. Anaerobic reduction of CHO-H466A using xanthine and xanthine oxidase. 
Anaerobic reduction of CHO-H466A with 300 µM xanthine and ~0.5 µM xanthine oxidase in 50 
mM sodium phosphate, 50 mM sodium pyrophosphate and 10% glycerol, at pH 8 and 15 °C. 
Curve 1: UV-visible absorbance spectrum of the fully oxidized species of the enzyme. 
Unnumbered curves: selected intermediate spectra recorded during the reduction of the enzyme 
showing the formation of anionic flavin semiquinone. Curve 20: UV-visible absorbance 
spectrum of the hydroquinone form of enzyme. 
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Figure 6.7. Potentiometric reduction titration of CHO-H466D in complex with choline.  
Curve 1: UV-visible absorbance spectrum of the fully oxidized CHO-H466D at an ambient 
redox potential of +267 mV at a concentration of ~20 µM in the presence of 10 mM choline, in 
20 mM Tris-Cl and 10% glycerol, pH 7, at 15 °C. Curves 2-4: selected intermediate spectra 
recorded during reduction of the ligand-bound CHO-H466D after each addition of sodium 
dithionite at ambient redox potentials of +40, –77, and –130 mV, respectively. Curve 5: UV-
visible absorbance spectrum of the fully reduced ligand-bound CHO-H466D at ambient redox 
potential of -217 mV, showing significant turbidity of the reduced enzyme solution. 
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Redox Potentiometry of Unliganded CHO-H466D, CHO-H466A, and CHO-WT. 
Previous studies established that with choline oxidase in complex with glycine betaine the 
replacement of His466 with alanine resulted in a decrease of the midpoint reduction-oxidation 
potential for the oxidized-reduced flavin couple from +132 mV to +106 mV at pH 7 (45). Since 
CHO-H466D does not bind glycine betaine, but forms a stable complex without reacting with 
choline (vide infra), here we have attempted to determine the reduction-oxidation potential of 
CHO-H466D in the presence of 10 mM choline at pH 7 and 15 oC. However, significant 
turbidity of the enzyme solution developed during the course of the reduction (Figure 6.7), 
preventing the determination of the reduction-oxidation potential of CHO-H466D in complex 
with a ligand. Consequently, the midpoint reduction-oxidation potential of CHO-H466D, and 
those for CHO-WT and CHO-H466A for comparison, were determined on the free enzymes in 
the absence of ligands at pH 7. With both CHO-WT and CHO-H466A, the midpoint reduction-
oxidation potentials for the first and second reducing equivalents were well separated, resulting 
in the thermodynamic stabilization of the flavin anionic semiquinone species (Figure 6.8A-D). In 
agreement with the observed potentials for the first and second electron transfer equilibria, 100% 
and 90% of flavin semiquinones were seen with CHO-WT and CHO-H466A, respectively 
(Figure 6.8E and Table 6.2). In contrast, with CHO-H466D no flavin semiquinone was observed 
during reduction of the enzyme at pH 7 resulting in the determination of the E'm, 7 values for the 
oxidized-reduced enzyme couple (Figure 6.8F). In all cases, the analyses of the data according to 
the Nernst formalism yielded lines in plots of Eh versus log ([oxidized or semiquinone 
species]/[semiquinone or reduced species]) with slopes of ~59 and 35 for the one- and two-
electron transfers, respectively, in agreement with the expected values of 57 and 28.5 mV at 15 
oC (Figure 6.8 and Table 6.2). As illustrated in Table 6.2, the E'm, 7 for the transfer of the two 
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electrons with CHO-H466D had a value that was ~130 mV and ~160 mV more negative than the 
calculated midpoint potentials for the corresponding two-electron transfers in CHO-H466A and 
CHO-WT. These data are consistent with a significant effect of the amino acid residue at 
position 466 on the electrophilicity of the enzyme-bound flavin in choline oxidase. Interestingly, 
the midpoint reduction-oxidation potential for the oxidized-semiquinone couple in wild type 
choline oxidase was +211 mV, which is to our knowledge the highest value for such 
thermodynamic equilibrium reported for a flavoprotein oxidase (9, 11, 51-56). 
 
 
 
Table 6.2. Midpoint Reduction-Oxidation Potentials for the Enzyme-FAD of Unliganded CHO-
WT, CHO-H466A, and CHO-H466D, at pH 7a 
Enzyme E′1 (mV)b 
[slope, mV] 
E′2 (mV)c 
[slope, mV] % Sq 
E′m, 7 (mV)d 
[slope, mV] 
CHO-WT +211 ± 2 [60 ± 3] -65 ± 2 [57 ± 4] 100 +73e 
CHO-H466A +91 ± 2 [57 ± 3] -6 ± 2 [59 ± 3] 90 +42.5e 
CHO-H466D naf Na 0 -89 ± 1 [35 ± 1] 
a Conducted in 20 mM Tris-Cl, pH 7, at 15 °C. b Midpoint potential (n =1) of the 
oxidized/semiquinone FAD redox couple. c Midpoint potential (n =1) of the 
semiquinone/hydroquinone FAD redox couple. d Midpoint potential (n =2) of the 
oxidized/hydroquinone FAD redox couple. e Calculated midpoint potential for CHO-WT and 
CHO-H466A (E′m, 7  = (E′1 + E′2)/2; (57)).  f Not available. 
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Figure 6.8. Potentiometric reduction-oxidation titration of CHO-WT, CHO-H466A, and CHO-
H466D.  
Potentiometric reduction-oxidation titration of CHO-WT (Panel A and B), CHO-H466A (Panel 
C and D), and CHO-H466D (Panel F) at concentrations of ~20 µM, in 20 mM Tris-Cl, pH 7 at 
15 °C. Curves 1, UV-visible absorbance spectra of the oxidized species of enzymes; curves 2, 
UV-visible absorbance spectra of the maximum red anionic semiquinone that formed during the 
reductive titrations; curves 3, UV-visible absorbance spectra of the fully reduced species of 
enzymes. Panel E, quantitation of the amount of flavin semiquinone formed with CHO-WT (left 
panel) and CHO-H466A (right panel). Insets, determination of the midpoint reduction potentials: 
Panel A, B, C, and D Nernst plots of the potentiometric data for the reduction of the enzyme-
bound flavin in CHO-WT and CHO-H466A (panel A and C: OxÆSq; panel B and D: SqÆRed), 
data were fit to eq (3); panel F, Nernst plot of the potentiometric data for the reduction of the 
enzyme-bound flavin in CHO-H466D (OxÆRed), data were fit to eq (3). 
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Binding of Choline, Glycine Betaine, and Sulfite to CHO-H466D. In agreement with 
the lack of oxygen consumption of CHO-H466D when assayed polarographically with choline as 
substrate, the anaerobic mixing of this mutant protein with 10 mM choline resulted in no 
bleaching of the flavin peak at ~450 nm over 60 min of incubation, as shown in Figure 6.9A. 
However, a 4 nm batochromic shift associated with an increase in absorbance at 375 nm was 
observed in the UV-visible absorbance spectrum of CHO-H466D in the presence of choline 
(Figure 6.9A). These spectral changes were similar to those seen for the CHO-H466A variant in 
complex with glycine betaine (Figure 6.10B), suggesting that CHO-H466D retained the ability to 
bind choline at the active site without subsequent oxidation of the substrate. The lack of 
reactivity of CHO-H466D with choline was exploited for the determination of an equilibrium 
constant for the dissociation of choline from the enzyme (Kd) of 0.45 ± 0.04 mM at pH 8, which 
was carried out spectrophotometrically by following the UV-visible spectral changes of the 
enzyme in the visible region at increasing concentrations of choline (Figure 6.9B). Such a Kd 
value was four-times lower than the Kd value of ~1.8 mM that was recently determined through 
rapid reaction studies of CHO-WT reacting with choline at pH 8 (58), suggesting that reversing 
the charge at position 466 results in a slightly tighter binding of choline to the active site of the 
enzyme.  
The lack of enzymatic activity of CHO-H466D prevented a kinetic determination of the 
inhibition constant for binding of glycine betaine to the enzyme, as was previously carried out 
for both CHO-WT (40) and CHO-H466A (45). Consequently, the determination of the 
dissociation constant for glycine betaine binding was carried out on the wild type and mutant 
forms of choline oxidase by following the spectral changes associated with mixing of the enzyme 
with increasing concentrations of ligand. With both CHO-WT and CHO-H466A, Kd values for 
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glycine betaine binding that were in good agreement with those previously determined using the 
kinetic approach could be determined at pH 6 (Figure 6.10A-B and Table 6.1) (40, 45). In 
contrast, no significant spectral changes could be observed with CHO-H466D at concentrations 
of glycine betaine as high as 80 mM (Figure 6.10C), suggesting that choline oxidase lost the 
ability to bind glycine betaine upon replacing the active site histidine with aspartate. 
Wild type choline oxidase was shown previously to form a tight reversible N(5)-flavin 
sulfite adduct with a Kd value of ~50 µM at pH 7 and 15 °C (40). In contrast, with CHO-H466A 
an N(5)-flavin sulfite adduct could be obtained only in the presence of exogenous imidazole, 
while in the absence of imidazole no adduct could be formed even after 3.5 h of incubation of 
CHO-H466A with 100 mM sulfite (45). Similarly, no spectral changes could be detected here 
when CHO-H466D was incubated for 3 h at pH 6 and 15 oC in the presence of 100 mM sodium 
sulfite (Figure 6.11), consistent with lack of stabilization of the sulfite-flavin adduct in CHO-
H466D. 
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Figure 6.9. Binding of choline to CHO-H466D.  
Panel A, UV-visible absorbance spectra of CHO-H466D were recorded at a concentration of ~30 
µM in 20 mM Tris-Cl, pH 8 and 15 °C, before (thick solid curve), after one hour of anaerobic 
incubation of the enzyme with 10 mM choline (dotted curve) and after the addition of dithionite 
powder (thin solid curve). Inset, difference spectrum of the enzyme bound choline to the free 
enzyme; panel B, difference absorbance spectra of CHO-H466D at a concentration of ~20 µM in 
20 mM Tris-Cl, pH 8 and 15 °C, during the aerobic titration of choline in the concentration range 
between zero (curve 1) and 3.5 mM (curve 12). Inset, Absorbance values at 500 nm as a function 
of choline concentration; data were fit to eq 1. 
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Figure 6.10. Binding of glycine betaine to CHO-WT, CHO-H466A and CHO-H466D. 
Difference spectra of CHO-WT (panel A) and CHO-H466A (panel B) during the aerobic 
titration of glycine betaine in a concentration range between zero (curves 1, panel A and B) and 
62 mM (curve 10, panel A) or 23 mM (curve 11, panel B). Insets, Absorbance values at 457 nm 
(panel A) and 496 nm (panel B) as a function of glycine betaine concentration for CHO-WT and 
CHO-H466A; the curves are fits of the data to eq 1. Panel C, UV-visible absorbance spectra of 
CHO-H466D before (solid curve) and after aerobic titration of glycine betaine up to a final 
concentration of ~80 mM (dotted curve). Absorbance spectra were recorded at enzymes 
concentration of ~20 µM in 20 mM sodium phosphate, 20 mM sodium pyrophosphate and 10% 
glycerol, pH 6. 
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Figure 6.11. Reaction of CHO-H466D with sulfite.  
UV-visible absorbance spectra of CHO-H466D before (solid curve) and after 3 h of aerobic 
incubation with 100 mM sodium sulfite (dotted curve). Enzyme concentration was 15 µM in 100 
mM sodium pyrophosphate, pH 6, at 15 °C.  
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Discussion 
A recent biochemical and mechanistic study on a mutant form of choline oxidase in 
which the active site histidine at position 466 was replaced with alanine established the 
involvement of His466 in the reductive half-reaction in which choline is oxidized to betaine 
aldehyde, but not in the following oxidative half-reaction in which oxygen is reduced to 
hydrogen peroxide (45). Of particular interest was the finding that in catalysis His466 is 
protonated, as suggested by the observation that the enzymatic activity of CHO-H466A could be 
partially rescued in the presence of exogenous imidazolium, but not imidazole (45). The 
positively charged His466 was proposed to play multiple roles in the oxidation of choline 
catalyzed by choline oxidase, by contributing to the polarity of the active site, stabilizing the 
negatively charged transition state, and activating the flavin for the oxidation reaction (45). As 
illustrated in Scheme 6.2, the contribution of His466 to the active site polarity would be required 
for the efficient removal of the substrate hydroxyl proton that results in the activation of the 
substrate (species 1 and 2). The stabilization of the resulting choline alkoxide species (species 2) 
and the activation of the enzyme-bound flavin (species 3) would correctly position and facilitate 
the quantum mechanical transfer of the hydride from the substrate α-carbon to the N(5) flavin 
locus (species 3) (39, 45, 58). The recent determination of the crystal structure of choline oxidase 
showed that His466 is located in the active site at ~3.3 Å from the N(1) locus of the flavin (Figure 
6.1) (George Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; unpublished results), 
consistent with the proposed roles for this residue in catalysis. In the present study, we have 
prepared a second variant of choline oxidase in which His466 was replaced with an aspartate 
residue by site-directed mutagenesis, and investigated the effects of reversing the charge in 
proximity of the N(1) locus of the flavin by using biochemical and biophysical approaches. 
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From a biophysical standpoint, reversing the protein positive charge at position 466 in 
choline oxidase results in the lack of stabilization of the negative charge that is produced on the 
N(1) locus of the enzyme-bound flavin in the one- and two-electron reduced forms of choline 
oxidase. Evidence for this conclusion comes primarily from the UV-visible absorbance spectrum 
of the two-electron reduced form of CHO-H466D at pH 6, which is consistent with the enzyme-
bound flavin hydroquinone being in the neutral state (47-49). The lack of changes in the UV-
visible absorbance spectrum of the reduced flavin upon raising the pH from 6 to 10 is further 
consistent with stabilization of the neutral flavin hydroquinone in CHO-H466D being due to the 
effect of the negatively charged aspartyl side chain, since such a residue is expected not to 
change its ionization state above pH 6. In contrast, the wild type enzyme stabilizes the anionic 
form of hydroquinone between pH 6 and 10, as shown by the well-resolved peak at 356 nm in 
the UV-visible absorbance spectrum of the two-electron reduced enzyme. These data, in turn, 
suggest that the histidyl side chain at position 466 either decreases the pKa value for the 
ionization of the N(1) FAD locus in the reduced enzyme to values below 6 or hinders solvent 
accessibility to the N(1) locus, thereby preventing its protonation during flavin reduction. In 
agreement with these conclusions, the alanyl variant of the enzyme, which carries a small and 
neutral side chain proximal to the FAD N(1) position, exists as a mixture of neutral and anionic 
hydroquinones at pH 6 and as the anionic species at pH 8. Different stabilization of the negative 
charge on the N(1) locus of the flavin in the hystidyl, alanyl, and aspartyl enzymes is 
independently suggested by the observation that the anionic flavin semiquinone was stabilized at 
pH 7 only in the wild type and H466A mutant enzymes, but not in CHO-H466D. These results 
suggest that at least in choline oxidase the removal of the positive charge in proximity of the 
N(1) locus of the flavin is not sufficient to destabilize the anionic flavin semiquinone, and that 
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such a destabilization requires the presence of a protein negative charge. Finally, the lack of 
changes in the UV-visible absorbance spectrum of oxidized CHO-H466D in the presence of 
sodium sulfite, which was previously observed to form a tight reversible N(5)-flavin adduct with 
the wild type enzyme (40), provides independent evidence that replacing the protein positive 
charge at position 466 results in lack of stabilization of the negative charge on the N(1)-C(2)=O 
flavin locus.  
The most dramatic effect arising from the lack of stabilization of the negative charge on 
the pyrimidine ring of the reduced flavin in CHO-H466D is that about 75% of the enzyme-bound 
FAD is tightly, but not covalently, bound to the protein moiety. This conclusion is supported by 
the analysis of the supernatant obtained upon acid treatment of the enzyme containing aspartate 
at position 466 followed by centrifugation to remove the denatured protein. In contrast, both 
CHO-WT and CHO-H466A have been recently reported to contain only covalently bound FAD 
(38, 45), suggesting that replacing the protein positive charge close to the N(1) atom of the flavin 
with a neutral residue is not sufficient to affect the flavinylation of the enzyme. With both the 
aspartyl and alanyl mutant proteins the total FAD content was three- to four-fold lower than that 
previously observed for the wild type enzyme, in which a 1:1 stoichiometry of FAD to protein 
was established, further suggesting that the presence of a protein positive charge close to the 
N(1) position of the flavin is important for the formation of the covalent linkage between FAD 
and the protein in choline oxidase. These results are in keeping with other studies recently 
reported on trimethylamine dehydrogenase, sarcosine oxidase, N-methyltryptophan oxidase, and 
p-cresol methylhydroxylase (20, 59-62), suggesting that a positively charged microenvironment 
close to the flavin N(1)-C(2)=O locus is important for the stabilization of negatively charged 
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reduced flavin that is proposed to transiently form during the covalent attachment of the flavin to 
either the 6- or 8-position of the isoalloxazine ring (62).  
From a functional standpoint, the most notable effect of reversing the protein positive 
charge on the side chain at position 466 in choline oxidase is a ~160 mV decrease in the 
midpoint reduction-oxidation potential of the enzyme-bound flavin for the two-electron transfer 
occurring between the oxidized and reduced enzyme-bound flavin. Such an effect arises from 
both the lack of covalent linkage between the enzyme-bound flavin and the protein and the 
presence of the negatively charged aspartyl side chain near the flavin N(1) locus. Earlier results 
on a number of flavin-dependent enzymes containing covalently bound flavins, namely 
cholesterol oxidase (63), vanillyl-alcohol oxidase (55), and p-cresol methylhydroxylase (54), 
showed that, irrespective of the type of flavin linkage and protein, removing the covalent linkage 
between the flavin and the enzyme results in a decrease of the E'm, 7 value of the bound flavin of 
~100 mV. If one assumes a similar contribution to the E'm, 7 value of ~100 mV from the covalent 
linkage in choline oxidase, the effect of the negative charge of the aspartyl side chain on the 
midpoint reduction-oxidation potential of the flavin in CHO-H466D can be estimated at -60 mV. 
Since a 30 mV decrease in the E'm, 7 value was observed in this study upon replacing His466 with 
alanine, it can be concluded that the electrophilicity of the enzyme-bound flavin is increased by  
~6 kJ mol-1 in the presence of a positive charge and decreased by a similar extent in the presence 
of a negative charge near the N(1) locus of the flavin. A similar energetic contribution of a 
protein positive charge near the flavin N(1) locus on the electrophilicity of the flavin was 
previously reported for lactate monooxygenase, where substituting Lys266 with a methionine 
residue resulted in a decrease of 30 mV in the midpoint reduction-oxidation potential of the 
flavin (35). Although replacement of a histidine with either an aspartate or glutamate residue was 
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previously reported in cholesterol oxidase from Brevibacterium sterolicum, no potentiometric 
data were reported in that study (64). Consequently, this is the first instance in which the effect 
of reversing the charge near the flavin N(1) locus on the electrophilicity of the enzyme-bound 
flavin has been investigated in a flavin-dependent oxidase. 
Reversing the positive charge of His466 with aspartate in choline oxidase results in the 
complete loss of enzymatic activity, as suggested by the lack of both oxygen consumption and 
bleaching of the enzyme-bound flavin upon mixing CHO-H466D with choline. The loss of 
enzymatic activity correlates well with the ∆E'm, 7 value of ~160 mV observed between CHO-
H466D and CHO-WT, which accounts for a ~250,000-fold decrease in the rate of hydride 
transfer to the flavin in the H466D mutant enzyme as compared to the wild type enzyme3. 
However, the 30 mV decrease in the E'm, 7 value observed here for CHO-H466A, which agrees 
well with the previously reported value of ~25 mV (45), cannot fully explain the 20-fold 
decrease in the rate of choline oxidation that was previously reported for CHO-H466A as 
compared to the wild type enzyme (45). With CHO-H466A, the decrease in catalytic activity was 
explained by both a decrease in the flavin electrophilicity, which is reflected in the E'm, 7 value, 
and the lack of stabilization of the negatively charged alkoxide species that is transiently formed 
in the oxidation of choline (45). The data presented here with CHO-H466D, which could not 
bind glycine betaine or sulfite, suggest that also the H466D variant likely lost the ability to 
stabilize extra negative charges in the active site4. Similar results in which the enzyme did not 
                                                 
3 A more rigorous approach for the correlation of the loss of enzymatic activity of CHO-H466D with the change in 
the midpoint oxidation-reduction potential of the enzyme-bound flavin would entail a study of the linear free energy 
relationship of the rate of flavin reduction using choline oxidase reconstituted with a number of flavin analogues. 
Such an analyses was beyond the purpose of the current study. 
4 The denaturation of the enzyme that ensues upon anaerobic reduction of CHO-H466D in complex with saturating 
concentrations of choline is also consistent with inability of CHO-H466D to accommodate an extra negative charge 
in the active site. Indeed, while the anaerobic reduction of the free unliganded enzyme results in the stabilization of 
the neutral hydroquinone, it is likely that the presence of choline in the active site hinders solvent access to the N(1) 
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show catalytic activity upon replacing the protein positive charge near the flavin N(1) locus were 
previously reported for active site mutant forms of cholesterol oxidase in which His447, which is 
the residue equivalent to His466 of choline oxidase, was replaced by either a glutamate or 
aspartate residue. However, in that study the characterization of the enzyme-bound flavin was 
not reported. 
Our recent study on the H466A mutant protein of choline oxidase showed that the 
enzymatic activity of the enzyme is only 20-times lower than that of the wild type enzyme and 
that, most importantly, the enzymatic activity could be partially rescued in the presence of 
exogenous imidazolium but not imidazole in the assay reaction mixture (45). Although these data 
are consistent with H466 acting as an electrostatic catalyst by stabilizing the transient alkoxide 
species that forms in the oxidation of choline (species 2 and 3 in Scheme 6.2), they do not 
unequivocally rule out His466 as being the general base catalyst that removes the hydroxyl proton 
of the substrate (species 1 in Scheme 6.2). Indeed, His466 would still be able to electrostatically 
stabilize the anionic species of the substrate after removing the hydroxyl proton from the 
substrate and acquiring a positive charge. If this were the case, substitution of His466 with 
aspartate would be expected to generate a mutant enzyme with at least partial catalytic activity, 
since the negatively charged aspartyl side chain at position 466 would be neutralized upon 
abstracting the substrate hydroxyl proton, thereby allowing the transient formation of the 
alkoxide species. However, the observation that CHO-H466D is completely devoid of enzymatic 
activity with choline is not consistent with Asp466 acting as a base in the active site of the 
aspartyl mutant of choline oxidase.  
                                                                                                                                                             
position of the bound flavin, thereby preventing its protonation during reduction with the consequent unfolding of 
the protein due to charge repulsion between Asp466 and the negatively charged reduced flavin. 
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In summary, the results of the biochemical and biophysical investigation of a choline 
oxidase variant in which the protein charge near the flavin N(1) locus was reversed by site-
directed mutagenesis suggest that the enzyme has lost the ability to stabilize negative charges in 
the active site, irrespective of whether they develop on the flavin or are borne on active site 
ligands. This effect results in the defective flavinylation of the protein, decreased electrophilicity 
of the enzyme-bound flavin and, consequently, loss of catalytic activity in the enzyme. The latter 
conclusion is further consistent with His466 in the wild type enzyme not acting as a general base 
catalyst in the reductive half-reaction in which choline is initially activated to the alkoxide 
species upon removal of its hydroxyl proton. Taken together, the data presented here provide 
further evidence for the importance of a protein positive charge close to the N(1) flavin in 
choline oxidase and, by extension, in flavoprotein oxidases, and indicate that the enzyme loses 
its functionality upon reversing, but not neutralizing, such a positive charge.     
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CHAPTER VII 
On the Role of the Active Site Residue His310 of Choline Oxidase 
 
Abstract 
Choline oxidase (E.C. 1.1.3.17) from Arthrobacter globiformis is a member of the 
Glucose-Methanol-Choline (GMC) oxidoreductase enzyme superfamily. The enzyme catalyzes 
the oxidation of choline to glycine betaine through two sequential flavin-linked hydride transfers 
from choline and the ensuing betaine aldehyde intermediate to molecular oxygen. The presence 
of a protein positive charge close to the N(1) locus of the bound flavin is a common 
characteristic feature of flavoprotein oxidases. Recent studies revealed that in the active site of 
choline oxidase the protein positive charge is provided by His466, which is located at a distance 
of ~3.3 Å from the N(1) locus of the enzyme-bound flavin (His466Nε2-N(1)-FAD). The X-ray 
crystal structure of choline oxidase also showed that another histidine residue, His310, is located 
at a distance of ~2.9 Å from His466 (His466Nδ1-His310Nδ1). To assess the contribution made by 
His310 in catalysis, a mutant form of the enzyme was prepared in which the active site residue 
His310 was substituted with alanine. Polarographic preliminary results on the enzyme obtained by 
substituting His310 by an alanine residue showed that the purified mutant enzyme completely lost 
its catalytic activity with choline as substrate, suggesting the involvement of His310 in catalysis. 
However, spectrophotometrically, CHO-H310A was still able to bind choline with the 
subsequent reduction of the enzyme-bound flavin, which happened significantly slower than with 
the wild-type form of choline oxidase (16 h vs 1 s) and in a biphasic way. The results obtained 
herein also indicated the involvement of His310 in the flavinylation process and the binding of the 
coenzyme to the polypeptide chain of the protein as the removal of this residue resulted in a 
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significant alteration of the stoichiometric amount of the flavin. Therefore, these results together 
with the structural information suggest an important role of His310 in catalysis and the 
modulation of the enzyme-bound flavin. 
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Introduction 
Choline oxidase (E.C. 1.1.3.17) is a flavin-dependent cytosolic enzyme that catalyzes the 
oxidation of choline to glycine betaine via an enzyme-bound aldehyde intermediate (Scheme 
7.1). This reaction is of considerable interest for medical and biotechnological applications, since 
accumulation of glycine betaine in many pathogens and plants enables their stress-resistance 
towards hyperosmotic environments (1, 2). Therefore, the study of choline oxidase has potential 
for the development of therapeutic agents that inhibit the biosynthesis of glycine betaine and 
render pathogenic bacteria susceptible to either conventional treatments or the innate immune 
system, and for the improvement of water stress resistance in genetically engineered crops 
lacking efficient glycine betaine biosynthetic systems. Choline oxidase has been characterized in 
its biophysical, structural, and mechanistic properties. The enzyme is a homodimer with a mass 
of 120 kDa (3), contains covalently linked FAD in a 1:1 stoichiometry (3), and under turnover 
cycles between its fully oxidized and reduced states (4, 5). A detailed picture of the mechanism 
of the reaction catalyzed by choline oxidase was obtained from the biophysical, kinetic, 
structural and mechanistic studies of the wild-type Arthrobacter globiformis choline oxidase as 
well as selected mutant forms of the enzyme (4-11). In summary, during the reductive half-
reaction, the alcohol substrate, choline, is activated through the proton abstraction of its hydroxyl 
group by an unidentified active site base with pKa of 7.5 with the subsequent formation of an 
alkoxide species (4). This choline alkoxide intermediate species is transiently stabilized in the 
active site through an electrostatic interaction with the N(3) atom of the protonated imidazole 
side chain of His466 (Figure 7.1) (10). Hydride transfer from the α-carbon of the substrate to the 
N(5) locus of the isoalloxazine nucleus of the enzyme-bound FAD occurs quantum mechanically 
from the activated choline alkoxide species (6). The trimethylammoniun headgroup of the 
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substrate alcohol is the major determinant for substrate binding and specificity, with little 
participation of the ethyl moiety (9).  
The presence of a protein positive charge close to the N(1) locus of the bound flavin is a 
common characteristic feature of flavoprotein oxidases. In recent studies our group showed that 
in the active site of choline oxidase the protein positive charge is provided by His466 (10, 11), 
which is located at a distance of ~3.3 Å from the N(1) locus of the enzyme-bound flavin 
(His466Nε2-N(1)-FAD) (George Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; 
unpublished results). The X-ray crystal structure of choline oxidase also showed that another 
histidine residue, His310, is at a distance of ~2.9 Å from His466 (His466Nδ1-His310Nδ1) (Figure 7.2). 
In addition, the X-ray crystallographic data of the enzyme also showed that the N(3) atom of 
His310 is located at a distance of ~2.8 Å from the carbonyl main chain oxygen atoms of Thr380 
and Val507 (Figure 7.2). These structural data, along with our previous studies on the role of the 
conserved active site His466 residue suggest that His466 is hydrogen bonded to both N(1)-FAD 
and His310Nδ1 through its N(3) and N(1) atoms, respectively. Moreover, these data also suggest 
that His310 is hydrogen bonded to the carbonyl oxygen atoms of Thr380 and Val507 through its 
N(3) atom (Figure 7.2). Accordingly, one would expect the existence a proton-transfer network 
between the protonated conserved active site residue His466 and His310.    
In the present study, to assess the contribution made by His310 in catalysis, a mutant form 
of choline oxidase was prepared in which His310 was substituted with alanine. 
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Scheme 7.1. Reaction catalyzed by choline oxidase. 
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Figure 7.1. Line draw showing the interaction of His466 with the N(1)−C(2)═O locus of FAD 
and the choline alkoxide species in the transition state for the oxidation of choline catalyzed by 
choline oxidase. 
The positioning of His466 relative to the flavin is from the X-ray crystallographic structure of the 
enzyme recently determined at 1.86 Å resolution (George Lountos, Fan Fan, Giovanni Gadda, 
and Allen M. Orville; unpublished results), the positioning of choline is arbitrary. 
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Figure 7.2. Crystal structure of choline oxidase. 
X-ray crystallographic structure of the active site of choline oxidase determined at 1.86 Å 
resolution (George Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; unpublished 
results). 
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Experimental Procedures 
Materials. Escherichia coli strain Rosetta(DE3)pLysS was from Novagen (Madison, 
WI). The QuikChange Site-Directed Mutagenesis kit was from Stratagene (La Jolla, CA). The 
QIAprep Spin Miniprep kit was from Qiagen (Valencia, CA). Oligonucleotides used for site-
directed mutagenesis and for sequencing of the mutant gene were custom synthesized by the 
DNA Core Facility of the Department of Biology of Georgia State University or by Sigma 
Genosys (The Woodlands, TX). Oligonucleotides, bovine serum albumin, chloramphenicol, 
tetracycline, isopropyl-β-D-thiogalactopyranoside (IPTG), lysozyme, sodium hydrosulfite 
(dithionite), sodium sulfite, betaine aldehyde, glycine betaine, Luria-Bertani agar and broth, and 
PMSF were from Sigma (St. Louis, MO). Choline chloride and ampicillin were from ICN 
(Aurora, OH). Wild-type choline oxidase (CHO-WT) from Arthrobacter globiformis strain 
ATCC 8010 was expressed from pET/codA1 and purified to homogeneity as previously 
described (3). The fully oxidized FAD-containing CHO-WT was prepared as described in ref.(9). 
All other reagents were of the highest purity commercially available. 
Instruments. UV-visible absorbance spectra were recorded using an Agilent 
Technologies diode-array spectrophotometer model HP 8453 equipped with a thermostated water 
bath. Rapid kinetics was carried out on a Hi-Tech SF-61 stopped-flow spectrophotometer 
thermostated at 15 C. 
Site-Directed Mutagenesis. A QuikChange kit was used to prepare the mutant forms of 
choline oxidase (CHO-H310A; CHO-H310D; and CHO-H310N). The method used was 
essentially according to the manufacturer’s instructions, using pET/codA1 plasmid (3) as a 
template and Cho-H310Af (5′ CGAGCACCTGCAGGACGCCCCGGAAGGCGTGG 3′); Cho-
H310Df (5′ GGGCGAGCACCTGCAGGACGACCCGGAAGGCGTGGTGC 3′); Cho-H310Nf 
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(5′ GGGCGAGCACCTGCAGGACAACCCGGAAGGCGTGGTGC 3′)  and Cho-H310Ar (5′ 
GCACCACGCCTTCCGGGGCGTCCTGCAGGTGCTCGCC 3′); ChoH310Dr (5′ 
GCACCACGCCTTCCGGGTCGTCCTGCAGGTGCTCGCC 3′); Cho-H310Nr (5′ 
GCACCACGCCTTCCGGGTTGTCCTGCAGGTGCTCGCC 3′) oligonucleotides as forward 
and reverse primers, respectively (underlined letters indicate mismatches). DNA was sequenced 
at the DNA Core Facility at Georgia State University using an Applied Biosystems Big Dye Kit 
on an Applied Biosystems model ABI 377 DNA sequencer. Sequencing confirmed the presence 
of the mutant genes in the correct orientation. E. coli strain Rosetta(DE3)pLysS competent cells 
were transformed with pET plasmids harboring the mutant genes by electroporation. 
Expression and Purification of CHO-H310A. CHO-H310A was expressed and purified 
to homogeneity as judged by SDS-PAGE using the same procedure used previously for the 
purification of CHO-WT and CHO-H466A (3, 10). The enzyme as purified was stored at -20 °C 
in 20 mM Tris-Cl and 10% glycerol (to increase the solubility and stability of the purified 
enzyme), pH 8.  
Spectrophotometric Studies. The UV-visible absorbance spectra of CHO-H310A were 
acquired in 20 mM Tris-Cl and 10% glycerol, pH 8, at 15 °C. The extinction coefficient of CHO-
H310A was determined in 20 mM Tris-Cl, pH 8, after denaturation of the enzyme by incubation 
at 40 °C for 3.5 h in the presence of urea at a final concentration of 4 M, based upon the ε450 
value of 11.3 mM-1 cm-1 for free FAD (12). For the quantitation of the ratio of the covalently to 
the uncovalently bound flavin to the enzyme, ~ 20 µM of enzyme was incubated on ice for 30 
min after the addition of 10 % trichloroacetate, followed by removal of precipitated protein by 
centrifugation, and the determination of the concentration of FAD in the supernatant solution. 
For the anaerobic reaction of CHO-H310A with its organic substrate, choline, CHO-H310A in 
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20 mM Tris-Cl and 10% glycerol, pH 8, was made anaerobic by repeated cycles of alternate 
degassing under vacuum and flushing with ultra-pure O2-free argon in an anaerobic cell 
equipped with two side arms. The organic substrate, choline was loaded into one side arm and 
was mixed with CHO-H310A at final concentrations ranging from 0.5 to 20 mM and incubated 
for 16-40 h. 
Enzyme Assays. The enzymatic activity of CHO-H310A was measured by the method of 
initial rates as described for the wild-type enzyme (3, 5) using a computer-interfaced Oxy-32 
oxygen-monitoring system (Hansatech Instrument Ltd.). The effect of imidazole on the turnover 
number of CHO-H310A was determined by measuring the enzymatic activity with 10 mM 
choline as substrate for the enzyme in the presence of 100 mM of imidazole in air-saturated 50 
mM sodium pyrophosphate, pH 6 or 10.    
Data Analysis. Spectroscopic data points of the anaerobic incubation of CHO-H310A 
with its organic substrate choline were fit into eq 1 that describes a case of double-exponential 
decay, in which k1 and k2 represent the first-order rate constants for the fast and the slow phase of 
the reductive half reaction, respectively, t is time, At is the value of absorbance at 456 nm, A1 and 
A2 are the amplitude of the total change in the fast and the slow phase of the reductive half 
reaction, respectively, and A∞ is the absorbance at infinite time. Data points obtained for the 
observe rate of the slow phase of flavin reduction were fit to eq 2, where kobs is the observed rate 
for the reduction of enzyme bound flavin, kred is the limiting rate of flavin reduction at saturated 
substrate concentration, Kd is the dissociation constant, and A is the substrate concentration. 
 
∞+−+−= A)tkexp(A)tkexp(AAt 2211                                                                   (1) 
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Akk += d
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obs                                                                                                                  (2) 
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Results 
Expression and Purification of CHO-H310A. CHO-H310A was expressed and purified 
to high purity and quantity using the same protocol established for the CHO-WT (Figure 7.3). 
Similar to wild-type enzyme, about 100-150 mg of pure CHO-H310A could be typically 
obtained from 4.5 liters of Luria-Bertani culture medium. Polarographically, CHO-H310A as 
purified at final concentrations as high as 20 µM did not show any catalytic activity toward its 
organic substrate choline at final concentration of 20-30 mM at pH 7, at 25 °C.  In comparison, 
the CHO-WT at a final concentration of 0.1 µM typically shows a catalytic activity of ~15 s-1 
with 10 mM choline (3), suggesting that histidine at position 310 is essential for the catalytic 
activity in choline oxidase.  
 
1 2 3
A
10987654321
B
 
Figure 7.3. Expression and purification of CHO-H310A. 
Figure A: lane 1, molecular weight marker proteins; lane 2, total cell proteins before induction; 
lane 3, total cell proteins after induction with 0.1 mM IPTG for 5 hours at 23 oC. Figure B: lane 
1, molecular weight marker proteins; lane 2-10, pooled purified fractions of CHO-H310A in 200 
mM Tris-Cl, pH 8, after DEAE column chromatography. 
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Spectral Properties. The UV-visible absorbance spectrum of oxidized CHO-H310A at 
pH 8 showed the typical spectrum of the oxidized flavin with peaks centered at 272, 356 and 458 
nm in the near-UV and visible regions (Figure 7.4), suggesting that the enzyme-bound flavin 
cofactor in the mutant enzyme as purified is in the oxidized redox state. The enzyme-bound 
flavin of CHO-H310A showed an extinction coefficient at 458 nm of 11.6 mM-1 cm-1 (Figure 
7.4), consistent with the values of 11.4 mM-1 cm-1 at 452 nm, 12 mM-1 cm-1 at 458 nm, and 12 
mM-1 cm-1 at 450 nm that were previously determined for the wild-type, CHO-H466A, and 
CHO-H466D enzymes, respectively (5, 10, 11). Similar to wild-type or CHO-H466A forms of 
choline oxidase, CHO-H310A bound FAD covalently. A stoichiometry of ~0.11 FAD per 
monomer of protein was calculated for CHO-H310A, indicating that the flavin content of CHO-
H310A was significantly less than that of the wild-type choline oxidase, for which a 
stoichiometry close to unity was previously reported (3). A stoichiometry of ~0.3 FAD per 
monomer of protein was previously determined for both CHO-H466A and CHO-H466D mutant 
forms of choline oxidase (10, 11). This result suggests that histidine residue at position 310 
significantly affects the flavinylation and the coenzyme binding of choline oxidase.  
0.00
0.05
0.10
0.15
0.20
300 400 500 600 700 800
A
bs
ob
an
ce
Wavelength, nm  
Figure 7.4. Spectral properties of CHO-H310A.  
Solid curve, UV-visible absorbance spectrum of CHO-H310A in 20 mM Tris-Cl and 10% 
glycerol, pH 8; dashed curve, after incubation with 4 M urea at 40 ºC for 3.5 h. 
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Reaction of CHO-H310A with Choline. Purified CHO-H310A at final concentrations as 
high as 20 µM showed no oxygen consumption when assayed with 20-30 mM choline as a 
substrate at pH 7 and 25 °C. Nevertheless, the anaerobic incubation of CHO-H310A with choline 
at a final concentration ranging from 0.75 to 20 mM resulted in a biphasic reduction of the 
oxidized enzyme-bound flavin, with a fast phase that started right after mixing the enzyme with 
its organic substrate and lasted for ~30 min, and a slow phase that lasted for ~16-40 h until the 
full reduction of the bound flavin (Figure 7.5 and 7.6). This result clearly suggests that although 
CHO-H310A does not show any catalytic activity toward its organic substrate choline as 
measured polarographically, as assessed spectrophotometrically, CHO-H310A is still capable to 
bind and oxidize its organic substrate choline but with a significantly slower rate compared to 
that of CHO-WT or even CHO-H466A. The data points obtained for the observed rate of the fast 
phase of flavin reduction after the anaerobic incubation of CHO-H310A with different 
concentrations of choline (0.75-20 mM), were scattered and did not allow the determination of 
the kred and the Kd for such fast phase (Figure 7.7A). However, the data points obtained for the 
observed rate of the slow phase of flavin reduction, with the exception of the point at the highest 
concentration of choline (20 mM), fit to eq 2 (data not shown). The value obtained for kred by 
fitting those data points to eq 2 was ~200,000-fold lower than that for wild-type enzyme (4.37 
×10-4 s-1 vs 93 s-1), and the value determined for Kd was at least 2-fold higher than that of wild-
type enzyme (0.65 mM vs 0.29 mM) (4). Alternatively, the data points for the observed rate of 
the slow phase of flavin reduction fit to substrate inhibition equation (Figure 7.7B). However, 
due to the lack of the data points at the inhibitory phase it did not allow the determination of the 
kred, Ki and Km. The scattering of the data points that have been observed during the fast phase of 
CHO-H310A reaction with choline could be attributed either to the independence of the reaction 
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to the substrate concentration, or due to a conformational change of the enzyme upon the 
substitution of the active site residue His310 to alanine.  This conformational change could be 
studied in the future by examining the overall fold of the mutant enzyme and compare it with 
that of the wild type choline oxidase using either tryptophan fluorescence or CD-
spectrophotometer. 
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Figure 7.5. Anaerobic reaction of CHO-H310A with choline (1).  
Solid curves, UV-visible absorbance spectra of CHO-H310A before incubation with choline; 
dashed curves, UV-visible absorbance spectra of CHO-H310A after anaerobic incubation with 
0.75 mM of choline for 40 h (panel A), 1 mM choline for 16 h (panel B), 1.5 mM choline for 16 
h (panel C), 2 mM choline for 16 h (panel D), 5 mM choline for 16 h (panel E), and 10 mM 
choline for 5.5 h (panel F). Enzyme concentrations were 10-20 µM in 20 mM Tris-Cl and 10% 
glycerol, pH 8, at 15 °C.  
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Figure 7.6. Anaerobic reaction of CHO-H310A with choline (2).  
UV-visible absorbance values (•) at 456 nm as a function of time after the anaerobic incubation 
of CHO-H310A with 0.75 mM of choline for 40 h (panel A), 1 mM choline for 16 h (panel B), 
1.5 mM choline for 16 h (panel C), 2 mM choline for 16 h (panel D), 5 mM choline for 16 h 
(panel E), and 10 mM choline for 5.5 h (panel F). The curves are fits of the data to eq 1. 
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Figure 7.7. Anaerobic reaction of CHO-H310A with choline (3).  
Observed rate (•) of the decrease of absorbance at 456 nm as a function of choline concentration 
for CHO-H310A during the fast phase (panel A) and the slow phase (panel B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7.1. Anaerobic Spectral Incubation of CHO-H310A with 
Cholinea   
[Choline], mM 
Fast phase 
kobs, min-1 
Slow phase 
kobs × 103, min-1 
0.75 0.061 ± 0.001 1.0 ± 0.1 
1 0.063 ± 0.001 2.0 ± 0.3 
1.5 0.187 ± 0.002 4.0 ± 0.1 
2 0.35 ± 0.005 7.0 ± 0.2 
5 0.23 ± 0.005 10 ± 0.3 
10 0.26 ± 0.01 11 ± 0.2 
20 0.13 ± 0.005 6.0 ± 0.5 
a Enzyme concentrations were 10-20 µM in 20 mM Tri-Cl and 10 
% glycerol, pH 8, at 15 °C. 
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Discussion 
A proton-transfer network in the active site of choline oxidase. In a recent study in 
which His466 was replaced with alanine, our group showed that His466 is protonated and that, 
besides stabilizing the transient alkoxide species that is formed in catalysis, this protein group 
modulates the electrophilicity of the enzyme-bound flavin and the polarity of the active site 
(species 3 in Scheme 7.2) (10). In another recent study in which His466 was replaced with 
aspartate, our group was able to show that His466, which is located at a distance of ~3.3Å from 
the N(1) locus of the bound FAD, is responsible for stabilizing the negative charge that develops 
in the enzyme  active site (species 3,4, and 5 in Scheme 7.2) (11). The X-ray crystal structure of 
choline oxidase showed that His310 is located at a distance of ~2.9 Å from His466 (His466Nδ1-
His310Nδ1) (Figure 7.2). The X-ray crystal structure of the enzyme along with our previous studies 
on the role of the conserved active site His466 residue suggest the existence of a proton-transfer 
network between the protonated conserved active site residue His466 and His310; the latter residue 
is hydrogen bonded to the carbonyl oxygen atoms of Thr380 and Val507 through its N(3) atom 
(Figure 7.2).    
The preliminary results obtained herein by substituting the active site residue His310 of 
choline oxidase show that the resulting enzyme is completely devoid of any catalytic activity 
with choline as substrate, suggesting that His310 plays an essential role in the active site of 
choline oxidase. As shown in Scheme 7.2, our proposed model of the mechanism of reaction for 
the oxidation of choline catalyzed by choline oxidase in which a proton-transfer network 
between His466 and His310 is proposed can be summarized as follows. 1) During the reductive 
half-reaction, an unidentified active site base with a pKa of 7.5 activates the alcohol substrate 
with formation of an alkoxide species (species 1 and 2 in Scheme 7.2) (4, 5). 2) This alkoxide 
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intermediate is transiently stabilized in the active site through electrostatic interaction with the 
Nε2 atom of the protonated side chain of His466 (species 3 in Scheme 7.2) (10). 3) The protonated 
His466 also stabilizes electrostatically the negative charge that develops at N(1)-C(2)=O locus of 
the reduced flavin (anionic species) through its Nε2 atom  (species 3 in Scheme 7.2) (11). 4) The 
hydride transfer from the α-carbon of the substrate to the N(5) locus of the bound occurs 
quantum mechanically from the activated choline alkoxide species (species 3 in scheme 7.2) (6). 
5) His466 is hydrogen bonded to His310 (His466Nδ1-His310Nδ1); the latter residue is hydrogen bonded 
to the main chain carbonyl oxygen atoms of Thr380 and Val507. The main proposed role of such a 
proton-transfer network is to prevent the protonated His466 from losing its proton during the 
oxidative half-reaction. This proton-transfer network serves to transfer this proton from His466 to 
His310 before the reaction of molecular oxygen. As a result of such proton transfer, the negative 
charge at the N(1)-C(2)=O locus of the anionic hydroquinone is stabilized through hydrogen 
bonding with Nε2 atom of the imidazole side chain of His466  (species 4 in Scheme 7.2). 6) 
During the oxidative half-reaction, and after the transfer of the proton from His466 to His310, the 
electron delocalization from the N(1) locus of the anionic hydroquinone along with the proton 
transfer from an unidentified catalytic base results in the formation of the C(4a)-hydroperoxo-
flavin (species 5 in Scheme 7.2); 7) the highly unstable C(4a)-hydroperoxo-flavin abstracts the 
second proton from the hydride at N(5) locus of the FAD with the subsequent release of H2O2 
and the formation of oxidized enzyme-bound FAD (species 6 and 7 in Scheme 7.2); 8 ) finally, 
the oxidation of the hydrated betaine aldehyde occurs through a base catalyzed transfer of a 
hydride ion from the organic substrate to the enzyme-bound FAD, with a mechanism that is 
similar to that proposed for the oxidation of choline as proposed recently in a  study by our group 
on the mechanism of aldehyde oxidation (13).  
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In summary, the previously obtained results on the CHO-H466A and CHO-H466D 
mutants (10, 11) suggested that His466 plays an important role in the transient stabilization of 
choline alkoxide intermediate,  in stabilization of the negative charge that develops on the N(1)-
C(2)=O locus of the bound flavin, and in modulation of the electrophilicity of the bound FAD 
and the polarity of the active site. The preliminary results obtained herein on the CHO-H310A 
mutant form of choline oxidase suggested that His310 plays an essential role in the active site of 
choline oxidase because its substitution with alanine resulted in a complete loss of its catalytic 
activity toward choline as a substrate.  One would expect that CHO-H310A is completely devoid 
of activity with choline due to the fact that the substitution of His310 with alanine resulted in 
alteration of the position of His466 and in turn resulted in an completely inactive enzyme or at 
least 200,000-time slower than CHO-WT. In addition, the substitution of His310 with alanine 
would disrupt the proposed proton-transfer network between His466 and His310. In that sense, 
further site-directed mutagenesis studies (H310D and H310N) are currently underway in order to 
gain insights into the role played by such a proton-transfer network involving His310 and His466 in 
the reaction catalyzed by choline oxidase. 
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Scheme 7.2. Proposed role of His310 in the reaction catalyzed by choline oxidase. 
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CHAPTER VIII 
General Discussion 
Choline oxidase from Arthrobacter globiformis catalyzes the oxidation of choline to 
glycine betaine (1-3). This reaction is of considerable interest for biotechnological and 
biomedical applications. The biotechnological and biomedical importance come from the 
reaction product glycine betaine, which is one of the most commonly used compatible solutes 
that is accumulated in the cytoplasm of many plants and microorganisms to counteract 
hyperosmotic environments (4). The accumulation of glycine betaine was observed in many 
human pathogenic bacteria, allowing their growth and survival under hyperosmotic conditions 
that are frequently encountered at human infectious sites (5-7). The development of efficient 
specific inhibitors targeting glycine betaine synthetic pathway therefore has potential for the 
microbial treatment. Similarly, in transgenic plants, glycine betaine serves a similar function, 
enabling bioengineering of economically relevant crop plants with enhanced stress resistances 
(8-11). From a chemical standpoint, the oxidation reaction catalyzed by choline oxidase is of 
particular interest in that the cleavage of the substrate CH bond is energetically unfavorable due 
to the high pKa value of the CH group (12). In this study, the biophysical, biochemical, 
structural, and mechanistic properties of wild-type as well as selected mutant forms of choline 
oxidase are presented, providing a solid background for the medical and biotechnological 
applications of choline oxidase. In addition, the results obtained in this study have also shed light 
on other structurally and mechanistically related flavoprotein oxidases. 
The correct nucleotide sequence of the codA gene encoding for choline oxidase was 
established in this study. The codA gene contains large amount of GC (~70%), resulting in 
difficulties in PCR amplification. Addition of 2% of DMSO into the PCR reaction mixture 
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increased the efficiency of denaturation for the double stranded DNA and yielded a full-length 
PCR product. Sequence analysis was performed independently with two forms of the codA gene: 
the cloned codA gene directly from the genomic DNA of A. globiformis strain ATCC 8010; and 
the subcloned codA gene (a gift kindly provided by Dr. Norio Murata, National Institute for 
Basic Biology, Okazaki, Japan), which has been prepared by F. Fan. Similar sequencing results 
were obtained, both of which showed that the previously reported nucleotide sequence of codA 
in GenBank (13) contained seven flaws. These seven flaws resulted in a translated protein with a 
significantly altered amino acid sequence between position 298 and 410. The correct newly 
determined amino acid sequence of choline oxidase corresponds to the mass of the enzyme with 
one linked FAD (60.612 kDa), consistent with the experimental mass spectral determination 
(60.614 kDa). For comparison, the calculation of the incorrect previously reported amino acid 
sequence of the enzyme yields a molecular mass of 59.648 kDa. A significant increase in 
homology between choline oxidase and other members of the GMC oxidoreductase superfamily 
was also observed when the newly reported amino acid sequence was used (Figure 3.4 in 
Chapter III), which further strengthens our sequence analysis. Importantly, the recently solved 
X-ray crystal structure of choline oxidase clearly showed a covalent linkage between the 
His99Nε2 and FADC8M atoms, in contrast to the previously proposed His87Nε1 determined by 
mass spectroscopic studies which was based on the previously reported incorrect amino acid 
sequence of the enzyme (14). The previously reported incorrect nucleotide sequence of A. 
globiformis codA gene was recently replaced with a newer version in the GenBank (accession 
number X84895.2) that is identical to our sequence. 
In this study, our group has established an efficient protocol to express and purify the 
recombinant choline oxidase to high purity and quantity, allowing detailed biochemical and 
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mechanistic studies of this enzyme. The same protocol was also applied to express and purify 
different mutant forms of the enzyme. The cloned codA gene from A. globiformis was expressed 
to high quantity in Escherichia coli strain Rosetta(DE3)pLysS, which provides tRNAs for rare 
codons. The codA gene contains 27 of such rare codons due to its high GC content. The enzyme 
was then purified to homogeneity using 30 to 65% ammonium sulfate followed by anion 
exchange chromatography onto a DEAE-Sepharose Fast Flow column. Typically ~150-200 mg 
pure choline oxidase could be obtained from 4.5 liters liquid LB culture medium (Table 3.2 in 
Chapter III).  
The recombinant choline oxidase as purified was found to contain large amounts of 
anionic flavin semiquinone species (35-85%). At pH 8, enzyme-bound flavosemiquinone 
remains unusually stable when subjected to the treatments with molecular oxygen or oxidizing 
agents such as ferricyanide, suggesting that the unpaired electron resides in a solvent inaccessible 
region of the flavin (Figure 4.1 in Chapter IV). The enzyme-bound semiquinone undergoes a 
slow conversion to the fully oxidized form at pH 6 (Figure 4.4 in Chapter IV), indicating that an 
increase in proton concentration significantly destabilizes the flavin radical. The spectral studies 
of the enzyme under turnover showed only two states, i.e., the fully oxidized and reduced forms, 
indicating that the flavin semiquinone of choline oxidase is catalytically inactive (Figure 4.7 in 
Chapter IV). The kinetic data further support this conclusion by showing a good correlation 
between the turnover numbers of the enzyme with choline and betaine aldehyde as substrate and 
the content of oxidized flavin per active site (Table 4.2 in Chapter IV). The conversion of the 
kinetically inactive inert semiquinone form of flavin to the active oxidized form increases the 
specific activity of the purified enzyme at least by 2-folds. The unusual stabilization of 
flavosemiquinone along with the formation of a tight reversible flavin-N(5)-sulfite adduct in 
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wild-type choline oxidase was explained as a result of the stabilization of the negative charge 
that develops on N(1) locus of the flavin by a protein positive charge close to that region. Such 
protein positive charge was firstly assigned to the dipole of an adjacent α-helix, which is fully 
conserved among the GMC oxidoreductase superfamily (15-19). Our recent studies on the active 
site residue His466 clearly suggest that the protonated form His466 stabilizes the negative charge 
that develops on the N(1) locus of the bound flavin as well as the negative charge of the transient 
alkoxide intermediate during catalysis (Chapter V and VI) (20, 21). Interestingly, the midpoint 
reduction-oxidation potential for the oxidized-semiquinone couple in wild-type choline oxidase 
was 211 mV (Figure 6.8 and Table 6.2 in Chapter VI) (20), which is exceptionally the highest 
value for such thermodynamic equilibrium reported for a flavoprotein oxidase (22-27), consistent 
with the unusual stabilization of flavosemiquinone in choline oxidase. In addition, the mutant 
form of choline oxidase in which the positively charged histidine residue at position 466 was 
reversed (H466D) lost its ability to either stabilizes the semiquinone species of the bound flavin 
or the formation of flavin-N(5)-sulfite adduct, consistent with the proposed role of His466 in 
stabilizing the negative charge that develops on the N(1) locus of the bound FAD. Furthermore, 
the midpoint potential for the transfer of the two electrons with CHO-H466D showed a value 
that was ~130 mV and ~160 mV more negative than the calculated midpoint potentials for the 
corresponding two-electron transfers in CHO-H466A and CHO-WT, respectively (Figure 6.8 
and Table 6.2 in Chapter VI) (20). These data are consistent with a significant effect of the 
amino acid residue at position 466 on the electrophilicity of the enzyme-bound flavin in choline 
oxidase (20). 
Steady state kinetic studies suggested a sequential mechanism with either choline or 
betaine aldehyde as substrate over a pH range of 6.5 to 10. The pH dependence of the kinetic 
  
309
parameters at varying concentrations of both choline and oxygen indicated that a catalytic base 
with a pKa value of 7.5 is required during the reductive-half reaction of both choline and betaine 
aldehyde oxidation. Based on the amino acid sequence alignment comparison of choline oxidase 
with other members of the GMC enzyme superfamily, the fully conserved His466 was firstly 
proposed to be the catalytic base (28). However, pH-dependent studies with H466A showed 
similar pH-dependences although the pKa value is shifted (Figure 5.7 in Chapter V) (21), 
suggesting that His466 might not be the catalytic base. Strong evidence supporting this conclusion 
comes from the pH dependence of the imidazole effect with CHO-H466A, showing that 
imidazolium, but not imidazole, is the catalytically relevant species responsible for the partial 
rescue of the enzymatic activity of the mutant enzyme (Figure 5.6 in Chapter V) (21). These data 
are clearly difficult to reconcile with the assumption that His466 is the catalytic base since, if that 
were the case, maximal rescue of the enzymatic activity of the mutant enzyme would have been 
observed at increasing pH. In this respect, recent structural data showed that the Nε2 atom of the 
equivalent histidine residue in the active site of cholesterol oxidase, His447, is protonated, 
suggesting that this conserved residue in the GMC oxidoreductase superfamily may play a role 
other than acting as a specific base in catalysis (29). In this context, a number of observations 
presented in this study suggest that in choline oxidase His466 contributes to catalysis by 
modulating the electrophilicity of the flavin cofactor (by increasing its reduction-oxidation 
potential) and the polarity of the active site for efficient proton transfer of the hydroxyl proton 
from the alcohol substrate to the active site proton acceptor, and by stabilizing the negative 
charge that is formed in the transition state for the oxidation of choline to betaine aldehyde 
(Chapter V and VI) (20, 21). An alternative hypothesis arises from the observation of the 
recently solved X-ray crystallographic data of choline oxidase, which suggest that His351 may act 
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as the catalytic base. In agreement with that hypothesis, the X-ray crystal structure of choline 
oxidase with its substrate choline docked in the active site showed that His351 is located at a 
distance of ~3.3 Å from the hydroxyl group of choline (Figure 1.27 in Chapter I). However, 
further biochemical and mechanistic characterization on the His351 mutant enzymes is required 
to draw conclusions1.  
His466 is involved in the oxidation of the choline substrate, but not in the following 
reduction of molecular oxygen catalyzed by choline oxidase. Evidence supporting this 
conclusion comes from the steady-state kinetic data with CHO-H466A as compared to those 
with the wild-type enzyme, showing that the kcat/Km value for choline decreases by three orders 
of magnitude whereas that for oxygen is not significantly changed in the mutant enzyme. The 
lack of involvement of His466 in the oxidative half-reaction agrees well with previous kinetic data 
on choline oxidase as a function of pH, showing that no ionizable groups with pKa values 
between 6 and 10 are required for oxidation of the enzyme-bound reduced flavin in catalysis 
(30). 
Recent kinetic and mechanistic studies on the recombinant choline oxidase were carried 
out in our laboratory by Fan F. (31-33). These studies showed that the overall turnover with 
choline is limited by both chemical steps for alcohol and aldehyde oxidations (31). For alcohol 
oxidation, large deuterium isotope effects were observed by both steady state and pre-steady 
state kinetic approaches, indicating that the chemical step for choline oxidation is not masked by 
other steps (31). For aldehyde oxidation with betaine aldehyde as substrate, the kcat (133 s-1 at pH 
                                                 
1 The H351A mutant was constructed and purified in our laboratory. Preliminary kinetic characterization showed a 
~180 fold decrease in kcat/Km value as compared to the wild type enzyme, indicating the important yet not essential 
role of His351 in the catalysis by choline oxidase. In addition, pH-dependence studies with this mutant enzyme 
revealed a pKa value of  ~ 7.8, which may argue against the notion that His351 is the catalytic base. Nonetheless, this 
ongoing study needs to be completed to draw more definitive conclusions (Rungsrisuriyachai, K., and Gadda, G.; 
unpublished data). 
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10) determined by steady state kinetics is similar to kred (135 s-1 at pH 10) determined by pre-
steady state kinetics, suggesting that the chemical step for betaine aldehyde oxidation is also 
rate-limiting (31).  Both chemical steps of flavin reduction are significantly faster in the forward 
direction relative to the reverse direction, as suggested by the stopped-flow analyses of the 
reductive half-reactions with choline and betaine aldehyde (31). Unlike glucose oxidase and 
cholesterol oxidase, for which the chemical steps has been masked by other steps (34, 35), the 
rate-limiting chemical steps in choline oxidase allow an opportunity to unambiguously determine 
the chemical mechanism for catalysis. Primary deuterium and solvent kinetic isotope effects 
have been used to elucidate the mechanism for substrate oxidation by choline oxidase using both 
steady state kinetics and rapid kinetics techniques. The oxidation of choline catalyzed by choline 
oxidase occurs through an asynchronous hydride transfer mechanism, in which the substrate 
hydroxyl proton is abstracted to form an alkoxide intermediate followed by a hydride transfer to 
the flavin (31). An in-depth investigation of the hydride transfer in choline oxidation suggested 
the presence of quantum mechanical tunneling occurring within a highly pre-organized active 
site, through a process in which environmental vibrations (gating) is minimally involved (32). 
Evidence for this conclusion is provided by the temperature dependent studies on the kcat/Km and 
D(kcat/Km) values with choline as substrate (32). The large isotope effect on the preexponential 
factors (AH'/AD') determined from the temperature dependence of the kcat/Km values with choline 
and 1,2-[-2H4]-choline, with a value of ~14, rules out a classical over-the-barrier behavior for 
hydride transfer, for which AH'/AD' values between 0.7 and 1.7 are expected (36). Modeling 
choline into the active site of choline oxidase revealed an orientation of the substrate with its α-
carbon towards the N5 of flavin isoalloxazine ring, consistent with the proposed hydride transfer 
mechanism rather than carbanion mechanism. Although the distance between flavin N5 and α-
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carbon (~3-4 Å), is rather large when compared to the distance of 2.7 Å proposed for tunneling 
by computational calculations (37), this distance is similar to the donor/acceptor distance 
observed in liver alcohol dehydrogenase (~3.4 Å), for which the quantum mechanical tunneling 
is convincingly suggested (38, 39). 
Moreover, the recently solved X-ray crystal structure of choline oxidase at 1.86 Å 
resolution showed dimeric structure (George Lountos, Fan Fan, Giovanni Gadda, and Allen M. 
Orville; unpublished results). The overall structure of monomeric choline oxidase resembles that 
of p-hydroxy-benzoate hydroxylase, and folds into substrate- and flavin-binding domains as 
other GMC enzymes. Structural comparison of the choline oxidase with other members of the 
GMC oxidoreductase superfamily, e.g., cholesterol oxidase (17, 40, 41), glucose oxidase (15, 16, 
42), cellobiose dehydrogenase (19, 43), also revealed a highly conserved catalytic site. These 
structural similarities suggest a similar activation mechanism for the oxidation of their substrates. 
Mechanistic studies on cholesterol oxidase and glucose oxidase had been hampered since the 
chemical steps in these enzymes are masked by other kinetic steps (34, 35).  
The X-ray crystal structure of choline oxidase also showed that His466 is located at 
distance of ~3.3 Å from the N(1) locus of the enzyme-bound flavin, consistent with the proposed 
role of this residue in stabilizing the negative charge that develops on the N(1)-C(2)=O locus of 
the bound flavin (Chapter V and VI). Interestingly, another active site histidine residue, His310, 
was found to be located at a distance of ~2.9 Å from His466 (His466Nδ1-His310Nδ1) (Figure 7.2 in 
Chapter VII). These structural data strongly suggest the presence of a proton-transfer network 
between the protonated conserved active site residue His466 and His310 (Chapter VII).    
In this study, the preliminary results obtained by substituting the active site residue His310 
of choline oxidase with alanine show that the resulting enzyme is completely devoid of any 
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catalytic activity with choline as substrate. These data suggest that His310 plays an essential role 
in the active site of choline oxidase, and consistent with the proposed proton-transfer network 
between the protonated conserved active site residue His466 and His310.  
Overall, as shown in Scheme 8.1, and based on the results obtained from this study along 
with other structural, kinetic, and mechanistic data on wild-type choline oxidase, which have 
been determined by other members of our research group, the proposed mechanism of reaction 
for the oxidation of choline to glycine betaine catalyzed by choline oxidase can be summarized 
as following: 1) during the reductive half-reaction, an unidentified active site base with a pKa of 
7.5 activates the alcohol substrate with formation of an alkoxide species (species 1 and 2 in 
Scheme 8.1) (Chapter IV) (30, 31); 2) this alkoxide intermediate is transiently stabilized in the 
active site through electrostatic interaction with the Nε2 atom of the protonated  side chain of 
His466 (species 3 in Scheme 8.1) (Chapter V) (21); 3) similarly, the protonated His466 also 
stabilizes electrostatically the negative charge that develops at N(1)-C(2)=O locus of the reduced 
flavin (anionic species) through its Nε2 atom (species 3 in Scheme 8.1) (Chapter VI) (20); 4) the 
hydride transfer from the α-carbon of the substrate to the N(5) locus of the bound occurs 
quantum mechanically from the activated choline alkoxide species (species 3 in Scheme 8.1) 
(32); 5) His466 is hydrogen bonded to His310 (His466Nδ1-His310Nδ1) and the latter is hydrogen 
bonded to the main chain carbonyl oxygen atoms of Thr380 and Val507. The main proposed role of 
such proton-transfer network is to prevent the protonated His466 from losing its proton during the 
oxidative half-reaction. Thereby, this proton-transfer network serves to transfer this proton from 
His466 to His310 before the reaction of molecular oxygen. As a result of such proton transfer, the 
negative charge at the N(1)-C(2)=O locus of the anionic hydroquinone turned to be stabilized 
through hydrogen bonding with Nε2 atom of the imidazole side chain of His466  (species 4 in 
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Scheme 8.1) (Chapter VII); 6) during the oxidative half-reaction, and after the transfer of the 
proton from His466 to His310, the electron delocalization form the N(1) locus of the anionic 
hydroquinone along with the proton transfer from the unidentified catalytic base result in the 
formation of the C(4a)-hydroperoxo-flavin (species 5 in Scheme 8.1); 7) the highly unstable 
C(4a)-hydroperoxo-flavin abstracts the second proton from the hydride at N(5) locus of the FAD 
with the subsequent release of H2O2 and the formation of oxidized enzyme-bound FAD (species 
6 and 7 in Scheme 8.1); 8 ) finally, the oxidation of the hydrated betaine aldehyde occurs through 
a base catalyzed transfer of a hydride ion from the organic substrate to the enzyme-bound FAD, 
with a mechanism that is similar to that proposed for the oxidation of choline as proposed 
recently in a  study by our group on the mechanism of aldehyde oxidation (33).  
 In summary, the results obtained herein from the biochemical, biophysical, and 
mechanistic characterization of a choline oxidase variants in which the protein charge near the 
flavin N(1) locus was removed or reversed by site-directed mutagenesis suggest that in wild-type 
choline oxidase His466  plays important role in: 1) the transient stabilization of choline alkoxide 
intermediate during the oxidation of choline to betaine aldehyde; 2) stabilization of the negative 
charge that develops on the N(1)-C(2)=O locus of the bound flavin; 3) modulation of the 
electrophilicity of the bound FAD for efficient catalysis by increasing its reduction-oxidation 
potential; 4) the covalent attachment of the FAD cofactor to the protein moiety for efficient 
catalysis; 5) modulation of the polarity of the active site for efficient proton transfer of the 
hydroxyl proton from the alcohol substrate to the active site proton acceptor. In addition the 
results obtained in this study also suggest that His310 plays an essential role in the active site of 
choline oxidase and point out the possibility of its involvement in a proton-transfer network with 
His466. Interestingly, the present study on the biochemical and the mechanistic properties of wild-
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type choline oxidase along with its active site mutants can shed light on other functionally and 
structurally related flavoprotein oxidases. In addition, this study will also provide a foundation 
for future rational design of efficient transition state analogs and inhibitors that could be used for 
the development of therapeutic agents that inhibit the formation of glycine betaine, and in turn 
render pathogenic bacteria susceptible to conventional treatments. 
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